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Abstract 
Background:  Cerebral palsy (CP) is defined as a group of disorders of the development of 
movement and posture, causing activity limitations. Despite the known benefits of 
engaging in regular physical activity, children with cerebral palsy (CP) are less physically 
active than their typically developing peers. Active video games are gaining attention as a 
means of increasing physical activity in children with CP. ‘Move it to improve it’ or Mitii™ is 
a novel web-based multi-modal training program comprising upper-limb and visual 
perceptual training within the context of physical activity which uses virtual therapists to 
deliver an individualised therapy program. Should Mitii™ be effective in increasing physical 
activity it has the potential to reduce secondary health complications associated with 
physical inactivity. 
Aim:  The primary aim of this doctoral program was to test  the efficacy of Mitii™ to 
increase physical activity capacity and performance in independently ambulant children 
and adolescents with unilateral CP. Additional aims were to: i) determine the efficacy of 
virtual reality technologies to increase physical activity; ii) determine the clinimetric 
properties of measures of habitual physical activity; and iii) describe patterns of physical 
activity and characteristics associated with physical activity, in independently ambulant 
children and adolescents with CP.   
Research design and methodology:  A matched pairs, waitlist controlled randomised trial 
was chosen to assess Mitii™ in independently ambulant children and adolescents aged 
eight to 17 years with unilateral CP. Participants (n=102) were allocated to receive 20 
weeks of 6 days per week Mitii™ training (potential total dose 60 hours) immediately, or 
waitlisted receiving usual care. Outcomes were assessed at baseline and post-intervention 
(20 weeks).  Physical activity capacity was recorded using functional strength (a series of 
maximal repetition exercises) and walking endurance (six-minute walk test); physical 
activity performance was recorded using ActiGraph® tri-axial accelerometers. Secondary 
outcomes were mobility limitations (Mobility Questionnaire 28) and recreational 
participation (recreation domain of the Assessment of Life Habits).  
Results:  Two systematic reviews were performed prior to commencement of the 
randomised trial.  The first investigated the effect of virtual reality interventions to increase 
physical activity in children with CP. Included studies were of low methodological quality 
meaning few conclusions were able to be drawn, though there appeared to be a positive 
effect of virtual reality training. The second described the clinimetric properties of 
measures of physical activity in primary school aged children with CP. Accelerometers 
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were found to be the most valid and clinically useful tool to measure physical activity 
however, evidence for their reliability in children with CP was lacking. This led to a study 
examining the reliability of measuring physical activity in children with unilateral CP using 
accelerometers. Conclusions reached from this study were that three days of monitoring 
was required to produce reliable estimates (>0.7) of moderate to vigorous physical activity 
(MVPA) and agreement between repeated measures was good for light and MVPA (intra-
class correlation coefficient [ICC]=0.80). In combination with the systematic review, this 
study confirmed that accelerometers would be used to objectively measure physical 
activity performance over four days in the Mitii™ randomised trial. 
Analysis of cross sectional data collected during baseline assessments for the randomised 
trial found that independently ambulant children with unilateral CP performed insufficient 
MVPA to meet national recommendations of 60 minutes daily, recording on average 
0:44hrs per day. Characteristics associated with physical activity performance were age 
and sex, with younger children and males recording more physical activity than 
adolescents and females. Increased walking endurance and the frequency of participation 
in home and community environments (measured using the Participation and Environment 
Measure for Children and Youth) were significantly associated with increased physical 
activity. These findings suggest that physical inactivity is a problem in children with 
unilateral CP and that an intervention targeting an increase in physical activity capacity 
and/or participation could result in improved levels of physical activity. 
The randomised trial found a significant difference favouring the intervention group at 20 
weeks on assessment of functional strength and walking endurance, but not physical 
activity performance, recreational participation or mobility limitations. The response for 
walking endurance was dose dependent, indicating a positive training effect. 
Conclusions:  Delivering training using the web-based program Mitii™ and virtual trainers 
was effective at increasing physical activity capacity assessed using functional strength 
and walking endurance in independently ambulant children with unilateral CP. 
Improvements in physical activity capacity did not translate into improvements in physical 
activity performance or reduce inactivity. This reinforces the view that physical activity 
capacity and performance represent separate constructs requiring different treatment 
approaches. Mitii™ may have a role in increasing physical activity in children with CP; 
however may need to be considered in the context of multi-dimensional interventions 
which incorporate behavioural change strategies to overcome the barriers associated with 
participating in increased physical activity.  
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Chapter 1. Introduction, thesis outline and aims 
1.1 Introduction 
1.1.1 Background for cerebral palsy 
Cerebral Palsy (CP) is defined as a group of disorders of the development of movement 
and posture, causing activity limitations, which are attributed to non-progressive 
disturbances that occurred in the developing foetal or infant brain.1 Motor disorders of CP 
are often accompanied by disturbances of sensation, cognition, perception, behaviour, 
and/or seizure disorders, and by secondary musculoskeletal problems.1 In Australia, 
around 600-700 infants are born with CP each year, or 2-2.5 cases per 1,000 live births, 
making CP is the most common physical disability in childhood.2 This rate has remained 
fairly stable over the last 60 years despite advances in maternal and neonatal care. In 
2007, there were 33,797 Australians estimated to have CP, and this number is expected to 
increase over time as the population increases.3 There remains no cure for CP, meaning 
that an infant born with this condition will require a lifetime of investigations, interventions 
and equipment. In 2007, CP was estimated to cost AUD$1.47 billion (0.14% of GDP) per 
annum, equating to a per capita financial burden of AUD$43,431 per person with CP per 
annum, of which 43% of these costs are born by individuals with CP and their families.3 
Cerebral palsy is not only a costly but burdensome disease, impacting the individual, 
his/her family and society more generally. These findings highlight the importance of 
optimising health, function and fitness of individuals with CP to keep costs associated with 
the condition to a minimum. 
A model in which to consider the condition of CP is that conceptualised by the World 
Health Organisation (WHO) in the International Classification of Functioning, Disability and 
Health (ICF).4 The ICF focuses on components that make up health, including the 
interactive relationship between health conditions and contextual factors that contribute to 
wellbeing, rather than looking simply at physical, sensory, cognitive, and behavioural 
manifestations of a condition.5 Activity and participation are identified as important 
components of health in the ICF, along with environmental and personal factors (Figure 
1.1).  
2 
 
 
Figure 1-1 International Classification of Functioning, Disability and Health (ICF) model  
When considering CP at the health condition level of the ICF model, spasticity is the most 
common type of motor impairment, present in 86.6% of all people with CP.6 Spasticity 
describes muscle hypertonia characterised by resistance to passive stretch that provides 
minimal initial resistance followed by an incremental increase in muscle tone, proportional 
to the velocity of the stretch, and usually associated with increased deep tendon reflexes 
and muscle weakness.7 Spasticity is most commonly distributed unilaterally (hemiplegia; 
38.8%), however may be distributed bilaterally (diplegia; 37.5%) or less frequently, across 
all four limbs (quadriplegia; 20.9%).6 For the purposes of this doctoral thesis, the terms 
congenital hemiplegia and unilateral CP will be used interchangeably to describe children 
and adolescents with spastic hemiplegia.  Classification of CP using topographic pattern 
and type of motor impairment has demonstrated poor reliability.8 Classification systems 
which ascertain movement and function provide a more clinically relevant method by which 
to consider CP. 
The Gross Motor Function Classification System (GMFCS) for children aged 2-12 years, 
and the GMFCS Expanded and Revised for adolescents aged 12-18 years, are methods 
used for the classification of gross motor function in individuals with CP (Table 1.1).9 The 
GMFCS is a five-level ordinal grading system based on the assessment of self-initiated 
movement during sitting, standing and walking. Distinction between GMFCS levels is 
based on limitations in function, quality of movement and the use of assistive equipment. 
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In contrast to type and distribution of motor impairment, the GMFCS has been shown to be 
a valid and reliable method for classifying gross motor function in children with CP.9-11 
Upper limb use and function also varies considerably in children with CP. Performance of 
upper limb function can be classified using the Manual Ability Classification System 
(MACS).12 This is a valid and reliable tool that classifies how children with CP use their 
hands when manipulating objects in daily activities, such as eating, dressing or during 
play. The rating of children’s function on the MACS and GMFCS are highly correlated 
(r=0.79).12 Together, the GMFCS and MACS provide valid and reliable methods whereby 
the severity of CP can be described.  
Table 1.1. Gross Motor Function Classification System (GMFCS) levels, for children aged 6–12 years 
GMFCS level I. Children walk indoors and outdoors, and climb stairs without limitation. Children 
perform gross motor skills including running and jumping but speed, balance and coordination are 
impaired. 
GMFCS level II. Children walk indoors and outdoors, and climb stairs holding onto a railing but 
experience limitations walking on uneven surfaces and inclines and walking in crowds or confined 
spaces. Children have at best only minimal ability to perform gross motor skills such as running and 
jumping. 
GMFCS level III. Children walk indoors or outdoors on a level surface with an assistive mobility 
device. Children may climb stairs holding onto a railing. Children may propel a wheelchair manually or 
are transported when travelling for long distances or outdoors on uneven terrain.  
GMFCS level IV. Children may continue to walk for short distances on a walker or rely more on 
wheeled mobility at home, school and in the community. Children may achieve self-mobility using a 
power wheelchair.  
GMFCS level V. Physical impairments restrict voluntary control of movement and the ability to 
maintain antigravity head and trunk postures. All areas of motor function are limited. Children have no 
means of independent mobility and are transported.  
 
1.1.2 Understanding habitual physical activity 
Participation in regular physical activity is an important determinant of physical, mental and 
social health in children and adolescents. Benefits can be seen in the development and 
maintenance of bone, muscle and joint health, in body composition and weight control, and 
in increasing cardio-respiratory fitness and cognitive performance.13 Promotion of physical 
activity in children and adolescents with a disability should form an integral part of 
management to optimise and promote life-long health. Physical activity is defined as any 
body movement using skeletal muscles that results in energy expenditure.14 Using this 
definition, physical activity includes all gross and minor body movements, including 
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postural adjustments, incidental activity and activities of daily living.15 Physical activity can 
also include exercise, which is volitional, planned, structured, and repetitive with the aim of 
improving fitness or health; or sport, which involves structured often competitive physical 
activity governed by rules.15  According to the ICF framework, it is important to distinguish 
between an individual’s ‘capacity’, which describes the ability of a person to undertake 
physical activity (what they can perform at their best in a standardised controlled 
environment, for example, the shuttle walk test), versus their ‘performance’, (how they 
actually perform in the real world, for example, walking done in a typical day).4, 16 Physical 
activity performance therefore can be defined as habitual activity undertaken by a person 
as part of their regular daily life. When investigating physical activity, it is necessary to 
consider both capacity and performance. A child or adolescent may be able to perform 
well in an experimental setting, but how they translate this ability into daily life is arguably 
more important for participation and long term health and wellbeing. Physical activity 
capacity, including muscle strength and fitness are likely to be contributors to activities of 
daily living and physical activity, and conversely increased levels of physical activity are 
likely to result in increased muscle strength and fitness. As an example, if a child with CP 
does not have sufficient muscular strength in lower limb muscles or aerobic fitness, 
prolonged walking or walking up and down stairs may be limited. It is therefore also 
important to assess an individual’s capacity for exercise as well as performance in daily 
life.  
1.1.3 Measurement of physical activity capacity and performance 
Physical fitness assessments in children with CP have been examined using a Delphi 
survey of experts in the field.17 For GMFCS levels I and II, the six-minute walk test (6MWT) 
was suggested for sub-maximal assessment, and the 10m shuttle run test (SRT) was 
recommended for maximal aerobic exercise testing. The 6MWT is a simple, sub-maximal 
clinical exercise test which measures the distance walked under controlled conditions over 
six minutes. The 6MWT has excellent test-retest reliability (intra-class correlation 
coefficient [ICC]=0.98) in independently ambulant adolescents with CP.18 Percentile 
curves for the 6MWT have been created, though these were from 1,445 typically 
developing Chinese children aged 7-16 years.19 No reference curves for children and 
adolescents with CP exist. The 10-metre SRT is an adapted version of the 20-metre 
shuttle run test to accommodate children with CP classified at GMFCS level I or level II.20 
The 10m shuttle run test has been demonstrated to be valid (correlation to treadmill test: 
r= 0.96), reliable (SRT-I: ICCexercise time=0.97; ICCpeakHR= 0.87; SRT-II: ICCexercise time=0.99; 
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ICCpeakHR=0.94), and sensitive to change in children with CP.
20, 21 Height related reference 
percentile curves have been created through the testing of 306 children and adolescents 
(6-20 years) with CP (GMFCS I and II)22, providing accurate classification of maximal 
aerobic fitness specific to this population. 
There are many different methods to assess muscle strength and endurance. Isometric 
based muscle tests measure the ability of a muscle group to generate force in an open-
chain position without a change in muscle-tendon length.23 Typically, in clinical practice, 
this is assessed by manual muscle testing (using an ordinal scale), or with hand-held 
dynamometry. The inter-tester reliability of isometric strength testing using hand-held 
dynamometers in children with CP  is limited, with ICC values ranging from 0.42 – 0.82 
depending on the lower-limb muscle tested, and with large coefficient of variation (CV) 
values (22.2%-58.9%).23  If the contexts in which these tests are used are considered, 
typically interventions targeting an increase in physical activity capacity do not train 
isometric, open chain, isolated muscles of the lower limb in children with CP. In 
combination with evidence supporting exercise-type specificity, which suggests that the 
greatest training effects occur when the same exercise type is used for both testing and 
training24, isometric muscle strength testing does not  seem a particularly useful measure 
to evaluate physical activity capacity in children with CP. In contrast, dynamic closed-
chain, functional muscle strength tests record the maximum number of repetitions 
performed during a 30-second time period of a functional movement, for example sit to 
stand or step ups. Acceptable inter-tester reliability has been demonstrated for functional 
strength testing  in children with CP, with ICC values 0.91–0.96 and CV 1.1–39.9%.23 
These tests may represent a useful method to assess the response to functional based 
strength training in children with CP. 
Measurement of physical activity performance comprises four dimensions: frequency (how 
often a person does an activity); duration (how long a person does an activity in any one 
session); intensity (how hard a person works to do the activity); and mode (the type of 
activity the person performs).25 To adequately capture the volume of habitual physical 
activity, measures should document these elements over a number of days in free-living 
environments. This can be measured using subjective or objective methods. Subjective 
measures employ self or proxy (usually parent or teacher) report using questionnaires, 
diaries or logs, which recall physical activity performed over a specified number of days.26 
Objective measures of physical activity include direct observation, heart-rate monitors, 
accelerometers and pedometers.26 Two systematic reviews on this topic have been 
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published. One looked specifically at instruments which measure physical activity 
performance in adolescents.27 The other included children aged 0-18 with CP, but did not 
identify accelerometers or heart-rate monitors as tools used in the measurement of 
physical activity.28 It has been noted that physical activity was not clearly defined in this 
review and as a result the instruments selected do not relate specifically to physical activity 
performance.29 Further research is required to establish the most valid and reliable method 
to record physical activity performance in primary school aged children and adolescents 
with CP.  
1.1.4 Physical activity in children and adolescents with cerebral palsy 
Historically, children with CP were discouraged from engaging in fitness or strength 
training programs for fear of increasing muscle spasticity.30 Recent evidence, however, 
shows that strength or fitness training or participation in physical activity does not have 
adverse effects on spasticity or movement patterns, and should in fact be promoted in this 
population.30, 31 
Children with CP usually have poor aerobic and anaerobic cardiovascular fitness32, 33 and 
muscle strength34, 35 compared to typically developing children, often impacting on walking 
ability.36 This is thought to be due to both the primary impairments of CP (e.g. muscle 
biology and strength) and from the resulting secondary musculoskeletal impairments 
associated with CP (e.g. contractures and movement limitations).37 If physical activity is 
considered within the ICF framework, reduced cardiovascular fitness and muscle strength 
can be described at the body structure and function level. In the activity domain, motor 
impairments cause limitations to walking, running or balance, resulting in reduced physical 
activity. Consequently, reduced participation during daily activities or recreation may be 
demonstrated. This in turn can then lead to de-conditioning, further weakening muscles 
and reducing cardiovascular endurance, contributing a cycle of decreasing activity and 
participation in physical activity.37  
The WHO encourages promotion of physical activity in people with disabilities, stating 
sufficient opportunities, support and adaption of tasks should be provided to maximise 
participation.13 Physical activity in early years is particularly critical as patterns of physical 
activity acquired during childhood are more likely to be maintained, providing the 
foundation for healthy lifestyle choices in adult life.13 The current national guidelines 
suggest all children and adolescents, including those with disabilities, should engage in at 
least 60 minutes of moderate or vigorous physical activity every day, limit sedentary 
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screen time to less than two hours, and break up long periods of sitting as often as 
possible.38-40 The health benefits seen in typically developing children are equally pertinent 
to persons with disabilities. Engagement in sport and physical activity is linked to greater 
social interaction, community engagement and self confidence.41 There is some 
suggestion that additional benefits may also be afforded to persons with CP. These 
include the maintenance of physical function 42, and reduced incidence of chronic pain, 
fatigue and osteoporosis.43 Promotion of physical activity should form an integral part of 
management of the child or adolescent with CP to optimise and promote life-long health.  
Despite the known benefits of engaging in regular physical activity, people with CP 
participate in significantly less physically activity than typically developing peers44 or 
children with other physical disabilities.45 Physical activity levels have been studied in 
Dutch adolescents with CP in a cross-sectional sample (n=72), who were found to be 
insufficiently physically active, with 89% of the sample not meeting the recommended level 
of moderate intensity physical activity each day. 46 While participation in sporting activities 
was high (78%), only 46% of adolescents reported participating for 2 or more hours per 
week. In a similar study from the same research centre, young children with CP (5-7 
years) were also found to be less active than typically developing children (mean hrs/week 
[standard deviation (SD)]: CP=3.4 [SD1.9], typically developing children=5.8 [SD 2.3], 
p<0.001).47 Only 7% of children with CP performed physical activity at a sufficient level to 
meet the recommended guidelines and 79% of their reported hobbies were physically 
inactive.47 In Sweden, self-reported participation in sports was significantly lower (p=0.01) 
in adolescents with CP (n=64) than adolescents without disabilities (n=143), with 19% of 
those with CP reporting that they were never or seldom physically active (compared to 8% 
in control group).48  
These studies have utilised parental or self-report questionnaires to quantify time spent 
engaging in sports and physical activity. Parental report is dependent on accurate 
observation and recall of their child’s physical activity levels over a defined period of time; 
therefore this method of reporting is likely to bias results and has been shown to over-
estimate physical activity.49 While formal structured activities may be accurately captured 
using this method, incidental or unstructured physical activity may be missed, particularly 
as children typically engage in very short bursts of intensive physical activity interspersed 
with varying intervals of low to moderate activity.50 Further testing of the validity and 
reliability of these subjective questionnaires for children with CP is required. More recently 
studies have objectively measured physical activity in children with CP. Ambulatory 
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physical activity was compared between American youths (aged 10-13 years) with CP 
(n=81) and typically developing children (n=30) using the StepWatch™ monitor (Orthocare 
Innovations, WA, USA)51 recording daily step counts over 7-days and self-reported activity 
time and physical activity intensity.52 In this study, youth with CP reported lower levels of 
activity than typically developing children, and recorded only 8,400 steps compared to 
13,400 steps per day in typically developing children.52 Physical activity in ambulatory 
adolescents with CP (aged 7-13 years, n=62) has also been measured using the 
StepWatch™, recording more steps on school days (5169 [SD 1641]; total steps=10,338) 
than weekends (4158 [SD 20418]; total steps=8316; p<0.001).53 Step counts for optimal 
weight independent of dietary factors have been established in typically developing 
children aged 6-12yrs, with the recommendation that girls undertake 12,000 steps and 
boys 15,000 steps per day,54 but recommended counts for children with CP have not been 
established.  Further research is needed to establish whether increasing steps walked per 
day is an appropriate goal for children with CP, or whether low impact options (such as 
cycling or swimming) may be more appropriate considering the neuromuscular and 
musculoskeletal impairments associated with CP. 55   
Recently, there has been interest in quantifying sedentary time in children with CP.37 
Increasing evidence details the negative effects that prolonged inactivity has on 
cardiovascular and metabolic systems which appear to be independent of the amount of 
exercise a person undertakes.56, 57 Sedentary time is therefore an important construct to 
measure in addition to physical activity. A study of Australian adolescents with CP using 
the Physical Activity Questionnaire for Adolescents (PAQ-A) revealed that adolescents 
with CP were less physically active than typically developing children (from a normative 
dataset), that children with CP tended to participate in physical activities which were less 
structured and of lower intensity than non-disabled adolescents.58 Despite this, children 
with CP and typically developing children reported similar amounts of sedentary activity 
(such as televison and computer use).58 Children with CP are also reported to spend more 
time sitting, and are therefore more inactive than their typically developing peers when 
measured using an Uptimer.59 Finally, adolescents and young adults with bilateral CP 
classified at GMFCS levels II-IV have demonstrated reduced walking and increased 
sedentary duration with increasing GMFCS level measured using an ActivPAL3 
accelerometer (PAL Technologies Ltd., Glasgow UK).60 These findings confirm that 
physical inactivity is an important construct to measure when considering the impacts of 
inactivity on health. 
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1.1.5 Factors contributing to physical activity 
Participation is defined as the nature and extent of a person’s involvement in life situations, 
such as mobility, social relationships, home life, or education.4 A model categorising the 
factors which influence children’s participation in leisure and recreational activities, 
including physical activity, has been developed .61 Similar to the ICF, it recognises that 
factors from the child, their family and their environment have a direct and indirect 
influence on participation. Factors found to influence children with disabilities’ participation 
in sports and physical recreation were functional limitations, costs, lack of nearby facilities, 
and lack of suitable programs or equipment.61 Participation was also influenced by 
available time, positive modelling within the home environment, perceived self-
competence, and the social support from family, school and the community.61 Transport 
difficulties, physical access difficulties, and social exclusion have also been cited as 
barriers to participation in leisure and physical activity.62-64 These findings suggest that 
environment, family and peer factors are significant determinants in physical activity 
participation, not just the characteristics of the children themselves. Participation in 
physical activity should be encouraged by tailoring programs to the individual 
characteristics, as well as supporting their environment and family.65 Home based 
programs may offer a potential solution to overcome some barriers however research is 
required to understand the social, personal, and environmental factors which influence 
participation in physical activity and treatment response in children with CP.  
1.1.6 Interventions to increase physical activity in children with cerebral palsy 
Systematic review and meta-analyses have been inconclusive about the effects of 
progressive resistance training in children with CP 66, and so far there has been limited 
translation into walking ability.67 A systematic review of exercise programs (consisting of 
cardiovascular fitness and/or lower limb muscle strength training) in children with CP 
yielded twenty studies of limited methodological quality which suggested that muscle 
strength and aerobic capacity can be increased following intervention.68 Previous research 
has been criticized for a discrepancy between the training mode and the instrument 
employed within a study to measure an effect perhaps explaining inconclusive results thus 
far. 68 Additionally, interventions have typically been evaluated against measures at the 
ICF body structure and function level, with physical activity performance or participation 
rarely examined.68 These findings reinforce the need to not only assess physical activity 
capacity following exercise programs, but also determine if this translates across the ICF4 
into increased physical activity performance.68  
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While it is acknowledged that children and adolescents with CP need to increase physical 
activity levels, there is limited evidence to guide intervention choice. For children with CP, 
there is one systematic review evaluating interventions to increase physical activity.69 This 
comprehensive review identified only five studies (three randomised controlled trials, one 
pre-post and two qualitative studies) which assessed habitual physical activity following an 
intervention, noting a small but significant effect supporting interventions (effect size=1.0; 
95% confidence interval 0.28 to 1.72).69 While promising, this pooled-effect should be 
cautiously interpreted as the two interventions pooled for meta-analysis were very different 
(6 weeks of twice weekly closed-chain circuit training compared to 9 months of aerobic 
training four times a week) and assessed using measures which were difficult to compare 
(time spent in an upright position compared to total energy expenditure). Despite these 
limitations, this review provides preliminary evidence that structured exercise programs 
(either group or individual) and online educational support programs can increase physical 
activity in people with CP but further research is required to support this claim.  
One potential approach to increasing physical activity is through virtual reality and active 
video games systems that use whole body movements and standing positions during 
game play. There is preliminary data to confirm this in persons with CP. Energy 
expenditure whilst playing Nintendo® Wii™ Sports tennis and boxing for 15 minutes was 
calculated in a convenience sample of eight adults with bilateral spastic CP (GMFCS I-
II).70 Both games were found to provide moderate-intensity exercise, with mean energy 
expenditure being 4.5 (SD 1.1) Metabolic Equivalents (METs) for tennis and 5.0 (SD 1.1) 
METs for boxing. 70 Whilst these were adults with spastic diplegia, and therefore likely to 
have greater energy expenditure during standing game play, these results suggest active 
video games have a similar ability to increase energy expenditure in persons with CP as 
seen in typically developing children. Active video games represent an exciting opportunity 
to deliver home-based rehabilitation to improve physical function or reducing activity 
limitations71, while seemingly increasing physical activity.  
Research has explored the properties thought to be the ‘active ingredients’ of virtual reality 
interventions to improve motor outcomes and found that the game properties (allowing 
opportunities for repeated practice of tasks similar to that in the real work, feedback and 
individualisation of a task, and social interaction), user effects (positive effects on 
neuroplasticity, problem solving and motivation), and the ability to use the therapist as a 
support person are necessary components.72 A qualitative review of parents perceptions 
following home-training with the Playstation2 confirms many of these, with parents 
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suggesting that the virtual reality medium facilitated a positive experience and promoted 
more independent physical training, however there was a need identified for games to be 
tailored to the child’s abilities and for technology refinements.73 Future technologies should 
include these properties where possible to encourage success. 
1.1.7 Move it to improve it (Mitii™)  
Move it to improve it or Mitii™ is an internet based multi-modal training program 
comprising upper-limb and visual perceptual training within the context of meaningful 
physical activity. Mitii™ detects bodily movements using a green tracking band worn on 
the hand or head which is tracked by a web-camera attached to an internet connected 
computer. Mitii™ requires no specialist or costly equipment and can be delivered in the 
client’s home. A multidisciplinary team consisting of physiotherapists, occupational 
therapists and neuropsychologists act as virtual trainers remotely accessing the program 
to set up a series of activities via the program’s ‘cockpit’. This series is adjusted by the 
virtual trainers regularly to deliver an incrementally challenging and individualised program. 
Mitii™ therefore contains many of the above mentioned ‘active ingredients’ of therapy72, 
potentially overcoming the shortcomings found with other active video games.  
The feasibility of delivering Mitii™ has been confirmed in a pilot study of nine children with 
CP achieving on average 35 minutes of training daily for 20 weeks.74 Compliance was 
high, with an average of 85% of children meeting or exceeding this dose. In a pre-post 
design, children made significant gains in functional strength, cardiovascular endurance, 
motor and processing skills, and a range of visual perceptual skills. Improvements in 
physical activity capacity following the intervention are further described in Chapter 2. 
These results need to be confirmed using in a larger study with a strong design 
methodology. It would also be important to note whether improvements in physical activity 
capacity and functional abilities translate into increased physical activity performance. 
Mitii™ has the potential to deliver novel, intensive, and potentially cost-effective therapy 
remotely in the participants’ own homes using simple cheap equipment. Should Mitii™ be 
effective in increasing physical activity performance it has the potential to reduce 
secondary health complications associated with physical inactivity.   
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1.2 Thesis outline 
The literature review remains inconclusive whether active video games, specifically the 
new web-based intervention Move it to improve it or ‘Mitii™’, are able to increase physical 
activity capacity and performance in children and adolescents with unilateral CP.  
This doctoral program: 
i) Determines the efficacy of active video games to increase physical capacity and 
performance in children and adolescents with CP 
ii) Determines the clinimetric properties of measures of physical activity for children with 
CP 
iii) Describes patterns and characteristics associated with physical activity in 
independently ambulant children and adolescents with CP 
iv) Tests the efficacy of Mitii™ to increase physical activity capacity and performance in 
independently ambulant children and adolescents with unilateral CP. This is 
embedded in a larger clinical trial entitled “Mitii™: a randomised trial of novel web-
based upper limb intervention for congenital hemiplegia” funded by the “eBRAIN” 
program by a Queensland State Government, the Merchant Charitable Foundation, 
the Foundation for Children, and Perpetual Trustees. 
1.3 Objectives and hypotheses 
The overall aim is to determine if the web-based training program, Mitii™, can improve 
physical activity capacity and performance in independently ambulant children and 
adolescents with unilateral CP.  
Secondary objectives: 
i) To systematically review evidence on the ability of active video games to increase 
physical activity  
ii) To systematically review the clinimetric properties of measures of physical activity 
performance in primary school aged children with CP 
iii) To establish the variability of measurement performance and the test-retest reliability 
of accelerometers in controlled and free-living environments 
iv) To objectively measure the performance of physical activity 
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v) To measure the extent which physical, personal and environmental characteristics are 
associated with physical activity performance; in independently ambulant children and 
adolescents with CP. 
1.3.1 Primary objective: To evaluate the effects of Mitii™ on physical activity 
Primary objective: To compare Mitii™ to usual care at improving physical activity 
capacity and performance in a waitlist-control randomised trial. 
Hypothesis: Physical activity capacity (functional strength and 6MWT) and performance 
will increase significantly in independently ambulant children and adolescents with 
unilateral CP immediately following the Mitii™ training (20 weeks) compared to standard 
care. In addition, there will be significant improvements in mobility limitations 
(MobQues28), and recreational participation (LIFE-H). 
Rationale: Evidence in typically developing children suggests that physical activity 
capacity and performance can be increased following ‘active gaming’ or internet based 
treatments. It is expected that children with mild to moderate CP are likely to respond in a 
similar manner.  
Methods: Children and adolescents aged 8-18 years will be matched (according to age, 
gender and upper-limb functions [MACS]) and randomised in pairs to a waitlist controlled 
randomised trial of Mitii™ against usual care. Measures of physical activity capacity and 
performance, mobility limitations, and recreational participation will be administered at 
baseline and 20 weeks, and compared between groups (intervention or waitlist control). 
The primary objective is supported by the following secondary objectives: 
1.3.2 Objective 1: Review the evidence for active video games 
Hypothesis: There will be emerging evidence that active video games can increase 
physical activity capacity and performance in children with CP or early brain injuries. 
Rationale: Virtual reality as an intervention for children with CP is relatively new and 
research is rapidly evolving. The effect of active video game training on physical activity in 
children with CP has not been established. 
Method: Databases will be systematically searched for relevant literature using the 
following keywords: ‘Cerebral Palsy’ or ‘brain injury’, ‘physical activity’ and ‘virtual reality’.  
Studies were included if they met the following selection criteria: i) >80% of the total 
sample included children and adolescents (aged 6-18yrs) with a diagnosis of CP, ABI or 
TBI; ii) measured physical activity capacity and/or performance; iii) the intervention was 
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provided through virtual reality medium. The Downs and Black scale will be utilised to 
assess the methodological quality of studies (Downs and Black, 1998). A version of 
Cohen’s d will be used to calculate effect size. 
1.3.3 Objective 2: Review measures of habitual physical activity 
Hypothesis: The evidence of the validity or reliability of measures of physical activity 
performance in children aged 6-12 years with CP will be of limited methodological quality 
and not specific to this population. 
Rationale: While systematic reviews of evidence have been published in this area, there is 
limited evidence to support the validity and reliability of these instruments in primary school 
age children with CP.  
Methods: Databases will be systematically searched using the terms ‘cerebral palsy’, 
‘physical activity performance’, ‘measure*’ and ‘psychometrics’. Studies which assess 
physical activity over >1 day in a free-living situation, contain at least 60% of items relating 
to the domain of physical activity performance, and have evidence of validity, reliability or 
clinical utility in children aged 6-12 years with CP will be included. The quality of included 
measures will be appraised using the COSMIN checklist. 
1.3.4 Objective 3: Establish the reliability of accelerometers 
Hypothesis: Accelerometers will demonstrate good to excellent reliability in independently 
ambulant children and adolescents with unilateral CP. 
Rationale: Accelerometers are commonly used to assess physical activity in children and 
adolescents with typical development, however there is no evidence of their reliability in 
children with CP.  
Method: Performance variability will be established by the collection of four days of 
accelerometer records within the community. Activity counts will be converted into activity 
intensity using validated uni-axial derived cut points to classify the time spent in MVPA. 
Reliability of repeated measurement will be established by repeating a standardised 
movement protocol over two consecutive days whilst wearing an ActiGraph® 
accelerometer. Participants will initially rest for a 5 minute period to ensure accelerometer 
counts register as resting, and will then conduct 5 minutes each of selected activities: light 
(slow walking), moderate (comfortable walking) and vigorous (fast walking; and stepping 
on and off a block as fast as possible) interspersed with 5 minute rests. Heart rate will be 
15 
 
recorded concurrently to confirm exercise intensity, combined with direct observation of 
the tasks. 
1.3.5  Objective 4: Objectively measure physical activity performance 
Hypothesis: Independently ambulant children and adolescents with unilateral CP will 
perform physical activity at insufficient levels to meet the recommended level of MVPA. 
Rationale: Children with CP are thought to participate in less physical activity than 
typically developing peers, though most studies have used subjective measures, such as 
parental or self-report and few have compared results to the recommended level of 
physical activity. Quantification of physical activity levels using valid objective measures is 
required. 
Methods: Four day physical activity will be collected using ActiGraph® accelerometer 
records at baseline assessments will be analysed cross-sectionally. Activity counts from 
the accelerometer recordings will be converted into sedentary, light, and MVPA levels 
using cut-points (Evenson et al., 2008) and compared to recommended physical activity 
levels (at least 60 minutes of MVPA per day). 
1.3.6 Objective 5: Determine characteristics associated with physical activity 
Hypothesis: Physical, personal and environmental characteristics will be associated with 
reduced levels of physical activity in independently ambulant children and adolescents with 
unilateral CP.  
Rationale: Evidence in typically developing children suggests that personal and 
environmental characteristics contribute to physical activity performance. The addition of 
physical impairments in children with CP is likely to influence their ability to participate in 
daily and recreational tasks which would further reduce levels of physical activity. 
Methods: Physical activity performance will be measured over four days using an 
ActiGraph® accelerometer. Multiple linear regression analyses will be performed with 
characteristics as independent variables in the linear model determined using a backwards 
selection procedure. 
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1.4 Format of thesis 
The thesis is presented as a series of seven papers (variously published, in press or under 
review) in international peer review journals. Chapters 2 and 3 are published systematic 
reviews addressing thesis objectives one and two respectively and contributing to the 
literature review of the thesis. Specifically, Chapter 2 is a systematic review evaluating the 
efficacy of virtual reality interventions at increasing physical activity capacity and 
performance for children and adolescents with unilateral CP or early brain injuries. 
Chapter 3 is a systematic review investigating the clinimetric properties of measures of 
physical activity in primary school aged children with CP, conducted with the aim to inform 
the choice of physical activity measure for the intervention trial. Chapter 4 addresses 
thesis objective three to determine the reliability of accelerometers in children and 
adolescents with unilateral CP. Chapters 5 and 6 address thesis objectives four and five 
respectively. In these Chapters, cross sectional data from the children attending the 
baseline assessments of the randomised trial are presented. The performance of physical 
activity is determined, and the extent to which physical, personal and environmental 
characteristics determine physical activity is explored. Chapter 7 presents the published 
study protocol outlining the background information, design and instrumentation for the 
waitlist control randomised trial of Mitii™. Chapter 8 presents the results of the randomised 
trial and addressees the primary aim of the thesis to test the efficacy of Mitii™. Chapter 9 
is the final chapter and will link results from the papers, discuss the importance of the 
findings, highlight limitations and discuss future research directions.   
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Chapter 2. Using virtual reality to increase physical activity 
2.1 Introduction to Chapter 2 
This chapter consists of the published paper entitled “The effect of virtual reality 
interventions on physical activity in children and adolescents with early brain injuries 
including cerebral palsy”.  This paper describes and discusses results of a systematic 
review examining the effect of virtual reality interventions, including active video games, to 
increase physical activity capacity and performance in children and adolescents with CP. 
This systematic review was conducted to gain an understanding of the feasibility of these 
new technologies to increase physical activity. 
2.2 Paper 1: “The effect of virtual reality interventions on physical 
activity in children and adolescents with early brain injuries 
including cerebral palsy” 
This paper was published as a Clinical Letter in Developmental Medicine & Child 
Neurology and has been used with permission. 
Mitchell L, Ziviani J, Oftedal S, Boyd R. The effect of virtual reality interventions on physical activity in 
children and adolescents with early brain injuries including cerebral palsy. Developmental Medicine & 
Child Neurology, 2012. 54(7):667-671. DOI: 10.1111/j.1469-8749.2011.04199.x 
This was also presented as free paper at the 6th Biennial Conference of the Australasian 
Academy of Cerebral Palsy & Developmental Medicine, 30th May - 2nd June 2012, 
Brisbane, Australia. 
Mitchell L, Ziviani J, Oftedal S, Boyd R. Efficacy of virtual-reality interventions to increase physical 
activity in children and adolescents with cerebral palsy: a systematic review. Developmental Medicine 
& Child Neurology, 2012. 54(S5):48.
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SIR–Cerebral  palsy describes a group of permanent disorders 
in  the development of movement and  posture that causes 
activity limitations, attributed to non-progressive disturbances 
occurring in the developing brain.1 Despite the known health 
benefits of regular participation in physical activity, people 
with cerebral palsy tend to participate less than their typically 
developing peers and less than recommended guidelines.2 
Physical  activity is  defined as  ‘any body movement using 
skeletal muscles that results in energy expenditure’.3  Accord- 
ing to the International Classification of Functioning, Disabil- 
ity and Health (ICF), activity is divided into domains of 
capacity and performance.4   Physical activity performance can 
be defined  as activity undertaken by a person as part of their 
regular daily  life.  It is  important  to differentiate  this  from 
‘capacity’, which is what a person can achieve in an experimen- 
tal setting, such as a walking distance or strength test. 
There  is   preliminary   evidence that  interventions   can 
increase  physical  activity  in  children  with  cerebral  palsy.5 
Internet-delivered ‘active’ video games are emerging as a pop- 
ular modality for children especially where there are limita- 
tions in community access to interventions. Virtual reality 
creates interactive simulations that allow participants to inter- 
act with the system through movement of their body through 
3D  space.6   These  have the potential  to  deliver  novel and 
intensive therapies  to  children.  Internet-delivered  systems 
have the potential to overcome inequity of access to services to 
children  in  isolated  areas where services  can be limited. 
Reviews  of evidence  suggest  that active  game playing  and 
internet-based  interventions  can increase physical activity in 
typically developing children.7–9  There are no published sys- 
tematic reviews  of the efficacy of virtual  reality  training on 
physical activity in children with cerebral palsy. 
This study aimed to systematically review the literature for 
effectiveness and utility of virtual reality interventions on 
increasing physical activity capacity and performance in young 
people with cerebral palsy. Given this a new area of research, 
the population of interest was expanded  to include children 
and adolescents  with  traumatic- (TBI)  or  acquired-  (ABI) 
brain injuries. 
METHOD 
Databases including Medline (Pubmed), CINAHL, SPORT- 
DIscus, Embase, The Cochrane Library, and Scopus were sys- 
tematically searched for relevant literature using the following 
keywords: ‘Cerebral Palsy’ or ‘brain injury’, ‘physical activity’ 
and ‘virtual reality’. The search  was limited to studies 
published from 2000 to October 2011  as virtual reality inter- 
ventions were not commonly available prior to 2000. Studies 
were included if they met the following selection criteria: (1) 
more than 80% of the total sample included children and ado- 
lescents (aged 6–18y) with a diagnosis of cerebral palsy, ABI or 
TBI;  (2) measured physical  activity capacity  and ⁄ or perfor- 
mance; and (3) the intervention was provided through virtual 
reality medium. Studies were excluded if they were not pub- 
lished in English (owing to a lack of translation services). As 
there were thought to be few publications investigating this 
topic, all study types were included. 
The title and abstract of all retrieved references were 
screened by two authors (LM,  SO) independently. Full texts 
were then obtained for references which looked to meet inclu- 
sion criteria. Targeted reference scanning and citation track- 
ing of key articles was used to minimize the chance of missing 
key studies. Upon disagreement, all authors discussed the 
selection. The Downs and Black10 scale was used to assess the 
methodological  quality of randomized and non-randomized 
studies. A version of Cohen’s11  d was used to calculate effect 
size (Meanpost-treatment-Meanpre-treatment ⁄ SDpre-treatment). These 
were calculated  for outcomes where means, standard  devia- 
tions (SD), and participant numbers were reported or could be 
deduced. Where median and interquartile ranges (IQR) were 
presented, median was taken to represent the mean score and 
the IQR was divided  by 1.35. Effect sizes allow an understand- 
ing of the magnitude of impact across the studies. These were 
classified  as small (0.2), medium (0.5), and large (0.8).11 
 
RESULTS 
Initial database searching yielded 208 titles and abstracts. One 
hundred and ninety-five were excluded after initial review and 
13 full text papers were obtained. Only four studies met the 
inclusion criteria. No studies investigating children and ado- 
lescents with ABI or TBI were found. Participants in all stud- 
ies   trained   at   least   20 minutes   a   session,   mostly   daily. 
Interventions ranged from 5 days to 20 weeks. Total dose of 
therapy was  typically  between 7.5 and  11 hours, with  the 
exception of Mitii. This program was able to deliver intensive 
therapy remotely with a total dose of 70 hours (Table I). 
Only one of the studies looked primarily at physical activity 
performance following virtual reality intervention.12 Others 
looked at gross motor or upper limb function, and balance or 
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Table I: Participant and intervention characteristics of the included studies 
 
 
 
 
Study 
 
 
 
Participant characteristics 
 
 
 
Intervention 
Programme 
intensity 
(total dose) 
 
 
 
Delivery method 
 
 
Equipment required and 
cost (AUD$) 
 
 
Utility and feasibility of 
intervention 
Bilde et al.13 
 
• Nine children with cerebral 
 
Mitii (Move it to improve It): 
 
30min ⁄ d, 
 
Structured 
 
Computer with Internet 
 
Simple equipment, home 
 palsy Internet-based  cognitive 20wks (70h) program, $300–500, web-camera or therapy setting, training 
 • 6–13y,mean 10y–3mo and motor training  home-based, $30, Mitii $0 (from required, program 
 • Five males, four females program; using motion  supervised developers)=$330 individually tailored and 
 • MACS range: I-II detection via web cam and  remotely, (depending on computer progressed 
 
Deutsch et al.14 
• GMFCS range: I-II 
• Single participant with cerebral 
green tracking bands 
Wii Sports games: bowling, 
 
60–90min ⁄ 
individualized 
Non-structured 
cost) 
Wii System $200, game 
 
Commercially available, 
 palsy boxing,  baseball, tennis session, program, centre- $50=$250 home or therapy setting, 
 • 13-year-old male and golf 11 sessions, based, therapist  simple familiarization with 
 • GMFCS III  4wks (9h) supervised,  software required, difficult 
 • Spastic diplegia   generic  to tailor and progress, 
 
Sandland et al.12 
 
• 14 children with cerebral 
 
Sony Playstation 2 and the 
 
>20min ⁄ d, 
program 
Non-structured 
 
Playstation 2 Console $120, 
likely floor ⁄ ceiling effects 
Commercially available, 
 palsy EyeToy game Play3: this 4wks (11h) program, EyeToy USB camera $60, home or therapy setting, 
 • 6–16y,mean 10y–11mo includes about 20 different  home- based, games $50 each=$210 simple familiarization with 
 • Six males, eight females games  not supervised  software required, difficult 
 • MACS range: I–IV   by therapist,  to tailor and progress, 
 • GMFCS range: I–III   generic programs  likely floor ⁄ ceiling effects 
Brien and • Four adolescents with GestureTek’s Interactive 90min ⁄ d, Structured program, GestureTek system (32’’ Costly equipment, therapy 
Sveistrup15 cerebral palsy Rehabilitation and 5 consecutive centre-based, widescreen LCD display, setting only, training 
 • 13–18y,mean 16y, SD2.25 Exercise System software days (7.5h) therapist high-performance required, program 
 • Four males (IREX) Version 1.4  supervised, computer, video camera & individually tailored and 
 • GMFCS I   individualized green background screen) progressed 
     with GestureTek IREX  
     software=$13,000  
GMFCS, Gross Motor Function Classification System; MACS, Manual Ability Classification System. 
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Table II: Physical activity results from included virtual reality interventions 
 
 
 
Study 
 
 
Design 
 
Downs & Black score10 
Physical activity related 
outcome measures 
 
 
Physical activity related results 
Effect size and 95% 
confidence interval 
Effect size 
classification 
Bilde et al.13 
 
Pre-post 
 
Reporting: 6 ⁄ 11 External 
 
• Knee isometric muscle 
 
• Knee strength: some increase in 
 
Frontal steps: 0.8 
 
Large 
 pilot without validity: 1 ⁄ 3 Bias: 5 ⁄ 7 strength (isodynamometer) extension though  not statistically (-0.2 to 1.7)  
 control Confounders: 1 ⁄ 6 
Power: 1 ⁄ 2 _ Total: 14 ⁄ 29 
 
• Functional strength (unloaded, 
significant (p=0.2) 
• Functional strength: frontal step 
 
Side steps: 1.0 
 
Largea 
   loaded sit-stand, side and increased mean 11.6–17 steps (0.1–2.0)  
   front step ups, number in (p<0.001), lateral step test increased   
   30 seconds) 
• Bruce treadmill test 
mean 10.2–16.4 (p<0.01) 
• Bruce test: 9.8–12min on treadmill 
 
Sit to stand: 2.5 
 
Largea 
    (p<0.05) (1.2–3.7)  
   • 6min walk test • 6min walk test: no change Bruce treadmill: Small 
 
Deutsch et al.14 
 
Single 
 
Reporting: 5 ⁄ 11 External 
 
• Functional mobility 
 
• Functional mobility: Ambulation with 
0.2 (-0.7 to 1.2) 
Not calculated 
 
 case study validity: 0 ⁄ 3 Bias: 1 ⁄ 7 (retrospective chart data) forearm crutches, increased 4.6–45.7m   
  Confounders:0 ⁄ 6 • Walking distance during training, increased to 76.2m at   
 
Sundland et al.12 
 
Pre-post 
Power: 0 ⁄ 2 _ Total: 12 ⁄ 29 
Reporting: 9 ⁄ 11 External 
 
• Activity monitor (SenseWear 
12wks 
• 8 ⁄ 10 children increased physical activity 
 
TEE ⁄ day (cal): 
 
Small 
 pilot without validity: 1 ⁄ 3 Bias: 5 ⁄ 7 Pro3 Arm band): Worn over (4 children excluded from analysis) 0.3 (-0.6 to 1.1) Medium 
 control Confounders: 0 ⁄ 6 3d at baseline, 1st week of • Median (IQR): TEE ⁄ day calories 1789 Steps: 0.7 Medium 
  Power: 0 ⁄ 2 _ Total: 16 ⁄ 29 intervention, then last week (900) to 1966 (984) p<0.05 Step counts (-0.2 to 1.6) Small 
   of intervention 9815 (5569) to 12634 (7387) p<0.05, Time over 3METs (h):  
   • 1min walk test Spent more time ‘physically active’ 0.6 (-0.3 to 1.5) 1min  
    hr:min 5:44 (3:25) to 7:16 (3:47), p<0.05 walk test: 0.2 (-0.6 to 0.9)  
    • 1min walk test: No difference   
Brien and 
Sveistrup15 
Four single 
participant 
Reporting: 6 ⁄ 11 External 
validity: 0 ⁄ 3 Bias: 1 ⁄ 7 
• 6min walk test • 6min walk test: significant differences 
between baseline (40.45m) and 
6min walk test: 0.2 
(-1.2 to 1.6) 
Small 
 studies with Confounders:1 ⁄ 6  intervention (P3: 46.55m, SD23.48m),   
 multiple Power: 0 ⁄ 2 _ Total: 8 ⁄ 29  and follow up (P2: 40.22m, SD13.6m; P3:   
 outcome   46.55m, SD23.48m; P4: 43.46m;   
 assessments   SD14.31m)   
•  Timed Up and Down Stairs 
Assessed 3–6 times for 
baseline; five times during 
intervention phase (before 
each intervention), and then 
four times for follow-up 
• Timed up and down stairs: P2 significant 
change (baseline to intervention: mean 
change 1.3s, SD 1.23s; to follow-up: 
mean change 2.61s, SD0.36s) 
 
aDenotes statistically significant effect. 
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impairment measures, and included a measure  of physical 
activity as a secondary outcome (Table II). Studies were either 
single-arm pilot studies with few participants or case series, 
providing low-level evidence.10 Physical activity capacity, mea- 
sured  using  functional strength  and mobility, improved  fol- 
lowing training with both Wii  Sports (Nintendo EAD) and 
the Mitii program (Mitii  Development A ⁄ S, Copenhagen, 
Denmark; Table II).
13,14  
Physical  activity performance mea- 
sured using SenseWear-Pro3 Armband (BodyMedia  Inc., 
Pittsburgh, PA, USA) activity monitors was found to increase 
significantly following training with the Playstation 2 EyeToy 
(Sony Computer Entertainment),  though capacity  assessed 
using the 1-minute walk test did not improve (Table II).12   A 
5-day intensive burst of IREX (GestureTek Health, Toronto, 
Canada) therapy was found to increase and maintain walking 
distance over 6 minutes, though timed up and down stairs test 
did not change (Table II).
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Large  effects were seen for functional strength outcomes fol- 
lowing Mitii training, though only side-steps and sit-to-stand 
were significant (Table II).13   Effect sizes from the studies by 
Sundland and Brien were small to medium; however, large SDs 
and confidence intervals meant that these were not statistically 
significant (Table II).12,15 Meta-analysis was not possible as all 
included studies were pre-post designs and there was substan- 
tial variation in interventions and outcomes assessed. 
 
DISCUSSION 
This review set out to establish if virtual reality interventions 
were able to increase physical activity capacity and ⁄ or perfor- 
mance in children with CP or early brain injury. Systematic 
searching was only able to identify four studies which investi- 
gated the impact of virtual reality on physical activity. These 
studies provided evidence of a positive  effect,  though their 
methodological quality was limited. It should be noted that 
the Downs and Black scale is designed for the critical appraisal 
of randomized and non-randomized trials. Given the designs 
of the included studies, all studies obtained low scores using 
this checklist. 
Virtual reality as an intervention for children with cerebral 
palsy is relatively new and research is rapidly evolving. So far 
the emphasis has been on establishing the feasibility of virtual 
reality as a therapeutic modality for rehabilitation. This review 
has demonstrated  there has been less  research investigating 
the ability of virtual reality systems to increase physical activity 
capacity and performance in this population. This should be 
an important next step for research. Children today, particu- 
larly those with disabilities, spend increased time in sedentary 
screen-based leisure activities, such as watching television or 
playing video games. This displaces more active  behaviours 
which contribute to obesity  and other adverse  health out- 
comes.7 Given that people with cerebral palsy tend to partici- 
pate in less  physical activity than their typically  developing 
peers this is  an important  health promotion  consideration. 
Interventions which use screen time to increase physical activ- 
ity have the potential to overcome  these adverse health out- 
comes yet still appeal to children. High quality research that 
assesses the efficacy of virtual reality interventions against all 
dimensions of the ICF,4  including the translation of strength 
and fitness into increased  physical  activity  performance is 
required. A child or adolescent may be able to perform well in 
an experimental setting, but whether they translate this ability 
in daily life is arguably more important for participation and 
long-term health and well-being. This could be achieved by 
objectively monitoring habitual physical activity levels  using 
activity monitors before and after intervention ensuring 
sufficient participant numbers and a strong study design. 
While limited conclusions can be drawn about the effect of 
virtual reality on physical activity in children with early brain 
injuries including cerebral palsy at this stage, the evidence for 
typically developing children is promising. Systematic reviews 
have found  that  computer-  or  web-based interventions 
increased physical activity levels, though long-term effects were 
limited.8,9 Active video games have been shown to elicit greater 
energy expenditure and translate into increased habitual physi- 
cal activity.7 When used for paediatric rehabilitation in children 
with  cerebral palsy,  virtual reality systems  which use more 
‘active’ games utilizing whole body movements and standing 
positions have the potential to increase energy expenditure and 
therefore physical  activity  levels.  As demonstrated from this 
review, virtual reality interventions have the ability to deliver 
interventions remotely at a similar or greater intensity to 
one-on-one  therapies. As an example, Mitii provided up to 
70 hours of total therapy. This means that these systems may 
have the added benefit of increasing physical activity capacity 
and performance in addition to more rehabilitation aligned 
goals. Future high-quality research into the effectiveness of vir- 
tual reality interventions in children and adolescents with cere- 
bral palsy would benefit from the inclusion  of measures of 
physical activity capacity and performance to confirm this. 
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P. Use of a low-cost, commercially available gaming console 
(Wii) for rehabilitation of an adolescent with cerebral palsy. 
Phys Ther  2008;  88: 1196–207. 
15. Brien  M,  Sveistrup  H.  An  intensive  virtual  reality  pro- 
gram improves functional balance and mobility of adoles- 
cents  with  cerebral  palsy. Pediatr Phys  Ther 2011; 23: 
258–66. 
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2.3 Supplementary Information 
Effect size (Cohen’s d) and 95% Confidence Intervals of selected measures were 
calculated; however were unable to be published due to space restrictions. These are 
presented in Figure 2.1 and Table 2-1 for the thesis. 
 
 
 
* Denotes significant effect at p<0.05. KEY: Mitii™: Move it to improve it; IREX: GestureTek’s Interactive rehabilitation 
exercise system; TEE: Total energy expenditure; cal: calories; MET: metabolic equivalents.  
Figure 2-1. Effect size and 95% confidence intervals of virtual reality interventions in children 
and adolescents with cerebral palsy 
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Table 2-1. Effect size and 95% confidence intervals of virtual reality interventions in children and adolescents with cerebral palsy 
Study ID 
Pre Post Mean 
diff. 
95% CI Pooled 
SD^ 
SD 
p-value
#
 
Effect 
Size
$
 
95% CI Effect 
class. Mean n SD Mean n SD Lower Upper Lower Upper 
Bilde - Frontal step 11.6 9 7.1 17.0 9 5.9 5.4 -1.1 11.9 6.5 0.3 0.8 -0.2 1.7 Large 
Bilde - Side steps 10.2 9 5.9 16.4 9 5.5 6.2 0.5 11.9 5.7 0.4 1.0 0.1 2.0 Large* 
Bilde - Sit to stand 11.8 9 3.5 20.4 9 4.7 8.6 4.4 12.8 4.2 0.2 2.5 1.2 3.7 Large* 
Bilde - Bruce treadmill 9.8 9 8.9 12.0 9 7.0 2.2 -5.8 10.2 8.0 0.3 0.2 -0.7 1.2 Small 
Brien - 6min walk 40.5 4 22.4 44.1 4 15.0 3.7 -29.2 36.6 19.0 0.3 0.2 -1.2 1.6 Small 
Sundland - TEE/Day 1789.0 10 666.7 1966.0 10 728.9 177.0 -479.3 833.3 698.5 0.4 0.3 -0.6 1.1 Small 
Sundland - Steps 9815.0 10 4125.2 12634.0 10 5471.9 2819.0 -1733.7 7371.7 4845.5 0.2 0.7 -0.2 1.6 Medium 
Sundland - Time 
>3MET 5.8 10 2.6 7.3 10 2.8 1.5 -1.0 4.0 2.7 0.4 0.6 -0.3 1.5 Medium 
Sundland - 1 min walk 90.0 14 22.6 94.0 14 23.0 4.0 -13.7 21.7 22.8 0.5 0.2 -0.6 0.9 Small 
* Significant result as 95% Confident intervals do not cross line of no effect (ie.0). ^ Pooled Standard deviation based on paired data (1 degree of freedom). # P-value for 
difference in SD between pre- post- groups. $ Effect size measured using Cohens d formula. KEY: n: number; SD: standard deviation; Pre: pre-intervention; Post: post 
intervention; 95% CI: 95% confidence intervals. 
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2.4 Summary and conclusions 
This systematic review highlighted a paucity of research investigating the efficacy of virtual 
reality interventions to increase physical activity capacity and performance in children and 
adolescents with CP. Few conclusions are able to be drawn from the current literature on 
the efficacy of virtual reality interventions to increase physical activity in this population. 
This highlighted important areas for consideration in the proposed trial comparing Mitii™ to 
usual care: 
i) Studies investigating virtual reality were of low methodological quality, limited by small 
sample sizes and poor study design without a control group.  A matched pairs 
(children matched for age, gender and upper limb function) randomised trial with a 
larger sample size will be used to compare Mitii™ to usual care in the proposed trial. 
ii) The use of virtual reality to increase physical activity for children and adolescents with 
CP is a new area of research, evidenced by the lack of published studies. Given this is 
a new area and access to these interventions in clinical practice is currently limited, a 
waitlist controlled study design will be used. This will ensure equity of access to all 
participants. 
iii) Studies included in the systematic review often did not assess both physical activity 
capacity and performance following virtual reality intervention. For the proposed trial, 
outcome measures will be chosen that assess Mitii™ across the ICF, including 
physical activity capacity and performance.  
iv) Variable dosages of virtual reality interventions have been reported, ranging from 7.5 
hours to 70 hours. The study by Bilde et al74 investigating Mitii™ has the highest dose 
(being 30 minutes daily for 20 weeks [total dose=70hours]) and was the only study 
included in the review to have a significant effect despite large confidence interval 
bands. The proposed trial will use a similar dose of Mitii™ as used for the pilot study. 
Sub-analyses will allow exploration of dose-response for participants. 
v) The efficacy of Mitii™ will be examined against physical activity capacity and 
performance, mobility limitations and recreational participation in the proposed waitlist 
controlled randomised trial. A systematic review of the clinimetric properties of 
measures of physical activity is required to determine the most valid and reliable 
method to record this construct in children and adolescents with CP. 
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Chapter 3. Measurement of habitual physical activity 
3.1 Introduction to Chapter 3 
This chapter consists of the published paper entitled “A systematic review of the 
clinimetric properties of measures of habitual physical activity in primary school 
aged children with cerebral palsy”. The paper reported in this chapter describes 
and discusses the results of a systematic review examining the clinimetric 
properties of measures of physical activity performance in primary school aged 
children (6-12 years) with CP. This systematic review was conducted to 
determine the most valid, reliable and clinically useful methods to measure 
physical activity as part of the proposed trial. 
3.2 Paper 2: “A systematic review of the clinmetric properties of 
measures of habitual physical activity in primary school 
ages children with cerebral palsy” 
This paper was published in Research in Developmental Disabilities and has 
been reproduced with permission. 
 Mitchell L, Ziviani J, Oftedal S, Boyd R. A systematic review of the clinimetric properties of 
measures of habitual physical activity in primary school aged children with cerebral palsy. 
Research in Developmental Disabilities. 2013. 34:2419-2432. 
The material in this paper has also been presented as a free paper at the 6th 
Biennial Conference of the Australasian Academy of Cerebral Palsy & 
Developmental Medicine, 30th May - 2nd June 2012, Brisbane, Australia. 
Mitchell L, Ziviani J, Oftedal S, Boyd R. Measurement of habitual physical activity in primary 
school-aged children with cerebral palsy: a systematic review. Developmental Medicine & 
Child Neurology, 2012. 54(S5):29.  
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A B  S T  R A C T   
 
Regular participation i n    physical activity  is  an important determinant  of  health 
for children and adolescents with cerebral palsy (CP). However, there is little consensus 
on the most valid or  reliable method to measure physical activity in  this population. 
This  study aimed to systematically review the psychometric properties of habitual 
physical activity (HPA)  measures in primary school-aged children with CP. Databases 
were systematically searched for   measures assessing physical activity over more 
than one day and had evidence of validity, reliability and/or clinical utility in children 
aged 6–12 years with CP. Ten  measures met inclusion criteria and their quality was 
assessed in  twelve studies. Quality of the included studies was appraised using the 
consensus-based standards for the selection of health measurement instruments 
(COSMIN)  checklist. Measures were moderately to strongly correlated to criterion 
measures, with study quality rated as Fair (+) to Poor (0). Only  four measures had 
evidence of reliability. Accelerometers provide a valid measure of HPA with good 
clinical utility; however they do  not have documented reliability in  this population.  
No  one measure appears ideal to record HPA  in  primary school-age  children  with  
CP  and  further  research  is   necessary to  determine the psychometric properties of 
HPA measurement instruments in this population. 
© 2013 Elsevier Ltd.  All rights reserved. 
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1.  Introduction 
 
Participation in  regular physical activity is  recognised as  an  important determinant of physical, mental and social 
health for all children and adolescents, with extra beneﬁts, such as improved quality of life and prevention of secondary 
musculoskeletal problems, afforded to  children with a disability (WHO,  2003). Cerebral palsy (CP) describes a group of 
disorders of movement and posture which cause activity limitations, attributed to non-progressive disturbances that 
occur in  the developing foetal or  infant brain (Rosenbaum  et al., 2007). Spasticity is the most common type of motor 
impairment, present in  around 80% of  all  people with CP (Australian CP Register, 2006). Spasticity  describes muscle 
hypertonia  characterised by  resistance to passive stretch  that  provides minimal initial resistance followed by  an 
incremental increase in  muscle tone, proportional to the velocity of the stretch, and usually associated with increased 
deep tendon reﬂexes and muscle weakness (Sanger, Delgado, Gabler-Spira, Hallet, & Mink,  2003). Motor disorders of CP 
are often accompanied by disturbances of sensation, cognition, perception, behaviour, and/or seizure disorders, and by 
secondary musculoskeletal problems including muscle weakness and contractures (Rosenbaum et al., 2007). Worldwide, 
approximately one  in 500  infants are  born with CP each year making it the most common physical disability in childhood 
(Odding, Roebroeck, & Stam, 2006). This  prevalence highlights the need to  optimise health,  function and ﬁtness of 
individuals with CP through the promotion of regular participation in physical activity. Despite this fact, people with CP 
are less physically active than typically developing children (TDC; Maher, Williams, Olds, & Lane, 2007; Zwier et al., 2010) 
or compared to children with other physical disabilities, such as spina biﬁda or head injuries (Nelson, Neumark-Stzainer, 
Hannan, Sirard, & Story, 2006). Interventions to increase physical activity in this population appear essential. Increasing 
physical activity in  primary school aged children with CP (aged six  to 12  years) may be  of  particular importance,  as 
patterns of physical activity acquired during childhood years provide the foundation for healthy lifestyle choices in adult 
life  (WHO,  2003). Additionally,  interventions targeting biomechanical impairments  or reducing spasticity, including 
intramuscular Botulinum-Toxin,  casting and lower limb bony surgery are  typically provided to primary school aged 
children with CP. These interventions impact posture as well as walking or running abilities and could potentially cause 
changes in levels of physical activity. These interventions provide therapists with an important window of opportunity to 
promote physical activity. 
In order to assess the impact of physical activity interventions, accurate measurement is necessary. Physical activity is 
deﬁned by Caspersen as ‘any body movement using skeletal muscles that results in energy expenditure’ (Caspersen, Powell, 
& Christenson, 1985). When considering physical activity, one  must distinguish between an  individual’s ‘capacity’ (what 
they can perform at their best in a controlled environment), versus their ‘performance’ (how they actually perform in the real 
world, for  example, habitual physical activity [HPA] during regular daily life;  Holsbeeke, Ketelaar, Schoemaker, & Gorter, 
2009; WHO,  2001). Physical activity performance compromises four  dimensions: frequency (how often a person does an 
activity); duration (how long activity is  performed in  any  one  session); intensity (how hard a  person works to  do  the 
activity); and mode (the type of activity the person performs; US Department of Health and Human Services, 2008). Ideally 
measures should document these dimensions over a number of days in a naturalistic environment. 
Gross motor abilities, such as standing upright, walking or running, vary considerably in individuals with CP. The gross 
motor function classiﬁcation system (GMFCS) is a tool  used for the classiﬁcation of gross motor function in individuals with 
CP (Palisano et al., 1997). It is a ﬁve-level ordinal grading system based on the assessment of self-initiated movement during 
sitting, standing  and walking. According to  GMFCS  classiﬁcation, children with CP can   range from being wheelchair 
dependent requiring external support to  maintain an  upright posture (GMFCSV) to  a child who is able to  run and walk 
independently  with  only mild balance or  coordination impairments  (GMFCS).  Given the  huge  variability in  motor 
performance, physical activity measurement tools used for  children with CP need greater ﬂexibility than those used in 
independently ambulating TDC. Additionally, the biomechanical impairments associated with CP result in  an  increased 
energy cost during ambulation compared to  TDC, and algorithms used to  estimate energy expenditure in  TDC are  likely 
underestimate the true energy cost in a child with CP (Maltais, Pierrynowski, Galea, & Bar-Or, 2005). Given the functional and 
biomechanical differences between TDC and a child with CP, measurement of physical activity in children with CP requires 
special consideration. 
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Systematic reviews have looked at HPA performance measurement instruments in preschool aged children (Oftedal et al., 
2012) and adolescents with CP (Clanchy, Tweedy, & Boyd, 2011); however there is currently limited consensus on the best 
way to  measure HPA in  primary school aged children with CP. These reviews concluded that while there was limited 
evidence relating to validity and reliability of selected instruments, none were designed speciﬁcally for individuals with CP. 
An additional review has  investigated the validity and reliability of physical activity measures which were used in ﬁeld- 
based studies in a much broader age band (birth to 18 years) that included primary school aged children with CP (Capio, Sit, 
Abernethy, & Rotor, 2010). Physical activity was not clearly deﬁned in this review and, as a result, the instruments selected 
do not relate speciﬁcally to physical activity performance and some objective measures were not included (Maltais & van den 
Berg-Emons, 2011). This means that despite these reviews, there is a gap  in knowledge of the best way to measure HPA in 
primary school aged children with CP. 
The  current review therefore aims to  systematically review evidence of validity, reliability and clinical utility of HPA 
performance measures used in  primary school aged children with CP and assess the quality of  studies assessing the 
psychometric properties of these measures using an  objective measurement tool,  the consensus-based standards for  the 
selection of health measurement instruments (COSMIN) checklist (Mokkink, Terwee, Knol, et al., 2010; Mokkink, Terwee, 
Patrick, et al., 2010). 
 
2.  Methods 
 
2.1.  Search  strategy 
 
A systematic search including the maximum time period available in their archives was performed of: Medline (1966– 
February 2013), CINAHL (1982–February 2013), EMBASE (1988–February 2013), Web of Science (1900–February 2013), and 
SPORTDiscus (1800–February 2013). The search strategy used the controlled vocabulary terms and text words optimised for 
each database. The search terms included: ‘cerebral palsy’ AND ‘physical activity performance’ OR ‘habitual physical activity’ 
AND ‘measures’ OR ‘assessment’ OR ‘tool’ OR ‘outcomes’ OR ‘psychometrics’. Results were then limited to human studies for 
children aged 6–12 years and published in English (owing to a lack  of translations services). Reference lists and citations of 
key  articles were hand-searched for  relevant articles to  minimise the chance of missing key  studies. 
 
2.2.  Inclusion and  exclusion criteria 
 
The a priori inclusion criteria were measurement instruments that: (i) measure physical activity, deﬁned as ‘any  body 
movement using skeletal muscles that results in energy expenditure’ which therefore encompasses all gross and ﬁne  motor 
tasks, incidental movements  and  activities of  daily living (Caspersen et  al.,  1985); (ii)  record information on   HPA 
performance, therefore assess frequency (how often a person does an activity), duration (how long activity is performed in 
any  one  session), intensity (how hard a person works to do  the activity), and/or the mode (the type of activity the person 
performs; US Department of Health and Human Services, 2008) of physical activity over more than one  day  in a naturalistic 
environment; (iii) if questionnaires, have at least 60% of items related to the domain of physical activity performance; and 
(iv) have documented evidence of validity, reliability or clinical utility for measuring HPA performance in children aged 6–12 
years with CP across all  GMFCS levels. Assessment tools were excluded if they primarily assessed participation, body 
structures, physical function, or  physical activity capability. 
 
2.3.  Data  extraction 
 
Titles and abstracts were screened by  two authors (LM, SO) independently to identify publications that included a 
measure of HPA. Full text publications were obtained for those selected and reviewed by two authors (LM, SO) independently 
to  determine measures of  HPA  that  met the inclusion criteria and had documented evidence of  their psychometric 
properties. Conﬂicting viewpoints were discussed amongst all  authors until consensus was reached. For  each selected 
measure of HPA, data were extracted by the ﬁrst author (LM) on  the dimension of physical activity measured (frequency, 
intensity, duration and/or mode), the characteristics of each study, and the populations in which it had been tested. 
 
2.4.  Quality  review and  rating of study design 
 
The  studies that reported clinimetric properties were rated on  methodological quality using the COSMIN  checklist 
(Mokkink, Terwee, Knol, et al., 2010; Mokkink, Terwee, Patrick, et al., 2010) by the ﬁrst author (LM) and conﬁrmed amongst 
all authors. The COSMIN is described in detail elsewhere however, in summary, rather than scoring the overall quality of a 
paper, the COSMIN individually assesses each measurement property, such as  internal consistency, validity, reliability or 
responsiveness. Each clinimetric property is evaluated separately based on the study’s methodological quality and statistical 
methods. A four  point rating scale is used to classify each item on the checklist as Excellent (+++), Good  (++), Fair (+), or Poor 
(0). This therefore provides an overall quality score for each measurement property by taking the lowest rating of any  item 
(Terwee et al., 2011). When reporting study quality at an item level, these scores can be converted back to the original scores 
(yes, no, unknown) by transforming the Excellent (+++) to yes, and converting Good (++), Fair (+) or Poor (0) to no or unknown 
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depending on the evidence presented (Terwee et al., 2011). According to the COSMIN scoring system, internal consistency is 
considered Excellent (+++) when factor analysis was performed and Cronbach’s alpha calculated for at least seven items in a 
sample of more than 100,  with adequate description of the amount and handling of missing data (Terwee et al., 2011). 
Criterion validity can  be rated as Excellent (+++) when correlated to a ‘gold standard’ measure in a sample of more than 100 
subjects (Terwee et al., 2007). The gold  standard measurement of physical activity is considered to be the doubly labelled 
water  technique  (Trost, 2007). Reliability can   be  rated Excellent (+++)  when at least two independent measures are 
performed on stable participants at an appropriate time interval and Intraclass Correlation Coefﬁcient (ICC) for continuous 
variables or weighted Cohen’s Kappa coefﬁcient for ordinal measures are  calculated (Terwee et al., 2011). When assessing 
reliability, the COSMIN recommends a minimum sample size of 50 participants to be described as Good  (++), and over 100  to 
be considered Excellent (+++; Terwee et al., 2007, 2011). For the purposes of this review, where sample size  was less  than 
recommended a study could be  scored Excellent (+++) where a power calculation was provided or  the sample size  was 
justiﬁed. Responsiveness is the ability of the instrument to detect minimal clinically important change in the construct to be 
measured over time. Responsiveness should be tested by relating the smallest detectable change to the minimally important 
change of the instrument, or with a receiver operating characteristics (ROC; Terwee et al., 2007). According to the COSMIN, 
for  a  score of  Excellent (+++)  the construct should be  assessed against a  gold   standard measure longitudinally in  an 
unchanging population, with adequate description of the amount and handling of missing data. The  scoring criteria are 
described in more detail elsewhere (Terwee et al., 2011). 
 
2.5.  Statistical methods and  clinimetric properties 
 
Where available, evidence of statistical methods and clinimetric properties was extracted by the ﬁrst author (LM) and 
assessed against pre-determined criteria. Internal consistency is considered strong when Cronbach’s alpha is between 0.75 
and 0.95  (Terwee et al., 2007). Criterion validity is considered strong when correlation with a ‘gold standard’ measure is ;::0.7 
(Terwee et al., 2007). Reliability was rated strong when ICC for continuous variables or weighted Cohen’s Kappa coefﬁcient 
for  ordinal measures is ;::0.7. Responsiveness is considered strong with a ROC curve of ;::0.7  (Terwee et al., 2007). These 
properties and the appropriate statistical tests are  explained in more detail elsewhere (Terwee et al., 2007). 
 
2.6.  Clinical  utility 
 
The clinical utility of the instrument was scored by assigning a score against items deemed to represent the clinical utility 
of the measure: cost of purchasing a single device or  questionnaire (0 = >$1000, 0.5 = $500–$1000, 1 = <$500); specialist 
analysis software required (0 = yes,  1 = no); richness of HPA data output (one point each for  activity intensity, frequency, 
duration, mode of activity, collection over multiple days = maximum points ﬁve); acceptability to the participant based on 
unit size   or  administration time (<1 h)  if  questionnaire (0 = less   acceptable, 1 = acceptable); suitable for  use   for  both 
ambulant and non-ambulant children (0 = ambulant only,  1 = non-ambulant and ambulant); requires specialist training or 
skills to administer and score (0 = specialist skills required, 0.5 = basic training required, 1 = no specialist skills required); and 
overall feasibility for HPA research (this describes the ability of the tool  to be used in a large sample of children including the 
set-up, calibration, administration time and overall burden; 0 = not feasible, 1 = feasible), giving a total possible score out of 
11  (where the measure with the highest clinical utility has  the highest score). 
 
3.  Results 
 
3.1.  Included measures and  evidence 
 
Measurement and study selection is depicted in  Fig. 1. Searching yielded 789  titles and abstracts. Within this initial 
search, 13 potential measures were identiﬁed as being used to assess HPA in primary school aged children with CP (Table 1). 
Following review by  two authors (LM, SO), 762  titles and abstracts were excluded as  not assessing physical activity or 
containing measures meeting inclusion criteria. Full text was obtained for the remaining 27  papers and following further 
review by two authors (LM, SO), 12 full text papers and three of the identiﬁed measures were excluded. The Activity Scale for 
Kids – Performance version (ASKp; Laurentian University, ON, Canada), the System for Observing Fitness Time (SOFIT; Active 
Living  Research, University of California, CA, USA) and the Children’s Assessment of Participation and Enjoyment (CAPE; 
Pearson Education, TX, USA) were excluded as they were not deemed to  measure HPA according to  the inclusion criteria. 
Ten  measures of HPA were used in  the literature to  assess HPA of primary school aged children with CP. Objective 
measures included pedometers (AMP:  Dynastream Innovations, Cochrane, Canada; and Minimod: DynaPort Minimod, 
McRoberts, the  Netherlands;  Maher, Williams, Olds,  & Lane,  2010), Uptimer (Gormon ProMed, Melbourne, Australia; 
Crompton et al., 2007), StepWatch (Orthocare Innovations, Seattle, WA, USA; Bjornson, 2006; Bjornson et al., 2008; Bjornson, 
Belza,  Kartin, Logsdon, & McLaughlin, 2007; Stevens, Holbrook, Fuller, & Morgan, 2010; Van  Wely, Becher, Balemans, & 
Dallmeijer, 2012; Van Wely et al., 2010), accelerometers (RT3: Stayhealthy, Monrovia, CA, USA; and ActiGraph: ActiGraph, 
Fort  Walton Beach, FL, USA; van  den Berg-Emons, Bussmann, & Stam, 2010), heart rate monitors (HR FLEX method: deﬁned 
as the mean of the highest heart rate during rest and the lowest heart rate during the lightest imposed exercise; Trost, 2007), 
the Sensewear Pro3   Armband (BodyMedia Inc.,  Pittsburgh, PA, USA;  Sandlund, Waterworth, & Hager, 2011), and the 
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789 titles and abstracts 
13 measures used in literature 
 
 
762 titles and abstracts excluded: Not 
including measure of habitual physical 
activity performance 
 
 
27 full text papers obtained 
 
 
12 full text excluded based on inclusion 
criteria 
 
 
 
15 full text accepted (12 Studies and 3 
Systematic Reviews) with evidence of 
psychometric properties of HPA 
measures 
 
10 measures of HPA accepted 
3 measures excluded as not measuring 
HPA (ASKp, SOFIT, CAPE) 
 
 
 
 
 
 
 
Objective measures: 
Pedometer, Uptimer, StepWatch, 
Accelerometer,Heart rate ﬂex, 
Sensewear, IDEEA 
Subjective measures: 
MARCA, Questionnaires based on the 
Compendium for Physical Activity, PAQ-A 
 
 
Fig.  1.  Flow diagram for  the included measures of  habitual physical activity performance in children 6–12 years with cerebral palsy. 
 
 
Intelligent Device for Energy Expenditure and Activity (IDEEA) monitor (MiniSun LLC, Fresno, CA, USA; Aviram, Belokopytov, 
Ben-Chaim, & Rotstein, 2011). Subjective measures included the Multimedia Activity Recall  for  Children and Adolescents 
(MARCA; Maher et al.,  2010; Olds,  Ridley,  Dollman, & Maher, 2010), researcher designed questionnaires based on  the 
compendium for physical activity (Ainsworth et al., 2000; van Eck et al., 2008), and the Physical Activity Questionnaire (PAQ- 
A; Maher et al., 2007). These are  described in Table  1. 
Evidence of the psychometric properties of included measures was found in  twelve individual studies (Aviram et al., 
2011; Bjornson et al., 2007; Capio,  Sit, & Abernethy, 2010; Clanchy, Tweedy, Boyd, & Trost, 2011; Kuo, Culhane, Thomason, 
Tirosh, & Baker,  2009; Maher et al.,  2007; Maltais, Pierrynowski, Galea, & Bar-Or, 2005;  Maltais, Pierrynowski, Galea, 
Matsuzaka, & Bar-Or, 2005; Pirpiris & Graham, 2004; van  den Berg-Emons, Saris,  Westerterp, & van  Baak,  1996; Van Wely 
et al., 2012; Maher 2008). Only eight of the 10 measures identiﬁed in the literature as being measures of HPA in children with 
CP had evidence of their psychometric properties. These included: pedometers, Uptimer, StepWatch, accelerometers, HR 
FLEX, IDEEA, MARCA and the PAQ-A. The  Sensewear armband and questionnaires based on  the compendium for physical 
activity did  not have documented evidence of validity or reliability for primary school aged children with CP. Only  clinical 
utility data is reported for  these measures. The  characteristics of the studies are  presented in Table  2. 
 
3.2.  Quality  review and  rating of study design 
 
Overall, quality  of  studies investigating the  psychometric properties of  included HPA  measurement instruments 
according to the COSMIN checklist was Fair (+) to Poor (0) (Table 3). Given the included studies, it was only possible to assess 
criterion validity and reliability using the COSMIN  checklist. There was no  evidence for  the remaining measurement 
properties assessed in the COSMIN. Studies investigating validity of the Uptimer and ActiGraph accelerometer were of Fair 
(+) quality; studies assessing pedometers, the StepWatch, RT3 accelerometer, HR FLEX method and PAQ-A had Poor  (0) 
evidence of criterion validity according to the COSMIN (Table 3). Individual item scores for criterion validity are presented in 
Supplementary Table   1.  Only   four   instruments  had evidence of  reliability in  children with CP  (Table 3).  The  study 
investigating the reliability of the Uptimer was of Good (++) quality, in contrast to the studies examining the PAQ-A, HR FLEX 
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Table 1 
Description of  included and excluded measures. 
 
Measure Description 
 
Included objective measures 
Pedometer (AMP  and Minimod) Small waist mounted device which uses inertial sensors to detect vertical movement to record the 
number of  steps counted 
Uptimer Lightweight battery-operated activity monitor worn on the thigh. It  records  ‘‘uptime’’ or the time 
spent in an upright position, by  the activation of a series of three mercury tilt-switches arranged in 
the X/Y/Z  orthogonal axes. It  responds to changes in the limb posture with regard to gravity 
StepWatch A two-dimensional accelerometer worn around the ankle to detect ambulation. It  records stride 
count over a set time interval and patterns of activity. Data can be calculated into average daily step 
counts, time spent active, ratio of low to medium activity, and percent of time spent at high activity 
level. It is programmed to the gait pattern of a participant by  altering sensitivity and cadence values 
Tri-axial accelerometer  (ActiGraph 
and RT3  Accelerometer) 
 
 
 
 
 
Heart rate (HR)  monitors  using HR 
FLEX method  (HR-FLEX) 
Small device, usually worn on the waist, which records acceleration in three planes through piezo- 
electric elements which convert displacement into an electrical signal. This provides quantative 
information about vertical accelerations of  trunk or other body segments. Data are digitalised and 
magnitude is summed over a user-deﬁne sampling period (epoch) and the summed value or activity 
‘count’ is stored in the memory for  retrieval through a computer interface. Counts are then converted 
into activity intensity using cut-points to provide a real-time index of the intensity of physical activity 
performed over given time-interval and can be used to assess pattern, intensity and duration of 
activity 
HR-FLEX measures energy expenditure via  heart rate by  estimating VO2  relative to heart-rate (HR) 
above and below a critical HR intensity point – the HR-FLEX  point. Time spent above the HR FLEX 
point assumes there is  a linear response to between heart rate and energy expenditure. Physical 
activity levels can then be calculated by  comparing energy expenditure at rest to activity. It  is  a 
measure of physical activity intensity and duration though requires individual calibration to ensure 
its accuracy 
Sensewear Pro3 Armband                      Multi-sensor monitor worn on the triceps of  the right arm. It records skin temperature, dissipated heat from 
the body (heat ﬂux), galvanic skin response, and has a built-in three-axis accelerometer which 
records number of steps and movement. Speciﬁc algorithms are used to determine total energy 
expenditure (TEE),  active energy expenditure, METS,  physical activity level and duration 
Intelligent device for  energy expenditure 
and activity (IDEEA)  activity monitor 
Device that can analyse body motion and positions, measure physical activity, monitor behaviour 
patterns, and estimate energy expenditure in a free-living situation. It  consists of  5 sensors which 
measure angles of body segments and acceleration in 2 orthogonal directions, and the IDEEA recorder 
 
Included subjective measures 
Multimedia activity recall for  children 
and adults (MARCA) 
 
 
Computerised use of time recall diary, that is completed by either a parent/carer or self-administered 
(if >10 years) in an interview format with trained personnel in person or over the phone. The  MARCA 
converts time recorded in different activities (physical, self-care, occupation and transport) into MET 
activity levels using a compendium for  physical activity based on typically developing children or 
adults 
Physical Activity Questionnaire  (PAQ-A) The  PAQ-A  is  a self-administered 7-day recall instrument which assesses general levels of physical 
activity during the school year 
Questionnaires based on the Compendium 
for  Physical Activity 
Researcher created questionnaire in which participants or a proxy recall the amount of time spent in a 
particular activity over a deﬁned period. MET levels are then applied to each activity described using 
the Compendium for  Physical Activity described by  Ainsworth et al.  (2000) 
 
Excluded measures 
Activity Scale for  Kids – Performance   (ASKp)Measure of impairment or ability to perform certain tasks such as walking, turning a door 
handle. It therefore does not capture information about the frequency, duration or intensity of 
activity, or look speciﬁcally at exercise or sports activity 
System for  Observing Fitness time (SOFIT)   Measures physical activity performed during a structured exercise or physical educations class. It 
therefore does not provide information on performance of  habitual activity performed outside of 
session 
Children’s Assessment of  Participation and 
Enjoyment  (CAPE) 
The  CAPE is a questionnaire designed to examine participation in everyday activities outside of school 
classes. This provides information about the context of  participation, diversity of  participation, 
intensity of  participation, and enjoyment. It  therefore does not primarily capture information on 
performance of  habitual physical activity or capture activity in the school environment 
 
 
 
and the IDEEA, which were of Poor  (0) quality. Overall, small subject numbers in the included studies contributed to these 
low  scores. 
Supplementary data associated with this article can   be  found, in  the online version, at http://dx.doi.org/10.1016/ 
j.ridd.2013.04.013. 
 
3.3.  Statistical methods and  clinimetric properties 
 
3.3.1.  Validity 
Validity of included HPA measures is reported in Table  4. The Minimod pedometer demonstrated excellent classiﬁcation 
accuracy for  continuous walking though the AMP pedometer demonstrated greater accuracy for  lap  walking and stair 
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Table 2 
Characteristics of  studies describing measures of  habitual physical activity in children with cerebral palsy aged 6–12 years. 
 
Measure Study N Mean age (range) Motor disability Reference comparison Methods (measurement units) TDC reference group 
Pedometers Kuo  2009 20 10.5 ± 3.0  years CP, diplegia GMFCS  I–III Walking distance and step count Three walking conditions – continuous, N = 20,  10.3 ± 2.8  years 
(AMP  and 
Minimod) 
 
Uptimer Pirpiris 2004 Reliability: 300 
Validity: 35 
(4–16 years) 
 
 
11 ± 3.9  years CP, spastic type, mix of 
motor distributions 
using direct observation 
 
 
Reliability: N/A  Validity: Energy 
expenditure measured with 
Cosmed K4 VO˙ 2 monitor 
structured lap walking, and stair climbing 
(distance and video recorded step count) 
 
Reliability: Uptimer worn for  four 24-h 
periods on weekdays, and 2 consecutive 
24-h periods of weekend. One 24-h period 
wore units on both legs and torso (% 
agreement) Validity: 10 min continuous 
walking (heart rate, energy expenditure) 
(4–16 years) 
 
 
N/A 
 
StepWatch Bjornson 2007   81 11.8 ± 1.3  years 
(10–13 years) 
 
CP, GMFCS  I–III  Manual step count Monitor calibrated during walking trial at 
2 visits (step count) 
 
N = 30,  11.9 ± 1.2 
 
 
Accelerometer 
(RT3) 
Van  Wely 2012 62 10.1 ± 1.8  years 
(7–13 years) 
 
Maltais 2005a 11 13.0 ± 2.2  years 
(10.6-16.3 years) 
CP, spastic type, 
GMFCS  I–III 
 
CP, spastic type, 
GMFCS  I–II 
Manual step count Monitor calibrated during walking trial at 
selected speed (step count) 
 
Heart rate monitoring Pilot data: Measured two weekdays, and 1 
weekend day (PAL [ratio of  total EE to 
resting EE]) 
N/A 
N/A 
(Actigraph) Clanchy 2011 30 12.6 ± 2.0  years CP, GMFCS  I–III  Energy expenditure measured 
with Cosmed K4b
2 
VO˙ 2 monitor 
Three walking conditions–comfortable, 
brisk and fast paced (Metabolic equivalent 
[MET]  values) 
N/A 
(Actigraph) Capio 2010a 31 9.71 ± 2.52 years 
(6-14 years) 
CP, mix of  motor 
types and distribution, 
GMFCS  I–III 
Direct observation using System 
for  observing ﬁtness time 
(SOFIT) and heart rate (HR) 
Measured during 30-min school break 
(activity level and time and HR) 
N/A 
 
HR FLEX Method   van den Berg- 
Emons 1996 
 
9 10.7 ± 1.6yr 
(8-13 years) 
 
CP, spastic diplegia or 
quadriplegia, 3 ambulant, 
6 wheelchair bound 
 
Energy expenditure using double 
labelled water technique 
(TEEDLW) 
 
Measured two weekdays, and 1 weekend 
day (energy expenditure) 
 
N/A 
Maltais 2005b 11 13 ± 1.4  years 
(10.6-16.3 years) 
CP, spastic diplegia or 
hemiplegia, GMFCS  I–II 
Energy expenditure measured 
with Vmax29 Sensor Medics 
Corp VO˙ 2 monitor 
Treadmill walking at 60,  75,  and 90% of 
maximal walking speed, HR monitor worn 
11 hrs daily for  six  days (PAL) 
N/A 
 
Sensewear Pro3 
Armband 
 
ND  ND  ND  ND  ND  ND  ND 
 
IDEEA  Aviram 2011 Validity: 21 
Reliability: 12 
 
6.41 ± 1.9  years 
(4-10 years) 
6.25 ± 1.3  years 
(4.5-8 years) 
 
CP, GMFCS  I–III  Energy expenditure measured 
with Cosmed K4b
2 
VO˙ 2 monitor 
 
Validity: Simulated everyday activities, 
treadmill walking and climbing stairs 
(energy expenditure) Reliability: repeated 
treadmill walking and climbing stairs 
 
N = 7,  7.25 ± 0.97 years 
(5.67-8.5 years) 
 
MARCA  Maher, 2008 16 (11–17 years) CP, GMFCS  I–III  Pedometer Measured week of  activity (steps, PAL) N/A 
 
PAQ-A  Maher 2007 20 13.9 ± 2.1  CP, GMFCS  I–V  Pedometer and accelerometer Measured over one week (steps and 
activity counts) 
 
N/A 
 
Questionnaires 
based on 
compendium 
for  physical 
activity 
 
ND  ND  ND  ND  ND  ND  ND 
 
Key: ND, no data; PAL, physical activity level; EE, energy expenditure; SOFIT, system for  observing ﬁtness time; GMFCS,  gross motor functional classiﬁcation system; FWS,  fastest walking speed. CV, coefﬁcient of 
variation. 
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Measure  Study  COSMIN 
Internal 
Consistency 
Reliability  Measurement 
error 
Content 
validity 
Structural 
validity 
Hypothesis 
testing 
Cross- 
cultural 
validity 
Criterion 
Validity 
Responsiveness 
Pedometers 
(AMP and 
Minimod) 
 
Kuo  2009 NA  ND  ND  ND  NA  NA  NA  Poor (0)      ND 
Uptimer Pirpiris 2004 NA  Good (++)     ND  ND  NA  NA  NA  Fair (+)  ND 
StepWatch Bjornson 2007     NA  ND  ND  ND  NA  NA  NA  Poor (0)      ND 
Van  Wely 2012   NA  ND  ND  ND  NA  NA  NA  Poor (0)      ND 
 
Accelerometer 
(RT3) 
 
Maltais 2005a NA  ND  ND  ND  NA  NA  NA  Poor (0)      ND 
(ActiGraph) Clanchy 2011  NA  ND  ND  ND  NA  NA  NA  Fair (+)  ND 
Capio 2010a  NA  ND  ND  ND  NA  NA  NA  Fair (+)  ND 
 
HR FLEX 
Method 
 
van den Berg- 
Emons 1996 
 
NA  Poor (0)  ND  ND  NA  NA  NA  Poor (0)      ND 
Maltais 2005b     NA                      ND                   ND                          ND              NA                  NA                     NA              Poor (0)      ND 
IDEEA              Aviram 2011       NA                      Poor (0)         ND                          ND              NA                  NA                     NA              Poor (0)      ND 
MARCA             Maher, 2008        ND                      ND                   ND                          ND              ND                  ND                     ND              Fair (+)        ND 
PAQ-A                     Maher 2007         ND                      Poor (0)         ND                          ND              ND                  ND                     ND              Poor (0)      ND 
Key: NA, not applicable; ND,  no data. 
 
 
climbing (Kuo et al., 2009). The Uptimer was found to have moderate criterion validity and good-excellent discriminative 
validity (5 m:  r = 0.7;  50 m;  r = 0.83; and 500 m:  r = 0.84; Pirpiris & Graham, 2004), and the StepWatch to  have excellent 
criterion validity compared to  direct observation (Bjornson et al., 2007). The  RT3 accelerometer demonstrated excellent 
criterion validity to  HR FLEX (Maltais, Pierrynowski, Galea, Matsuzaka, & Bar-Or, 2005) and the Actigraph accelerometer 
demonstrated  excellent classiﬁcation accuracy (Clanchy, Tweedy, Boyd,  & Trost, 2011). HR FLEX demonstrated a  good- 
excellent correlation to  doubly-labelled water (van den Berg-Emons et al.,  1996) and oxygen consumption (Maltais, 
Pierrynowski, Galea, & Bar-Or, 2005). For  subjective measures the PAQ-A demonstrated poor validity to  accelerometer 
counts and pedometer steps (Maher et al., 2007). 
New  evidence conﬁrmed the Actigraph accelerometer is strongly correlated to direct observation using the SOFIT during 
structured activity and free play,  and more accurate than HR to direct observation (Capio, Sit, & Abernethy, 2010). The IDEEA 
demonstrated excellent criterion validity compared to  oxygen consumption, though it signiﬁcantly over-estimated the 
energy expenditure during simulated daily tasks and comfortable walking (Aviram et al., 2011). The MARCA was found to be 
poorly correlated to  pedometer steps (Maher, 2008). The  StepWatch was conﬁrmed to  have excellent criterion validity 
against manual step counting (Van  Wely et al., 2012). 
 
3.3.2.  Reliability 
The  Uptimer, HR FLEX method, the IDEEA and the PAQ-A were the only instruments to  have evidence of reliability in 
primary school aged children with CP (Table 4). Much of the evidence for reliability has been reported in previous clinimetric 
reviews (Capio, Sit, Abernethy, & Rotor, 2010; Clanchy, Tweedy, & Boyd, 2011). The Uptimer demonstrated good agreement 
between two monitors on different limbs (Pirpiris & Graham, 2004). HR FLEX method was more reliable with three sampling 
days compared to  two (van den Berg-Emons et al.,  1996), and the PAQ-A demonstrated moderate to  strong inter-rater 
reliability (Maher et al.,  2007). New  evidence was found which demonstrated the IDEEA to  have excellent test–retest 
reliability for  walking and stepping tasks (Aviram et al., 2011). 
 
3.4.  Clinical  utility 
 
The clinical utility of included measures is provided in Table  4. Questionnaire based measures had the greatest clinical 
utility, with the PAQ-A and the MARCA scoring nine and eight respectively out of a possible score of 11. These measures were 
less  costly than the other included measures and produced rich  data that captured the intensity, duration, frequency and 
mode of physical activity over multiple days. Accelerometers had high clinical utility, with a score of 8.5 out of a possible 11, 
due to  the relatively low  cost of each unit at $250, and rich  data provided. 
 
4.  Discussion 
 
This  study aimed to systematically review the validity, reliability and clinical utility of HPA performance measures for 
primary school aged children with CP. All included measures except the Sensewear armband and questionnaires based on 
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Table 4 
Evidence of  validity, reliability and clinical utility in children with cerebral palsy aged 6–12 years. 
 
Measure  Study Validity Reliability Clinical utility 
 
Pedometers (AMP 
and Minimod) 
 
Kuo  2009  COSMIN: Poor (0) 
Criterion: (mean difference ± 2SD): 
AMP:  walking: -4.8 ± 15.3 m, 
-3.5 ± 13.45 steps; laps: -3.6 ± 15.6 m, 
-11.2 ± 28.85 steps; detected 85–100% 
of stair climb 
 
Minimod: walking: -0.4 ± 4.35 m, 
-0.4 ± 3.7  steps; laps: -2.3 ± 25.6 m, 
-38.7 ± 49.1 steps; detected  19–84% of 
stair climb 
 
ND  AMP: Unit cost $10–$50 = 1; 
analysis software 
required = 0; output: steps 
over multiple days = 2; 
acceptable = 1; ambulant 
only = 0; not specialist = 1; 
feasible = 1 Score = 6 
Minimod: Unit cost <$500 
(actual cost not available) = 1; 
analysis software 
required = 0; output: 
intensity, duration, frequency 
of  steps over multiple 
days = 4; acceptable = 1; 
ambulant only = 0; not 
specialist = 1; feasible = 1 
Score = 8 
 
Uptimer Pirpiris 2004 COSMIN: Fair (+) 
Criterion: Signiﬁcant moderate 
correlation with VO2 (r = 0.61; p < 0.05) 
 
COSMIN: Good (++) 
Intra-unit variability: 
Excellent agreement 
between monitors worn 
on same lower limb 
(r = 0.99 [0.89–0.99]) 
opposite limb (r = 0.98 
[0.91–0.99]); moderate on 
torso (r = 0.52 [0.45– 
0.67]). Within-child 
variability 1.9%,  between 
child variability  4.5% 
 
Unit cost $950 = 0.5; analysis 
software required = 0; 
output: duration of  upright 
time over multiple days = 2; 
acceptable = 1; ambulant and 
non-ambulant = 1; basic 
training = 0.5; does not reﬂect 
HPA therefore not feasible = 0 
Score = 5 
 
StepWatch Bjornson 2007 COSMIN: Poor (0) 
Criterion: (mean ± SD) 99.7 ±2.9% 
accuracy 
 
ND  Unit cost $510 = 0.5; analysis 
software required = 0; 
output: intensity, duration, 
frequency of  steps over 
multiple days = 4; 
acceptable = 1; ambulant 
only = 0; basic training = 0.5; 
feasible = 1 Score = 7 
Van  Wely 2012  COSMIN: Poor (0)  ND 
Criterion: (mean ± SD) 99.8 ± 3.4% 
accuracy 
 
Accelerometer (RT3)  Maltais  2005a  COSMIN: Poor (0) 
Criterion: Strong correlation (r = 0.88) 
between PAL and activity counts 
 
ND  Unit cost $250 = 1; analysis 
software required = 0; 
output: activity counts which 
are converted into intensity, 
duration, frequency of 
activity over multiple 
days = 4; acceptable = 1; 
ambulant and non- 
ambulant = 1; basic 
training = 0.5; feasible = 1. 
Score = 8.5 
(Actigraph) Clanchy 2011 COSMIN: Fair (+)  ND 
Criterion: sensitivity of 91%, speciﬁcity 
of 86%, ROC curve analysis of 94% (95% 
CI = 88.2–97.7%), classiﬁcation 
accuracy: moderate–vigorous activity 
91% of  time, sedentary activity 92% of 
time, light physical activity 67% of time 
(Actigraph) Capio 2010a  COSMIN: Fair (+)  ND 
Criterion: Structured activities: Strong 
correlation to observed ﬁtness time 
(SOFIT): (r = 0.75, R2 = 0.56, P < 0.001); 
moderate correlation to HR (r = 0.65, 
R
2 
= 0.43, p < 0.001); Free play: 
moderate  correlation to SOFIT: 
(r = 0.67, R2 = 0.45, p < 0.001); poor 
correlation to HR (r = 0.14, R
2 
= 0.02, 
p < 0.001) 
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Measure Study Validity Reliability Clinical utility 
HR FLEX van den Berg- COSMIN: Poor (0) COSMIN: Poor (0) Unit cost $100-$500 
 Emons 1996 Criterion: strong correlation to TEEDLW Coefﬁcient of  variation: (depends on monitor) = 1; 
  (r = 0.88). 56% (5 values) of  HR values 5%, mean analysis software 
  lying within ± 10% of doubly-labelled 
water 
TEEHR = 7.1  ± 0.35 MJ d
-1
, 
increased with three 
required = 0; output: 
provides output in HR to 
   sampling days (5.9 ± 5.8%) 
than two (13.5 ± 6.3%) 
(p = 0.05) 
calculate activity intensity, 
duration and frequency over 
multiple days = 4; chest strap 
    and calibration with oxygen 
    consumption required 
    therefore less acceptable = 0; 
    ambulant and non- 
    ambulant = 1; requires 
    specialist = 0; requires 
    individual calibration 
    therefore less feasible for 
    large sample = 0. Score = 6 
 Maltais 2005b COSMIN: Poor (0) ND  
  Criterion: moderate correlation to peak   
  oxygen uptake (r = 0.44); strong   
  correlation at 60%FWS (r = -0.84; 
p < 0.05), strong correlation at 75%FWS   
  (r = -0.80; p < 0.05), strong correlation 
at 90%FWS (r = -0.83; p < 0.05)   
Sensewear activity ND ND ND Unit cost $1355 = 0; analysis 
    output: intensity, duration, 
    frequency of  activity over 
    multiple days = 4; 
    acceptable = 1; ambulant and 
    non-ambulant = 1; basic 
    training = 0.5; no evidence for 
    children with CP therefore 
    not feasible = 0. Score = 6.5 
IDEEA Aviram 2011 COSMIN: Poor (0) COSMIN: Poor (0) Unit cost $4860 = 0; analysis 
  Criterion: strong correlations during Test–retest: excellent software required = 0; 
  simulated activities (r = 0.72), correlation for  treadmill output: intensity, duration, 
  comfortable walking (r = 0.70), faster walking (ICC:  0.998) and frequency of  activity over 
  walking (r = 0.88), and climbing stairs climbing stairs (ICC: multiple days as well as mode 
  (r = 0.75) 0.985) (walking, running, stairs and 
    sitting) = 5; requires 5 small 
    accelerometer sensors 
    connected by  wires,  IDEEA 
    microprocessor, and software 
    therefore less acceptable = 0; 
    records walking tasks at this 
    stage therefore ambulant 
    only = 0; specialist skills = 0; 
    limited battery life,  cost and 
    equipment mean less 
    feasible = 0. Score = 5 
MARCA Maher 2008 COSMIN: Fair (+) ND Unit cost free (arrangement 
  Criterion: Poor correlation to  with research team) = 1; 
  pedometer (r = 0.24–0.31, p < 0.01)  MARCA  software 
    required = 0; output: 
    intensity, duration, frequency 
    and mode of  activity over 
    multiple days = 5; 
    administration time of 
    30 min/day recalled 
    (typically 4 day recall = 2 hrs) 
    therefore less acceptable = 0; 
    ambulant and non- 
    ambulant = 1; basic 
    training = 0.5; feasible = 1. 
    Score = 8.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
monitor software required = 0; 
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Table 4  (Continued ) 
 
Measure Study Validity Reliability Clinical utility 
PAQ-A Maher 2007 COSMIN: Poor (0) 
Criterion: Poor correlation to 
pedometer step counts (r = 0.24) or 
accelerometer counts (r = 0.21) 
COSMIN: Poor (0) Test–
retest: moderate to 
excellent agreement for 
individual PAQ-A  items 
(ICC = 0.51–0.99) and 
excellent agreement for 
overall score (ICC = 0.90) 
Cost free (questionnaire and 
administration booklet 
downloaded from the 
Internet) = 1; no software 
required = 1; output: 
intensity, duration, frequency 
and mode of  activity over 
multiple days = 5; 
acceptable = 1; questions for 
ambulant children only = 0; 
no training = 1; feasible = 1. 
Total score = 10 
Questionnaires based 
on compendium for 
physical activity 
ND ND ND Cost free (self-made 
questionnaire and 
compendium for  physical 
activity for  conversion to 
energy expenditure) = 1; no 
software required = 1; 
output: intensity, duration, 
frequency and mode of 
activity over multiple 
days = 5; acceptable = 1, 
questions could be chosen to 
reﬂect both ambulant and 
non-ambulant children = 1; 
basic training to 
develop = 0.5; feasible = 1. 
Total score = 10.5 
Key: COSMIN, Cosmin score based on measurement property; ND, No data; SD, standard deviation; PAL, physical activity level; SOFIT, System for  Observing 
Fitness Time; HR,  heart rate; TEEDLW,  total energy expenditure measured using doubly labelled water technique; GMFCS,  Gross Motor Functional 
Classiﬁcation System; FWS,  Fastest walking speed. CV, Coefﬁcient of  variation. 
 
 
the compendium for  physical activity, had evidence of  criterion validity against an  objective measure of  HPA. Quality 
appraisal using the COSMIN checklist appraised all  studies between Fair  (+) to  Poor  (0)  in  quality for  this measurement 
property. Evidence for reliability of the included measurement instruments was limited, with only the Uptimer, HR FLEX 
method, PAQ-A and the IDEEA demonstrating evidence of reliability in this population. 
Of the four  instruments with evidence of both validity and reliability, no one  measure appears ideal to measure HPA. The 
Uptimer, while a highly valid and reliable instrument to  measure time spent in  an  upright or  standing position in  both 
ambulant and non-ambulant children, has poor clinical utility (score = 5/11) when measuring HPA as it cannot capture all the 
dimensions that constitute physical activity performance. The  Uptimer would lend itself well to  a  child with limited 
ambulation, where the aim  was to  increase weight bearing and upright stance, but would have limited utility for  HPA 
research as  it cannot provide information on  the intensity of the activity being performed or  capture activity other than 
upright stance. The HR FLEX method demonstrated a moderate to strong correlation to energy expenditure and was reliable 
with three days of sampling (Maltais, Pierrynowski, Galea, Matsuzaka, & Bar-Or, 2005; van  den Berg-Emons et al., 1996) 
however has  only moderate clinical utility (score = 6/11) as it requires individual calibration to the participant which can be 
costly and time consuming. This would limit its feasibility in studies requiring a large sample size (Freedson & Miller, 2000). 
In contrast, the moderate to  excellent reliability and excellent clinical utility of PAQ-A (score = 10/11) means it would be 
useful for large sample population based research, however this measure is restricted by its  poor correlation to  objective 
measures of HPA in children with CP. The PAQ-A is designed for adolescents however it was included in the current review as 
it had been administered to  children aged 11  with CP (Maher et al., 2007). The  Physical Activity Questionnaire for  Older 
Children (PAQ-C) could be a more robust measure for children of primary school age  as it was designed for this age  group, 
therefore further testing in this population is required (Kowalski, Crocker & Donon, 2011). The IDEEA is a new device that can 
not only detect energy expenditure and therefore physical activity, it can  also  be used to estimate temporal and spatial gait 
parameters  (Mackey, Stott, & Walt, 2008) and detect transition through functional activities in  young people with CP 
(Mackey, Hewart, Walt, & Stott, 2009). This means it has the potential to capture all dimensions of physical activity, including 
the mode of activity being performed. Its limited clinical utility (score = 5/11), particularly the cost (at almost $5000 per  unit) 
and acceptability of the device (with ﬁve  sensors and connecting wires), may limit its use  to measure HPA in a naturalistic 
environment over multiple days. 
Devices measuring step counts, such as  pedometers, are  widely used in population based research in TDC and adults. 
Measuring steps walked per  day  provides an outcome that is easily understood and can be modiﬁed by the user in real  time. 
As a result, this has  been the focus of many successful health promotion campaigns for adults (De Cocker, De Bourdeaudhuij, 
Brown, & Cardon, 2007; Tudor-Locke, & Bassett Jr, 2004) and may be an appropriate method to increase physical activity in 
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ambulant children with CP. A step counting device such as  the StepWatch may have an  advantage over conventional 
pedometers in that it also provides an indication of activity intensity, classifying steps at medium or high step rates, however 
further research is needed to establish its validity and reliability in primary school aged children with CP. It is also important 
to  consider whether increasing steps walked per  day  is  an  appropriate goal  for  children with CP. Neuromuscular and 
musculoskeletal impairments or pain may make increased walking a particularly challenging goal (Palisano, 2012). For non- 
ambulant children with CP, a waist or ankle mounted step counting device such as  a pedometer or  the StepWatch is not 
necessarily relevant for measuring physical activity. A wrist mounted accelerometer could be more appropriate though these 
devices have not been validated in this population. 
Accelerometers have the greatest volume of evidence to support their validity in measuring HPA in primary school aged 
children with CP. Three studies of Fair (+) to Poor  (0) quality consistently reported a strong to excellent correlation between 
accelerometer counts and an objective measure of physical activity (Capio, Sit, & Abernethy, 2010; Clanchy, Tweedy, Boyd, & 
Trost, 2011;  Maltais, Pierrynowski, Galea, Matsuzaka, & Bar-Or, 2005).  This  combined with their good clinical utility 
(score = 8.5/11) could make them an ideal choice in measuring HPA in primary school aged children with CP. Accelerometers 
have the ability to  provide the user with information on  activity intensity, frequency, duration, energy expenditure 
(calculated using algorithms), as well as step counts over multiple days using a small and relatively inexpensive device that is 
acceptable to most wearers. A major limitation is the lack of documented evidence of their reliability and responsiveness to 
change in the CP population. The reliability of accelerometers has  been well documented in TDC. Reliability improves with 
increased recording days (ICC: 0.45  for one  day to 0.9 for eight days; De Vries et al., 2009), however acceptable reliability has 
been found with four  days of monitoring (r = 0.75–0.78; Janz, 1994). Reliability is inﬂuenced by seasonal variation, with less 
activity performed in  winter months (ICC: 0.54; De  Vries  et al.,  2009), as  well as  age,  with primary school aged TDC 
participating in  more moderate to  vigorous physical activity on  weekends and exhibiting less  day-to-day variability in 
activity (Trost, Pate,  Freedson, Sallis,  & Taylor, 2000). While the evidence from TDC can  be used to cautiously estimate the 
reliability of  accelerometers in  primary school aged children classiﬁed as  GMFCS I, who can  ambulate independently, 
differences in energy cost of walking and alterations in gait  patterns may mean that accelerometers record differently in this 
population. Additionally, the validity and reliability for children with more profound CP, who have signiﬁcant impairments 
with gait  requiring a walking frame or who use  wheeled mobility, is likely to be very different from TDC. Therefore it seems 
essential that the reliability and responsiveness to change of accelerometers in both ambulant and non-ambulant primary 
school aged children with CP be  established. 
This review has uniquely utilised the COSMIN checklist to assess the methodological quality of included measures of HPA. 
While the COSMIN provides a rigorous and standardised tool  to  guide quality appraisal, there are  some limitations when 
evaluating measures of HPA. The  COSMIN provides criteria to  assess methodological quality. For  criterion validity, this 
includes a sample size  of 50  children to  achieve an  Excellent (+++) score. While this may be  appropriate for  lower cost 
subjective measures of HPA such as questionnaires, unit cost of objective measures is likely to prohibit widespread testing in 
large samples of children. None of the studies included in  this review provided a sample size  calculation and as  a result 
scored poorly. Another potential limitation of this review is that any  published evidence was included, even when the aim  of 
the study was not to establish the validity or reliability of the HPA instrument. For some studies only a small section in a 
methods  section of  a  paper describes the  psychometric properties and this resulted in  low   COSMIN  scores as  the 
methodological quality was unknown or limited. It is important to note that this does not necessarily reﬂect the true quality 
of the HPA measurement instrument, but is simply the quality of the available evidence at this time. This highlights the need 
for further research to accurately establish the validity and reliability of HPA measurement instruments in primary school 
aged children with CP. Additionally, many measurement properties that are  covered in the COSMIN checklist have not been 
examined, such as  responsiveness to  change. These are  essential properties to  know when measuring change in  HPA 
following an  intervention and require further research. 
Once  the measurement properties of the current tools are  established in this population, researchers can  consider the 
future direction of physical activity measurement in children with CP. For a children with mild impairments who are able to 
ambulate independently, the current tools are  most likely appropriate. However further reﬁnement of algorithms which 
account for the differences in biomechanics and the energy cost of activities in children with CP may improve their accuracy. 
Children who ambulate with external supports, such as crutches or a walking frame, or who use  wheeled mobility are  likely 
to have different measurement requirements. The biomechanics and energy cost of a child walking with a walking frame are 
different from a  child walking unsupported and current measurement tools do  not take this difference into account. 
Measurement tools should have the ability to  capture non-ambulatory activity, such as  upper-limb movement during 
wheelchair propulsion or seated activities. Finally, some children with CP will  use  a wheelchair as their primary means of 
mobility but ambulate short distances with or without a walking frame. Measurement tools should have the ﬂexibility to 
transition between seated and standing activity so that physical activity can  be  captured across all  GMFCS levels. 
 
5.  Conclusion 
 
This  review has  provided a detailed summary of the validity, reliability and clinical utility of HPA measures in primary 
school aged children with CP. While questionnaire type measures, such as the PAQ-A and the MARCA have excellent clinical 
utility, they are  limited by  poor correlation to  more objective measures of HPA, such as  pedometers or  accelerometers. 
Accelerometers provide a valid measure of HPA with good clinical utility; however they do not have documented reliability 
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in this population. Further research, with sufﬁcient subject numbers and appropriate statistical analysis, which assesses the validity and 
reliability of HPA measures in primary school aged children with CP appears critical. 
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3.3 Summary and conclusions 
This systematic review concluded that evidence of validity or reliability specific to primary 
school aged children with CP is limited, though accelerometers appear to be the most valid 
and clinically useful tool to measure physical activity in this population. When considering 
this evidence in the context of this doctoral program: 
i) Accelerometers have the greatest volume of evidence to support their validity in this 
population. These findings confirm those documented in the review by Clanchy et 
al27, that accelerometers provide the most robust information about the patterns of 
physical activity. This combined with their excellent clinical utility means that they will 
be used to objectively measure physical activity performance in children and 
adolescents with CP in the proposed trial. 
ii) There is no documented evidence to support the reliability of accelerometers in 
children and adolescents with CP. A study to establish their reliability in this 
population will be undertaken as part of this doctoral program. 
iii) Studies investigating the validity or reliability of physical activity measurement 
instruments in children with CP are of limited methodological quality, as evidence by 
low COSMIN scores. It should be noted, however, that for many of the studies the 
assessment of validity or reliability was not the primary aim.  
iv) The COSMIN checklist and the results of this study will be used to guide the 
development of the reliability study’s methodology, ensuring sufficient subject 
numbers and appropriate statistical techniques are employed. 
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Chapter 4. Variability in measuring physical activity in children with 
cerebral palsy using accelerometers 
4.1 Introduction to Chapter 4 
This chapter consists of the paper entitled “Variability in measuring physical activity in 
children with cerebral palsy”. The paper reported in this chapter discusses the results of a 
study determining the reliability of the ActiGraph® accelerometer in independently 
ambulant children and adolescents with unilateral CP. This study was conducted to 
describe the variability in measuring physical activity performance in the sample of 
independently ambulant children with unilateral CP undertaking the randomised trial. 
4.2 Paper 3: “Variability in measuring physical activity in children with 
cerebral palsy” 
This paper is published in Medicine and Science in Sports and Exercise and is reproduced 
with permission. 
 Mitchell L, Ziviani J, Boyd R. Variability in measuring physical activity in children with cerebral palsy. 
Medicine and Science in Sports and Exercise. 2014 May 12 [Epub ahead of print]. 
The material in this paper was also presented as a free paper at the 7th Biennial 
Conference of the Australasian Academy of Cerebral Palsy & Developmental Medicine, 
11th to 14th March 2014, Hunter Valley, Australia; and has been presented as a free paper 
at the 68th American Academy of Cerebral Palsy and Developmental Medicine Meeting, 
10th to 13th September 2014, San Diego, USA.  
Mitchell L, Ziviani J, Boyd R. Test-retest reliability of the ActiGraph
®
 accelerometer in children and 
adolescents with congenital hemiplegia: how much more activity is needed? Developmental Medicine and 
Child Neurology. 2014. 56 (S2):49. 
Mitchell L, Ziviani J, Boyd R. (2014) “Using ActiGraph accelerometers in children and adolescents with 
congenital hemiplegia: days of monitoring needed and test-retest reliability”. Developmental Medicine and 
Child Neurology. 56(S5): 53. 
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ABSTRACT: 
Introduction: To establish the variability in measurement of habitual physical activity 
(HPA) using the ActiGraph® GT3X+ accelerometer in children with cerebral palsy (CP). 
Method: Repeated measures: Independently ambulant children with unilateral CP (n=30; 
aged 11y 3m [2y 4m]) completed standardized tasks over two consecutive days wearing 
an ActiGraph®GT3X+ accelerometer and heart rate monitor. Testing protocol comprised 
five minutes of seated rest (REST), walking at light (LW), moderate (MW) and vigorous 
(VW) pace, and rapid stepping on/off a step (STEP). Agreement was calculated between 
days using intra-class correlation coefficients (ICC; two-factor mixed agreement model). 
Minimum detectable difference was calculated (MDD=[SD√1-ICC]x1.96x√2). Performance 
variability: Participants (n=102) wore an ActiGraph®GT3X+ accelerometer for four days in 
the community. Activity counts were converted into activity intensity using uni-axial derived 
cut points to classify the time spent in moderate-to-vigorous physical activity (MVPA). 
Between-day intra-class reliability coefficients (R) and Spearman-Brown prophecy formula 
(ICCdesired/[1-ICCdesired])([1-ICCestimated]/ICCestimated) were calculated.  
Results: Agreement between repeated measures was strong for light and MVPA 
(ICC=0.80). For MVPA, the MDD was 1412 counts∙minute-1. In the community, 345 days 
(87%) were recorded. Three days of monitoring produced acceptable variability estimates 
of MVPA (R=0.63-0.73). Spearman-Brown prophecy analysis estimated three days would 
achieve a reliability coefficient of 0.7, and 11 days would achieve 0.9.  
Conclusion: Measurement of HPA using the ActiGraph® GT3X+ accelerometer is reliable 
under controlled walking and stepping conditions, as well as in a community environment 
in independently ambulant children and adolescents with CP. 
 
Keywords: measurement, psychometrics, physical activity, hemiplegia 
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INTRODUCTION 
Cerebral palsy (CP) describes a group of disorders of development of movement and 
posture, causing activity limitations, attributed to non-progressive disturbances that occur 
in the developing foetal or infant brain and accompanied by progressive musculoskeletal 
conditions.(23) Cerebral palsy is the most common physical disability in childhood, with an 
incidence of around 2 per 1,000 live births.(19) There remains no cure for CP, meaning 
that an infant born with this condition will require a lifetime of investigations, interventions 
and equipment. This highlights the need to optimise health, function and fitness of 
individuals to promote life-long health. Participation in regular physical activity is an 
important determinant of physical, mental and social health in children and adolescents. 
Benefits can be seen in the development and maintenance of bone, muscle and joint 
health, in body composition and weight control, and in increasing cardio-respiratory fitness 
and cognitive performance. (32) There is some suggestion that additional benefits may 
also be afforded to persons with CP. These include the maintenance of physical function 
(22), and reduced incidence of chronic pain, fatigue and osteoporosis. (13) However, 
associated activity limitations and accompanying musculoskeletal conditions mean that 
children and adolescents with CP typically do not perform sufficient physical activity to 
meet international health recommendations.(16, 33) This may place these individuals at 
risk of secondary health problems associated with physical inactivity.  
Physical activity is described as any body movement using skeletal muscles that results in 
energy expenditure.(6) According to the International Classification of Functioning, 
Disability and Health framework (ICF), it is necessary to distinguish between an 
individual’s capacity (what they can perform at their best in a standardized controlled 
environment), and their performance (how they actually perform in the real world).(14, 31) 
When considering physical activity measurement within the ICF framework, physical 
activity capacity and performance are to be considered separate constructs. Measurement 
tools should be valid and reliable at measuring these constructs. Previous systematic 
reviews of the clinimetric properties of measures of habitual physical activity (HPA) 
suggest that accelerometers are a valid means of measuring HPA in children and 
adolescents with CP. A methods based on the RT3 accelerometer has demonstrated 
excellent criterion validity to heart rate.(17) In previous research, the ActiGraph® 
accelerometer has been strongly correlated to direct observation and more accurate than 
heart rate during structured activity and free play.(5) Previous research methods have 
confirmed that the ActiGraph® has excellent classification accuracy against oxygen 
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consumption during standardized tasks.(8) In this study, children and adolescents wore an 
ActiGraph® accelerometer and a Cosmed portable indirect calorimeter during four 
activities: quiet sitting, comfortable walking, brisk walking and fast paced walking. Receiver 
operating curve (ROC) analysis indicated that of four sets of cut-points evaluated, 
Evenson cut-points (12) had the highest classification accuracy for sedentary (92%) and 
MVPA (91%), and second highest classification accuracy for light activity (67%).(8) 
Accelerometers have excellent clinical utility, as they can provide the user with information 
on activity intensity, frequency, duration, energy expenditure, as well as step counts over 
multiple days using a small and relatively inexpensive (US$250/unit) device that is 
acceptable to most wearers. Accelerometers therefore seem ideal for measuring HPA in 
children and adolescents with CP.(7, 18) A major limitation, however, is the lack of 
documented evidence of their reliability in individuals with CP.  
Accelerometer reliability can be determined by research which uses either a mechanical 
apparatus, or a subject mounted design. Using mechanical apparatus, such as hydraulic 
shaker tables, researchers have demonstrated strong reliability and small intrinsic 
measurement error among accelerometer devices.(11) The ActiGraph® GT1M (Pensacola, 
FL, USA) has previously demonstrated good reliability for measuring both activity counts 
and steps using a mechanical shaker platform (coefficient of variation [CV]: intra-
instrument = 2.9% for counts and 1.1% for steps; inter-instrument = 3.5% for counts and 
1.2% for steps).(24) In contrast, subject mounted designs require the devices to be worn 
by a participant in either a free-living activity assessment or a laboratory-based activity 
assessment. These designs therefore test the variability in measurement of physical 
activity in the population of interest rather than the device per se. Under controlled 
laboratory-based assessments, collecting repeated measures of a standardised series of 
tasks allows variations in the recording of physical activity to be measured which can then 
be attributed to the participant. This seems particularly important for children with a 
movement disorder such as CP, as alterations in gait biomechanics may influence the 
ability of an accelerometer device to consistently record physical activity. To date this has 
not been established in children or adolescents with CP. The reliability of accelerometers 
has been well documented in children with typical development (TDC). Reliability improves 
with increased recording days (intra-class correlation coefficient [ICC] ranges from 0.45 for 
1 day to 0.9 for 8 days)(10) and has been found to be acceptable with 4 days of monitoring 
(r = 0.75-0.78).(15) Reliability is influenced by season, with less activity performed in 
winter months (ICC = 0.54)(10), as well as age, with primary school aged TDC 
 46 
 
participating in more moderate to vigorous physical activity on weekends and exhibiting 
less day-to-day variability in activity across weekends and weekdays.(28) While the 
evidence from TDC could be used to estimate the reliability of accelerometers in 
independently ambulant children and adolescents with CP, differences in the energy cost 
of walking and alterations in gait patterns may mean that accelerometers record HPA 
differently in this population. It is essential therefore, that the reliability of accelerometers 
be established during both laboratory-based and free-living activity assessments children 
and adolescents with CP.   
This study aimed to determine i) the variability in recording physical activity from repeated 
measurements under standardised laboratory-based conditions to establish the minimum 
detectable difference (MDD), and ii) the variability in MVPA and number of days of 
monitoring required to measure HPA performance in the community, using the 
ActiGraph®GT3X+ tri-axial accelerometer in independently ambulant children and 
adolescents with unilateral CP. 
METHODS 
Sample: This study describes 102 children from the Mitii™ Australia study.(3) The study is 
a waitlist controlled randomized trial investigating the effect of the web-based training 
program, Mitii™ (Move it to improve it). Children were aged 8 to 17 years with unilateral CP 
(impacting on one side of their body) classified at a Gross Motor Functional Classification 
System (GMFCS) I (walks independently without limitations) or II (walks independently but 
with some limitations to gross motor abilities and balance and requires external upper-limb 
support on stairs).(20) Children were excluded if they had undergone upper-limb 
Botulinum Toxin Type-A injections or surgery in the previous 2 or 6 months respectively, 
had unstable epilepsy or medical conditions that would prohibit them completing the Mitii™ 
training. For the collection of repeated measures under laboratory-based assessment 
conditions, a sample of 30 children was selected from the full cohort using consecutive 
series sampling. Sample size was calculated a priori based on a test-retest scenario with 
two repeated observations, α at 0.05, β at 0.2, to detect an ICC ρ1>0.6 (against a null 
hypothesis of ρ0 = 0.2), and it was determined that 27 participants were required.(30) Data 
were collected on 30 participants to account for attrition. Written and informed consent was 
obtained from parents or guardians as well as all participants greater than 12 years of age 
before entering the trial. Ethical approval was obtained by the Medical Ethics Committee of 
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the University of Queensland (2011000608) and The Royal Children’s Hospital Brisbane 
(HREC/11/QRCH/35). Trial registration number: ACTRN12611001174976. 
Instrumentation: For recording the agreement between repeated measurements under 
controlled laboratory-based assessment conditions, participants were fitted with an 
accelerometer and heart rate (HR) monitor. For measurement of performance variability in 
the community, participants were fitted with an accelerometer.  
Accelerometer: Accelerations were recorded using ActiGraph®GT3X+ tri-axial 
accelerometer (ActiGraph® Corporation, FL, USA). This device uses a three axis 
accelerometer and ActiGraph® proprietary digital filtering algorithms to measure the 
amount and frequency of human movement. The ActiGraph®GT3X+ records accelerations 
ranging in magnitude from ±6G’s. The accelerometer output is sampled by an Analog to 
Digital Convertor according to user settings, set to 100 Hz. Raw Actigraph® data was post-
processed in ActiLife™ software to convert activity counts in user defined time intervals, 
known as epochs, set to five seconds. Activity counts provide a real-time index of the 
intensity of physical activity performed. Greater intensity is reflected by higher activity 
counts. Before each trial, the ActiGraph® was initialized according to manufacturer 
specifications and placed on an elastic belt worn by the participant around the waist. The 
ActiGraph® was positioned on the mid-axilla line at the level of the iliac crest on the side of 
the body not impacted by neurological impairment. The same ActiGraph® unit was worn 
on the two consecutive days, however units varied between participants.  
Heart rate monitor: HR was recorded in five second epochs using a Polar RS400® monitor 
(Polar Electro Oy, Kempele, Finland). The monitor was positioned according to the 
manufacturer’s instructions with the chest strap moistened and placed around the chest in 
line with the middle of the sternum. 
Agreement between repeated measurements: 
Procedure: The agreement between repeated measurements of physical activity was 
collected by completing a standardized series of tasks on two consecutive days 
(approximately 45 minutes per day) whilst wearing an ActiGraph® accelerometer and 
concurrently measuring HR, fitted by an experienced physiotherapist using anatomical 
landmarks. Both devices were synchronised to an external timepiece and video recordings 
of the standardized tasks were taken to allow time coding. This occurred during the two 
day assessment and Mitii™ training portion of the study.(3) All testing were performed in a 
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climate controlled facility. Prior to data collection all participants were familiarised with the 
protocol. The testing protocol comprised an initial 5 minute seated rest period (REST), 
followed by standardized tasks (Table 1). Walking tasks were performed on a clearly 
defined linear 10m track (return lap = 20 metres). The speed at which the participant 
walked in each trial was verbally cued: for light paced walking (LW) participants were 
asked to walk for 5 minutes at a “slow and comfortable walking speed—like you do with 
friends at school”; for moderate paced walking (MW) participants walked for 5 minutes at a 
pace “like you are hurrying to get back to class after the bell has rung”; and for vigorous 
paced walking (VW), for 6 minutes “as fast as you possibly can without falling over or 
running”. Where required, during the walking trials, study personnel walked with the 
participant to monitor comfort and assist them to maintain a constant speed. Walking 
speed was calculated in real time by researchers noting the time taken to complete each 
20 metre lap of the walking track. When variations in walking speed occurred, this was 
noted and study personnel asked the participant to increase or decrease walking speed 
accordingly. Following the walking trials, participants completed a stepping task for 3 
minutes using a 20 cm aerobic step block, being instructed “to step on and off the step 
block as quickly as possible” (STEP). Between each task and at the conclusion of the 
protocol, participants rested for 5 minutes in a seated position watching a movie on a 
tablet device. The current procedure was based on that described in Clanchy et al.(8) The 
walking speed for these tasks was coded into activity intensity based on the available 
literature using pre-defined metabolic equivalent (MET) levels (8, 21) and confirmed in real 
time using direct observation and during analysis using HR monitoring. MET intensity of 
physical activities was classified as sitting watching TV 1.2 METs; walking with light effort 
2.9 METs; walking with moderate effort 3.6 METs; walking with hard effort 4.6 METs; and 
climbing stairs with moderate effort 7.0 METS.(21) 
Table 1. Standardized movement protocol and corresponding activity level 
Activity intensity 
level 
MET 
level 
Task 
Time 
(minutes) 
Lap speed 
(20m lap per 30 
seconds) 
Sedentary <1.5 REST 5 N/A 
Light >1.5-3 LW 5 ½ 
Moderate 3-6 MW 5 < 2 
Vigorous >6 VW 6 >2 ½ 
  STEP 3 N/A 
 (N/A: Not applicable; MET: metabolic equivalent; HR: heart rate; REST: seated rest; 
LW: light walking; MW: moderate walking; VW: vigorous walking; STEP: stepping on/off 
step-block) 
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Data reduction: After completion of the two days of testing, data from the respective 
instruments were downloaded to a personal computer. ActiGraph® activity counts were 
downloaded in ActiLife™ software v6 (ActiGraph® Corporation, FL, USA). HR data were 
downloaded using Polar ProTrainer5™ software (Polar Electro Oy, Kempele, Finland). 
Activity counts and HR data were synchronised using direct observation from the video 
recordings and data collated in Microsoft® Excel™ 2010 (Microsoft Corporation, USA). 
Synchronised activity counts and HR data from each participant were manipulated in 
MATLAB R2011a (MathWorks, MA, USA) to extract two minutes (48 epochs) of data from 
the end of each standardized task from each day, from between 30 seconds and 2 
minutes 30 seconds from the completion of each task. This time interval was chosen to 
allow for slight alterations in task time and HR is known to plateau at this time as steady 
state is reached.(2) Axis-1 (Y-axis) activity counts were converted to activity intensity using 
Evenson cut points (counts∙min-1: Sedentary≤100, light>100, moderate≥2296, 
vigorous≥4012)(12) to provide an activity intensity cut point level for each 5 second epoch.  
Statistical analysis: Agreement between repeated measurements was calculated using 
ICC between days for each task (two-factor mixed effects agreement model) from day 1 
and day 2, within each activity intensity bracket (sedentary, light = LW, moderate = MW, 
vigorous = VW and STEPS; and MVPA combining MW, VW and STEPS). Standard error 
of the mean (SEM) was calculated using SEM = standard deviation (SD)√1-ICC. Minimum 
detectable difference was calculated (MDD = SEMx1.96x√2).(1, 9) The correlation 
between activity counts obtained by the ActiGraph®, increase in HR for each task relative 
to resting heart rate and walking speed from video recordings was calculated using 
Pearson’s correlation coefficients (ρ). Classification accuracy was calculated by the 
percentage of agreement between ActiGraph® activity intensity and pre-determined task 
intensity.  
Performance variability: 
Procedure: Children received a calibrated ActiGraph® GT3X+ tri-axial accelerometer 
(ActiGraph® Corporation, FL, USA) to record physical activity. Children were instructed to 
wear the device for all waking hours for four days (comprising two weekend and two week 
days where possible). During this time, parents registered the wear time of the device, as 
well as recording activity patterns, on an activity diary provided.  
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Data reduction: After four days the device and activity diary were returned for data 
extraction and analysis. Data from the ActiGraph® were downloaded to a personal 
computer. ActiGraph® activity counts were downloaded in ActiLife™ software v6 
(ActiGraph® Corporation, FL, USA). All representative and complete data (where > eight 
hours of data was recorded each day) was included in the analysis. Device wear time was 
determined by visually inspecting the activity diary and comparing to ActiLife™ output.  
Where there were obvious differences in the accelerations recorded by the device and the 
diary the data in the diary was deemed to be incorrect and amended to reflect the new 
times. Where actual wear time was unable to be determined from the activity diary and 
activity counts values of zero occurred for >20minutes, this was set as non-wear time and 
excluded from the analysis. Days and times of device wear were noted in a log file and 
processed in ActiLife™, with non-wear time as determined by software algorithms 
excluded from the analysis. Axis-1 (vertical axis) activity counts were converted to activity 
intensity using Evenson cut points (vertical counts∙min-1: Sedentary<100, light>100, 
moderate≥2296, vigorous≥4012)(12) providing a total of daily time spent in each level of 
activity intensity.   
Statistical analysis: Variability was calculated using between-day intraclass reliability 
coefficients (R) and 95% confidence intervals (CI) using repeated measures analysis of 
variance (ANOVA). The required days of monitoring needed to achieve reliabilities of 0.70, 
0.80, and 0.90, respectively, were calculated using the Spearman-Brown prophecy formula 
(where [days of monitoring needed for desired reliability] = [ICCdesired/(1-ICCdesired)][(1-
ICCestimated)/ICCestimated]).(26) Sub-analyses were conducted to determine the difference in 
reliability estimates between children (aged 8-12 years) and adolescents (aged 13-18 
years). Data are mean (SD), activity counts are in counts per five second epoch unless 
stated otherwise. Data was analysed using IBM SPSS v22 (IBM Corp., NY, USA). 
RESULTS 
Sample characteristics: Participants were children and adolescents with congenital 
hemiplegia (52 males [51%]; mean age 11y3m [2y4m], range 8 – 17 year) classified at 
GMFCS levels I=44 and II=58. Of the 102 participants enrolled in the study, 99 completed 
a baseline assessment. Of those, 93 returned ActiGraph™ recordings (94%) and 357 of a 
potential 396 days were collected (90%).  In 12 instances, wear time was less than eight 
hours and excluded from the analysis, providing 81 children and 345 days (87%) for 
analysis of performance variability in the community. On average, children wore the device 
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for 11:44 (1:56) hours daily. The sample of participants for the repeated measurement 
study was representative of the larger sample. This sample were aged 8-17 years (mean 
11y11m [2y7m]) classified at GMFCS levels I (n=16) or II (n=14), contained 16 males 
(53%) and 13 with right hemiplegia (43%). Activity counts and HR data was collected on all 
30 participants with no missing data. 
Agreement between repeated measurements: Standardized task speed, Axis-1 activity 
counts and HR increased significantly with increasing task intensity compared to REST 
levels (Table 2). The average speed on Days 1 and 2 for SW was 1.43km/hr and 
1.41km/hr respectively, with an ICC of 0.98; for MW was 2.53km/hr and 2.51km/hr, with an 
ICC of 0.86; for VW was 3.95km/hr and 3.89km/hr, with an ICC of 0.90; and for STEPS 
was 64 repetitions and 67 repetitions with an ICC of 0.94. With the exception of HR during 
VW and STEP tasks, these were strongly and significantly correlated between days, 
indicating the standardized tasks were consistent across days (Table 2). Agreement 
between ActiGraph® calculated and standardized task activity intensity for each 5 second 
epoch was 80 - 98% during REST, LW, VW and STEP tasks, but only 17% during MW 
(Table 2). Overall agreement for MVPA was 64%. Mean counts per minute and walking 
speed correspond to the expected level of activity intensity of the standardized tasks 
(Table 2).  Agreement between repeated measures was strong for axis-1 activity counts 
under LW (ICC = 0.80) and MVPA (ICC = 0.80). When MVPA was broken down into 
standardised tasks, the agreement between repeated measures was strong under MW 
(ICC = 0.80) but reduced for vigorous intensity VW (ICC = 0.70) and STEP tasks (ICC = 
0.66; Table 3). Reliability for REST was unable to be calculated as activity counts were 
primarily 0 counts per epoch. MDD was 179 counts per minute for REST, 926 for LW, and 
1412 for MVPA (Table 3). 
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Table 2. Correlations between days for ActiGraph® Axis-1 activity counts, speed and heart rate by standardized tasks. 
Task 
Axis-1 counts 
Speed HR (bpm) Agreement 
Correlation day 1 and 2 (ρ) 
(counts/epoch) (counts/minute) Axis-1 counts 
Walking 
speed 
HR 
REST 0.5 (5.3) 6.0 N/A 87.8 (12.7) 98% N/A N/A N/A 
LW 52.9 (61.5) * 634.8 1.4 (0.5) 105.5 (14.1)* 80% 0.82 0.98 0.78 
MW 125.2 (82.4) * 1502.4 2.5 (0.4) 110.4 (15.1) * 17% 0.82 0.86 0.78 
VW 355.9 (107.1) * 4270.8 3.9 (0.5) 139.8 (18.4) * 94% 0.78 0.90 0.51 
STEP 286 (110.6) * 3432.0 64.8 (9.5) 139.6 (16.2) * 81% 0.84 0.94 0.45 
MVPA 254.57 (139.5) 3054.0 N/A 129.9 (20.9)* 64% 0.83 0.90 0.81 
Data are mean (SD); * p<0.05 compared to REST level; (HR: heart rate; bpm: beats per minute; Agreement: percent agreement between ActiGraph calculated and standardised 
task intensity; REST: seated rest; LW: light walking; MW: moderate walking; VW: vigorous walking; STEP: stepping on/off step-block; MVPA: combination of MW, VW and STEP 
tasks; N/A: Not applicable; speed: speed of walking in km/hour or stepping, in repetitions) 
 
 
 
Table 3. Agreement between repeated measures for ActiGraph® Axis-1 counts, and the minimum detectable difference in counts per minutes of 
physical activity 
Task 
Axis-1 counts SEM 
(counts/5 
sec epoch) 
MDD 
ICC 95% CI (counts/minute) 
LW 0.80 0.76 - 0.83  27.8 926 
MW 0.80 0.77 - 0.83  36.5 1214 
VW 0.70 0.66 - 0.74  58.5 1945 
STEP 0.66 0.60 - 0.72  64.3 2139 
MVPA 0.80 0.77 – 0.83 42.5 1412 
 (N/A: Not applicable; ICC: Intraclass correlation coefficient; 95% CI: 95% confidence 
intervals; SEM: standard error of mean; MD: minimum detectable difference; REST: seated 
rest; LW: light walking; MW: moderate walking; VW: vigorous walking; STEP: stepping 
on/off step-block; MVPA: MW, VW and STEP combined) 
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Performance variability: Between day intra-class reliability coefficients indicated that 
between three to four days of monitoring produced acceptable estimates of daily MVPA (R 
= 0.69 to 0.73; Table 4). Two days of monitoring produced more variability (R = 0.63 [0.44 
– 0.76]). Spearman-Brown analysis estimated that around three days of monitoring would 
be necessary to achieve a reliability coefficient of 0.70, and to achieve a reliability 
coefficient of 0.90, between 10 to 11 days of monitoring would be necessary. When 
comparing the variability estimates between children and adolescents there were 
considerable differences between groups. Adolescents 13 years and older were much less 
variable in their HPA performance between days, with two days providing acceptable 
estimates of daily MVPA (R = 0.72 [0.48 – 0.87]). Reliability estimates increased with 
increasing numbers of days monitored (Table 4). Children produced much more variable 
estimates of daily MVPA, with four days of monitoring required to produce acceptable 
estimates of daily MVPA (R = 0.73 [0.58 – 0.83]). Spearman-Brown analysis estimated 
that between three and four days of monitoring would be necessary to achieve a reliability 
coefficient of 0.70 in children with unilateral CP, and between one and two days for 
adolescents.  
 
Table 4. Performance variability in moderate to vigorous physical activity (MVPA) based on days 
of monitoring in children and adolescents with unilateral cerebral palsy 
  
Variability 
(Reliability coefficient [95% confidence intervals]) 
Days to 
achieve 
reliability of 
  Number 2 day 3 day 4 day 0.7 0.8 0.9 
Total 81 0.63 (0.44 - 0.76) 0.69 (0.56 - 0.79) 0.73 (0.61 - 0.82) 2.7 4.7 10.6 
Children 58 0.57 (0.28 - 0.74) 0.63 (0.43 - 0.77) 0.73 (0.58 - 0.83) 3.5 6.0 13.6 
Adolescents 23 0.72 (0.48 - 0.87) 0.74 (0.44 - 0.88) 0.78 (0.58 - 0.88) 1.8 3.1 7.0 
 
DISCUSSION 
This study aimed to establish variability of measurement of HPA performance in the 
community and determine the number of days of monitoring required using the 
ActiGraph®GT3X+ tri-axial accelerometer, as well as establishing underlying variability in 
recording physical activity in independently ambulant children and adolescents with 
unilateral CP through the collection of repeated measurements in a controlled 
environment. To our knowledge, this is the first time the reliability accelerometers has 
been established in children or adolescents with CP. Results indicate three days of 
monitoring is necessary to produce reliable estimates of MVPA. Furthermore, using the 
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current research method the ActiGraph® has moderate to strong agreement between 
repeated measures during standardized walking and stepping tasks in a controlled 
environment. This information is critical, as in order to accurately measure population 
based interventions to increase physical activity for young persons with CP, valid and 
reliable measurement tools are required.  
Agreement between repeated measures: There is limited published data supporting the 
test-retest reliability of the accelerometers in TDC or adults. One study has previously 
explored test-retest reliability in adults under free-living conditions, with good to excellent 
correlation (ICC = 0.70 - 0.90).(25) The current study utilised a standardised protocol in a 
controlled environment using repeated measures, meaning the results assess HPA 
capacity rather than performance in a free-living environment. However this was chosen to 
overcome methodological issues which have been present in previous research of HPA 
measurement in children with CP. Previous systematic reviews of measures of physical 
activity in children with CP have appraised study quality with the Consensus-based 
Standards for the selection of health Measurement Instruments (COSMIN) criteria (27), 
which offers a rigorous and standardized tool to guide study appraisal. However, when the 
COSMIN criteria have been applied, previous studies investigating the validity of measures 
of physical activity ranged from Fair to Poor in quality.(18) Were the COSMIN criteria 
applied to the current study, it would score Excellent in quality, therefore the results of this 
study can therefore be interpreted with confidence. The agreement between repeated 
measures demonstrated in the current study was moderate to strong, with ICC values of 
0.66 for stepping tasks and up to 0.80 for standardized walking tasks. The higher ICC 
values for light and moderate intensity walking tasks may be due to external pacing by 
study personnel. While children were verbally encouraged during the stepping task, there 
was no external pacing; meaning the actual speed and effort of the task may have varied 
between days depending on the motivation of the participant. This could also explain the 
lower ICC values for the VW standardized task compared to the slower walking speeds. 
Participants were verbally encouraged to walk more than 2½ laps per 30 seconds for this 
task, however were not asked to slow down if they were exceeding this pace. However, 
walking and stepping speed between days was similar with ICC values above 0.86. While 
some of the variability demonstrated may be due to differences in walking speeds, it may 
be that gait biomechanics in children with unilateral CP were variable during high intensity 
tasks between days contributing to a difference in recorded activity counts. Ankle foot 
orthotic use was consistent between days as this is known to change walking patterns,(4) 
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however while consistent and sturdy footwear was encouraged, in some instances children 
wore different footwear between days. Additionally, in many cases the time of the 
standardised assessment varied between days. It may be that children were more or less 
fatigued depending on the day’s activities and that muscle tone associated with increased 
effort and walking biomechanics were different as a result of this during the vigorous 
intensity tasks. This is important to consider when measuring physical activity performance 
in children with CP. In a community setting these factors are likely to change between 
recording days and may influence the accuracy of the device. However moderate to strong 
ICC values were recorded and as such the ActiGraph® and the analytical methods used 
within this study can be used with confidence to record HPA in the community. 
Performance variability: The results from this study suggest that overall variability in MVPA 
is similar between children or adolescents with CP and their typically developing peers. 
Research in TDC has shown that four days of monitoring has produced reliability 
estimates between 0.75 and 0.78.(15) Our results are comparable as overall estimates of 
variability for four days of monitoring was 0.73 (0.61 – 0.82). However, when examining 
the differences between children and adolescents, the results from this study are 
conflicting with TDC. Previous research in TDC has indicated that with three to four days 
of monitoring, reliability estimates for adolescents ranged from 0.64 to 0.66, and increased 
to 0.77 to 0.79 for children.(29) The results from this study suggests that children with 
unilateral CP demonstrate a wider variation in reliability estimates compared to 
adolescents (children: 0.57 – 0.73; adolescents: 0.72 – 0.78). These differences could be 
due to small subject numbers and an inequality between the number of children and 
adolescents in the current study. Given the larger number of children being monitored, a 
wider range of natural daily variation in children’s MVPA would have resulted. Alternatively 
this could reflect more consistent physical activity behaviours in adolescents with CP. 
Previous research has indicated physical activity performance typically declines with age 
(29), so it may be that more consistent sedentary behaviour was demonstrated resulting in 
less variability. Further research is required to confirm these results in adolescents with 
CP.  
 Limitations: There are some potential limitations to this study which must be 
acknowledged. Accelerometers were worn for a maximum of four days so it is unclear 
what the reliability would be for longer periods of time. However acceptable reliability was 
found with three days of monitoring and did not improve greatly with four days. Therefore it 
could be assumed that additional days would not improve the reliability significantly. In the 
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current study, the agreement between repeated measurements has only been tested 
during walking and stepping tasks under controlled conditions. The standardized tasks 
used in the current study were chosen based on the protocol by Clanchy and 
colleagues(6) where the validity of the ActiGraph® has been established against oxygen 
consumption. The validity during other tasks, such as running or jumping, or during a free-
living situation has not been established in this population and requires further research. It 
is also important to note that the results only apply to independently ambulant children and 
adolescents with unilateral CP. The validity and reliability of accelerometers in individuals 
with different motor distributions or classified at different GMFCS levels, such as those 
who walk with walking aids or require physical assistance, has not been established. 
Walking patterns and energy expenditure levels are likely to be quite different between 
independently ambulant children and those with more severe motor impairments; therefore 
it is important to determine the validity and reliability of HPA measurement instruments 
specific to each group.  
 Conclusions: Accelerometers have been previously shown to be valid and clinically 
useful tools for measuring physical activity in children and adolescents with CP.(7, 8, 18) 
This study has demonstrated that at least three days of monitoring using the ActiGraph® 
GT3X+ tri-axial accelerometer appears necessary to produce reliable estimates of MVPA 
performance in the community. Accelerometers would seem an ideal tool to measure 
physical activity in the community and could be used to accurately record changes over 
time or following an intervention in independently ambulant children and adolescents with 
unilateral CP.  
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4.3 Summary and conclusions 
This study concluded that ActiGraph® accelerometers are reliable instruments for detecting 
physical activity in independently ambulant children and adolescents with unilateral CP. 
When considering this evidence in the context of this doctoral program: 
i) The results from this study suggest that overall variability in MVPA are similar 
between children or adolescents with CP and their typically developing peers. 
ii) Children (8-12 years) with unilateral CP demonstrate a wider variation in reliability 
estimates compared to adolescents (13-18 years), requiring more days of monitoring 
to obtain a reliable estimate of physical activity compared to adolescents with CP. 
Overall, three days of monitoring within the community are required to produce a 
reliable estimate of physical activity performance in children and adolescents with 
CP. 
iii) The agreement between repeated measures demonstrated in the current study were 
moderate, with ICC values of 0.66 for stepping tasks and up to 0.80 for standardized 
walking tasks. Large variation in activity counts between repeated measures resulted 
in a large minimum detectable difference (MDD) for MVPA. This is important to 
consider within the randomised trial, as a large increase in physical activity would be 
needed to be significant.  
iv) The ActiGraph® accelerometer is an ideal tool to measure physical activity in the 
community and could be used to accurately record changes over time or following an 
intervention in independently ambulant children and adolescents with unilateral CP. 
v) This study in combination with evidence of validity and clinical utility presented in 
Chapter 3, confirms that accelerometers will be used to objectively measure physical 
activity performance over four consecutive days in independently ambulant children 
and adolescents with unilateral CP in the proposed randomised trial. 
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Chapter 5. Performance of habitual physical activity 
5.1 Introduction to Chapter 5 
This chapter consists of the paper entitled “Habitual physical activity performance of 
independently ambulant children and adolescents with cerebral palsy: are they doing 
enough?” The paper reported in this chapter describes and discusses the results of a 
study which describes the patterns of physical activity in independently ambulant children 
and adolescents with unilateral CP and provides a comparison to national physical activity 
recommendations. This study was conducted to determine the extent to which physical 
inactivity was present in the sample of children with unilateral CP undertaking the 
randomised trial. 
5.2 Paper 4: “Habitual physical activity performance of independently 
ambulant children and adolescents with cerebral palsy: are they 
doing enough?” 
This paper has been accepted for publication in Physical Therapy. 
 Mitchell L, Ziviani J, Boyd R. Habitual physical activity performance of independently ambulant 
children and adolescents with cerebral palsy: are they doing enough? Physical Therapy. Accepted 25 
September 2014. 
The material in this paper has also been presented as a free paper at the 7th Biennial 
Conference of the Australasian Academy of Cerebral Palsy & Developmental Medicine, 
11th to 14th March 2014, Hunter Valley, Australia; and presented as a poster at the 68th 
American Academy of Cerebral Palsy and Developmental Medicine Meeting, 10th to 13th 
September 2014, San Diego, USA.  
Mitchell L, Ziviani J, Boyd R. Habitual physical activity performance of independently ambulant children 
and adolescents with cerebral palsy: are they doing enough? Developmental Medicine and Child 
Neurology. 2014. 56(S2):49.  
Mitchell L, Ziviani J, Boyd R. (2014) Patterns of habitual physical activity performance in independently 
ambulant children and adolescents with congenital hemiplegia. Developmental Medicine and Child 
Neurology. 56(S5): 24. 
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ABSTRACT: 
Background: Despite the health benefits of regular physical activity, children with cerebral 
palsy (CP) are thought to participate in reduced levels of physical activity.  
Objective: To assess physical activity and determine the proportion complying with the 
recommended 60 minutes of moderate to vigorous physical activity (MVPA) daily in 
independently ambulant children and adolescents with unilateral CP. 
Design: Cross sectional study. 
Method: Children (n=102, 52 males, mean age 11y3mo[2y4mo]) with spastic hemiplegia 
classified at Gross Motor Functional Classification System (GMFCS) levels I=44 and II=58 
recorded physical activity over four days using ActiGraph®GT3X+ accelerometers. Activity 
counts were converted into daily and hourly time spent inactive and in light or MVPA using 
uni-axial cut points (inactive: ≤100; light: 101-2295; MVPA: ≥2296 vertical counts∙min-1) 
and recorded step counts. Differences between groups were examined using t tests 
(p<0.05).  
Results: Of a potential 396 days, 341 days were recorded (86%) with an average wear 
time of 11:44(1:56) hours. On a typical day, participants recorded 438(234) counts∙min-1, 
7541(3894) steps, spent 8:36(1:09)hrs inactive, 2:38(0:51)hrs in light activity, and 
0:44(0:26)hrs in MVPA. Only 25% of participants met the recommended level of MVPA on 
at least one day. Physical activity was highest in boys (vs girls; p<0.001), children (vs 
adolescents p<0.001) and on weekdays (vs weekends; p=0.05).  
Limitations: Participants were limited to children classified GMFCS I-II and with unilateral 
spasticity. 
Conclusions: The majority of independently ambulant children with unilateral CP do not 
perform sufficient physical activity to meet public health recommendations.   
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INTRODUCTION 
Modern lifestyles mean that children and adolescents spend an increasing amount of time 
sedentary, including watching TV, computer and game-console use, or sitting in an 
automobile, which will typically displace more active behaviours. This is concerning as 
regular physical activity is essential for children and adolescents with patterns of physical 
activity acquired during childhood more likely to be maintained in adult life.(1) As a result, 
many countries have adopted guidelines which suggest all children and adolescents, 
including where possible those with disabilities, should engage in at least 60 minutes of 
moderate to vigorous physical activity (MVPA) every day, and limit sedentary screen time 
to less than two hours.(2, 3) The adoption of recommendations for both MVPA and 
sedentary time reflects the independent risks associated with these behaviours.  
Insufficient physical activity and increased sedentary time are often found in tandem but 
are different constructs, and the detrimental health consequences associated with 
prolonged sedentary behaviours are thought to be independent of the protective effect of 
regular MVPA.(4)  
Cerebral palsy (CP) describes a group of disorders of the development of movement and 
posture, causing activity limitations, which are attributed to non-progressive disturbances 
that occurred in the developing infant brain.(5) As CP is the most common physical 
disability of childhood(6), encouraging regular participation in physical activity is an 
important health promotion consideration. Physical activity is described as any body 
movement using skeletal muscles that results in energy expenditure.(7) Participation in 
regular physical activity is important for physical, mental and social health in children and 
adolescents(1), with additional benefits for persons with CP, including the maintenance of 
physical function(8) and reduced incidence of chronic pain, fatigue and osteoporosis.(9) 
Despite the known health benefits of engaging in regular physical activity, people with CP 
are generally less physically active compared to children with typical development 
(TDC)(10)  or children with other physical disabilities.(11) Only 7-11% of children and 
adolescents with CP reported meeting the recommend levels of physical activity measured 
using subjective questionnaires.(12-15) There are, however, limitations with using parental or 
self-report questionnaires. These are dependent on accurate observation and recall of 
physical activity and while formal structured activities, such as organised sport or physical 
education classes, may be accurately captured using this method, incidental or 
unstructured physical activity can be missed.(16) This is particularly important for children, 
 64 
 
who typically engage in short bursts of intensive physical activity interspersed with varying 
intervals of low to moderate activity.(16)  
An alternative method to assess physical activity is using objective activity monitors, which 
are worn by the user over a number of days recording movement in real time. 
Accelerometer based activity monitors are commonly used, as they provide a valid method 
to measure physical activity in children with CP.(17, 18) These devices detect accelerations 
in one to three orthogonal planes (vertical, medio-lateral and antero-posterior) registering 
movement and storing them as ‘activity counts’, which can be converted into interpretable 
output regarding physical activity amount and intensity using cut-points. There is a growing 
body of evidence which supports the idea that children and adolescents with CP are not 
sufficiently physically active measured using accelerometers.(19-25) The ActiGraph® 
accelerometer (ActiGraph® Corporation, FL, USA), is one of the most widely used activity 
monitors in scientific peer reviewed publications in TDC(26) and is increasingly being used 
to record physical activity in children with CP.(21, 25) It is also one of the few accelerometer 
based devices used to record physical activity in children with CP which has evidence to 
support its reliability(27) and has been validated against oxygen consumption in ambulant 
children and adolescents with CP.(28) This validity study determined that Evenson(29) 
vertical-axis activity counts are able to accurately classify sedentary (92%) and MVPA 
(91%) in ambulatory children and adolescents with CP.(28) The feasibility of using the 
accelerometers in children with CP, was first established in a group of 23 adolescents 
classified at Gross Motor Functional Classification System (GMFCS) levels I to IV.(21) In 
this study, daily MVPA was 30.7 minutes, corresponding to 4.5% of monitoring time, with 
independently ambulant adolescents (GMFCS I-II) more physically active than those using 
a walking aid or wheelchair (GMFCS III-IV).(21) Sedentary time has since been assessed 
using the same type of accelerometer in 17 ambulatory (GMFCS I-III) children and 
adolescents with CP, presenting with a mix of motor types and distributions.(25) In this 
study, children with CP were significantly more sedentary and took fewer breaks from 
sedentary time than matched typically developing controls.(25) While these studies provide 
important information about physical activity in children with CP,  there are some potential 
limitations due to the heterogeneity of the samples and small sample size, as physical 
activity levels are thought to be influenced by GMFCS and motor distribution.(19) It would 
be useful to explore physical activity in a more homogeneous group of children and 
adolescents with CP.  
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The current study aims to assess physical activity of independently ambulant (GMFCS I-II) 
children and adolescents with unilateral CP using the ActiGraph®GT3X+ tri-axial 
accelerometer and to determine the proportion complying with the recommended level of 
MVPA (60 minutes daily). Additionally, this study aims to explore physical activity and 
inactivity in this population by comparing: 1) GMFCS level I and II; 2) children and 
adolescents; 3) boys and girls; and 4) weekdays and weekend days.  
METHOD 
Participants: This study describes a cross-sectional analysis of baseline assessments from 
102 children from the Mitii™ Australia study for which recruitment, methods, outcome 
measures, their psychometric properties and analysis has been described in detail in the 
study protocol.(30) In brief, this is a waitlist controlled randomized trial investigating the 
effect of the web-based training program, Mitii™ (Move it to improve it). Participants were 
aged 8-17 years with unilateral CP, classified at a GMFCS I-II (I: walks independently with 
aids and can climb stair without a handrail; II: require upper-extremity assistance to climb 
stairs but walk independently without aids).(31) All children presented with spastic motor 
type and unilateral distribution of CP (hemiplegia). As Mitii™ is a primarily upper-limb 
intervention, children were excluded or delayed if they had undergone upper-limb 
Botulinum Toxin Type-A injections or surgery in the previous 2 or 6 months respectively, 
had unstable epilepsy or medical conditions that would prohibit them completing the Mitii™ 
training. Written and informed consent was obtained from parents or guardians and all 
participants older than 12 years of age before entering the trial. Ethical approval was 
obtained by the Medical Ethics Committee of the University of Queensland (2011000608) 
and The Royal Children’s Hospital Brisbane (HREC/11/QRCH/35). Trial registration 
number: ACTRN12611001174976.  
Procedure: Participants received an ActiGraph®GT3X+ tri-axial accelerometer (ActiGraph® 
Corporation, FL, USA) to record physical activity. Each accelerometer was initialized 
according to manufacturer specifications to record step counts and accelerations at 100 
Hz. Accelerometer units were fitted during assessment on an elastic belt that was worn by 
the participant around the waist. Children were instructed to wear the belt so that the 
accelerometer unit was positioned on the mid-axilla line at the level of the iliac crest on the 
side of the body least impacted by neurological impairment and to wear the device for all 
waking hours for four consecutive days (including two weekend and two week days where 
possible). During this time, parents registered the wear time of the device on an activity 
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diary provided. After four days the device and activity diary were returned for data 
extraction and analysis.  
Data reduction: Activity counts from the accelerometer were downloaded to a personal 
computer and manipulated in ActiLife™ software v6 (ActiGraph® Corporation, FL, USA). 
Device wear time was validated by visually inspecting the activity diary and comparing to 
ActiLife™ output. All representative and complete data (where at least one day of >eight 
hours of data was recorded each day) was included in the analysis. Activity counts values 
of zero occurring for >20 minutes determined using software algorithms was set as non-
wear time and excluded from the analysis. Vertical axis activity counts were converted to 
activity intensity using Evenson cut points(29) to classify activity counts as inactive (≤100 
counts∙min-1), at light intensity 101-2295 counts∙min-1), and MVPA (≥2296 counts∙min-1). 
To account for differences in wear time between participants, activity was normalized to 
actual monitoring time to calculate minutes per hour, and daily time spent in each activity 
state was calculated using a 12 hour standardized wear time. The pattern of physical 
activity throughout a day was determined by plotting the mean vertical axis counts∙min-1 for 
each hour of the day against time (6am to 9pm), by age group (child <13 years and 
adolescent ≥13 years), sex, and day type.  
Statistical analysis: Data was collated in Microsoft® Excel™ 2010 (Microsoft Corporation, 
USA) and analyzed using IBM SPSS v22 (IBM Corp., NY, USA). Data was examined for 
normality by visually inspecting histograms and with the Shapiro-Wilk test which revealed 
all variables were normally distributed. Descriptive statistics were calculated for all 
variables. The proportion of participants meeting the recommended level of MVPA (60 
minutes) on at least one recorded day was calculated (%). As data were normally 
distributed and had equal variances, paired (day type) and independent (GMFCS, age, 
sex) two-sided t-tests were calculated. Data are presented as mean (one standard 
deviation); ɑ was set at 0.05. 
RESULTS 
Participant characteristics: Of the 102 participants enrolled in the study, 99 completed a 
baseline assessment. Of those, 91 returned valid and complete accelerometer recordings 
(92%) and 341 days of a potential 396 days were collected (86%). Participants were 
children and adolescents with unilateral CP with 48 males, mean age of 11y3mo (2y4mo) 
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and classified at GMFCS levels I=44 and II=47. Personal characteristics are presented in 
Table 1.  
Physical activity and compliance with the recommended level of MVPA: Physical activity 
levels and compliance the recommended level of MVPA are presented in Table 2. On 
average, participants wore the monitor for 11:44 (1:56) hours daily and recorded 438 (234) 
counts∙min-1, took 7541 steps, spent 8:36 (1:09) hrs (72% of recorded time) inactive 
corresponding to 43.1 minutes per hour, 2:38 (0:51) hrs light activity (22% of recorded 
time), and 0:44 (0:26) hrs (6% of recorded time) in MVPA corresponding to 3.7 minutes 
per hour (Table 2) Only 25% of participants met the recommended level of MVPA on at 
least one day (Table 2).   
Physical activity by GMFCS, age, sex and day type: Physical by GMFCS, age, sex and 
day type are presented in Table 2. There were no significant differences in physical activity 
between children classified at GMFCS levels I and II, children were significantly more 
physically active than adolescents, boys were significantly more physically active than 
girls, and there were more steps recorded on weekdays than weekend days (Table 2). The 
pattern of physical activity over a typical day is presented in Figure 1. Boys’ generally 
recording higher activity counts throughout the day than girls, and this pattern remained 
consistent across day types (Figure 1).The pattern of daily physical activity was similar 
between age groups, though children were more active than adolescents throughout most 
of the day (Figure 1). When comparing by day type, weekdays were characterized by 
peaks and troughs of activity, with participants demonstrating higher volumes of MVPA at 
8am, 1pm, and 3-5pm and were most sedentary at 9am and 7-9pm, whereas weekend 
MVPA peaked between 10am-2pm (Figure 1).  
DISCUSSION 
Recommendations for healthy levels of physical activity suggest that 60 minutes of MVPA 
is required on a daily basis for children and adolescents. The results of the current study 
suggest that the majority of independently ambulant children and adolescents with 
unilateral CP are not sufficiently physically active to meet these recommendations, with 
only 25% participating in 60 minutes of MVPA on at least one day of monitoring and on 
average recording 0:44hrs in MVPA. The proportion of children participating in 60 minutes 
of MVPA daily, while somewhat alarming, is comparable to a study which also utilised 
uniaxial accelerometers, where 26% of children engaged in more than 60 minutes of 
 68 
 
MPVA on at least one day of monitoring.(21)  However, despite using objective 
accelerometers to record physical activity, few children participated in 60 minutes of MVPA 
on one day of the sampling period and were daily compliance assessed, the proportion of 
participants performing 60 minutes MVPA each day would likely reduce further. Currently 
the physical activity guidelines stipulate times for MVPA and sedentary time, but it is 
unclear what role light physical activity has in the health of children. In the current study, 
on average children with CP recorded 2:38hrs of light activity daily, which when combined 
with 0:44hrs of MVPA may in fact be sufficient to promote long term health. Considering 
the role of light physical activity seems particularly relevant for children with CP where 
musculoskeletal impairments and altered biomechanics may mean that achieving 60 
minutes of MVPA daily is not an appropriate goal. Further research which links physical 
activity to long term health outcomes and which considers the individual requirements of 
children with CP seems necessary to determine what level of physical activity is truly 
recommended for this population and if a combination of light and MVPA is sufficient to 
improve health.  
Recently, there has been interest in quantifying sedentary time in children with CP(32) as 
increasing evidence details the negative effects that prolonged inactivity has on 
cardiovascular and metabolic systems which appears to be independent of the amount of 
exercise a person undertakes.(33) Sedentary behaviour refers to any waking activity 
characterised by a low energy expenditure (≤1.5 metabolic equivalents) while in a seated 
or reclining posture.(34) If this definition is considered, despite being validated against 
energy expenditure in children with CP(28), accelerometers cannot truly determine if a 
person is sedentary as they do not provide a direct measurement of energy expenditure 
nor can they describe the posture of the wearer. Furthermore, is unclear whether a child 
with CP is in fact even sedentary while in a seated position, as postural instability and the 
muscle activation required to maintain the posture may result in an energy expenditure 
greater than 1.5 metabolic equivalents.(32) While more research is required to define 
sedentary behaviour in children with CP, the current study provides important insights on 
physical inactivity in this population. Participants in the current study were inactive for 72% 
of a typical day, with inactivity highest in adolescents and girls. Previous studies have 
found similar findings of physical inactivity, with ambulatory children and adolescents with 
CP significantly more inactive taking fewer breaks from sedentary time compared to 
typically developing controls (25) and spending almost 80% of their time inactive.(23, 35) While 
the participants in the current study were more physically active, these levels are alarming 
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when combined with the low levels of physical activity, especially in the context of these 
children representing some of the most physically able children with CP. Consistent with 
published literature(23, 24, 36) there were no differences in physical activity between GMFCS 
I and II in the current study. However, physical activity levels have been shown to reduce 
with increasing GMFCS level(19, 21, 37) and with bilateral distribution of motor impairment(19), 
which would likely result in a greater reduction in physical activity were these children 
included in the current study.  
Ambulatory activity has previously been assessed in children with CP, recording on 
average 9586 steps daily, ranging from 10,680 steps for children classified at GMFCS I to 
5734 steps for children classified GMFCS III(19) and 6342 steps per day for adolescents.(38) 
While research is necessary to validate the step counting feature of the accelerometer 
used in the current study, our results and previous evidence(19,20,38) suggest that children 
and adolescents with CP are not performing sufficient ambulatory activity to meet the 
suggested 12,000 to 15,000 steps per day recommended for TDC.(39)  
Consistent with previous research in children with CP (19, 37) and TDC(40), children were 
more physically active than adolescents. Physical activity was significantly greater in 
males compared to females, which is also consistent with TDC.(41) While levels of physical 
activity were similar between weekdays and weekend days, participants recorded more 
step counts and were more likely to meet the recommended level of MVPA on a weekday, 
consistent with previous evidence in children with CP(19) and TDC.(42) Similar to evidence in 
TDC(40), the daily pattern of physical activity differed by day type, with hourly activity counts 
illustrating that weekday physical activity is characterised by deep peaks and troughs, 
most likely representing periods sitting sedentary in a classroom, interspersed with free 
play opportunities during breaks as well as before or after school. Boys appear to be more 
active during these breaks, with higher peaks than girls, returning to similar levels of 
activity during sedentary periods. Weekend activity fluctuates less throughout a typical 
day. This is likely to represent less structured activity compared to weekdays, though boys 
do exhibit higher weekend activity levels between 8am and 11am, suggestive of organised 
sport or active tasks being performed at this time.  
Limitations:  There are some potential limitations to this study which must be 
acknowledged. Compared to physical activity research in TDC, which often include 
hundreds of subjects, our subject numbers were small. Obtaining accelerometer data from 
a larger population would be costly (with units costing US$250 each) and accessing a 
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larger group of children with CP would require coordination with multiple service providers.  
The exclusion criteria included children with recent upper limb Botulinum Toxin Type-A 
injections, but did not consider lower limb interventions which had the potential to influence 
physical activity. Additionally, screen time was not recorded and physical activity was 
collected for a maximum of four days, which while reliable to record physical activity in 
children and adolescents with CP(27), may mean that additional activity may have been 
missed that could have been captured with additional days. Participants were also 
restricted to those with a unilateral motor distribution to create a more homogeneous 
sample, limiting the risk of bias. It should be noted that hemiplegia is the common motor 
distribution, with spastic hemiplegia representing between 21-40% of the population with 
spasticity and 60% with other motor types.(6) Further research to confirm similar patterns 
and levels of physical activity in children with bilateral CP or those who are not 
independently ambulant would be useful. It should be noted that there is the potential for 
inflated Type I error rate as multiple t-tests were conducted. 
Clinical Implications: The results of the current study suggest that the majority of 
independently ambulant children and adolescents with unilateral CP are not sufficiently 
physically active to meet the recommended level of MVPA, with physical inactivity most 
problematic in girls, adolescents and on weekends. Interventions targeting an increase in 
physical activity should ideally target these more vulnerable groups. Research suggests 
that physical activity interventions should identify the barriers and facilitators of physical 
activity specific to each individual and troubleshooting ways these can be overcome or 
accommodated to encourage physical activity participation(43) This can be a complex 
process as many barriers to participation in physical activity have been identified in 
children with CP and disability more broadly, including personal characteristics such as 
self-esteem and perceived competence in sports and physical activity; family 
characteristics, such as lifestyle, available time, positive role modelling, and financial 
resources; as well as community support, including nearby facilities, transportation, 
suitable activity programs, equipment, or social support.(43, 44) Clinicians and policy makers 
need to consider strategies to overcome the barriers to participation in physical activity to 
promote lifelong health in children and adolescent with CP. 
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Table 1. Characteristics of participants included in study 
(N=102) 
  Number (n) 
GMFCS 
      I 44 
     II 58 
Sex 
      Females 50 
     Males 52 
Side of hemiplegia 
      Left 50 
     Right 52 
Age (y, mo), mean (SD) 11y 3mo (2y 4mo) 
     Children (<13 years) 69 
     Adolescents (≥13 years) 33 
Height (cm), mean (SD)  148.4 cm (13.9 cm) 
KEY:  Data are number or mean (SD). KEY: GMFCS: 
Gross Motor Functional Classification System. 
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Table 2: Daily and hourly physical activity in independently ambulant children with unilateral cerebral palsy and by GMFCS, age, gender and day type 
 Total sample GMFCS Level Age 
 I II P-value Child Adolescent P-value 
Number (n) 91 44 47  61 29  
Wear time (hh:mm) 11:44 
(11:22-12:05) 
11:59 
(11:23-12:33) 
11:27 
(11:01-11:51) 
0.01* 11:29 
(11:06-11:51) 
12:09 
(11:21-12:55) 
0.01* 
Activity counts (counts∙min
-1
) 438 
(389-486) 
427 
(368-485) 
446 
(370-521) 
0.46 474 
(413-534) 
357 
(280-433) 
<0.001* 
Steps (counts) 7541 
(6740-8341) 
8128 
(6963-9292) 
7390 
(6404-8375) 
0.06 8096 
(7184-9007) 
7000 
(5616-8383) 
0.01* 
Daily time spent in activity 
Inactive (h:mm) 8:36 
(8:16-8:55) 
8:38 
(8:09-9:06) 
8:40 
(8:11-9:08) 
0.94 8:20 
(7:59-8:39) 
9:14 
(8:46-9:40) 
<0.001* 
Light (h:mm) 2:38 
(2:30-2:45) 
2:39 
(2:27-2:50) 
2:35 
(2:24-2:45) 
0.7 2:53 
(2:39-3:06) 
2:07 
(2:04-2:09) 
<0.001* 
MVPA (h:mm) 0:44 
(0:38-0:49) 
0:43 
(0:36-0:49) 
0:44 
(0:36-0:52) 
0.39 0:47 
(0:40-0:53) 
0:39 
(0:30-0:48) 
<0.01* 
Minutes per hour spent in activity 
Inactive (min/hour) 43.1 
(41.92-44.27) 
42.9 
(41.27-44.52) 
43.1 
(41.41-44.78) 
0.81 41.6 
(40.29-42.90) 
46.2 
(44.16-48.23) 
<0.001* 
Light (min/hour) 13.2 
(12.31-14.08) 
13.4 
(12.12-14.67) 
13.1 
(11.87-14.32) 
0.53 14.4 
(13.44-15.35) 
10.6 
(9.071-12.12) 
<0.001* 
MVPA (min/hour) 3.7 
(3.26-4.13) 
3.6 
(3.03-4.16) 
3.8 
(3.02-4.57) 
0.39 3.9 
(3.37-4.42) 
3.2 
(2.47-3.92) 
<0.01* 
Compliance with 
60 minutes MVPA 
25% 27% 23% 0.67 30% 17% 0.21 
Data are mean (95% CI); time represents time spent in each activity state with wear time standardized to 12 hours;  compliance with 60 minutes MVPA represents the per cent of 
participants who recorded at least 60 minutes of MVPA on one or more recorded days; * denotes p<0.05. KEY: counts·minute-1: activity counts per minute; h:mm: time in hours and 
minutes; inactive: activity counts ≤100 counts·minute-1; light: 101-2295 counts∙min-1; MVPA: moderate to vigorous physical activity with counts∙min-1 ≥2296; GMFCS: Gross Motor 
Functional Classification System; Child <13 years; Adolescent ≥13 years. 
 
  
 78 
 
Table 2 continued....: Daily and hourly physical activity in independently ambulant children with unilateral cerebral palsy and by GMFCS, age, gender 
and day type 
 Gender Day Type   
 Girls Boys P-value Weekend Weekday P-value 
Number (n) 43 48  133 133  
Wear time (hh:mm) 11:37 
(10:49-12:23) 
11:48 
(11:17-12:18) 
0.41 11:16 
(11:03-11:28) 
12:00 
(11:51-12:08) 
<0.001* 
Activity counts (counts∙min
-1
) 375 
(313-436) 
494 
(424-563) 
<0.001* 436 
(387-484) 
437 
(409-464) 
0.94 
Steps (counts) 6957 
(5844-8069) 
8423 
(7420-9425) 
<0.001* 7141 
(6417-7864) 
8139 
(7698-8579) 
0.02* 
Daily time spent in activity 
Inactive (h:mm) 8:50 
(8:16-9:22) 
8:41 
(8:12-9:09) 
0.001* 8:34 
(8:18-8:49) 
8:39 
(8:25-8:52) 
0.58 
Light (h:mm) 2:33 
(2:22-2:42) 
2:43 
(2:30-2:54) 
<0.001* 2:43 
(2:35-2:49) 
2:35 
(2:30-2:39) 
0.21 
MVPA (h:mm) 0:37 
(0:30-0:43) 
0:51 
(0:43-0:58) 
<0.001* 0:42 
(0:37-0:48) 
0:46 
(0:43-0:49) 
0.17 
Minutes per hour spent in activity 
Inactive (min/hour) 44.3 
(42.56-46.03) 
41.9 
(41.78-42.01) 
<0.001* 42.8 
(41.69-43.90) 
43.2 
(42.50-43.89) 
0.56 
Light (min/hour) 12.7 
(11.35-14.04) 
13.7 
(12.54-14.85) 
0.04* 13.6 
(12.76-14.43) 
12.9 
(12.36-13.43) 
0.16 
MVPA (min/hour) 3.0 
(2.43-3.56) 
4.3 
(3.70-4.89) 
<0.001* 3.4 
(2.99-3.80) 
3.8 
(3.55-4.04) 
0.1 
Compliance with 
60 minutes MVPA 
14% 35% 0.02* 8% 18% 0.05* 
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Figure 1. Average daily (6am-9pm) physical activity patterns by age group (child n=61; adolescent n=29), 
sex (female n=43; male n=48), day type (weekend n=133; weekday n=208); plotted values are mean 
activity levels (counts∙minute-1). 
. 
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5.3 Summary and conclusions 
The study presented within this chapter concluded that only 25% of independently 
ambulant children and adolescents with unilateral CP participated in the recommended 
level of MVPA (60 minutes daily) on at least one day of monitoring. This finding, combined 
with the high level of inactivity demonstrated, suggests that even the most physically 
capable children with unilateral CP are at risk of health problems associated with inactivity. 
When considering this evidence in the context of this doctoral program: 
i) Recommendations for healthy levels of physical activity suggest that 60 minutes of 
MVPA is required on a daily basis for children and adolescents. The results of the 
current study suggest that the majority of independently ambulant children and 
adolescents with unilateral CP are not sufficiently physically active to meet these 
recommendations, with only 25% participating in 60 minutes of MVPA on at least one 
day of monitoring and on average recording 0:44hrs in MVPA. 
ii) In the current study, children with CP recorded 2:38hrs of light activity daily, which 
when combined with 0:44hrs of MVPA may in fact be sufficient to promote long term 
health. Considering the role of light physical activity seems particularly relevant for 
children with CP.  Musculoskeletal impairments and altered biomechanics may mean 
that achieving 60 minutes of MVPA daily is not an appropriate goal and light activity 
needs to be considered within physical activity guidelines. 
iii) Participants in the current study were inactive for 8:36hrs daily or 44 minutes per 
hour, constituting 72% of a typical day, with inactivity highest in adolescents (9:14hrs, 
77% of day) and girls (8:50hrs, 74% of day). These levels are alarming when 
combined with the low levels of physical activity, especially in the context of these 
children representing some of the most physically able children with CP. Previous 
studies have found similar findings of physical inactivity, with ambulatory children and 
adolescents with CP significantly more inactive and taking fewer breaks from 
sedentary time than matched typically developing controls. 
vi) Physical activity levels were similar between children classified at GMFCS levels I 
and II, suggesting gross motor functional limitations are not a determinant of physical 
activity in this group of independently ambulant children with CP.  
vii) The physical activity levels of the children in the current study were comparable to 
published literature investigating ambulatory children with CP. However, physical 
activity levels have been shown to reduce with increasing GMFCS level and with 
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bilateral distribution of motor impairment. The children and adolescents included in 
the current study therefore represent some of the most physically active children and 
adolescents with CP.  It is therefore important to consider potential ceiling effects 
within the Mitii™ randomised trial (Chapter 8). 
viii) The patterns of physical activity demonstrated in independently ambulant children 
and adolescents with unilateral CP were similar to published examples from typically 
developing children. Consistent with typically developing children, on average males 
participated in more physical activity than females and children more than 
adolescents. Weekday activity was characterised by peaks of activity interspersed 
with periods of inactivity compared to weekend activity which was more consistent.  
ix) The current study did not look at physical activity levels across seasons (e.g. summer 
compared to winter), as the sample size was not sufficient to allow an adequate 
comparison across the year. This is a potential limitation of the current study and 
should be considered for future research. In addition, the results of this study have 
been compared to examples published within the literature, however, it should be 
noted that these studies originate from countries other than Australia (predominately 
Canada and the USA). It is possible that environmental and cultural factors within the 
populations studied differ to those investigated in the current study, which may then 
influence physical activity performance.  
x) While accelerometers are valid and reliable devices for recording physical activity, a 
potential limitation of their use, and therefore of the current study, is their inability to 
capture water sports or cycling. These activities are frequently recommended for 
children and adolescents with cerebral palsy as they are thought to carry a reduced 
of musculoskeletal injury. In the current study, participants were asked to remove the 
accelerometer during water activities. The activity log completed by parents or 
caregivers throughout the recording period included information about the times 
which the device was removed for swimming; however this was unable to be used to 
provide a valid measure of physical activity which may have occurred whilst 
swimming. Additionally, while the device may have been worn during cycling, it has 
not been validated during this activity. There is the potential that children completed 
additional physical activity while swimming or cycling which was not captured in the 
current study, and therefore must be acknowledged as a potential limitation. 
xi) Further research which determines the extent to which personal and environmental 
characteristics are associated with physical activity in this population would be useful 
to target the Mitii™ intervention accordingly. 
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Chapter 6. Characteristics associated with habitual physical activity 
performance 
6.1 Introduction to Chapter 6 
This chapter consists of the paper entitled “Characteristics associated with habitual 
physical activity performance among independently ambulant children and adolescents 
with unilateral cerebral palsy”. The current paper reported in this chapter describes 
physical, personal and environmental characteristics associated with physical activity 
measured using the ActiGraph® accelerometer in children and adolescents with unilateral 
CP. This study was conducted to explore potential modifiable factors which may influence 
physical activity performance as a target for the Mitii™ randomised trial. 
6.2 Paper 5: “Characteristics associated with habitual physical activity 
performance among independently ambulant children and 
adolescents with unilateral cerebral palsy” 
This paper has been published in Developmental Medicine and Child Neurology and has 
been reproduced with permission. 
 Mitchell L, Ziviani J, Boyd R. Characteristics associated with habitual physical activity performance 
among independently ambulant children and adolescents with unilateral cerebral palsy. Developmental 
Medicine and Child Neurology. [Epub ahead of print] 21 August 2014. doi: 10.1111/dmcn.12560 
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Regular participation in physical activity is important for 
physical, mental and social health in all children and ado- 
lescents, including those with a  disability.1  Cerebral palsy 
(CP) describes  a group of disorders of movement and 
pos- ture which cause activity limitations, attributed to non- 
progressive disturbances that occur in the developing fetal 
or infant brain.
2  
As CP is the most common physical dis- 
ability in childhood,
3  
participation in regular physical activity 
should be promoted to  enhance  health, function and 
fitness. Despite the importance of regular participation in  
physical activity, children with  CP are less  physically 
active than children with typical development.4 
For children with disabilities including CP, gross motor 
functional limitations are likely to affect physical activity.5–7 
Children with CP also typically present with reduced car- 
diorespiratory fitness and muscle strength which may influ- 
ence daily  function  and contribute  to  reduced physical 
activity.8  There are, however, many more factors beyond 
impairment contributing to reduced physical activity in chil- 
dren with CP and disabilities. Personal characteristics such 
as self-esteem and perceived competence are known to influ- 
ence participation in sports and physical activity.5,7  Family 
characteristics, including  lifestyle, available time, positive 
role modelling and financial resources also influence partici- 
pation in physical activity.5,7  Within  the community, physi- 
cal activity can be further limited by a  lack of nearby 
facilities, transportation, suitable activity programmes, 
equipment or social support.5,7 Typically, barriers to physi- 
cal activity have been identified through qualitative studies, 
and there has been limited research aimed at quantifying the 
influence of personal, family or environmental characteris- 
tics on physical activity in children with CP. Where this has 
been undertaken,  severe functional limitations measured at 
Gross Motor Function Classification System (GMFCS) lev- 
els IV or V and low body mass index have been found to be 
associated with reduced reported physical activity.9  Higher 
GMFCS  level (Level III),  bilateral distribution  of motor 
impairment and not  participating in a  sporting club on 
© 2014 Mac Keith Press DOI: 10.1111/dmcn.12560    1 
 
 
AIM This study aimed to quantify the contribution of physical, personal  and environmental 
characteristics  to physical activity  among  independently ambulant children  with  unilateral 
cerebral palsy (CP). 
METHOD One-hundred  and two children  with  unilateral CP (52 males, 50 females; 52 right 
hemiplegia; mean age 11y 3mo, range 8–17y [SD 2y 4mo]) classified  at Gross Motor  Function 
Classification System (GMFCS) levels I = 44 and II = 58 participated. Physical activity  was 
measured over 4 days using ActiGraph  accelerometers  recording  as activity  counts. GMFCS, 
functional strength,  6-minute  walk test (6MWT), mobility limitations (MobQues28), age, sex, 
Assessment of Life-Habits  recreation  domain,  Participation and Environment Measure for 
Children  and Youth (PEM-CY) and environmental characteristics  were considered  for 
selection  in a linear regression  model.  These served as independent variables  which  were 
determined using a backwards  selection  procedure. 
RESULTS Younger age, male sex, increased performance on the 6MWT, and increased 
participation in the home and community measured using the PEM-CY were significantly 
associated with  activity  counts (p<0.001). However, the model  fit was somewhat weak 
(R2=0.32), indicating that much of the variation was unexplained. Older age and reduced 
community participation were associated with  high inactivity (p<0.001). 
INTERPRETATION Physical activity interventions should primarily target adolescents and 
females. Walking  endurance  and participation in the home and community may represent 
modifiable characteristics  to increase physical  activity. 
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weekend days have also been associated with lower ambula- 
tory activity in children with CP.6 Studies  such as these are 
important in determining the influence of potentially modi- 
fiable characteristics on physical activity that can help guide 
the development of interventions to increase physical activ- 
ity for this population. 
This study aimed to quantify the extent to which physi- 
cal, personal and environmental characteristics are associ- 
titions of sit to stand, lateral step up using a 20cm step and 
half-kneel to standing over a 30-second period. A composite 
score was created summing repetitions from each task which 
was used to create a single variable in the linear modelling 
procedure. The 6MWT was performed using standardized 
verbal encouragement along a  flat, straight, 10m corridor 
with cones marking the turn-around at each end as per Ma- 
her et al.15 and the distance in metres recorded. The Mob- 
Ques28 is a  parent-reported questionnaire which  scores 
limitations for indoor and outdoor mobility  activities, for 
example, riding a bicycle  or walking on uneven surfaces with 
a total score calculated using the formula: MobQues28 = (Σ 
Item scores/112)*100.16 
Personal characteristics included participant age and sex, 
and recreational participation measured using the Assess- 
ment of Life  Habits (LIFE-H) recreation domain. The 
LIFE-H assesses a person’s ability to perform everyday 
tasks producing a domain-weighted score ranging  
from 0 to 10, calculated using the  formula: Domain  
Score = (ΣScores*10)/(number  of applicable life habits*9). 
The recreation domain of the LIFE-H assesses the child’s 
ability to participate during recreational tasks, such as  
indoor and outdoor sporting or play activities, and the level  
of difficulty and assistance required during participation.17 
Environmental characteristics  were measured  using the 
Participation and Environment Measure for Children and 
Youth (PEM-CY), which examines the frequency of partic- 
ipation in home, school and community environments (cal- 
culated by the mean participation frequency within each 
domain on a scale  of 0–7, representing never participates 
to daily participation), and the extent to which features of 
these environments are perceived to support or challenge 
the young person’s participation.18 Environmental and 
family characteristics  were also recorded via a  parent or 
caregiver questionnaire including demographic information 
such as household   annual income, family structure includ- 
ing number of siblings, maternal and paternal education, 
and the school environment (special education or  main- 
stream primary  and secondary school). Postal code was 
recorded and converted using Socio-Economic Indexes for 
Areas (SEIFA) providing a relative index of socio-economic 
advantage and disadvantage.
19
 
ated with  physical activity  in  a  group 
ambulant children with unilateral CP. 
of independently 
METHOD 
Participants 
This study describes a cross-sectional analysis of baseline 
assessments from 102 children from the Mitii Australia 
study for which recruitment, methods, outcome measures, 
and their psychometric properties and analysis has been 
described in  detail in  the study protocol.
10   
In  brief, 102 
children (52 males, 50 females; mean age 11y 3mo, range 
8–17y [SD 2y 4mo]) with unilateral CP and classified at 
GMFCS levels I and II.11  As Mitii is primarily an upper- 
limb intervention, children were excluded if they had under- 
gone upper-limb botulinum neurotoxin type A (BoNT-A) 
injections or surgery in the previous 2 or 6 months, respec- 
tively.  Additionally,  children  were excluded if  they had 
unstable epilepsy or  medical conditions which would 
prohibit Mitii training. Written and informed consent was 
obtained from parents or guardians and all participants 
>12 years of age before entering the trial. Ethical approval 
was obtained by the Medical Ethics Committee of The 
University of Queensland (2011000608), The Royal Chil- 
dren’s Hospital Brisbane (HREC/11/QRCH/35) and the 
Cerebral Palsy Alliance Ethics Committee (2013-04-01). 
Australian clinical trials registration number: ACTRN12 
611001174976. 
Procedures and materials 
Physical activity was recorded using an ActiGraph GT3X+ 
tri-axial accelerometer (ActiGraph Corporation, Pensacola, 
FL, USA) initialized according to manufacturer specifica- 
tions to record step counts and accelerations at a frequency 
of 100Hz in 5-second epochs. ActiGraph units were fitted 
on an elastic belt worn at the level of the iliac crest on the 
mid-axilla line of the least impaired side of the body and 
participants were instructed to  wear the  device for all 
waking hours for  four  consecutive days (including two 
weekend and two week days where possible). During this 
time, parents registered the wear time of the device on an 
activity diary. Accelerometers have good validity and 
reliability for children with CP.12,13 
Physical characteristics thought to be associated with 
physical activity were GMFCS levels I or II,11 physical activ- 
ity capacity measured using functional strength and 6-min- 
ute walk test (6MWT), and mobility limitations measured 
using the 28-item Mobility Questionnaire (MobQues28). 
Functional strength was tested according to the protocol 
outlined by Verschuren et al.14 which records maximal repe- 
Statistical analysis 
Acceleration data were downloaded to a personal computer 
and manipulated in ActiLife software v6 (ActiGraph Cor- 
poration). Device wear time was validated by visually 
inspecting the activity diary and comparing to acceleration 
data in  ActiLife.   All  representative and complete data 
(where >8h of data were recorded  each day) were included 
2    Developmental Medicine & Child Neurology 2014 
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• Increased walking endurance is associated with increased physical activity. 
• Increased  participation   in the home  and  community  is  associated  with 
increased physical activity. 
• Increasing age   and  reduced  community  participation   are  associated  with 
high inactivity. 
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in  the analysis  and where activity counts values of  zero 
occurred for  >20 minutes, this was deemed as  non-wear 
time  and excluded from  the  analysis using ActiLife 
software algorithms. Vertical axis activity counts were con- 
verted to activity intensity using Evenson cut points20  to 
provide a  total of daily time spent inactive (≤100 vertical 
counts/min), at light  intensity (101–2295  vertical counts/ 
min) and at moderate to vigorous intensity (MVPA; ≥2296 
vertical counts/min). To  account for  differences in  wear 
time between participants, wear time was standardized to 
12h using the formula: (time spent in  activity state/wear 
time)*12.  Average activity  counts/minute, standardized 
inactive time and MVPA over 4 days were used for the lin- 
ear regression modelling. 
Data were collated in Microsoft  Excel 2010 (Microsoft 
Corporation,  Redmond, WA,  USA)  and analyzed using 
IBM SPSS v22 (IBM Corp., New York, NY, USA). Contin- 
uous data were examined for normality by visually inspect- 
ing  histograms and with  the  Shapiro–Wilk  test. All  of 
these variables were normally distributed. As physical activ- 
ity  data were normally  distributed  and variances were 
equal, differences in physical activity between groups were 
calculated using independent t-tests and linear regression 
was performed. Standard multiple  linear regression was 
calculated using the following steps: variables  were corre- 
lated with  activity  counts using Pearson or  where non- 
normally distributed, Spearman correlation coefficients (ρ); 
variables with  ρ>0.20 were entered as  independent vari- 
ables into a  direct  linear regression model; since no a 
priori hypotheses had been made to determine the order of 
entry of predictor variables, a backward selection proce- 
dure was employed  which selected up to five variables with 
significant regression co-efficient  values p<0.20; and 
another linear regression  analysis was conducted with the 
selected variables to form the final model. Assumptions of 
the model were checked, including normality, co-linearity, 
homoscedasticity and Mahalanobois’ distance. For the 
primary analysis, activity counts served as the dependent 
variable, with age, sex, GMFCS, functional strength 
composite score, 6MWT laps, MobQues28 total score, 
LIFE-H, PEM-CY home, school and community score, 
household income, siblings, parent education and SEIFA 
score considered as independent variables in the model. 
Where required, categorical variables were dummy coded: 
sex (0: males, 1: females), household income (0: <$50 000 
annually, 1: >$50 000 annually). Secondary analyses were 
completed with two subsets of data: first, where children 
participated in high levels of physical activity (≥40min 
MVPA daily), with time spent in MPVA as the dependent 
variable; and second, where children were predominantly 
inactive with ≥75% of time spent inactive, with time inac- 
tive as the dependent variable. Data are presented as mean 
(standard deviation) and α was set at 0.05. 
(Table I). Of the 102 participants enrolled in the study, 99 
completed a baseline assessment. Of those, 91 returned 
valid ActiGraph recordings (89%). On average, participants 
recorded 438 (234) counts/minute, were inactive for 8:26 
(1:55) hours and participated in 0:43 (0:25) hours MVPA 
daily. Results for differences in physical activity by 
GMFCS level, age and sex are presented in Table II. 
Pearson and Spearman correlations were calculated to 
select variables correlated with physical activity counts 
(Table III). From this, variables selected for stage one of 
the linear regression model included 6MWT, PEM-CY 
home, school and community participation, age, sex and 
SEIFA score (Table III) and were significantly associated 
with physical activity counts (p<0.001; Table IV). Two 
extreme multivariate outliers were identified using Maha- 
lanobois’ distance and therefore removed. In both 
instances, both participants recorded low functional 
strength scores and low school participation. Homoscedas- 
ticity was examined via several scatterplots and these 
indicated reasonable consistency of spread through the 
distributions. Colinearity between variables was not found 
with all correlations and colinearity statistics within accept- 
able ranges. Variables selected using the backward selec- 
tion procedure for inclusion in the final model were 
6MWT laps, PEM-CY home and community participa- 
tion, age and sex. There was a significant association 
between selected variables and physical activity counts 
(p<0.001). However, model fit was somewhat weak 
(R2=0.32), indicating that much of the variation was unex- 
plained (Table IV). A secondary series of analyses were 
conducted for children who participated in high levels of 
physical activity and those who were highly inactive, with 
correlations and results of the regression analyses presented 
in Tables III and IV. 
DISCUSSION 
This study aimed to quantify the extent to which physical, 
personal and environmental characteristics were associated 
with physical activity in a group of independently ambulant 
children with unilateral CP. Overall, characteristics associ- 
ated with increased physical activity were younger age, 
male sex, increased walking endurance, and increased par- 
ticipation in the home and community measured using the 
PEM-CY. Looking more specifically at participants record- 
ing high levels of physical activity or inactivity, high levels 
of MVPA were associated with younger age, male sex and 
increased community participation measured, whereas high 
levels of inactivity were associated with older age, and 
reduced community participation. 
The personal characteristics which most influenced 
physical activity in independently ambulant children with 
unilateral CP were sex and age. This is consistent with 
CP6,9,21 previous research  in  children with and children 
with   typical  development22  where  males and  children 
RESULTS 
Participants were children and adolescents with unilaterall 
CP classif ied at GMFCS levels I = 44 and II = 58 
<13 years old generally participate in more physical activity 
compared to females and adolescents. Interestingly, in the 
current  study, while sex  was associated  with  increased 
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surveys indicate males spend more  time  playing  video 
games.23  More research would be useful to determine the 
influence of sex on inactivity in children with CP. 
In  the current study, physical characteristics  including 
GMFCS, mobility limitations and functional strength were 
generally not  associated  with  physical activity.  Walking 
endurance, however, was found to be a  significant, albeit 
small (B=6.8), predictor within the linear regression model. 
While  this is a cross-sectional   study and therefore causal 
associations  cannot be made, according to these findings 
targeting an increase  in  physical capability may produce 
modest increases  in  physical activity. This  finding  is of 
interest given the children selected  in  the current study 
were independently ambulant, meaning it is likely that they 
would  achieve the  majority  of  their  physical activity 
through ambulatory activity, for example during activities 
of  daily living,  walking or  running  for  play, or  moving 
within  a  school environment. Previous research  has con- 
firmed that higher energy costs of walking were associated 
with levels of physical activity in children with CP24  and 
reduced levels of cardiovascular fitness are typical in this 
population.8 Potentially, gains in physical activity could be 
made by  increasing walking  capacity, by  reducing  the 
energy cost of walking through improved biomechanics  as 
well  as   increasing cardiovascular fitness. Conversely, 
increased cardiovascular fitness and  walking  endurance 
would be a  desired outcome of increased participation in 
physical activity, highlighting the multidimensional nature 
of physical activity. 
The frequency of participation in home and community 
activities was associated with  physical activity in the cur- 
rent study. The relationship with community participation 
was particularly strong (B=54.3), contributing  a  larger 
increase in physical activity in the regression model than 
age (B=-22.6)  and at a  similar  level to  sex  (B=-60.3). 
Community  participation  also demonstrated an  inverse 
relationship with inactivity in those participants who spent 
the majority of their time inactive. To our knowledge this 
is the first time this finding has been reported in children 
with  CP. The  community section of  the PEM-CY  asks 
questions about the frequency of participation in activities 
such as neighbourhood  outings, organized physical activity, 
unstructured  physical activity  or  getting  together  with 
other children. While  not measuring physical activity per 
se, it is logical that a child with increased participation in 
these activities is likely to be more active and record a higher 
level of both planned and incidental physical activity. Con- 
versely, children who do not typically engage in these activi- 
ties are likely  to be more inactive. Exploring  barriers to 
participation  in  home and community  environments is 
therefore critical  to increasing a  child’s participation and 
physical activity. For example, for younger children many of 
the community activities mentioned in the PEM-CY would 
require adult support to enable full  participation, such as 
assistance with transportation or financial support. Previous 
research has identified a lack of access to transportation, lack 
of time and financial restrictions as barriers to participation 
Characteristics Number  (n) 
Physical 
GMFCS level 
I 
II 
Functional  strength 
6MWT 
Metres 
Speed (km/hr) 
MobQues28,  mean (SD) 
Personal characteristics 
Sex 
Females 
Males 
Side of hemiplegia 
Left 
Right 
Age (y, mo), mean (SD) 
Children  (<13y) 
Adolescents  (>13y) 
LIFE-H recreation,  [max=10] mean (SD) 
Environmental characteristics 
PEM-CY, [max=7] mean (SD) 
Home participation 
School participation 
Community participation 
School type 
Special education 
Primary 
Secondary 
Other 
Siblings 
Yes 
No 
Maternal education   
Secondary not completed 
Completed secondary  school 
Trade/vocational education 
University education 
Missing 
Paternal education   
Secondary not completed 
Completed secondary  school 
Trade/vocational education 
University education 
Missing 
Household  income 
<$25 000 
$25 000–$50 000 
$50 000–$75 000 
>$75 000 
    SEIFA score, mean (SD) 
44 
58 
46 (21) 
378 (76) 
3.8 (0.8) 
90.4 (8.9) 
50 
52 
50 
52 
11y 3mo (2y 4mo) 
68 
33 
7.6 (2.4) 
5.2 (0.6) 
3.3 (1.0) 
2.3 (0.9) 
5 
60 
33 
4 
85 
12 
16 
13 
34 
24 
16 
12 
35 
24 
11 
12 
17 
53 
1003 (70.9) 
Data are n (%) or mean (SD). GMFCS, Gross Motor  Function  Classi- 
fication  System; 6MWT, six-minute walk test; km/hr, speed mea- 
sured in kilometres per hour; MobQues28, 28-item Mobility 
Questionnaire; LIFE-H, Assessment of Life Habits recreational 
domain;  PEM-CY, Participation and Environment Measure for Chil- 
dren and Youth; SEIFA score, Socio-Economic Indexes for Areas 
measure of relative  advantage  and disadvantage derived  from 
postal code. 
physical activity it  did not appear to influence sedentary 
behaviour in a secondary  analysis of highly inactive partici- 
pants. This is similar to evidence from typically developing 
children, where it is unclear whether females or males are 
more sedentary.23  While objective data suggests that teen- 
age females are more inactive than teenage males, subjective 
4    Developmental Medicine & Child Neurology 2014 
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GMFCS level Age Sex 
I II p-value Children Adolescents p-value Females Males p-value 
0.01a 
0.46 
0.06 
0.94 
0.70 
0.39 
0.01a 
<0.001a 
0.01a 
<0.001a 
<0.001a 
<0.01a 
Wear time 
Counts/min 
Step counts 
Inactive 
Light activity 
MVPA 
11:59 (1:53) 
427 (199) 
8128 (3940) 
8:38 (1:07) 
2:39 (0:52) 
0:43 (0:23) 
11:27 (1:56) 
446 (264) 
7390 (3448) 
8:40 (1:11) 
2:35 (0:52) 
0:44 (0:28) 
11:29 (1:50) 
474 (240) 
8096 (3631) 
8:20 (1:03) 
2:53 (0:46) 
0:47 (0:26) 
12:09 (2:05) 
357 (209) 
7000 (3800) 
9:14 (1:09) 
2:07 (0:50) 
0:39 (0:25) 
11:37 (2:02) 
375 (206) 
6957 (3722) 
8:50 (1:10) 
2:33 (0:53) 
0:37 (0:23) 
11:48 (1:50) 
494 (247) 
8423 (3542) 
8:41 (1:06) 
2:43 (0:49) 
0:51 (0:25) 
0.41 
<0.001a 
<0.001a 
0.001a 
<0.001a 
<0.001a 
Data are mean (SD). aDenotes p<0.05 when groups  compared  with  independent t-tests. GMFCS, Gross Motor  Function  Classification 
System; MVPA, moderate  to vigorous physical  activity. 
Activity counts (n=91) High MVPA (n=39) High inactivity (n=31) 
Variable Correlation (q) p-value Correlation (q) p-value Correlation (q) p-value 
GMFCSa 
Functional  strength 
6MWT (metres) 
MobQues28 
Age 
Sexa 
LIFE-H recreation 
PEM-CY home 
PEM-CY school 
PEM-CY community 
Household incomea 
Siblingsa 
Maternal  educationa 
Paternal educationa 
School typea 
SEIFA score 
0.31 
0.08 
0.24 
0.01 
0.77 
0.49 
0.03b 
0.97 
<0.001b 
<0.001b 
0.89 
<0.001b 
<0.01b 
<0.001b 
0.31 
0.77 
0.82 
0.56 
0.20 
0.04b 
0.12 0.43 
0.53 
0.33 
0.87 
<0.01b 
0.04b 
0.69 
0.79 
0.58 
0.15 
0.49 
0.97 
0.98 
0.42 
0.37 
0.87 
-0.05 0.79 
0.70 
0.34 
0.11 
<0.01b 
0.36 
0.61 
0.24 
0.65 
0.18 
0.63 
0.85 
0.61 
0.22 
0.82 
0.54 
-0.09 -0.07 
0.18 
0.30 
0.51 
0.17 
0.09 
0.22 
-0.09 
-0.25 
0.09 
-0.04 
-0.09 
-0.02 
0.04 
-0.11 
-0.14 
0.03 
-0.33 
0.22 
0.06 
-0.03 
0.08 
0.22 
-0.10 
0.01 
-0.01 
-0.13 
0.09 
-0.03 
-0.40 
-0.41 
0.02 
0.31 
0.30 
0.38 
0.11 
-0.03 
0.03 
0.06 
-0.14 
-0.23 
aRepresents a categorical variable  or variable  which  was not normally distributed and therefore  a non-parametric test (Spearman  Rank) 
was performed. All other variables  were normally distributed and correlation was calculated  using Pearson correlation coefficient. 
bDenotes p<0.05. MVPA, moderate  to vigorous physical  activity;  GMFCS, Gross Motor  Function  Classification System; 6MWT, six-minute 
walk test; MobQues28,  28-item Mobility Questionnaire; LIFE-H recreation,  Assessment  of Life Habits recreational  domain;  PEM-CY, Partici- 
pation  and Environment Measure for Children  and Youth, SEIFA score, Socio-Economic Indexes for Areas measure of relative  advantage 
and disadvantage derived  from  postal code. 
in physical activity in children with CP, which supports the 
current findings.5 Other potential barriers to physical activ- 
ity are a lack of access to, or awareness of, appropriate sport 
and exercise opportunities in the community, such as clinics 
or sporting groups which cater to the needs of a child with a 
disability.
5 
Individual barriers were not examined in the cur- 
rent study and further research would be required to confirm 
what factors contributed to reduced participation. In addi- 
tion to participation frequency and involvement, the PEM- 
CY enquires about supports and resources available within 
the environments that would enable participation. This tool 
could be useful for clinicians identifying barriers and 
enablers which may be limiting individual children’s partici-
pation specific to each environment. 
While non-significant, there was a negative association 
between physical activity counts and lower socio-economic 
status measured using the SEIFA index derived from postal 
codes. This aligns with the research in children with typical 
development, where there is a suggestion   that socio-eco- 
nomic status influences physical activity. Children with typi- 
cal development from low socio-economic status 
demonstrated  a trend towards increased sedentary time and 
lower physical activity compared with children from higher 
socio-economic  status, although this was found to be non- 
significant when body mass index was considered.25   While 
non-significant in the current study, increasing access  to 
physical activity opportunities which may be influenced by 
cost or community support is important to consider in chil- 
dren with CP. 
In saying all this, it should be noted that while signifi- 
cant, the linear regression modelling between the variables 
of interest and physical activity accounted for only 33% of 
the variance in physical activity. This highlights the multi- 
factorial nature of physical activity participation, as  there 
are likely to be many more factors contributing to physical 
activity  than the variables explored. Both  clinicians and 
Characteristics  Associated with  Unilateral  CP Louise E Mitchell  et al.    5 
Table III: Association between physical activity or inactivity and physical, personal and environmental characteristics  in independently ambulant 
children with cerebral palsy 
Table II: Differences in physical activity by Gross Motor Function Classification System level, age and sex in independently ambulant children 
with CP 
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Activity counts (n=91) High physical  activity  (n=39) High inactivity (n=31) 
Final modela Model  1 Final model Model  1 Final model 
B (95% CI) p-value B (95% CI) p-value B (95% CI) p-value B (95% CI) p-value B (95% CI) p-value 
<0.001 
<0.01 
0.06 
<0.001 
0.07b 
<0.01b 
<0.001 
<0.001b 
<0.001 
<0.01 
Constant 
Age (y) 
Sex (male 
as reference) 
6MWT 
(metres) 
PEM-CY 
home 
PEM-CY 
community 
PEM-CY 
school 
SEIFA score 
MobQues28 
F (df) 
R2 
473.84 (-21.67 to 969.35) 0.06 
0.01b 
0.10b 
 
0.14b 
 
0.03b 
 
<0.01b 
443.03 (204.98 to 681.09) 0.89 (0.51 to 1.26) 7.64 (5.43 to 9.86) 
0.19 (0.12 to 0.26) 
NA 
8.52 (7.64 to 9.41) 
0.10 (0.03 to 0.16) 
NA 
-24.01 (-39.04 to -9.16) -22.62 (-36.85 to-8.38) 
-60.27 (-124.77 to 4.24) 
 
6.76 (-3.10 to 16.59) 
 
5.85 (0.67 to 11.03) 
-0.02 (-0.05 to 0.01) 
-0.18 (-0.30 to -0.06) 
 
NA 
-55.51 (-121.59 to 10.58) 
 
7.57 (-2.62 to 17.76) 
 
5.77 (0.54 to 10.99) 
0.17 NA NA 
0.03 NA 0.04 (-0.28 to 0.35) 
-0.25 (-0.45 to-0.05) NA 
0.82 Excluded 
0.04b 0.01b 60.99 (17.38 to 104.59) 54.31 (14.10 to 94.52) <0.01 0.08 (0.01 to 0.15) -0.04 (-0.20 to-0.14) 
 
NA 
0.69 
-15.83 (-53.38 to 21.73) 
 
0.01 (-0.43 to -0.44) 
NA 
5.02 (7,75) 
0.40 Excluded NA 
0.98 Excluded NA 
NA 
8.11 (3,79) 
NA NA 
Excluded 
4.91 (2,28) 
-0.01 (-0.03 to 0.01) 
10.47 (4,77) 
0.43 
<0.001 
0.35 
<0.001 
0.33 
7.00 (5,77) <0.001 
0.32 
<0.001 
0.24 
0.02 
0.26 
aAll variables  included  within the initial  modelling procedure  were significant and therefore  retained  in the final model.  Assumptions of the model  were checked, including normality, co-lin- 
earity, homoscedasticity and Mahalanobois’ distance. bDenotes p<0.2 and variable  included  in final phase of modelling. B, unstandardized coefficient; 95% CI, 95% confidence  interval  for 
unstandardized coefficient; NA, not applicable  as variable  not identified for selection  in the model;  6MWT, six-minute walk test; PEM-CY, Participation and Environment Measure for Chil- 
dren and Youth; Excluded, p>0.2 in initial  model  and therefore  excluded  from  selection  in final model;  SEIFA score, Socio-Economic Indexes for Areas measure of relative  advantage  and 
disadvantage derived  from  postal code; MobQues28,  28-item Mobility Questionnaire, F, F statistic;  df, degrees of freedom;  R2, R square value for regression  model. 
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Table IV: Multiple linear regression models for characteristics associated with physical activity measured using accelerometer activity counts and for participants with high moderate to vigorous physical 
activity and high levels of inactivity 
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researchers  should ensure that interventions targeting an 
increase in  physical activity  should be  similarly  multi- 
dimensional and ideally tailored  to  the individual.  This 
may be an increase in strength or cardiovascular fitness, to 
increase walking endurance for  one child  or  it  may be 
increasing community participation through the identifica- 
tion of appropriate sporting programmes for another child. 
What the research suggests is identification of barriers and 
facilitators of physical activity specific to  each individual 
ing endurance or increased community participation. It is 
unlikely that there is simply one causal direction. Nonethe- 
less, identifying which characteristics appear to most influ- 
ence physical activity  allows for  the  development of 
targeted interventions to increase physical activity. 
CONCLUSION 
Characteristics associated  with  increased  physical activity 
were younger age, male sex, increased  walking endurance 
and increased  participation in  the home and community 
measured  using the PEM-CY.  This  information  can be 
used to guide clinicians to identify children who may be at 
risk  of  reduced physical activity  and provide a  starting 
point  for  identifying  areas which  should be targeted to 
increase physical activity. 
and  troubleshooting  ways these can 
accommodated to  encourage physical 
tion.5 
be  overcome or 
activity  participa- 
Some limitations of study must be acknowledged: only 
independently ambulant children with  unilateral CP were 
selected for participation. This group was selected to allow 
for a more homogeneous sample given that the characteris- 
tics associated with physical activity for children with more 
severe  motor impairment may be quite different. Further 
research is  necessary  to  confirm  the  generalizability of 
these results. This study was also conducted as  part of a 
larger, clinical trial meaning  assessment burden limited the 
inclusion of additional child-reported variables as well as 
information  on lower limb  interventions. The  data were 
also collected from a cross-sectional sample,  meaning cau- 
sal associations between variables are unable to be made. 
There may be the potential for  the associations  demon- 
strated in fact to represent reverse causality, for example, 
high levels of physical activity resulting in increased walk- 
ACKNOWLEDGEMENTS  
Funding was provided by Smart Futures Coinvestment Program 
Grant from the Queensland Government: ‘EBrain’ (RB; JZ); Aus- 
tralian Postgraduate Award (APA) (LEM);  and NHMRC Career 
Development Fellowship Level 2, no. 1037220 (RNB). All sources 
of  funding  are project grants or  stipends for  researchers.  The 
funding bodies had no involvement in the study design, analysis or 
interpretation or data, writing of the manuscript or in the deci- sion 
to  submit the manuscript for  publication. No  conflict  of interest 
such as  financial gain exists between  the authors of this article 
and the companies  producing the equipment that is the focus of 
this research. 
REF ER ENC ES 
 
1. World  Health  Organization. Health  and development 
through physical activity and sport. [Internet]  Geneva: 
World   Health  Organization,  2003.  http://whqlibdoc. 
who.int/hq/2003/WHO_NMH_NPH_PAH_03.2.pdf 
(accessed 26 Mar 2014). 
2. Rosenbaum P, Paneth N, Leviton A, et al. A report: the 
definition and classification of cerebral palsy April 2006. 
Dev Med Child Neurol Suppl 2007; 109: 8–14. 
3. Odding E, Roebroeck ME, Stam HJ. The epidemiology 
of cerebral palsy: incidence, impairments and risk fac- 
tors. Disabil Rehabil 2006; 28: 183–91. 
4. Carlon SL, Taylor  NF,  Dodd  KJ, Shields N.  Differ- 
ences in habitual physical activity levels of young peo- 
ple with  cerebral palsy and their  typically developing 
peers: a   systematic review. Disabil Rehabil 2012; 35: 
647–55. 
5. Verschuren O, Wiart L, Hermans D, Ketelaar M. Iden- 
tification of facilitators and barriers to physical activity 
in children and adolescents with cerebral palsy. J Pediatr 
2012; 161: 488–94. 
6. Van Wely L, Becher JG, Balemans ACJ, Dallmeijer AJ. 
Ambulatory activity of children with  cerebral palsy: 
which characteristics  are important? Dev Med Child Neu- 
rol 2012; 54: 436–42. 
7. Rimmer J, Riley B, Wang E, Rauworth A, Jurkowski J. 
Physical activity participation among persons with  dis- 
abilities: barriers and facilitators. Am J Prev Med 2004; 
26: 419–25. 
8. Verschuren O, Darrah J, Novak I, Ketelaar M, Wiart L. 
Health-enhancing physical activity in children with cere- 
bral palsy: more of the same is not enough. Phys  Ther 
2014; 94: 297–305. 
9. Lauruschkus K,  Westbom L,  Hallstrom  I,  Wagner P, 
Nordmark  E. Physical activity in a  total population of 
children and adolescents  with  cerebral palsy. Res  Dev 
Disabil 2013; 34: 157–67. 
10. Boyd RN,  Mitchell  LE,  James  ST,  et al. Move it  to 
improve it (Mitii):  study protocol of a randomised   con- 
trolled  trial  of a  novel web-based  multimodal  training 
program  for  children  and  adolescents with   cerebral 
palsy. BMJ Open 2013; 3: e002853. 
11. Palisano R, Rosenbaum P, Walter S, Russell D, Wood 
E, Galuppi B. Development and reliability  of a system 
to classify gross motor function in children with cerebral 
palsy. Dev Med Child Neurol 1997; 39: 214–23. 
12. Mitchell  LE, Ziviani J, Oftedal S, Boyd RN. A system- 
atic review of the clinimetric properties of measures of 
habitual physical activity in primary school aged children 
with cerebral palsy. Res Dev Disabil 2013; 34: 2419–32. 
13. Mitchell  L, Ziviani J, Boyd R. Variability  in measuring 
physical activity in children with cerebral palsy. Med Sci 
Sports   Exerc 2014;  DOI:   10.1249/MSS.00000000000 
00374 [Epub ahead of print]. 
14. Verschuren O, Ketelaar M, Takken T,  Van Brussel M, 
Helders PJ, Gorter  JW. Reliability of hand-held dyna- 
mometry  and functional  strength tests for  the  lower 
extremity in children with cerebral  palsy. Disabil Rehabil 
2008; 30: 1358–66. 
15. Maher  CA,  Williams  MT,   Olds  TS.  The  six-minute 
walk test for children with cerebral palsy. Int J Rehabil 
Res 2008;  31: 185–8. 
16. Roorda LD, Scholtes VA, van der Lee JH, Becher J, Dall- 
meijer AJ. Measuring mobility limitations in children with 
cerebral palsy: development,  scalability, unidimensional- 
ity, and internal consistency of the mobility questionnaire, 
MobQues47. Arch Phys Med Rehabil 2010;  91: 1194–209. 
17. Fougeyrollas P, Noreau L,  Lepage C.  Assessment  of 
Life  Habits,  Children  Long  Form.  Quebec: RIPPH/ 
INDCP,  2002. 
18. Coster W,  Law M,  Bedell G, Khetani M,  Cousins M, 
Teplicky R. Development of the participation and envi- 
ronment  measure for  children  and youth:  conceptual 
basis. Disabil Rehabil 2012; 34: 238–46. 
19. Australian    Bureau    of     Statistics.   Socio-economic 
indexes  for    areas  (SEIFA).    [Internet].    Canberra 
(cited 2011). http://www.abs.gov.au/ausstats/abs@.nsf/ 
mf/2033.0.55.001 (accessed 30 January 2014). 
20. Evenson KR, Catellier DJ, Gill  K, Ondrak KS, McMur- 
ray RG. Calibration of two objective measures of physi- 
cal activity for children. J Sports Sci 2008;  26: 1557–65. 
21. Stevens  SL,  Holbrook  EA,  Fuller  DK,  Morgan  DW. 
Influence of  age on step activity patterns in  children 
with  cerebral palsy and typically  developing children. 
Arch Phys Med Rehabil 2010;  91: 1891–6. 
Characteristics  Associated with  Unilateral  CP Louise E Mitchell  et al.    7 
 
 
 
90 
22. Trost  SG,  Pate RR,  Sallis JF, et al.  Age and gen- 
der differences in  objectively measured  physical activ- 
ity  in  youth.  Med  Sci   Sports   Exerc 2002;  34:  350– 
5. 
23. Lou  D.  Sedentary behaviors  and youth: current trends 
and the impact on health 2014. [Internet]. http://active- 
livingresearch.org/files/ALR_Brief_SedentaryBehav- 
iors_Jan2014.pdf (accessed 14 April 2014). 
24. Maltais DB,  Pierrynowski MR,  Galea VA,  Bar-Or  O. 
Physical activity level is associated with the O2  cost of 
walking in cerebral palsy. Med Sci Sports Exerc 2005; 37: 
347–53. 
25. Drenowatz C, Eisenmann JC, Pfeiffer KA, et al. Influ- 
ence of socio-economic  status on habitual physical activ- 
ity and sedentary behavior in 8- to 11-year old children. 
BMC Public Health 2010; 10: 214–24. 
8    Developmental Medicine & Child Neurology 2014 
 
 
 
 
 
91 
6.3 Summary and conclusions 
This study concluded that there was a significant association between age, sex, walking 
endurance and participation in the home or community environment, and the performance 
of physical activity. When considering this evidence in the context of this doctoral program: 
i) Characteristics associated with increased physical activity were younger age, male 
sex, increased walking endurance and increased participation in the home and 
community measured using the PEM-CY. These may represent characteristics which 
can be tailored to increase physical activity in independently ambulant children with 
unilateral CP.  
ii) Looking more specifically at participants recording high levels of physical activity or 
inactivity, high levels of MVPA were associated with younger age, male sex, and 
increased community participation measured using the PEM-CY; whereas high levels 
of inactivity were associated with older age, and reduced community participation. 
iii) It should be noted that while significant, the model accounted for only 33% of the 
variance between selected variables and physical activity. This highlights the multi-
factorial nature of physical activity participation as there are likely to be many more 
factors contributing to physical activity than the variables explored. 
iv) Non-modifiable characteristics associated with physical activity in independently 
ambulant children and adolescents with CP are age and sex. It would be useful to 
consider sub-analysis of the effectiveness of the Mitii™ randomised trial within these 
groups to consider if Mitii™ has additional effectiveness in those who are typically not 
participating in physical activity. 
v) Potentially modifiable factors associated with physical activity were walking 
endurance and participation in the home and community. The Mitii™ intervention 
demonstrated increases in physical activity capacity, including walking endurance, 
during pilot testing (see Chapter 2). While a causal relationship cannot be suggested, 
this suggests that if similar improvements can be made in the randomised trial, this 
may translate into improvements in physical activity performance.  
vi) The PEM-CY is collected at baseline to inform participation in the home, school and 
community environments. Participation scores measured with the PEM-CY may need 
to be considered within the statistical analyses of the Mitii™ randomised trial if there 
are differences between groups at baseline.
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Chapter 7. Study protocol and thesis methodology 
7.1 Introduction to Chapter 7 
This chapter consists of the published study protocol entitled “Move it to improve it 
(Mitii™): study protocol of a randomised controlled trial of a novel web-based multi-modal 
training program for children and adolescents with cerebral palsy”. This paper describes 
the entire randomised trial which tests the efficacy of Mitii™ against upper-limb activity, 
occupational performance and executive function. The paper included in this chapter 
includes a detailed description of the study methodology and the measures pertaining to 
this doctoral thesis.  
This doctoral thesis explores the results of the primary component of the study, looking at 
the effect of Mitii™ training at 20 weeks. The outcomes included in this doctoral thesis 
include: physical activity capacity measured by functional strength and walking capacity 
using the 6MWT; physical activity performance measured using ActiGraph® accelerometer 
records; mobility limitations using the MobQues28 and recreational participation measured 
with the recreational domain of LIFE-H. Retention of effects and the effect of the Mitii™ 
training in the waitlist control group were considered beyond the scope of this doctoral 
program but could be explored upon completion. 
7.2 Paper 6: “Move it to improve it (Mitii™): study protocol of a 
randomised controlled trial of a novel web-based multimodal 
training program for children and adolescents with cerebral palsy” 
This paper was published in BMJ Open and has been reproduced with permission. 
Boyd R, Mitchell L, Ziviani J, James S, Smith A, et al. (2013) “Move it to improve it (Mitii
TM
): study protocol 
of a randomised controlled trial of a novel web-based multimodal training program for children and 
adolescents with cerebral palsy”. BMJ Open. 3(4):pii.  doi: 10.1136/bmjopen-2013-002853 
Downloaded from bmjopen.bmj.com on April 11, 2013 - Published by group.bmj.com  
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ABSTRACT 
Introduction:  Persons with cerebral palsy require a 
lifetime of costly and resource intensive interventions 
which are often limited by equity of access. With 
increasing burden being placed on health systems, new 
methods to deliver intensive rehabilitation therapies are 
needed. Move it to improve it (Mitii) is an internet-based 
multimodal programme comprising upper-limb and 
cognitive training with physical activity. It can be accessed 
in the client’s home at their convenience. The proposed 
study aims to test the efficacy of Mitii in improving upper- 
limb function and motor planning. Additionally, this study 
hopes to further our understanding of the central 
neurovascular mechanisms underlying the proposed 
changes and determine the cost effectiveness of Mitii. 
Methods and analysis: Children with congenital 
hemiplegia will be recruited to participate in this waitlist 
control, matched pairs, single-blind randomised trial. 
Children be matched at baseline and randomly allocated 
to receive 20 weeks of 30 min of daily Mitii training 
immediately, or waitlisted for 20 weeks before receiving 
the same Mitii training ( potential total dose=70 h). 
Outcomes will be assessed at 20 weeks after the start of 
Mitii, and retention effects tested at 40 weeks. The 
primary outcomes will be the Assessment of Motor and 
Process Skills (AMPS), the Assisting Hand Assessment 
(AHA) and unimanual upper-limb capacity using the 
Jebsen-Taylor Test of Hand Function ( JTTHF). Advanced 
brain imaging will assess use-dependant neuroplasticity. 
Measures of body structure and functions, activity, 
participation and quality of life will be used to assess Mitii 
efficacy across all domains of the International 
Classification of Functioning, Disability and Health 
framework. 
Ethics and dissemination: This project has received 
Ethics Approval from the Medical Ethics Committee of 
The University of Queensland (2011000608) and the 
Royal Children’s Hospital Brisbane (HREC/11/QRCH/35). 
Findings will be disseminated widely through conference 
presentations, seminars and peer-reviewed scientific 
journals. 
Trial registration: ACTRN12611001174976 
ARTICLE SUMMARY 
Article focus 
▪    The  main aim of this proposed  study was  to 
determine  if 20 weeks  of intensive  move  it to 
improve  it  (Mitii) training can improve  upper- 
limb (UL) activity  (unimanual  and bimanual), 
occupational performance and cognitive skills in 
children and adolescents with CP compared  with 
standard care. 
▪    The secondary aim is to further our understand- 
ing of  the central neurovascular  mechanisms 
underlying  changes in UL function, motor plan- 
ning and executive  function (using functional 
MRI and transcranial  magnetic  stimulation to 
measure  central activation  in the parts of the 
brain controlling movement). 
▪    It is hypothesised that Mitii will be more effective 
than Usual Care  (occupational    therapists/phy- 
siotherapists) for children with congential hemi- 
plegia (aged 8–18 years) to  improve  activity 
(unimanual capacity and bimanual performance) 
by a   mean difference  of  five  points on the 
Assisting  Hand Assessment  and 10% decrease 
in time on the Jebsen-Taylor  Test  of Hand 
Function  and motor and process skills 
(Assessment  of Motor and Process  Skills) will 
improve  by 0.5 logit scores  following Mitii 
intervention. 
 
 
 
BACKGROUND 
Cerebral palsy (CP)  describes  a group  of dis- 
orders  of the  development of movement and 
posture,  causing  activity limitations,  which are 
attributed   to    non-progressive   disturbances 
that   occurred  in  the   developing   foetal   or 
infant  brain.  The  motor  disorders  of CP are 
often accompanied by disturbances of sensa- 
tion, cognition, perception, behaviour and/or 
r.boyd@uq.edu.au    seizure  disorders  and  by secondary 
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ARTICLE SUMMARY 
Key messages 
▪    Persons  with cerebral  palsy require  a lifetime  of costly and 
resource  intensive  interventions  which are  often limited by 
equity of access.  With increasing  burden being placed  on 
health systems, new methods to deliver intensive rehabilitation 
therapies are needed. 
▪    Mitii  is  an  internet-based   multimodal training program 
consisting of UL and cognitive training within the context of 
meaningful  physical  activity.  This is the first time this new 
technology  will be tested to a  randomised   trial and it  is 
expected this trial. 
 
Strengths and limitations  of this study 
▪    This study uses a  strong design methodology,  utilising a 
matched paired, waitlist controlled, single blinded randomised 
trial. 
▪    This study will use outcomes measures across all domains of 
the International  Classification  of Functioning,  Disability and 
Health Framework to test the efficacy of Mitii. 
 
 
 
musculoskeletal problems.
1  
In Australia, around 600–700 
infants are born with CP each year, making it the most 
common physical disability in childhood.
2  
There  remains 
no  cure  for  CP, meaning that  an  infant  born  with this 
condition will require a  lifetime  of  investigations,  inter- 
ventions  and  equipment. In  2007,  CP was estimated   to 
cost AUD$43,431 per  person  with CP per  annum.
3  
CP is 
not  only a costly but  burdensome condition, impacting 
the individual,  his/her family and  society more  generally. 
These   impacts   highlight   the   need   to  optimise   health, 
function  and   ﬁtness   of  individuals  with  CP  to  reduce 
costs associated with the condition. 
Several intensive therapy  approaches delivered  by a 
therapist  directly  to  the   child   with  CP  are   currently 
offered  to improve upper limb (UL)  function. A system- 
atic review and meta-analysis of all non-surgical  UL inter- 
ventions found  some evidence  to support  these intensive 
training   approaches  (eg,   modiﬁed-Constraint Induced 
Movement Therapy  (mCIMT) and bimanual training 
(BIM))  to improve  the  amount of use (effect  size (ES) 
=1.54) and efﬁciency of movement (ES=0.44) of the 
impaired arm  and  new  repertoires of hand  skills 
(ES=1.22). Our  group  recently  completed a single blind 
(evaluator masked) randomised trial (INCITE 
NHMRC:368500)  which directly compared two intensive 
UL training  approaches, mCIMT and BIM to improve 
unimanual capacity, bimanual performance, societal par- 
ticipation  and  quality of life.
4  
Children attended 60 h of 
direct  training  in groups  with either  context  or method 
of training  over 10 days. In a matched pairs design  of 32 
pairs  of  children with  congenital hemiplegia (64  chil- 
dren  in  total) there  were  minimal  differences  between 
the  two  approaches,  both   improving   activity  perform- 
ance  equally  in  the  short  term  (3 weeks)  with mCIMT 
yielding   greater  changes    in   unimanual   capacity   at 
6 months.
5  6  
 
In addition to functional changes  children receiving 
mCIMT had greater and earlier  use-dependent neuro- 
plasticity,  measured with  Transcranial Magnetic 
Stimulation   (TMS)  immediately   postintervention,  than 
those  receiving  BIM which  was sustained  at  6 months.
7
 
These  results suggest that  a minimum of 60 h in a block 
of training  is required to drive neuroplasticity, which has 
implications  for the  current dose and  intensity  of stand- 
ard  training   regimens   for  children  with  unilateral CP. 
These   ﬁndings  support  the   need   for  training   to  be 
intensive,  repetitious  and  incrementally challenging in 
order  to drive neuroplasticity. 
The  challenge is that  while both  interventions are 
effective   they   are   costly  and   require  60 h   of  direct 
rehabilitation provided  by specialist trained occupational 
therapists    (OTs)    and/or   physiotherapists (PTs). 
Implementing direct  intensive  interventions in specialist 
settings also potentially  limits access to children who live 
in   major   metropolitan  centres.    The   reality   is  that 
current clinical  practice  affords  children with unilateral 
CP only consultative or time-limited  therapy following 
pharmacological   intervention   (1–12 h/year).   Limited 
available  health  resources  mean  the  amount of therapy 
may be insufﬁcient to drive neuroplastic changes  neces- 
sary for  functional improvements  to  occur.  Alternatives 
for intensive rehabilitation programmes are required. 
Internet-delivered programs and ‘active’ video games are 
emerging as a popular modality  for paediatric interven- 
tions. These systems have the potential to deliver novel, 
engaging  and intensive therapies to children in both 
metropolitan and  more  isolated  areas where  services are 
limited,  in a potentially  cost effective manner. 
‘Active’  video  games  not  only  have  the  potential to 
deliver UL interventions, but also to use otherwise sed- 
entary screen  time to promote physical activity. Children 
today,  particularly   those   with  motor   disabilities  which 
limit participation in sports or exercise,  spend  increased 
time  in sedentary screen-based leisure  activities, such  as 
watching  television  or  playing  sedentary  video  games. 
This displaces more  active behaviours  which in part  con- 
tributes  to obesity and  other  adverse  health  outcomes.
8
 
It  is known  that  children and  adolescents with CP are 
less  physically  active   than   their   typically  developing 
peers
9  10  
or compared with children with other  physical 
disabilities,  such  as spina  biﬁda  or head  injuries.11  This 
is an  important health  promotion consideration as pat- 
terns  of physical activity acquired during  childhood are 
more  likely to  be  maintained into  adult  life, providing 
the      foundation    for     healthy      lifestyle     choices.
12
 
Additionally,  for school-aged  children with CP, interven- 
tions including intramuscular botulinum toxin type-A, 
casting and surgery usually followed by a limited  amount 
of therapy are common at this age. Success of these 
interventions  should  be  assessed  against  all dimensions 
of  the  International  Classiﬁcation  of  Functioning, 
Disability and  Health  (ICF),
13  
including their  impact  on 
physical activity capacity and  performance, as well as 
participation. 
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Activities of  daily living (ADL;  ie,  life  tasks required 
for self-care and self-maintenance) are fundamental in 
supporting participation across school, home  and com- 
munity environments.
14 
Children and adolescents with 
unilateral  CP  often   experience  difﬁculties   with  ADL 
due    to    their    motor    and    associated    difﬁculties.15 
Performance of ADL is a high priority for parents/ 
guardians.
16 
Therapy  targeting ADL for children with 
unilateral CP often  involves task-speciﬁc training  to 
stimulate motor learning.
17 
Alternatively, therapy may 
address  deﬁcits  in motor  and  cognitive  skills that  are 
considered prerequisites for successful performance of 
ADL. Rehabilitation that  involves a combination of UL, 
gross motor,  cognitive  and  visual perceptual training  is 
likely to improve performance of ADL. Enhanced-ADL 
ability may increase  independence for children and 
adolescents and reduce the burden of care for 
parents/guardians. 
Underpinning participation in many daily tasks are 
executive  functions.   This  describes  an  umbrella term 
for functions  such as planning, working memory, 
inhibition,  mental   ﬂexibility,  as  well as  the  initiation 
and   monitoring  of  action.
18   
Children  with  mild  CP 
have  demonstrated  impairments with  executive  func- 
tion  in  multiple   domains.
19   
Therapies  that  not  only 
target improvement in physical impairments but also 
components of  executive  function have  the  potential 
to improve  a child’s performance and  participation in 
more complex activities, including academic  school 
performance. 
An  effective  web-based  multimodal training   that 
enhances cognitive and motor  abilities using multidiscip- 
linary virtual trainers  may be a cost effective means of 
delivering  therapy  and  facilitate  translation of skills into 
home   and  community  environments.  This  has  signiﬁ- 
cant  implications   for  equity  of  access  for  children  in 
diverse  geographical  locations.   Move  it  to  improve  it 
(Mitii)     is    an    internet-based    multimodal    training 
program  comprising UL  and  cognitive  training   within 
the  context  of meaningful physical activity. Mitii detects 
bodily movements generated by a child using a green 
tracking band worn on the hand, head or knee. These 
movements  are  tracked  by a web camera  attached to an 
internet-connected computer. Mitii requires no specialist 
or costly equipment and  can be delivered  in the  client’s 
home.  PTs, OTs and psychologists act as virtual trainers 
remotely  accessing  the  program  to  set  up  a  series  of 
‘games’ via the  program’s  ‘cockpit’. These  are  graded 
regularly   to  deliver  an  incrementally challenging and 
individualised  programme. 
The  feasibility of delivering  Mitii has been  conﬁrmed 
in  a  pilot  study  of nine  children achieving  on  average 
35 min of training  daily for 20 weeks (total  dose 70 h).20 
Compliance was high,  with an  average  of 85%  of chil- 
dren   meeting  or   exceeding  this  dose.   In   a  prepost 
design, children made signiﬁcant  gains in motor and 
processing  skills, functional strength, endurance and  a 
range  of visual perceptual skills. 
METHODS 
Aims and hypotheses 
The  main  aim  of this proposed study  is to determine if 
20 weeks of intensive Mitii training  can improve UL activ- 
ity  (unimanual  and   bimanual),  occupational  perform- 
ance and  cognitive skills in children and  adolescents with 
CP compared with standard care. The secondary  aim is to 
further our understanding of the central  neurovascular 
mechanisms underlying changes in UL function, motor 
planning and  executive  function (using  functional MRI 
( fMRI)  and  TMS  to  measure central   activation  in  the 
parts   of  the   brain   controlling  movement).  This  is  an 
essential  next  step  towards  providing  effective  treatment 
and  sustained  outcomes.  Further aims are to test the  efﬁ- 
cacy of Mitii across all dimensions of the ICF. 
The primary hypothesis to be tested  is: 
1.  In a waitlist randomised controlled trial, Mitii will be 
more   effective  than   Usual  Care  (OT/PT) for  chil- 
dren  with congential hemiplegia (aged  8–18 years) to 
improve activity (unimanual capacity and  bimanual 
performance) by a mean  difference of ﬁve points  on 
the  Assisting Hand  Assessment (AHA) and  10% 
decrease  in time on the Jebsen-Taylor Test of Hand 
Function ( JTTHF),   and   motor   and   process   skills 
(Assessment  of Motor and Process Skill, AMPS) will 
improve  by  0.5  logit  scores  following  Mitii 
intervention. 
Secondary hypotheses: 
Mitii   will  be   more    effective   than    Usual   Care   at 
improving: 
1. Use-dependent  neuroplasticity (cortical   excitability 
on TMS) and  neurovascular changes  ( fMRI), which 
will be more  extensive and retained for longer; 
2. Visual   perception   (visual    discrimination,   visual 
memory and visual sequential memory); 
3.    Executive  functioning (EF;  information processing, 
attentional control,  cognitive  ﬂexibility,  goal setting, 
working  memory  and  behavioural manifestations of 
EF in daily life); 
4.    Psychological        functioning      (Strengths      and 
Difﬁculties Questionnaire (SDQ)); 
5. Participation  (Assessment   of  life  habits  (LIFE-H)) 
for categories  of personal care,  nutrition, education 
and recreation; 
6.    Occupational performance (Canadian occupational 
performance measure  (COPM)  performance and 
satisfaction); 
7.    Functioning and  participation domains  of quality of 
life (CP-QOL-Child  or CP-QOL-Teen); 
8.    Functional  abilities  in  self-care  and  daily  activities 
(mobility questionnaire-28 (MobQues28)); 
9. Physical activity capacity immediately  following Mitii 
training  (Functional strength: repeated sit to stand, 
half-kneel  to stand  and step up tests; and 6 min walk 
test (6MWT)); 
10. Physical  activity  performance (ActiGraph) and 
greater compliance with the  national physical activ- 
ity recommendations
21 22
; 
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11.  Mitii  will  be   more   cost-effective  compared   with 
Usual Care  as shown  by resource use and  effective- 
ness  based  on  function  (AMPS)  and  quality  of life 
(CP-QOL). 
 
Ethics 
Full ethical approval has been  obtained from the Medical 
Ethics Committee of The University of Queensland 
(2011000608)     and    the    Royal    Children’s   Hospital 
Brisbane  (HREC/11/QRCH/35). Written  and  informed 
consent will be  obtained from  parents or  guardian and 
all participants over 12 years of age, by study coordinators 
and  personnel, upon  entering the  trial before  matching 
and  randomisation. The  proposed Mitii clinical trial has 
been  registered with the Australian and New Zealand 
Clinical Trials registration: ACTRN12611001174976. 
 
Study sample and recruitment 
Children and youth with spastic-type congenital hemiple- 
gia aged  8–18 years  will be recruited across Queensland 
and  New South  Wales, Australia.  Potential  study partici- 
pants  will be identiﬁed through a population-based 
research database,  which currently  comprises over 1600 
children  with  CP  at  the   Queensland  Cerebral  Palsy 
and Rehabilitation Research Centre  (QCPRRC), the 
Queensland   Cerebral   Palsy   Register   (QCPR), 
Queensland CP Health  Service and  advertising  to  OTs, 
PTs and  Paediatricians at the  Royal Children’s Hospital, 
Brisbane and in the community. The recruitment process 
will target  both  publicly funded services and  private 
practitioners with the expectation that the sample will be 
representative of children with congenital hemiplegia. 
 
Inclusion and exclusion criteria 
Children with mild  to  moderate congenital hemiplegia 
will be recruited, who are: (1)  Gross Motor  Function 
Classiﬁcation (GMFCS) I or II23; Manual Abilities 
Classiﬁcation    scale   (MACS)   I,   II,   III24;    (2)    aged 
8–18 years   with   sufﬁcient    cooperation  and   cognitive 
understanding  to  perform  the   tasks  and   (3)   able  to 
access  the  internet  at  home   ( phone line  or  internet 
access).    Children   will   be    excluded   if   they    have 
(1)  received  UL  or  lower-limb  surgery  in  the  previous 
6 months;  (2) unstable  epilepsy (ie, frequent seizures not 
controlled by medication) or (3)  a respiratory, cardiovas- 
cular  or  other   medical   condition  that   would  prevent 
them  participating safely in the  Mitii training.  Diagnosis 
of CP will be  conﬁrmed by a paediatrician or  clinician 
and in accordance with published recommendations.
25
 
 
Sample size 
Sample size calculation is based on the primary hypothesis 
comparison between the functional effects of Mitii com- 
pared  with standard  care  at 20 weeks on  the  AMPS. This 
study   examines    a  continuous  response  variable   from 
matched waitlist control  and immediate-intervention 
participants with one waitlist control  per immediate- 
intervention  participant. In  a previous  study of Mitii the 
response within each  group  was normally  distributed with 
SD 0.58 on  the  AMPS.
20  
To detect  a clinically signiﬁcant 
difference  (0.35  units  or  greater) between   groups   with 
80% power and  α=0.05, 44 children are  required in each 
group.  Allowing for 10% attrition, the  sample  size will be 
98 particiapnts. To assist in achieving this sample size, parti- 
cipants  will be  offered  reimbursement of travel  expenses 
and ﬂexible appointment times and locations. 
For hypothesis  two, based on our previous  randomised 
trial  using  3T fMRI we see activation  in the  representa- 
tive cortex  for  motor   studies  with  good  signal-to-noise 
ratio.  Participant numbers will allow for some  loss of 
information due  to participant refusal  (10%)  and  scans 
where  motion  is a confounder (10%).  With  40 partici- 
pants  in an  analysis of baseline  to week 20 changes  on 
fMRI, this study will have  80% power  to detect  a differ- 
ence  between  groups  of 0.65 SD. If the  supplementary 
motor  area (SMA) is considered, given coefﬁcient of 
variation    (CV)   for   control    participants   performing 
motor  tasks (CV of  11%  in  PM1 and  35%  in  SMA),
26 
and  activation  signal of 1.5%, we are  able  to detect  dif- 
ferences  in % activation levels over time as small as 0.47. 
 
Design 
The  efﬁcacy of Mitii will be tested  using a waitlist control 
assessor masked randomised controlled trial (RCT) con- 
ducted according to CONSORT guidelines  (see ﬁgure  1). 
Participants  will be  consented  to  the   study  and   then 
matched in pairs. All participants of the study will receive 
Mitii training.  Within the pair, each participant will be ran- 
domised  to either: 
1.  Immediate intervention group 
Families  return  home   with  Mitii  equipment  and 
begin training  immediately;  or 
2.  Waitlist delayed intervention (control) group 
Families  continue  care  as  usual  for  20 weeks  and 
then  return to Brisbane  for 1-day reassessment then 
receive the same intervention as the immediate 
intervention group. 
 
Children will not  be  provided   with  any  concomitant 
treatments, such as arm splinting, casting or UL intra- 
muscular  botulinum toxin  type-A injections  during  the 
baseline   to   20-week  intervention   period.   Participants 
who have received  intramuscular botulinum toxin type-A 
in  the  UL the  previous  2 months  will have  assessments 
and interventions postponed until after their standard 
follow-up has been  completed (usually 6–8 weeks postin- 
jection).  All concurrent therapies provided  by local ser- 
vices duration, frequency  and  content will be  recorded 
by questionnaire at 20-week follow-up. 
 
Randomisation 
Children  will  be  matched  in  pairs  according  to  age 
(within  12-month  age bands), gender and  level of func- 
tional    ability   based    on   MACS  level,   at   screening. 
A matched pairs design is the design of choice  as it mini- 
mises the likelihood  of group  differences at baseline  that 
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Figure 1   CONSORT flow chart of the move it to improve it (Mitii) cerebral palsy study. 
 
 
has   often   been  present  in   rehabilitation  studies.27  28 
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Eligible children: children 8 to 18 years with unilateral spastic type CP, not 
due to or have had Botox within 2 months or surgery within 6 months of 
baseline or over study period. Recruited from the QCPR /ACPR/QCPRRC 
registers.  
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Matching for age, gender and functional level on 
MACS, then randomisation 
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‘1’ or  ‘2’ to  each  member of the  pair.  As each  pair  is 
entered, they will be allocated  the next consecutive  enve- 
lope,  which  will be  opened by the  non-study  personnel 
who will read  and  record the  treatment allocation  from 
the  paper  inside  the  envelope.  Treatment allocation  will 
be  recorded  on  a  piece   of  folded   paper   inside  each 
envelope,   in  random  order   (either  1:Waitlist  2: 
Immediate; or 1:Immediate 2:Waitlist, with the  sequence 
being  computer generated). Study personnel will be 
informed of group  allocation;  however,  participants and 
their  parents/guardians  will not  be  informed of  their 
group  allocation  until after their  baseline  assessments. 
 
Blinding 
Functional MRI and  TMS data  will be  qualitatively ana- 
lysed by neurologists masked  to  group  allocation. 
Paediatric  neurologists with fMRI training  will independ- 
ently   rate   scan   quality   (0–5),   region    of   activation, 
change   over  time  and  patterns of reorganisation. Data 
on the AHA and  Melbourne assessment  of unilateral UL 
function   (MUUL)   will be  rated  from  video  recordings 
analysed by assessors masked  to group  allocation  and 
assessment time point. 
 
Adverse events 
Any minor  and  major  event  associated  with the  training 
model   will  be   screened  at   20 weeks  by  open-ended 
questions. 
 
Study procedure 
Children will attend the  Queensland Cerebral Palsy and 
Rehabilitation Research  Centre  in Brisbane  for 1 day for 
baseline assessments. Participants in the immediate 
intervention group  will spend  an additional day for Mitii 
training   and  then   return home   with  Mitii  equipment 
and start the training  immediately.  The delayed interven- 
tion  (Waitlist control) group  will continue care  as usual 
for  20 weeks  and   then   return  to  Brisbane   for  1-day 
reassessment and then  receive the Mitii training  and equip- 
ment.  For each  participant, data  will be collected  at base- 
line (T1). For the Immediate intervention group,  follow-up 
assessments will be conducted postintervention at 20 weeks 
postrandomisation (T2), and then  retention (40-week post- 
randomisation, T3).  For the  Waitlist group,  an  additional 
baseline  assessment will be conducted at 20 weeks postran- 
domisation (T2), and  then   postintervention  at  20 weeks 
after commencing the  Mitii training  (40 weeks postrando- 
misation,  T3). Retention of effects will be collected  in the 
Waitlist group  by an additional assessment at 60 weeks post- 
randomisation (T4; see ﬁgure  1). 
 
Mitii intervention 
Mitii is delivered  in the participant’s home  through an 
internet-connected computer with a web camera  using a 
cloud  server-based interactive  training  system  employing 
Adobe Flash technology.  The system has been  developed 
through   collaboration  between    The    Helene   Elsass 
Centre,     a    private    software    development    company 
(Head-ﬁtted; Århus, Denmark) and the University of 
Copenhagen. It has now been  made  commercially  avail- 
able  through  collaboration between  the  Helene Elsass 
Centre   and  the  Ministry  of  Research  under the  name 
Mitii (Move it to improve it; Mitii developments, 
Charlottenlund, Denmark). 
A child  is initially assessed by a multidisciplinary  team 
(PT,  OT  and  psychologist)   to  ascertain   ﬁne   and  gross 
motor  skills and  cognitive  abilities.  A deidentiﬁed alias 
account  is created for the child in Mitii and therapists 
develop an individually tailored  group of tasks/games 
available in the  program. The  child  then  logs onto  Mitii 
(through internet access) and  completes  the  activities in 
his/her  own   home    or   local   environment.  Activities 
include  gross motor  control  (eg,  unilateral and  bilateral 
UL movement,  sit-to-stand, balance) as well as cognitive 
tasks  (eg,   matching,  ordering,  moving   and   tracking 
objects; see table  1). The  combination of UL and  lower- 
limb gross motor,  cognitive and visual perceptual training 
is designed  to have a multimodal effect by training  mul- 
tiple networks which then  enhances performance in each 
area.  It  consists  of  a  number of  training   modules   or 
‘games’ in which the  child  has to analyse visual informa- 
tion, solve a cognitive problem (ie, mathematical question 
or similar) and respond with a motor act (ie, bend  to pick 
up  needle and  pop  the  balloon  with the  right  answer). 
The  participant interacts  with the  system  through move- 
ment  of a  green  tracking  band  worn  on  the  hands  or 
head.  The  computer program identiﬁes the  movements 
of the  child  from  video  images  sampled  from  a simple 
web camera  attached to the computer. 
 
Mitii training 
Participants log into the Mitii website and access their 
individualised   training   programmes  at  their   conveni- 
ence,  enabling training   to  be  completed at  any  time. 
The  speciﬁc  content and  progression of the  programme 
will be decided from  a weekly evaluation  of participants’ 
performance. The  different modules  will be  combined 
uniquely according to the speciﬁc cognitive and motor 
abilities  of  each   child.  The   level  of  difﬁculty  can  be 
adjusted   by increasing   the  difﬁculty  of  the  perceptual 
(eg, increasingly complex forms have to be correctly 
identiﬁed), cognitive (eg, increasingly difﬁcult mathem- 
atical  questions) or  motor  challenges   (eg,  child  has  to 
do more repetitions or work with higher  load). This is 
completed by therapists  (PT,  OT and  psychologists)  who 
are  in  weekly email  contact   with  the  participants and 
their  families.  This  has  the  effect  that  the  participants 
and their  parents have a private ‘virtual’ coach  who over- 
sees their  training. 
A series of individual  tasks or games will be combined 
in a sequence to make a daily programme of 30-min dur- 
ation.   Mitii  should   be  completed  in,  at  least,  30 min 
daily for  6 days/week  for  20 weeks to  provide  sufﬁcient 
training  intensity  ( providing  a total  dose of 60 h).  Tasks 
can  be  divided  into  those  training  gross-motor  or  phys- 
ical activity (eg,  repetitive  sit-to-stand exercises)  or those 
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Table  1    Tasks and domains trained  within the Mitii programme and the corresponding actions, parameters that can  be manipulated by therapists and results  received for 
each task  (Please note: Content  of Mitii is copyright to Mitii Development  A/S) 
 
Task Task description Action Parameters adjusted Domains trained Results displayed 
Memory Memorise  a Look at number  of images. Number  of images displayed Upper limb movement % Correct 
 sequence of images Images disappear and  client Number  of images in Memory/cognition Time spent  on exercise 
  must memories them in order sequence Visual perception  
  which they were shown.  Displays Length of time displayed   
  sample of images and  uses Complexity of images   
  upper  limb movement to recreate Position  of images   
  sequence Number  of repetitions   
Brick Ability to recognise Sequence of images displayed, Number  of images Upper limb movement % Correct 
 the outline of a one  of which matches shape. Rotation  of figures Memory/cognition Time spent  on exercise 
 picture Client uses upper  limb to drag Position  of images Visual perception  
  corresponding image  to shape Position  of shape   
   Number  of repetitions   
   Complexity of images   
Figure builder Ability to construct a An image  is in the middle of Number  of images Upper limb movement Number  of pieces missed 
 complete image  from screen. Small pieces of this and Number  of pieces Memory/cognition Time spent  on exercise 
 smaller  pieces other images are falling down Interval between pieces Visual perception  
  either side.  Use  upper  limb to Speed of falling pieces   
  reach and drag corresponding Number  of repetitions   
  piece  to recreate image  from Complexity of images   
  bottom to top    
Figure ground Ability to pick out a Large background image Time held over correct  place Upper limb movement Time spent  on exercise 
 figure from an presented. Use upper  limb to Precision of placement Visual perception  
 unorganised pick up small brick and drag to Number  of repetitions   
 background corresponding place  in image Complexity of background   
Spatial Ability to perceive Use  upper  limb to touch the Number  of images Upper limb movement % Correct 
relation spatial  orientation  of image  in the sequence which Interval between images Visual perception Time spent  on exercise 
 a figure differs. (eg, Pear, Apple, Orange, Time held over correct  image   
  Car. The car is different.) Number  of repetitions   
   Complexity of images   
Visual closure Ability to recognise Series of incomplete images Number  of images Upper limb movement % Correct 
 an incomplete figure displayed, and complete single Position  of images Visual perception Time spent  on exercise 
  image.  Use upper  limb to drag Internal between images   
  incomplete image  to complete Time held over correct  image   
  image.  Correct  image  is one that Repetitions   
  if complete, would be identical to Complexity of images   
  the presented complete image    
Continued 
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Table  1    Continued 
 
Task Task description Action Parameters adjusted Domains trained Results displayed 
Balloon Ability to complete Equation  and a number  of Complexity of equation Upper limb movement % Correct 
mathematics mathematical answer options  are presented in Number  of terms  in equation Memory/cognition Time spent  on exercise 
 calculations balloons.  Use  upper  limb to drag Size  of number  in equation Visual perception  
  pin and pop balloon with correct Time held over correct  balloon   
  answer Time equation displayed   
   Time answer displayed   
   Position  of balloons   
   Position  of pin   
   Number  of repetitions   
Combination Ability to coordinated Series of images presented on Number  of images presented Bimanual  upper  limb % Correct 
(two-hand both upper  limbs both sides. Use both hands to Number  of matching  pairs coordination Time spent  on exercise 
exercise)  drag two matching  items into a Location of goal circle Memory/cognition  
  circle in the centre  of the screen Size  of goal circle Visual Perception  
   Time held on correct  image Time challenge  
   Time held in goal circle   
   Number  of repetitions   
   Time bomb   
   Complexity of images   
Flight Ability to balance Use  band  on head to steer the Airplane speed Balance Time spent  on exercise 
simulator against series of plane  against a series of lateral Wind direction  Balance distribution 
 lateral displacements wind gust  disturbances Time of wind gust   
   Strength of wind gust   
   Exercise duration   
Follow Ability to control Use  band  on head to steer an Route  of object Lower limb strength Time spent  on exercise 
 gross motor object  around  screen Speed of object movement Balance % Correct  route 
 movements and  Amplitude of object   
 activate  larger  movement   
 muscle  groups  Size  of object   
   Number  of repetitions   
Get up/get Activate larger Use  band  on head to steer Location of object Lower limb strength Time spent  on exercise 
down muscle  groups  to object  from top to bottom of Number  of repetitions Balance Time per repetition 
 increase intensity screen while doing gross motor Time bomb Time challenge  
 and pulse  rate movement (eg, Sit to stand,    
  Squat to stand, Lunge  to stand,    
  Step  on/off block)    
Follow the Follow a sequence Video sequence uploaded and Video created by therapist Lower limb strength  
leader of movements client follows visualising therefore can  modify Balance  
  themselves and the video in a    
  split screen view    
Continued 
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combining  cognitive  or  visual  perception  and   an  UL 
task  (eg,  moving  the  UL  to  solve a  mathematic  equa- 
tion).   To   ensure   each   participant  receives   a  similar 
training  programme, all sequences will comprise 
approximately 60% cognitive-UL and 40% gross-motor 
training  tasks individualised  to the child’s abilities. Step 
blocks and  balance  foam can be added  as the  child  pro- 
gresses to add additional challenge to the tasks. 
 
Participant and data management 
The percentage of eligible participants successfully 
recruited,  and   number  of   eligible   participants   who 
choose  not  to  participate will be  recorded. Participant 
retention will be  recorded throughout the  trial  period. 
All data will be analysed by intention to treat,  whereby a 
participant’s  assessment   from   the   last  available  time- 
point  is carried   forward  in  the  event  of  withdrawal  or 
loss to  follow-up.  Treatment dose  is automatically 
recorded by the  Mitii program and  will be monitored by 
the therapists.  Strategies to manage  engagement in the 
programme will be  discussed  with  the  participant and 
parent/guardian during  their initial Mitii training.  All 
participants will receive  a Mitii rewards  chart  which seg- 
ments  the  20-week programme into  four  5-week blocks 
and  allows small rewards to be decided in advance  for 
completing each  stage. Other strategies  such  as parent/ 
guardian involvement,  feedback,  positive reinforcement 
and  incorporating Mitii into  the  family routine will also 
be   discussed.   Therapists   will  contact   participants  via 
email,  telephone and  Skype  to  troubleshoot any  tech- 
nical problems and to support  engagement. 
 
Classification measures 
Classification of the brain lesion 
Brain  lesion  will be classiﬁed  using  a qualitative  and 
quantitative structural MRI classiﬁcation  system. The 
classiﬁcation   system  is based  on  the  presumed  timing 
and  nature of the  insult  that  resulted   in  CP including 
both  genetic  and non-genetic aetiologies  such as cortical 
malformations and hypoxic ischaemic injury
29 
and a 
quantitative  system  to  grade   the   location,   extent   and 
severity of the brain  lesions with an asymmetry index.
30
 
 
Gross motor function classification system 
The  gross motor  function classiﬁcation  system (GMFCS) 
classiﬁes the child’s ability to carry out self-initiated move- 
ments  related to sitting  and  walking across ﬁve  levels.23 
The  GMFCS has strong  construct validity with the  Gross 
Motor Function Measure  (r=0.91)
31 
and good interobser- 
ver reliability between  professionals  and  between  profes- 
sionals and parents.
32 
In this sample of children with 
hemiplegia, all children will be GMFCS level I (walks 
without limitations) and II (walks with limitations). 
 
Manual abilities classification system 
MACS classiﬁes  the  child’s ability to  handle objects  in 
daily activities on one  of ﬁve levels.24  MACs has reported 
construct  validity,  and   excellent    inter-rater  reliability 
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(Intraclass  Correlation Coefﬁcient (ICC)=0.97 between 
therapists   and  ICC=0.96  between  therapists   and 
parents).
33 
All children in the sample will be MACS level 
I (able  to handle objects easily and  successfully), level II 
(able  to handle most objects but with somewhat  reduced 
quality  and/or speed  of  achievement so that  alternate 
ways   of   performance  might   be   used)    or   level   III 
(handles objects  with difﬁculty;  needs  help  to  prepare 
and/or modify activities). 
 
Anthropometric data 
Height  will be measured to the  nearest  0.5 cm while the 
child is standing  with the back against a wall. 
 
Wechsler Intelligence Scale for Children–fourth edition 
short form 
The seven subtest short-form  version of the Wechsler 
Intelligence Scale for Children fourth  edition  (WISC-IV) 
will be  used  to  measure intellectual functioning across 
four indices: verbal comprehension index (VCI), per- 
ceptual  reasoning index (PRI), Working Memory Index 
(WMI)  and  processing   speed   index   (PSI).  An  overall 
short  form,  full-scale intellectual functioning score  will 
be calculated from the  index  scores. The  VCI consists of 
the  Vocabulary and  Similarities  subtests, the  PRI is com- 
prised  from  Block  Design  and  Matrix  Reasoning   subt- 
ests, the WMI is derived  from the Digit Span subtest and 
the PSI from the Coding  and  Symbol Search  subtests. In 
the  Vocabulary subtest,  children will name  pictures  or 
provide  deﬁnitions of words (eg, ‘what is a hat’). For 
Similarities,  children will describe   how  two words  that 
are common objects or represent common concepts  are 
similar (eg,  ‘in what ways are  a cat and  a mouse  alike’). 
In   Block   Design,   children  will  reproduce  a   set   of 
red-and-white  blocks either  modelled or printed, two- 
dimension  geometric patterns,  within  a  speciﬁed   time 
limit.   Matrix   Reasoning   will  involve  the   child   being 
shown an array of pictures  with one  missing square  and 
they will need  to select the picture  that ﬁts the array from 
ﬁve options.  In Digit Span, children will repeat  a string of 
verbally presented numbers in both  a forward and  back- 
ward direction. Finally, in Symbol Search, children will 
visually scan  a  search   group   of  symbols  and   indicate 
whether  or not a target symbol is in the search group  and 
in Coding,  children will transcribe a digit code.  Both the 
Symbol Search  and  the  Coding  tasks need  to be rapidly 
completed within  2 min.  Index  scores will be  converted 
into  scaled  scores  in  accordance  with  normative   data 
based   on   the   child’s  age   and   gender   (mean=100, 
SD=15).
34    35   
All index  scores  of  the  WISV-IV SF have 
shown moderate to high levels of internal consistency 
(α=0.87–0.96)  and  are  equivalent  to  those  documented 
for  the  full  WISV-IV, with  the  exception  of  the  WMI 
which is marginally lower than its full-length equivalent. 
 
Neurovascular measures 
Neurovascular  outcomes  will be  collected   at  baseline 
and 20 weeks. 
Whole-brain fMRI studies 
Functional imaging  at  3T on  a  Siemens  MAGNETOM 
Trio  MR scanner will be conducted on  the  research- 
dedicated scanner at the  Centre  for Advanced  Imaging 
at  the  University  of  Queensland. The  3T scanner pro- 
vides approximately twice the signal-to-noise ratio com- 
pared  with conventional 1.5T scanners  which will reduce 
the  time  in  the  scanner and  improve  the  resolution  of 
data  collected.   Published   methods
4  
will be  utilised  for 
conducting serial fMRI studies preparing in a mock MRI 
scanner  and   the   motor   paradigm  will  consist   of  a 
2-condition  block design (wrist extension compared with 
rest),   visually  cued   via  instructions  projected   on   a 
screen,  timed  with an auditory cue for the  rate  of move- 
ment  at 2 Hz. The task and rest periods  are 30 s with the 
activation cycle repeated four times. 
Children with sufﬁcient  comprehension will also com- 
plete  a complex  motor  task as an  additional task in the 
scanner. This task is timing  versus  sequencing task per- 
formed   in  a  block  design   (two  runs   of  6 min  each), 
where   the   participant  alternates  between   a  block  of 
single   index-ﬁnger   button-pressing   and    a   block   of 
random  sequences of  three-ﬁnger  button-presses. For 
the   sequence   task,   visual   cues   of   ‘123,   321,   213’ 
numbers denote a random sequencing of pushing  three 
buttons   with  their  index,  third   and  fourth   ﬁngers   on 
buttons  with their  dominant hand.  This complex  task is 
designed  to differentiate activation in the primary motor 
cortex  and  different aspects  of the  basal ganglia  circuit. 
The   rationale behind  the  simple  and  complex   move- 
ment  is based on previous studies that showed these 
movements  are  able  to  induce   activation  of the  motor 
cortex   and   basal  ganglia  circuits.36   Notably  increased 
complexity  of ﬁnger movements  increases  activation  of 
the   basal  ganglia  circuit,   and   thus   provides   an  ideal 
model  to utilise fMRI to locate  function speciﬁc  regions 
of the cortex  associated  with ﬁnger movements. 
An additional 5 min  of resting-state  fMRI will also be 
collected   for  analysis  of  functional  connectivity   (FC). 
Tasks performed prior to resting-state fMRI can inﬂuence 
FC.
37  
The  movements performed in the  scanner will be 
rated  for  speed,  range  of motion,  ability to  isolate  and 
the  presence of mirror  movements  in  the  contralateral 
hand.   Functional MRI will be  acquired using  a  BOLD 
acquisition  sequence  (gradient-recalled-echo,  echo- 
planar  imaging  (EPI),  repetition time=3.0 s, Echo  Time 
(TE)=30 ms,   Flip   angle=850,   Slice   thickness=3 mm, 
FOV=216 mm,    44   slices,   72×72   matrix    yielding   an 
in-plane  resolution of 3.0 mm×3.0 mm).  A single  set of 
T2-weighted  anatomical, FLAIR and  three-dimensional 
T1 volumes will also be collected.  Functional MRI image 
processing,  analysis and  visualisation  will be  performed 
using iBrain software
38   
and  SPM software (Welcome 
Department of Imaging  Neuroscience, London, UK). 
Detailed information about preprocessing and postpro- 
cessing of the  fMRI has been  published.
4 
The  same pro- 
cessing and established analysis of data will be utilised for 
this   proposed   Mitii   project.    In   addition,   temporal 
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autocorrelation will be modelled using a white noise and 
autoregressive AR(1) model  within SPM. Motion  correc- 
tion  parameters will be included as covariates.
39  
Due  to 
heterogeneity in  lesion  location  and  size across  partici- 
pants, group  analysis of intraparticipant change  in activa- 
tion will be using region  of interest  with iBrain software.
38
 
 
Diffusion imaging and structural connectivity 
Diffusion-weighted    images   will  be   acquired  using   a 
twice-refocussed single-shot EPI sequence (64 directions, 
b  value  3000 s/mm
2
, 60 contiguous slices with 2.5 mm 
thickness  covering  the  whole  brain,  in-plane  resolution 
2.35×2.35 mm,  acquisition   time  approximately 10 min). 
White   matter    tractography   will  be   performed   with 
MRtrix using probabilistic tractography, with ﬁbre  orien- 
tations  obtained using  constrained spherical  deconvolu- 
tion,   taking   into   account  the   presence  of   crossing 
ﬁbres.40 41  An automated technique has been  developed 
to generate whole brain  tractograms, from which individ- 
ual  white matter  pathways  (eg,  motor  and  sensory)  can 
be extracted for statistical analysis.
42
 
To  improve  our   understanding  of  cortical   plasticity 
post-training,  cortical  reorganisation will be  investigated 
using a combined fMRI-structural connectivity analysis 
strategy. In this approach, regions  of corticomomtor acti- 
vation derived from the fMRI analysis (generated post- 
therapy) will be used as target  masks for extracting white 
matter  motor  pathways.  This  will enable  the  identiﬁca- 
tion  of all corticomotor networks  exhibiting plasticity as 
a  result   of  the   motor   training    paradigms.    Plasticity 
within these  neural  circuits will be measured by compar- 
ing  apparent ﬁbre  density,43  a  quantitative measure  of 
the organisation of WM ﬁbres,  derived over the entire 
pathway.  This  strategy  enables  both  an  anatomical view 
of cortical reorganisation and quantitative measures  of 
altered connectivity induced by therapy.  We also propose 
to measure plasticity based on an analysis of structural 
connectivity.  In this approach, connectivity  matrices  will 
be generated based on parcellation of cortical and sub- 
cortical using Freesurfer image analysis suite (http:// 
surfer.nmr.mgh.harvard.edu) and the whole brain  tracto- 
grams,  as  outlined  above.  Hit-testing   every  streamline 
with every cortical parcellation will generate the connect- 
ivity matrices.  Diffusivity indices  (Fractional Anisotropy 
(FA)  and  Mean  Diffusivity (MD)),  quantitative markers 
of the  integrity  of white matter,  will be  encoded  within 
the connectome to enable  assessment of motor  task gen- 
erated reorganisation.
44 45   
Network-based  statistics
46   
will 
be performed between  the FA and  MD connectomes for 
the control  (CP without intervention) and intervention 
groups to identify statistically signiﬁcant  cortical networks 
that are associated with neural  reorganisation. 
 
Transmagnetic stimulation (TMS) 
Transmagnetic stimulation  (TMS)  (MAGSTIM 200)  will 
be performed on all participants in both  groups  at base- 
line  then  at 20–22 weeks postintervention.  The  baseline 
study   will  be   conducted  following   fMRI  to   prevent 
contamination of fMRI ﬁndings by TMS. A ﬁgure  of eight 
TMS coil is used to stimulate  the brain  and surface EMG 
electrodes are used to record motor  evoked potentials 
(MEPs) from the target muscles, right and left abductor 
pollicis brevis (APB). TMS will be performed at the same 
time  of day  to reduce variability. MEPs will be recorded 
on  a  Synergy  EMG  machine using  band-pass  ﬁltering 
10 Hz–5 kHz,  sweep  speed   100 m  and  gain  100 V/div. 
Auditory EMG feedback  will be given to ensure  voluntary 
relaxation of the target muscles during  stimulation. 
The  experimental session will record the  following 
parameters: 
 
 
Motor threshold 
Stimulation   will start  at  30%  of  maximum output and 
increase  in 5% increments until  the  MEP is established. 
Only 1% changes  in intensity will then  be used  to calcu- 
late   the   threshold  value.   Motor   threshold  (MT)   is 
deﬁned as the lowest level of stimulus intensity which 
produced an  MEP in the  target  muscle  of peak-to-peak 
amplitude >100 μV on 50% or more  of 10 trials.47 
 
 
MEP recruitment  curves 
The  maximum compound muscle  action  potential 
(CMAP)  amplitude  of  the  resting   APB will be  deter- 
mined    by  supramaximal   stimulation    of   the   median 
nerve  at  the  wrist. For  each  participant, the  average  of 
the  CMAP amplitudes obtained  after  three   stimuli  will 
be  calculated deﬁned  as  100%.48     MEPs  obtained  by 
single-pulse TMS using different randomised stimulus 
intensities  of 110%, 120%, 130% and  140% MT will be 
expressed   as  a  percentage  of  the  CMAP  in  order   to 
obtain     recruitment    curves.
49       
An    average    of    10 
peak-to-peak  MEPs recorded for each  stimulus  intensity 
will be calculated. 
For  MTs  and   recruitment  curve  measurements, the 
stimulus  will be  delivered   to  the  contralateral cerebral 
hemisphere  using   the   appropriate  direction  of   coil 
current ﬂow  (anticlockwise  for  left  cortical  stimulation 
and  clockwise for right  cortical  stimulation). This will be 
performed using  a ﬂat  circular  9 cm diameter magnetic 
coil (14 cm external diameter) connected to a Magstim 
stimulator  (Magstim,  Whitland,  Dyfed, UK). The  centre 
of the coil will be positioned over the vertex and  held  in 
a plane  tangential to it. The  coil will be held  in place by 
a support  stand,  and  its position  will be  checked regu- 
larly through each experiment. 
 
 
Ipsilateral motor pathways 
This will be performed using a ﬁgure-of-eight-shaped coil 
(outer  diameter of  each  loop  70 mm)   connected  to  a 
Magstim stimulator  (Magstim, Whitland,  Dyfed, UK). The 
coil  will be  placed  tangentially  over  the  ipsilateral  hand 
motor  cortex  with the  handle pointing back and  laterally 
45° away from the midline  at the optimal  site for the activa- 
tion of the APB. This is thought to be the best position  for 
activating    the    pyramidal    cells    transsynaptically    and 
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preferentially elicits late I-waves.
50 
The direction of current 
induced in the brain will be anterior to posterior. 
 
Primary outcome measures 
Assessment of motor and process skills 
AMPS is a standardised, criterion-referenced, observa- 
tional  assessment  of the motor  abilities of people  2 years 
of  age  and   older.   An  OT  evaluates  the   quality  of  a 
person’s  ADL task  performance at  the  level of  activity 
and  participation in a culturally  relevant  manner.
51  
For 
the  assessment,  the  patient   selects  a  minimum of  two 
daily activities (eg, dressing, eating and food preparation) 
from  116 task options,  for which the  quality of activity is 
scored  on  the  degree of  exertion, efﬁcacy,  conﬁdence 
and  independence in  16 ADL motor  and  20 ADL pro- 
cessing  skills. The  child  is also given ratings  for  overall 
functioning levels. The  performance of children in each 
of the  motor  and  processing  skills is scored  from  1 to 4 
(1=deﬁcient performance that  impeded the  action  pro- 
gression and  yielded unacceptable outcomes,  through to 
4=competent performance that supported the action pro- 
gression  and  yielded  good  outcomes). These  raw scores 
are  entered into  the  AMPS computer-scoring software, 
and converted through many-faceted  Rasch analyses into 
linear   ADL motor   and  ADL process  ability  measures, 
ranging  from 4 to –3 for motor  skills and 3 to –4 for pro- 
cessing  skills. Test–retest  reliability  of the  AMPS is high 
for both motor  (r=0.9) and process (r=0.87) skill scales in 
an adult  population.
51  
This measure is also very sensitive 
to  change,  as it evaluates  the  smallest  possible  units  of 
ADL  task  performance  and   involves  116  task  options 
which vary in challenge. 
 
Assisting hand assessment 
Bimanual  performance will be  assessed using  the  AHA. 
This  is a  Rasch  analysed  measure of  the  effectiveness 
with which  a child  with a unilateral impairment makes 
use of his/her  impaired hand  in bimanual tasks.
52   
The 
test  consists  of  22  items  that  are  videotaped and  each 
scored  on  a four-point  rating  scale, yielding  a range  of 
scores between  22 and 88. Scaled scores are calculated by 
transforming  the  total  raw  score  to  a  percentage and 
range  from 25 to 100. Rasch analysis allows conversion  of 
these   ordinal   scores  into   logits  (log  odds   probability 
units)  which are equal  interval measures.  Inter-rater and 
intrarater reliability is high for summed  scores (ICC=0.98 
and  0.99, respectively).  There  are  three  versions  of the 
AHA;  small  kids  (18 months   to  5 years),   school   kids 
(6–12 years) and an adolescent version is under develop- 
ment  (>13 years).  Test–retest  reliability is high  for small 
kids (ICC=0.99)  and school kids (ICC=0.98)  and reliabil- 
ity between  the  two forms  (small  kids vs school  kids)  is 
also high (ICC=0.99).
53 
The AHA is responsive to change 
due   to   UL  intervention.
54    
Investigation   of  reliability 
yielded a smallest detectible difference of 3.89 raw scores 
for the small kids and 3.65 raw scores for the school kids 
version.
53 
The AHA requires standardised training  and 
certiﬁcation  of  raters.52   The   AHA  will  be  scored   by 
certiﬁed raters  who will be  masked  to  group  allocation 
and order  of assessment. 
 
Jebsen-Taylor test of hand function 
Activity limitations  will be measured for unimanual  cap- 
acity using the JTTHF.
55 
The JTTHF evaluates speed  and 
dexterity  in six timed  tasks with an  individual  score  for 
each UL. The tasks are of varying complexity and use 
everyday  items to assess grasp  and  release  abilities. The 
original  test designed  and  validated  in adults  and  typic- 
ally developing  children will be  modiﬁed with omission 
of the writing activity and  by reducing the  maximum 
allowable  time  of each  task to  2 min  to  both  minimise 
frustration and  allow comparison with similar  studies  in 
children with congenital hemiplegia.
27  28   56   
JTTHF  has 
been shown to be responsive to change due to an inter- 
vention; however, there  are some difﬁculties  with stability 
of     test–retest      performance    in     the     unimpaired 
limb.
27 28  56  57  
There  is high inter-rater reliability 
(ICC=0.82–1.0)  for  each  subtest  and  test–test  reliability 
with  ﬁve  patients   and   two  raters   (r=0.84–0.85)   in  an 
aging   adult    population.
58    
JTTHF   has   demonstrated 
good  responsiveness  to  detect  change  due  to  interven- 
tions that improve UL speed  and manipulation.
27
 
 
Secondary outcomes will assess Mitii against all dimen- 
sions of the ICF: 
 
Body structure and function domain 
Executive functioning 
EF  will  be   assessed   across   four   domains:   attentional 
control,  information processing,  cognitive ﬂexibility and 
attentional control  in accordance with Anderson’s paediat- 
ric model  of EF.
59  
A neuropsychological test battery will be 
utilised to assess these domains comprising of subtests from 
the  Delis-Kaplan  Executive  Function  System  (D-KEFS)
60 
and  the  WISC-IV.
35  
Behavioural  manifestations of  EF in 
daily life will also be assessed using  the  Behaviour  Rating 
Inventory of Executive Function (BRIEF).
61 
All scores will 
be  converted  into  scaled  scores  according to  normative 
data based on the child’s age and gender. 
 
Colour-word interference test ( from the D-KEFS) 
The  Inhibition  condition  from  the  Colour-Word 
Interference Test will be used  to measure attentional 
control.   Children  will  be  required  to  name   the   ink 
colour  that  colour  words are  printed in across ﬁve rows 
(eg,  say  ‘red’ for  the  word  ‘blue’ printed in  red  ink). 
The  total time (seconds) taken  to complete the  task will 
be the primary outcome measure, with longer  time indi- 
cative of poorer attentional control.  Raw scores  will be 
converted     into     scaled     scores     (mean=10,    SD=3). 
Excellent test–retest reliability has been shown for the 
Colour-Word  Interference Test (r=0.90).
62
 
 
Trail making test ( from the D-KEFS) 
The Number Sequencing condition from the Trail Making 
Test  will be  used  to  measure attentional control  and  the 
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Number-Letter Switching condition will be used to measure 
cognitive  ﬂexibility.  In  Number Sequencing, children will 
connect numbers printed on  an  A3 sheet  in  numerical 
order  from 1 to 16, while in Number-Letter Switching, chil- 
dren  will be required to switch back and forth between con- 
necting   numbers from  1  to  16  in  numerical order   and 
letters from A to P in alphabetical order,  also printed on an 
A3 sheet   (eg, ‘1-a-2-b-3-c’). The total time (seconds) taken 
to complete each task will be recorded, with a longer  time 
indicating greater difﬁculty with attention control  or cogni- 
tive  ﬂexibility.  Raw scores  will be  converted  into  scaled 
scores  (mean=10,  SD=3).  Adequate  test–retest   reliability 
for Number Sequencing (r=0.77) and Number-Letter 
Switching (r=0.20–0.55) has been documented.62 
 
Tower test ( from the D-KEFS) 
The  Tower Test will be used  to measure goal setting. 
Children will move ﬁve disks across three  pegs to build a 
target  tower as illustrated  in a picture  within a speciﬁed 
time   limit.  They   will  be   instructed  to  use  the   least 
number of possible  moves  to  complete the  tower;  they 
can only move one disk at a time and they must not place 
a larger  disk on top  of a smaller  disk. The  total achieve- 
ment  score, which is based on the total number of moves 
needed to build  the  tower, and  the  total number of rule 
violations  will be  used  to  measure goal  setting  abilities. 
The lower the achievement score and the higher  the rule 
violations  score  indicate  greater goal setting  difﬁculties. 
Raw scores  will be  converted  into  scaled  scores 
(mean=10, SD=3).  The  Tower  Test  has  a  moderate to 
high level of internal consistency (α=0.43–0.84) and 
adequate test–retest reliability (r=0.51).62 
 
Digit span ( from the WISC-IV) 
Digit Span  Backwards is a verbal WMI task that  requires 
children to  temporarily store  and  manipulate informa- 
tion and will be used as a measure of cognitive ﬂexibility. 
A string  of numbers will be given orally to the  children 
increasing    from   two  digits  to   eight,   and   they   have 
to repeat  the  number string  in the  reverse  order  (eg,  if 
‘3–7–2’ the  child  should  say ‘2–7–3’).  A score  of one  is 
given  to  each  string  repeated correctly  in  the  reverse 
order  with a lower overall score indicating poorer cogni- 
tive ﬂexibility.  Raw scores  will be  converted into  scaled 
scores (mean=10, SD=3). Digit Span Backwards has been 
shown to have a good  internal consistency  (α=0.80) and 
adequate test–retest  reliability (r=0.74).63 
 
Coding ( from the WISC-IV) 
Coding  will be  used  as a  measure of information pro- 
cessing.  Children  will have  to  copy  simple  geometric 
shapes  that  are  paired  with numbers within  2 min.  The 
overall number of correctly copied  geometric shapes will 
be  calculated, with  a  lower  number indicating poorer 
information  processing.   Raw  scores  will be  converted 
into scaled scores (mean=10, SD=3). Good  internal con- 
sistency (α=0.82) and test–retest reliability (r=0.81) for 
Coding  has been  shown.
63
 
Symbol search ( from the WISC-IV) 
Information   processing    will  also   be   assessed   using 
Symbol Search.  Children will visually scan for target 
symbols in groups  of ﬁve  symbols and  indicate  whether 
the target  symbol is in the group  or not by placing  a line 
through the  word ‘yes’ or  ‘no’. Children will be told  to 
work as fast as they  can  in 2 min.  The  total  number  of 
correctly identiﬁed symbols minus the total number of 
incorrectly   identiﬁed  symbols  will be  calculated,  with 
lower scores indicating poorer information processing. 
Raw scores  will be  converted  into  scaled  scores 
(mean=10, SD=3). Symbol search  has been  documented 
to have an adequate internal consistency  (α=0.79) and  a 
high level of test–retest  reliability (r=0.80).63 
 
Behaviour Rating Inventory of Executive Function 
In addition to cognitive measures  of EF, behavioural 
manifestations of executive  functions  in daily life will be 
measured using the BRIEF, an 85-item parent-rated ques- 
tionnaire. Parents  rate  items (eg,  ‘does not  think  before 
doing’) on  a three-point scale ranging  from  1 (never) to 
3 (often). Two index  scores will be obtained from  the 
BRIEF:  (1)   the   behavioural  regulation  index   (BRI), 
which is derived  from four subscales: initiate,  WMI, plan, 
organisation of materials  and  monitor and  (2)  the meta- 
cognition index  (MCI),  which is derived  from three  sub- 
scales: inhibit,  shift and  emotional control.  The  BRI and 
MCI will then   be  combined to  form  an  overall  global 
executive  composite  score  (GEC).  Raw scores will be 
converted  into  T scores (mean=50, SD=10), with higher 
T scores  indicating a greater level of executive  dysfunc- 
tion.  A T score  of 65 and  above,  which is 1.5 SDs above 
the  mean,  will be used as the  cut-off for abnormal eleva- 
tions  across  all scales.
61   
The  BRIEF has  been  found  to 
be ecologically valid measure of EF and  has been  shown 
to  have  good   internal  consistency   (α=0.80–0.98)  and 
high   test–retest   reliability  on   the   BRI  (r=0.92),   MCI 
(r=0.88)  and the GEC (r=0.86).
61
 
 
Test of visual perceptual skills 
The  Test of visual perceptual skills-3 (TVPS-3) consists of 
seven subscales: visual discrimination, visual memory, visual 
spatial relationships, form constancy, visual sequential 
memory, ﬁgure-ground and  visual closure.64  Performance 
will be  determined by the  number of correct  answers in 
each  test  (maximum 16  in  each  of  seven  tests). 
Performance will be  scaled  according to  normative  data 
and  converted into  a percentage score for the age group. 
The TVPS-3 is a reliable and valid measure of visual percep- 
tion in persons aged 4–18 years.64 
 
Melbourne assessment of unilateral upper limb function 
MUUL measures  both  UL impairment and quality of UL 
function.
65   
It  is designed   for  children aged  5–15 years 
with  CP  and  consists  of  16  criterion-referenced  items 
measuring aspects of reach,  grasp, release  and manipula- 
tion.  The  maximum possible  raw score  is 122, with raw 
scores  being  computed into  percentage scores. 
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Inter-rater and intrarater reliability for the MUUL is very 
high for total test scores (ICC=0.95 and 0.97, respectively) 
and  moderate to  high  for  individual  items  (ICC=0.69– 
0.91).
66  
The  MUUL  also has  good  internal consistency 
(α=0.96).66 Construct and content validity for the MUUL 
was established  during  test development.66 
 
Lower-limb functional strength 
Mitii will focus on training  functional strength therefore 
assessment of Repetition Maximum during  functional 
exercise   will  be   used   to   assess  strength.  Functional 
strength will be tested  according to the  protocol 
outlined by Verschuren et al.67 
 
Lateral step-up 
This is the  number of step  up  repetitions onto  a bench 
during  30 s. This is tested  with the  stool height  adjusted 
to  the  GMFCS level  (I,  II=15–20 cm  stool).  The  child 
stands  with  the  leg  being  tested  on  the  stool  and  the 
non-testing leg on the ﬂoor,  with feet parallel  and  shoul- 
der  width apart.  The  child then  extends  the  test leg (on 
the  stool) to  within  10° of full knee  extension, so that 
the  non-test  leg is off the  ground, then  lowers the  foot 
back  down  to  the  ﬂoor   until  either   the  toes  or  heel 
touches.
68 
This is considered one full cycle. The child 
should maintain dorsiﬂexion of the non-test foot and a 
horizontal pelvis throughout by keeping  hands  on hips 
throughout the  test. This is repeated and  the  cycle com- 
pleted  within 30 s is recorded starting  with the  right  leg 
for all children. This is then  repeated for the left leg. 
 
Sit-to-stand 
This tests the  number of sit-to-stand repetitions that  can 
be achieved within 30 s, with sit-stand-sit considered a full 
cycle. The seated position  is reached when the knees and 
hips are in 90° ﬂexion. Full standing  is considered within 
15° full extensions  of the  hips and  legs. The  sit-to-stand 
must be achieved with arms free and without any support 
from the chair or the child’s body. 
 
Half kneel-to-stand 
This is the  number of repetitions of half  kneel-to-stand 
that   can  be  completed  in  30 s.  The   child  is  in  half- 
kneeling  position  on  a mat,  with the  buttocks  clear  of 
the  lower  leg  and/or the  ﬂoor.   The  child  must  then 
assume  a  standing   position  without  using  the  arms  or 
any external support, such as the ﬂoor  or furniture. 
Repetitions  are  counted each  time  the  participant 
achieves  a  standing  position  where  both  legs and  hips 
are within 15° of full extension. This is recorded starting 
with the  right  leg in front,  and  then  repeated with the 
left leg in front. 
For all tests, children will be given two practice  repeti- 
tions per extremity prior to formal testing. Between each 
practice  and  testing,  30 s rest will be provided.  Between 
tests 180 s (3 min)  rest will be provided.  The  tests will be 
assessed in the  above order:  lateral  step test right,  lateral 
step  test  left,  sit-to-stand,  half  kneel-to-stand  right,  half 
kneel-to-stand    left.   Children   will   be    instructed   to 
perform as many repetitions as possible  in 30 s and  will 
be verbally encouraged. 
Acceptable  intertester reliability has been  demonstrated 
for functional strength testing in 25 children with CP 
((ICC>0.91;  CV=12.1–22.7%). Reliability for the  tests were 
strong   (lateral   step  up  ICC=0.94;  Sit-to-stand  ICC=0.91; 
Half  kneel-to-stand  ICC=0.93–0.96). Mean  repetitions for 
the lateral step up were 13.2 (SD=10.5; SE of measurement 
(SEM)=2.4 reps; CV=17.8%) for the left side, and 12.6 
(SD=10.4;  SEM=2.6 reps;  CV=22.7%)  for  the  right  side. 
Mean  number of repetitions for  the  sit-to-stand was 14.4 
(SD=5.0;  SEM=2.6 reps;  CV=22.7%).  Half  kneel-to-stand 
was less, with an average of 7.5 reps (SD=5.5; SEM=1.1 reps; 
CV=28.6%)  for  the  left  side  and  6.0  (SD=5.3;  SEM=1.4 
reps; CV=39.9%) for the right side.
67
 
 
Six-minute walk test 
The   6MWT  is  a  simple,  submaximal   clinical  exercise 
test   which   measures    the    distance    walked   (6MWD) 
under  controlled  conditions  over   6 min.   The   6MWT 
has  been  found  to  be  reliable  in  independently  ambu- 
lant   adolescents  with  CP.
69    
In   this  population,  test– 
retest  reliability was excellent  (ICC=0.98).  Percentile 
curves  for  the  6MWT have  been  created, though these 
were  from  1445  typically developing   Chinese   children 
aged  7–16 years.70  No reference curves for children and 
adolescents with CP exist. While children with CP may 
exhibit  lower  6MWD compared with  typically develop- 
ing  children due  to  muscle  spasticity, aberrant gait pat- 
terns  and  functional restrictions,   GMFCS Levels I  and 
II are  able to walk with little to no restrictions  therefore 
one  could  expect  similar test results to a typically devel- 
oping  child.  The  6MWT will be  performed using  stan- 
dardised verbal  encouragement  asking  the  children to 
walk as fast as possible  along  a ﬂat,  straight,  10 m corri- 
dor  with cones  marking  the  turn-around at each  end  as 
per  Maher  et al.69 
 
Passive range of motion 
UL and lower-limb passive range  of motion  for the 
unimpaired and  impaired side will be assessed by occu- 
pational  and PTs at baseline. 
 
Activity domain 
Habitual physical activity 
Habitual  physical activity (HPA)  will be measured using 
ActiGraph GT3X+ tri-axial accelerometer (Pensacola, 
Florida, USA). This detects  accelerations of a magnitude 
and  frequency  with raw acceleration data,  proportional 
to the amount of HPA done  by an individual.  ActiGraph 
units  will be  ﬁtted  during  assessment  and  worn  during 
waking hours  for 4 days. After 4 days it will be returned 
by registered post for data extraction and analysis. An 
activity diary will be coupled with an ActiGraph  to detect 
and  log accelerations of human movement. Data will be 
considered for analysis where  accelerations are recorded 
for   >4 h/day.   Analysis  will  convert   counts   to   activity 
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intensity using Evenson cut points
71 
to allow comparison 
to the national physical activity guidelines.
21  22  
The 
ActiGraph  will also be set up to detect  step counts. 
The  ActiGraph  is a valid instrument to detect  HPA in 
children and  adolescents with CP. The  ActiGraph  accel- 
erometer  is  strongly   correlated  to  direct   observation 
during  structured activity and  free play, and  more  accur- 
ate than  heart  rate.
72  
It has also demonstrated excellent 
classiﬁcation   accuracy,   and   Evenson   cut   points   were 
found  to be the  most accurate for adolescents with CP.
73
 
In typically developing  children, the reliability of acceler- 
ometers  has been  shown to increase  with increased 
recording days (ICC: 0.45 for 1 days to 0.9 for 8 days).
74
 
Seasonal variation  has been  demonstrated with less activ- 
ity being  performed in the  winter months  (ICC=0.54).
74
 
Age has also been  found  to inﬂuence reliability, with typ- 
ically developing  primary school aged children partici- 
pating  in more  moderate to vigorous physical activity on 
weekends and exhibiting less day-to-day variability in 
activity, requiring only 4–5 days monitoring, in  contrast 
to   adolescents  who   exercise   less  on   weekends   and 
require 8 or 9 days of monitoring.
75  
Acceptable  reliabil- 
ity has  been  found  with 4 days of monitoring (r=0.75– 
0.78).
76  
However,  there  is no  evidence  that  documents 
the   reliability  of  the   ActiGraph   in  children  with  CP. 
Children in the  present study will be ﬁtted  with an 
ActiGraph  accelerometer to  collect  4 days of free  living 
activity  after   the   assessments   and   training   days. 
Additionally,  further work on  the  reliability of the 
ActiGraph  in  children and  adolescents with CP will be 
conducted. Participants will rest for a 5 min  period  and 
measurement  properties, whereas  the  MobQues47   can 
be used  for clinical  applications. Content validity of the 
instrument has been  demonstrated as 46 of the 47 test 
questions  relate  to ‘mobility’ according to the deﬁnitions 
of the  ICF. Construct validity was demonstrated as 
MobQues  scores decreased with increasing  GMFCS level 
( p<0.001).  In  a  subgroup  of  162  children,  MobQues 
score  was  positively  correlated  to  GMFM-66 
(MobQues47, r=0.75; MobQues28,  r=0.67, p<0.001).
77 
It 
has  also  been   demonstrated  to  be  a  reliable   instru- 
ment.
78  
For  the  strong  inter-rater reliability  was found 
for theMobQues47 (ICC=0.92) and MobQues28 
(ICC=0.87).  The  SEM was 7.8 and  8.9, respectively. As 
expected, the  intrarater reliability was higher  for both 
MobQues  versions (ICC=0.96–0.99; SEM=3.5–4.9).78  The 
English  version  has  not  yet  been  cross-validated  there- 
fore  the  results  demonstrated may  differ  slightly to that 
in  an  English  speaking   population.  Data  sharing   has 
been   arranged  with  the   MobQues   authors   to  enable 
cross cultural  validation of this tool. To allow this the 
MobQues47  clinical  version  will be  used  at  baseline  to 
obtain  a full dataset,  and  then  the  MobQues28  will be 
collected   at  subsequent  assessments.  The   MobQues28 
will be  extracted from  the  baseline  assessment  to  allow 
comparison across time points. 
 
 
Participation domain 
Canadian occupational performance measure 
Individualised goals will be  measured using  the  COPM 
to evaluate  self-perception of occupational performance 
79   80
 
then   conduct  selected   light,   moderate  and   vigorous 
over  time. COPM  will be  administered by one  OT 
assessment  tasks, interspersed with 5 min  rest periods  in 
a  standardised  manner   while  wearing   an   ActiGraph 
monitor and concurrently measuring heart  rate and clas- 
sifying the  activity using  direct  observation.   All partici- 
pants  will have  the  option   to  undergo this  assessment 
during  the assessment and the Mitii training  2-day visit. 
with   the   child/adolescent  and   parent.  COPM   is  a 
standardised individualised,  client-centred measure that 
evaluates client’s self-perception of occupational per- 
formance. Clients identify areas of difﬁculty in everyday 
occupational performance and  rate  their  performance 
and  satisfaction  for each  problem on a scale of 1–10. An 
average  score  for performance and  satisfaction  is calcu- 
67
 
Mobility questionnaire 
lated. The COPM was designed  for all ages and disabil- 
The  MobQues  measures  mobility of children with CP by 
assessing amount of difﬁculty  the  children have  in exe- 
cuting  mobility activities. It addresses  mobility limitations 
ity groups.  There  is good  evidence  of construct, content 
and  criterion validity. The  retest  reliability  of  the  per- 
formance and  satisfaction  scores  on  the  COPM  is high 
80–82
 
a child  experiences in  daily life and  covers  a range  of 
(ICC=0.76–0.89). The    COPM   has   demonstrated 
83  84
 
severity levels. The MobQues  focuses on 47 mobility 
activities,  from  which  the  MobQues47  and  the 
MobQues28  scores can be calculated by scoring 47 or 28 
responsiveness  to change  in paediatric clinical trials, 
and   a  two-point  change   on  COPM  performance  has 
been  reported as being clinically signiﬁcant.79
 
mobility activities, respectively. Response options of the 
MobQues  are:  impossible  without  help  (score  0),  very 
difﬁcult (score 1), somewhat difﬁcult (score 2), slightly 
difﬁcult   (score   3),  not   difﬁcult   at  all  (score   4).Total 
scores are calculated by adding  all item scores (range 0– 
4)  divided  by the  maximum possible  score  and  multi- 
plied  by 100 to obtain  scores on a scale of 0–100 (with a 
low score representing severe limitations  in mobility): 
MobQues47=(Σ   item/188)·100;  MobQues28=(Σ   item/ 
112)·100.  For  research  purposes,   the   shorter  version 
(MobQues28)    is     recommended    due     to     better 
 
Assessment of life habits 
The LIFE-H is designed  for children aged 5–13 years and 
measures  life habits in home,  school and neighbourhood 
environments.
85 86  
It is a questionnaire completed by the 
parent/caregiver about  the  child.  The  child  version  is 
based on an adult  version. The longer  version consists of 
197 items divided into 12 categories  and includes  regular 
activities (eg, eating meals, communication and mobility) 
and social roles. A weighted score ranging  from 0 to 10 is 
generated for each category and overall total. 
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Evidence  of  construct  validity and   criterion  validity, 
with strong  correlations between  the  LIFE-H and  PEDI 
and  Functional Independence Measure  for Children 
(WeeFIM), are established.
85 87  
Adequate to excellent 
internal consistency  (α=0.73–0.90 for categories,  0.97 for 
daily activities and 0.90 for social roles), intrarater 
(ICC=0.83–0.95 for daily activities), inter-rater (ICC=0.8– 
0.91 for daily activities and ICC=0.63–0.9 for social roles) 
and  test–retest  reliability (ICC=0.73 for total  score)  have 
also been  established.
88 
Four categories  will be evaluated 
in  this  study  including  nutrition  (eg,   mealtime   activ- 
ities), personal care  (eg,  dressing), education and  recre- 
ation.  These  areas  were  considered to  reﬂect many  of 
the identiﬁed difﬁculties  confronted by children with 
congenital hemiplegia that might be amenable to the 
intervention programme. 
 
Participation and environment measure for children 
and youth 
Participation  and   environment  measure  for   children 
and  youth (PEM-CY) is a newly developed, parent-report 
measure for children aged 5–17 years that  examines  par- 
ticipation  and environment across three  settings: home, 
school and community.
89  
No interview is required for 
administration with parents completing the assessment 
either  online  or  using  a paper  based  form,  which  sup- 
ports  its use in this large-scale study. The  PEM-CY exam- 
ines the extent  to which youth participate in important 
activities within the  home,  school  and  community envir- 
onments  and   the   extent   to  which  particular  features 
of  these   environments  are   perceived   to   support    or 
challenge the  youth’s participation. Evidence  of the  psy- 
chometric properties of this new instrument are  limited 
to  date,   however   data   from   a  sample   of  576  youth 
showed  internal consistency  was moderate to good 
(α>0.59) across the scales. Test–retest reliability was 
moderate-to-good (ICC>0.58)  across a 1-week to 4-week 
period  using the online  version of the assessment.
90  
The 
PEM-CY will be collected  at baseline. 
 
Strengths and Difficulties Questionnaire 
The SDQ will be used to measure  parents’ perceptions of 
prosocial  and difﬁcult  behaviours  in their  child.91 92  The 
SDQ has a total of 33 items. The ﬁrst 25 items are divided 
into ﬁve scales and  assess the  frequency  of emotional 
symptoms, conduct problems, inattention/hyperactivity, 
peer  problems and prosocial  behaviour (eg, ‘considerate 
of other  people’s feelings’). These  items are rated  upon 
reﬂection of  the  last  6 months   on  a  three-point  scale, 
from zero (not true) to two (certainly true). A total score for 
each scale (0–10) and an overall total difﬁculty score (0– 
40) will be calculated, with higher  scores indicating more 
distress on all scales except prosocial behaviour. A clinical 
cut-off  of  ≥17  will be  utilised  on  the  total  difﬁculties 
score.  The  total  score  on  the  ﬁve  scales and  the  overall 
total  difﬁculties  score will be utilised  as measures  of the 
child’s psychological  functioning. Moderate to high 
internal   consistency     (α=0.73–0.82)    and     test–retest 
reliability  (r=0.77–0.85)  has  been  shown  on  the  overall 
total difﬁculties score.93 94 
 
Cerebral palsy quality of life 
QOL   will  be   measured  using   a   condition  speciﬁc 
measure, either  the  cerebral palsy QOL (CPQOL)-Child 
parent report,
95  
or  for children 9 years  or age or older, 
the   CPQOL-Teen.
96    
Results  of  factor  analysis  demon- 
strated  that  the  CPQOL  measures  seven broad  domains 
of QOL: social well-being and acceptance, functioning, 
participation,   physical   health,    emotional   well-being, 
access to  services, pain,  impact  of disability and  family 
health.       The      psychometric     properties      of      the 
CPQOL-Child  are excellent,  with strong  internal consist- 
ency  (α=0.74–0.92  for  parent-proxy report;  α=0.80–0.90 
for child  self-report). Test–retest  is adequate (ICC=0.76– 
0.89)  and  it is moderately correlated with generic  QOL 
and  health  (r=0.30–0.51).97  98  The  CPQOL-Teen, for 
adolescents  aged  13–18 years  has  strong   psychometric 
properties, with strong  internal consistency  (α=0.81–0.95 
for the  primary caregiver  report;  α=0.84–0.96 for the 
adolescent  self-report) and  strong  test–retest  reliability 
for adolescents (ICC=0.84–0.87) and for primary care- 
givers (ICC=0.72–0.92).  In terms  of validity, all domains 
of the  CPQOL-Teen parent report (r=0.40–46)  and  ado- 
lescent   report  (r=0.58–0.68)   were   correlated  with   a 
generic  QOL instrument.
99
 
 
Environmental and personal factors 
A study  questionnaire was developed to  capture demo- 
graphic  information that  has  been  shown  in  the  litera- 
ture to inﬂuence a child’s participation. These include 
family ethnicity,  household income,  parental education 
and   employment,  family  structure   and   supports   and 
family interests.  This will be collected  at baseline  assess- 
ments  then  any changes  will be measured at subsequent 
assessments.   A  measure  of  social  advantage/disadvan- 
tage  will be  derived  from  postcode   of  residence  using 
the Index of Relative Socio-economic  Advantage/ 
Disadvantage  from  the  Australian  Bureau  of Statistics.
100
 
Deciles  will be  reported  on  a  continuum  with  lower 
scores   reﬂecting   greater  socioeconomic  disadvantage 
and higher  scores reﬂecting socioeconomic advantage. 
 
Economic analysis 
An economic analysis will be conducted to synthesise 
health  outcomes and costs to both families and health 
systems. Costs will be obtained for healthcare use (mea- 
sured  through self/proxy reports) and measured directly 
for  the  intervention  (including  the  number and  dur- 
ation  of visits by the  intervention  team). Standard costs 
will be  assigned  to  the  resource use  (eg,  medical  care, 
allied health  visits and  diagnostic/investigational services 
will be  assigned  a cost according to a fee schedule and 
medications will be  priced  based  on  their  description, 
dosage  regimens  and  whether  or  not  they  are  listed  on 
the  Pharmaceutical Beneﬁts   Schedule).  Outcomes will 
be measured as change  in QOL from  baseline  to end  of 
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intervention based on the CPQOL. The base case model 
timeframe  will  be   20 weeks  consistent   with  the   trial 
follow-up  and  all  costs  and  outcomes will be  extrapo- 
lated   for  at  least   10 years,   with  an   annual  discount 
rate   of  5%  applied   to  both   costs  and   outcomes, to 
estimate future  expected costs and beneﬁts. Sensitivity 
analyses will be undertaken around key parameters to 
assess  the   effect  on   results   from   varying  these   para- 
meters.  These  can  then  be  compared with other 
healthcare interventions and value for money judgments 
made   by  policy-makers.   An   incremental  cost- 
effectiveness     ratio     (ie,     (costMiTii − costusual       care)/ 
(outcomeMiTii – outcomeusual care) will be calculated. 
 
Statistical analysis 
Analysis will follow standard  principles  for  RCTs, using 
two-group  comparisons  on  all  participants on  an 
intention-to-treat basis. External  and  internal validity of 
results  will be checked using  baseline  and  general 
descriptive  information available for all eligible families; 
comparing the  characteristics of families who completed 
the  study with those  who enrolled in the  study but  did 
not  complete, and  those  who did  not  enrol.  Data  from 
each  outcome measure will be summarised for each 
treatment group  and  descriptive  statistics  ( frequencies, 
means,   medians,   95%  CIs)  calculated depending on 
data distribution. The primary comparison immediately 
postintervention  (20 weeks) will be the  AMPS and  AHA 
scores. Outcomes between  treatment groups  will be com- 
pared   at  follow-up  using  generalised  estimating   equa- 
tions  (GEEs),  with time  (0, 20 and  40 weeks) and  study 
group  (Mitii, usual care),  as well as a time by group 
interaction  as  covariables.   We  will  use   the   Gaussian 
family, identity link and an exchangeable correlation 
structure. Secondary analyses will compare the outcomes 
between  groups  for  participation (domains of LIFE-H) 
and  QOL  (domains of CP-QOL).  For dichotomous  out- 
comes  we will compare outcomes between-group out- 
comes using GEEs with the  logistic family and  logit link. 
For continuous variables we shall compare using the 
Gaussian  family and  identity  link  ( possibly after  trans- 
formation, depending on  the  distribution). The  magni- 
tude  of  BOLD  changes  between  groups  will be 
determined using iBrain: ROI will be delineated for each 
individual  primary motor  cortex  (PM1),  SMA and ipsilat- 
eral  motor  cortex  (PM1ipsi)  and  active voxels in  those 
regions  will be  counted. These  data  will be  compared 
for  each  region   over  time  using  GEEs. In  participants 
where mirror  movements did not occur, lateralisation 
between    ipsilateral    and    contralateral   PM1   will   be 
assessed  to  determine the  incidence and  magnitude  of 
brain   reorganisation.  For  TMS  data  changes   in  mean 
MT  to  TMS  from   ipsilateral   and   contralateral  hemi- 
spheres  will be analysed in each  group  at each  F/U. The 
probability  of ipsilateral  projections appearing as a result 
of each  treatment paradigm will also be analysed. 
Statistical signiﬁcance will be  at p<0.05 with adjustment 
for   multiple    comparisons,   and   all   analyses   will  be 
intention to treat.  Sensitivity analyses using imputation 
techniques will investigate  whether   the  effect  estimates 
are  biased  as  a  consequence of  non-ignorable  missing 
data. 
 
 
DISCUSSION 
Current models  of  rehabilitation for  children with  CP 
are costly, limited by inequity of access and often  not 
provided at sufﬁcient intensity to drive neuroplasticity to 
improve outcomes.  An effective web-based multimodal 
training   that   enhances   motor   and   cognitive   abilities 
using virtual trainers  is likely to be a cost effective means 
of delivering  therapy.  It is also likely to lead to better 
translation of skills into  the  community as participants 
are responsible for their  own training  in the home  envir- 
onment. This study has the  potential to establish  a new 
cost-effective  evidence-based  therapy   accessible  equally 
by urban, rural  and  remote children and  their  families. 
Should  our  hypotheses  be  correct,  Mitii has the  poten- 
tial to revolutionise delivery of intensive rehabilitation to 
children and adolescents with CP. 
 
Author affiliations 
1School of Medicine, Queensland Cerebral Palsy and Rehabilitation Research 
Centre, The University of Queensland, Brisbane, Queensland, Australia 
2Children’s Allied Health Research, Children’s Health Queensland, Brisbane, 
Queensland, Australia 
3School of Health and Rehabilitation Sciences, The University of Queensland, 
Brisbane, Queensland, Australia 
4Centre for Online Health, University of Queensland, Brisbane, Queensland, 
Australia 
5CSIRO, ICT—Australian  e-Health Research Centre, Royal Brisbane and 
Women’s Hospital Centre for Clinical Research, The University of Queensland, 
Brisbane, Queensland, Australia 
6Queensland Brain Institute, The University of Queensland, Brisbane, 
Queensland, Australia 
7School of Psychology, The University of Queensland, Brisbane, Queensland, 
Australia 
8Queensland Children’s Medical Research Institute, The University of 
Queensland, Brisbane, Queensland, Australia 
9School of Population Health, The University of Queensland, Brisbane, 
Queensland, Australia 
10Griffith Health Institute and School of Medicine, Griffith University, Brisbane, 
Queensland, Australia 
 
Acknowledgements   The authors would like to thank the staff from the Helene 
Elsass Centre and The University of Copenhagen, who have provided the Mitii 
program, advised on the Mitii content and have provided ongoing support to 
the Mitii training. 
 
Contributors   RNB, JZ, LS, AS and SR are the chief investigators (CIs) who 
designed and established this research study. The content of the therapy 
programme Mitii was developed by the Helene Elsass Centre then adapted 
and modified in English for the Australian study. LEM drafted the first version 
of this manuscript. All authors have contributed  to the writing of the 
manuscript and have critically reviewed and approved the final version. RNB, 
JZ and LEM were responsible for ethics applications and reporting.  SR, RC 
and RNB were responsible for the design, implementation,  data collection, 
analysis of the Advanced Brain Imaging studies. RNB, JZ, LS, KW, LEM and 
STJ will take lead roles on data management and preparation of publications 
on the clinical outcomes of the study and RNB, SR, RC will take lead roles on 
the neuroscience publications  from the study. TAC and PAS will lead the 
economic evaluation and associated publications. KW advised on EF 
assessments and will advise on their interpretation.  QCPRRC is responsible 
Downloaded from bmjopen.bmj.com on April 11, 2013 - Published by group.bmj.com  
110 
Mitii : ra ndomised contro lled  t rial  of a web-based p rogram for cerebra l p alsy 
 
for the coordination, delivery, ethics, outcomes and study publication. The 
CI’s oversee scientific conduct of the trial. 
 
Funding  Project grant: Foundation for Children Grant (RNB and JZ), 
Queensland Government Smart Futures PhD Scholarship (STJ), Smart Futures 
Co-Investment  Program Grant (RNB, JZ, AS, SR, TAC and PAS); NHMRC 
Career Development  Fellowship (RNB, 1037220),  NHMRC TRIP Fellowship (LS, 
1036183), APA Scholarship (LEM). The funding bodies have not and will not 
contribute to the study design; the collection, management, analysis and 
interpretation of data; the writing of the final reports or the decision to submit 
findings for publications. 
 
Competing interests None. 
 
Patient consent Obtained. 
 
Ethics approval The University of Queensland and the Royal Children’s 
Hospital Queensland. 
 
Provenance and peer review Not commissioned; internally peer reviewed. 
 
Data sharing statement  All data from this study will be submitted to peer 
review journals. LEM and STJ will use the data from this study to contribute 
to their PhD thesis. 
 
 
 
REFERENCES 
1.     Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition 
and  classification of cerebral palsy  April 2006.  Dev Med Child 
Neurol Suppl 2007;109:8–14. 
2.     Odding E, Roebroeck ME, Stam  HJ. The epidemiology  of cerebral 
palsy: incidence, impairments and  risk factors.  Disabil Rehabil 
2006;28:183–91. 
3.     Access Economics. The econonic impact of cerebral palsy  in 
Australia in 2007.  Canberra: Access Economics, 2008. 
4.     Boyd R, Sakzewski L, Ziviani J, et al. INCITE: a randomised trial 
comparing constraint induced  movement therapy  and  bimanual 
training in children with congenital hemiplegia. BMC Neurol 
2010;10:4. 
5.     Sakzewski L, Ziviani J, Abbott DF, et al. Randomized trial of 
constraint-induced movement therapy  and  bimanual  training on 
activity outcomes for children with congenital hemiplegia. Dev Med 
Child Neurol 2011;53:313–20. 
6.     Sakzewski L, Ziviani J, Abbott DF, et al. Participation outcomes in a 
randomized trial of 2 models  of upper-limb rehabilitation  for children 
with congenital hemiplegia. Arch Phys Med Rehabil  2011;92:531–9. 
7.     Boyd R, Abbott D, Badawi N, et al. Use-dependant neuroplasticity 
in an RCT of constraint induced  movement therapy  versus 
bimanual training for children with congenital hemiplegia [abstract]. 
Dev Med Child Neurol 2010;52(Suppl 5):11. 
8.     Foley L, Maddison  R. Use  of active video games to increase 
physical  activity in children: a (virtual) reality? Pediatr  Exerc  Sci 
2010;22:7–20. 
9.     Maher CA, Williams MT, Olds T, et al. Physical and  sedentary 
activity in adolescents with cerebral palsy.  Dev Med Child Neurol 
2007;49:450–7. 
10.     Zwier JN, van Schie  PEM, Becher JG, et al. Physical activity in 
young  children with cerebral palsy.  Disabil Rehabil 
2010;32:1501–8. 
11.     Nelson  MC, Neumark-Stzainer D, Hannan PJ,  et al. Longitudinal 
and  secular trends  in physical  activity and  sedentary behavior 
during adolescence. Pediatrics 2006;118:e1627–34. 
12.     WHO. Health and  development through  physical  activity and  sport. 
Geneva: WHO, 2003. 
13.     WHO. International  classification of functioning,  disability and 
health.  Geneva, Switzerland: WHO, 2001. 
14.     Christiansen C, Baum C, eds.  Occupational therapy—overcoming 
human  performance deficits. New Jersey: Slack Incorporated, 1991. 
15.     Van Zelst BR, Miller MD, Russo RN, et al. Activities of daily living 
in children with hemiplegic  cerebral palsy: a cross-sectional 
evaluation using the assessment of motor and  process skills. Dev 
Med Child Neurol 2006;48:723–7. 
16.     Cusick A, McIntyre S, Novak I, et al. A comparison of goal 
attainment scaling  and  the Canadian occupational performance 
measure for paediatric rehabilitation  research. Pediatr  Rehabil 
2006;9:149–57. 
17.     Krebs HI, Fasoli SE, Dipietro L, et al. Motor learning  characterizes 
habilitation of children with hemiplegic  cerebral palsy.  Neurorehabil 
Neural Repair  2012;26:855–60. 
18.     Chan  RCK, Shum  D, Toulopoulou  T, et al. Assessment of 
executive functions:  review of instruments and  identification of 
critical issues. Arch Clin Neuropsychol 2008;23:201–16. 
19.     Bodimeade H, Whittingham  K, Lloyd O, et al. Executive  function in 
children and  adolescents with the congential hemiplegia type of 
cerebral palsy  [Doctor of psychology]. The University of 
Queensland, St Lucia, Brisbane, Qld Australia, 2011. 
20.     Bilde PE, Kliim-Due M, Rasmussen B, et al. Individualized, 
home-based interactive  training of cerebral palsy  children delivered 
through  the Internet.  BMC Neurol 2011;11:32. 
21.     Department of Health and  Ageing. Australia’s physical  activity 
recommendations for 5–12 year olds. Canberra, 2004. 
22.     Department of Health and  Ageing. Australia’s physical  activity 
recommendations for 12–18 year olds. Canberra, 2004. 
23.     Palisano R, Rosenbaum P, Walter S, et al. Development 
and reliability of a system to classify gross motor function in 
children with cerebral palsy.  Dev Med Child Neurol 
1997;39:214–23. 
24.     Eliasson AC, Krumlinde-Sundholm L, Rosblad B, et al. The manual 
ability classification system (MACS) for children with cerebral palsy: 
scale development and  evidence of validity and  reliability. Dev Med 
Child Neurol 2006;48:549–54. 
25.     Badawi N, Watson  L, Petterson B, et al. What constitutes cerebral 
palsy? Dev Med Child Neurol 1998;40:520–7. 
26.     Loubinoux I, Carel C, Alary F, et al. Within-session and 
between-session reproducibility of cerebral sensorimotor activation: 
a test-retest effect evidenced with functional magnetic resonance 
imaging. J Cereb  Blood Flow Metab 2001;21:592–607. 
27.     Charles JR, Wolf SL, Schneider JA, et al. Efficacy of a child-friendly 
form of constraint-induced movement therapy  in hemiplegic 
cerebral palsy: a randomized control trial. Dev Med Child Neurol 
2006;48:635–42. 
28.     Gordon  AM, Schneider JA, Chinnan A, et al. Efficacy of a 
hand-arm bimanual  intensive  therapy  (HABIT) in children with 
hemiplegic  cerebral palsy: a randomized control trial. Dev Med 
Child Neurol 2007;49:830–8. 
29.     Krageloh-Mann I, Horber V. The role of magnetic resonance 
imaging in elucidating  the pathogenesis of cerebral palsy: a 
systematic review. Dev Med Child Neurol 2007;49:144–51. 
30.     Guzzetta A, Sinclair K, Clarke D, et al. A novel semi-quantitative 
scale for classification of brain MRI for children with cerebral palsy 
[abstract].  Dev Med Child Neurol 2010;52(Suppl 5):74. 
31.     Palisano RJ, Hanna SE, Rosenbaum PL, et al. Validation of a 
model of gross motor function for children with cerebral palsy. 
Phys Ther 2000;80:974–85. 
32.     Morris C, Galuppi BE, Rosenbaum PL. Reliability of family report 
for the gross motor function classification system. Dev Med Child 
Neurol 2004;46:455–60. 
33.     Morris C, Kurinczuk JJ,  Fitzpatrick R, et al. Reliability of the manual 
ability classification system for children with cerebral palsy. 
Dev Med Child Neurol 2006;48:950–3. 
34.     Crawford JR, Anderson A, Rankin  PM, et al. An index-based 
short-form of the WISC-IV with accompanying analysis of the 
reliability and  abnormality  of differences. Br J Clin Psychol 
2010;49:235–58. 
35.     Wechsler D. Wechsler intelligence  scale for children—fourth 
edition: administration and  scoring  manual. New York: 
Psychological Corporation, 2004. 
36.     Lehericy S, Bardinet  E, Tremblay  L, et al. Motor control in basal 
ganglia  circuits using fMRI and  brain atlas  approaches. Cereb 
Cortex 2006;16:149–61. 
37.     Waites  A, Stanislavsky A, Abbott D, et al. The effect of prior 
cognitive state on resting state networks  measured with functional 
connectivity.  Hum Brain Mapp 2005;24:59–68. 
38.     Abbott D, Jackson G. iBrain((R))—software  for analysis and 
visualisation of functional MR images. Neuroimage 2001;13:S59. 
39.     Frackowiak  R, Friston K, Frith C, et al. Human  brain function. 
2nd edn.  San  Diego: Academic  Press, 2003. 
40.     Tournier JD, Calamante F, Connelly A. Robust determination of the 
fibre orientation  distribution in diffusion MRI: non-negativity 
constrained super-resolved spherical deconvolution. Neuroimage 
2007;35:1459–72. 
41.     Tournier JD, Calamante F, Connelly A. MRtrix: diffusion 
tractography in crossing fiber regions. Int J Imaging Syst Technol 
2012;22:53–6. 
42.     Rose S, Guzzetta A, Pannek K, et al. MRI structural connectivity, 
disruption  of primary sensorimotor pathways, and  hand  function in 
cerebral palsy.  Brain Connect 2011;1:309–31. 
43.     Raffelt D, Tournier JD, Rose S, et al. Apparent  fibre density:  a 
novel measure for the analysis of diffusion-weighted magnetic 
resonance images. Neuroimage 2012;59:3976–9. 
Downloaded from bmjopen.bmj.com on April 11, 2013 - Published by group.bmj.com  
111 
Mitii: ra ndomis ed  contro lled  t rial  of a web-based program for cerebra l p alsy 
 
44.     Rose S, Pannek K, Bell C, et al. Direct evidence of intra- and 
interhemispheric corticomotor  network degeneration in amyotrophic 
lateral sclerosis: an automated MRI structural connectivity study. 
Neuroimage 2012;59:2661–9. 
45.     Rose S, Rowland  T, Pannek K, et al. Structural  hemispheric 
asymmetries in the human  precentral gyrus  hand  representation. 
Neuroscience 2012;210:211–21. 
46.     Zalesky  A, Fornito A, Bullmore ET. Network-based statistic: 
identifying differences in brain networks. Neuroimage 
2010;53:1197–207. 
47.     Rossini  PM, Barker AT, Berardelli A, et al. Noninvasive electrical 
and  magnetic stimulation of the brain, spinal-cord and  roots—basic 
principles  and  procedures for routine clinical-application. Report  of 
an IFCN committee. Electroencephalogr Clin Neurophysiol 
1994;91:79–92. 
48.     Facchini  S, Muellbacher W, Battaglia  F, et al. Focal enhancement 
of motor cortex excitability during motor imagery:  a transcranial 
magnetic stimulation study. Acta Neurol Scand 2002; 
105:146–51. 
49.     Sohn  YH, Kaelin-Lang  A, Jung  HY, et al. Effect of levetiracetam on 
human  corticospinal excitability. Neurology  2001;57:858–63. 
50.     Brasil-Neto  JP,  Cohen  LG, Panizza M, et al. Optimal focal 
transcranial magnetic activation  of the human  motor cortex: effects 
of coil orientation,  shape of the induced  current  pulse,  and  stimulus 
intensity. J Clin Neurophysiol 1992;9:132–6. 
51.     Fisher  A, Bray Jones K. Assessment of motor and  process skills. 
vol. 1. development, standardization, and  administration manual. 
7th edn.  Forts Collins, CO: Three  Star Press, 2010. 
52.     Krumlinde-Sundholm L, Eliasson A. Development of the assisting 
hand  assessment: a rasch-built  measure intended for children with 
unilateral  upper  limb impairments. Scan J Occup  Ther 
2003;10:16–26. 
53.     Holmefur M, Krumlinde-Sundholm L, Eliasson A. Interrater  and 
intrarater  reliability of the assisting hand  assessment. Am J Occup 
Ther 2007;61:79–84. 
54.     Holmefur M, Aarts P, Hoare  B, et al. Retest and  alternate forms 
reliability of the Assisting  Hand Assessment [PhD Thesis]. 
Karolinska  Institutet, Solna,  Sweden, 2009. 
55.     Taylor N, Sand PL, Jebsen RH. Evaluation  of hand  function in 
children.  Arch Phys Med Rehabil  1973;54:129–35. 
56.     Eliasson A, Shaw  K, Ponten E, et al. Feasibility of a day-camp 
model of modified constraint induced  movement therapy  with and 
without Botulinum Toxin A injections  for children with hemiplegia. 
Phys Occup  Ther Pediatr  2009;29:311–33. 
57.     Eliasson AC, Krumlinde-Sundholm L, Shaw  K, et al. Effects of 
constraint-induced movement therapy  in young  children with 
hemiplegic  cerebral palsy: an adapted model. Dev Med Child 
Neurol 2005;47:266–75. 
58.     Hackel ME, Wolfe GA, Bang SM, et al. Changes in hand  function in 
the aging  adult as determined by the Jebsen test of hand  function. 
Phys Ther 1992;72:373–7. 
59.     Anderson P. Assessment and  development of executive function 
(EF) during childhood.  Child Neuropsychol 2002;8:71–82. 
60.     Delis DC, Kaplan  E, Kramer JH. Delis-kaplan executive function 
system (D-KEFS) examiner’s manual. San  Antonio, TX: The 
Psychological Corporation, 2001. 
61.     Gioia G, Isquith P, Guy S, et al. Behavior  rating inventory of 
executive function. Odessa, FL: Psychological Assessment 
Resources, 2000. 
62.     Delis DC, Kaplan  E, Kramer JH. Delis-Kaplan  executive function 
system (D-KEFS) technical  manual. San  Antonio, TX: The 
Psychological Corporation, 2001. 
63.     Wechsler D. Wechsler intelligence  scale for children—fourth 
edition: technical  and  interpretative manual. San  Antonio, TX: 
The Psychological Corporation, 2003. 
64.     Martin NA. Test of visual perceptual skills. 3rd edn.  Novato,  CA: 
Academic  Therapy  Publications, 2006. 
65.     Randall  M, Johnson L, Reddihough D. The melbourne assessment 
of unilateral upper  limb function test: test administration manual. 
Melbourne:  Royal Children’s Hospital, 1999. 
66.     Randall  M, Carlin JB, Chondros P, et al. Reliability of the 
Melbourne  assessment of unilateral  upper  limb function. Dev Med 
Child Neurol 2001;43:761–7. 
67.     Verschuren O, Ketelaar  M, Takken  T, et al. Reliability of 
hand-held dynamometry and  functional strength tests  for the lower 
extremity in children with Cerebral Palsy.  Disabil Rehabil 
2008;30:1358–66. 
68.     Worrell TW, Borchert  B, Erner K, et al. Effect of a lateral step-up 
exercise protocol on quadriceps and  lower extremity performance. 
J Orthop Sports  Phys Ther 1993;18:646–53. 
69.     Maher  CA,  Williams  MT, Olds  TS.  The  six-minute  walk  test 
for children  with cerebral  palsy.  Int  J Rehabil  Res 
2008;31:185–8. 
70.     Li AM, Yin J, Au JT, et al. Standard reference for the 
six-minute-walk test in healthy  children aged 7 to 16 years. Am J 
Respir  Crit Care  Med 2007;176:174–80. 
71.     Evenson KR, Catellier DJ, Gill K, et al. Calibration  of two objective 
measures of physical  activity for children. J Sports  Sci 
2008;26:1557–65. 
72.     Capio CM, Sit CH, Abernethy  B. Physical activity measurement 
using MTI (actigraph) among  children with cerebral palsy. 
Arch Phys Med Rehabil  2010;91:1283–90. 
73.     Clanchy  KM, Tweedy  SM, Boyd RN, et al. Validity of accelerometry 
in ambulatory children and  adolescents with cerebral palsy.  Eur J 
Appl Physiol 2011;111:2951–9. 
74.     De Vries SI, Van Hirtum HWJEM, Bakker  I, et al. Validity and 
reproducibility of motion sensors in youth: a systematic update. 
Med Sci Sports  Exerc  2009;41:818–27. 
75.     Trost SG, Pate RR, Freedson PS,  et al. Using objective  physical 
activity measures with youth: how many  days of monitoring are 
needed? Med Sci Sports  Exerc  2000;32:426–31. 
76.     Janz KF. Validation of the CSA accelerometer for assessing 
children’s physical  activity. Med Sci Sports  Exerc  1994; 
26:369–75. 
77.     van Ravesteyn NT, Scholtes VA, Becher JG, et al. Measuring 
mobility limitations in children with cerebral palsy: content  and 
construct validity of a mobility questionnaire (MobQues). Dev Med 
Child Neurol 2010;52:e229–35. 
78.     Van Ravesteyn NT, Dallmeijer AJ, Scholtes VA, et al. Measuring 
mobility limitations in children with cerebral palsy: interrater  and 
intrarater  reliability of a mobility questionnaire (MobQues). Dev Med 
Child Neurol 2010;52:194–9. 
79.     Law M, Baptiste  S, Carswell  A, et al. The canadian occupational 
performance measure. 3rd edn.  Ottawa,  Ontario: COAT 
Publications ACE, 1999. 
80.     Law M, Polatajko  H, Pollock N, et al. Pilot testing  of the Canadian 
occupational performance measure: clinical and  measurement 
issues. Can  J Occup  Ther 1994;61:191–7. 
81.     Dedding  C, Cardol M, Eyssen I, et al. Validity of the Canadian 
occupational performance measure: a client-centred outcome 
measurement. Clin Rehabil  2004;18:660–7. 
82.     McColl M, Paterson M, Davies  D, et al. Validity and  community 
utility of the Canadian occupational performance measure. Can  J 
Occup  Ther 2000;67:22–30. 
83.     Lowe K, Novak I, Cusick  A. Low-dose/high-concentration localized 
botulinum toxin A improves upper  limb movement and  function in 
children with hemiplegic  cerebral palsy.  Dev Med Child Neurol 
2006;48:170–5. 
84.     Wallen M, O’Flaherty  SJ,  Waugh  MCA. Functional  outcomes of 
intramuscular botulinum toxin type A and  occupational therapy  in 
the upper  limbs of children with cerebral palsy: a randomized 
controlled  trial. Arch Phys Med Rehabil  2004;88:1–10. 
85.     Fougeyrollas P, Noreau  L, Lepage C. Assessment of life habits, 
children long form. Quebec: RIPPH/INDCP,  2002. 
86.     Noreau  L, Fougeyrollas P, Vincent C. The LIFE-H: Assessment of 
the quality of social participation.  Technology and  Disability 2002; 
14:113–18. 
87.     Noreau  L, Lepage C, Boissiere L, et al. Social  participation  in 
children with cerebral palsy: measurement issues and  applications. 
Dev Med Child Neurol 2004;45:43–4. 
88.     Noreau  L, Lepage C, Boissiere L, et al. Measuring participation  in 
children with disabilities  using the assessment of life habits.  Dev 
Med Child Neurol 2007;49:666–71. 
89.     Coster  W, Law M, Bedell G, et al. Development of the participation 
and  environment measure for children and  youth: conceptual basis. 
Disabil Rehabil  2012;34:238–46. 
90.     Coster  W, Bedell G, Law M, et al. Psychometric evaluation of the 
participation  and  environment measure for children and  youth. Dev 
Med Child Neurol 2011;53:1030–7. 
91.     Goodman R. The strengths and  difficulties questionnaire: a 
research note.  J Child Psychol Psychiatry 1997;38:581–6. 
92.     Goodman R. The extended version  of the strengths and  difficulties 
questionnaire as a guide  to psychiatric  caseness and  consequent 
burden. J Child Psychol Psychiatry 1999;40:791–9. 
93.     Goodman R. Psychometric properties of the strengths and 
difficulties questionnaire. J Am Acad Child Adolesc  Psychiatry 
2001;40:1337–45. 
94.     Hawes DJ, Dadds MR. Australian  data  and  psychometric properties 
of the strengths and  difficulties questionnaire. Aust N Z J Psychiatry 
2004;38:644–51. 
Downloaded from bmjopen.bmj.com on April 11, 2013 - Published by group.bmj.com  
112 
Mitii : ra ndomised contro lled  t rial  of a web-based p rogram for cerebra l p alsy 
 
95.     Waters  E, Davis E, Boyd R, et al. Cerebral palsy  quality of life 
questionnaire for children (CP QOL-Child) manual. Melbourne: 
Deakin  University, 2006. 
96.     Davis E, Shelly A, Waters  E, et al. Quality of life of adolescents 
with cerebral palsy: perspectives of adolescents and  parents. 
Dev Med Child Neurol 2009;51:193–9. 
97.     Davis  E, Waters  E, Mackinnon  A, et al. Paediatric  quality of  life 
instruments:  a  review  of  the  impact  of the  conceptual 
framework  on  outcomes. Dev Med Child Neurol 
2006;48:311–18. 
98.     Waters  E, Davis E, Mackinnon  A, et al. Psychometric properties of 
the quality of life questionnaire for children with CP. Dev Med Child 
Neurol 2007;49:49–55. 
99.     Davis E, Mackinnon  A, Davern  M, et al. Description  and 
psychometric properties of the CP QOL-Teen:  a quality of life 
questionnaire for adolescents with cerebral palsy.  Res Dev Disabil 
2013;34:344–52. 
100.     Australian Bureau  of Statistics. Census of population and housing: 
socio-economic indexes for areas (SEIFA), 2006. Canberra: ABS, 
2008. 
Downloaded from bmjopen.bmj.com on April 11, 2013 - Published by group.bmj.com  
113 
 
Move it to improve it (Mitii): study protocol 
of a randomised controlled trial of a novel 
web-based multimodal training program for 
children and adolescents with cerebral 
palsy 
 
Roslyn N Boyd, Louise E Mitchell, Sarah T James, et al. 
 
BMJ Open 2013 3: 
doi: 10.1136/bmjopen-2013-002853 
 
 
 
Updated information and services can be found at: 
http://bmjopen.bmj.com/content/3/4/e002853.full.html 
 
 
 
 
 
References 
 
 
Open Access 
 
 
 
 
 
 
 
Email alerting 
service 
These include: 
 
This article cites 78 articles, 12 of which can be accessed free at: 
http://bmjopen.bmj.com/content/3/4/e002853.full.html#ref-list-1 
 
This is an open-access article distributed under the terms of the 
Creative Commons Attribution Non-commercial License, which permits 
use, distribution, and reproduction in any medium, provided the original 
work is properly cited, the use is non commercial and is otherwise in 
compliance with the license. See: 
http://creativecommons.org/licenses/by-nc/3.0/ and 
http://creativecommons.org/licenses/by-nc/3.0/legalcode 
 
Receive free email alerts when new articles cite this article. Sign up in 
the box at the top right corner of the online article. 
 
 
 
Topic 
Collections 
Articles on similar topics can be found in the following collections 
 
Neurology (71 articles) 
Paediatrics (109 articles) 
Research methods (68 articles) 
 
 
 
 
 
 
 
 
 
To request permissions go to: 
http://group.bmj.com/group/rights-licensing/permissions 
 
 
To order reprints go to: 
http://journals.bmj.com/cgi/reprintform 
 
 
To subscribe to BMJ go to: 
http://group.bmj.com/subscribe/ 
 114 
7.3 Methods specific to this doctoral thesis 
7.3.1 Study design 
A waitlist randomised controlled trial was chosen to ensure equity of access to this novel 
treatment program, with the aim to compare the Mitii™ training with standard care. 
Standard care was not provided to the control group by the study team, rather they were 
able to access their usual therapies which were recorded via questionnaire at 20 weeks. 
This approach was selected as the study sought to recruit children from more rural and 
remote areas which would make the delivery of standard therapy prohibitive. This must be 
acknowledged as a potential limitation in the study design, as there is the potential for a 
placebo effect in the intervention group as the control group does not receive the same 
level of attention as the intervention group.  
7.3.2 Selected outcome measures 
This doctoral thesis explores the results of the primary component of the study, looking at 
the effect of Mitii™ training at 20 weeks. The outcomes included in this doctoral thesis 
include: physical activity capacity measured by functional strength and walking endurance 
using the 6MWT; physical activity performance measured using ActiGraph® accelerometer 
records worn before and after completion of the Mitii™ intervention; mobility limitations 
using the MobQues28 and recreational participation measured with the recreational 
domain of LIFE-H. Retention of effects and the effect of the Mitii™ training in the waitlist 
control group were considered beyond the scope of this doctoral program but remain to be 
explored upon completion. 
7.3.3 Physical activity exercises and progression 
Gross-motor exercises comprised approximately 40% of the overall program and included 
sequences of repetitive multi-joint body-weight functional exercises such as sit to stand, 
alternate lunging, step ups or side steps onto a block, squatting, balancing on balance 
foam, to various interactive elements of the Mitii™ program, e.g. flying a spaceship while 
squatting and balancing on foam, or lunging to shoot a pirate ship with a cannon ball. 
Exercise intensity in week one was determined by setting tasks at approximately 75% of 
repetition maximum determined during baseline assessments and then progressed 
weekly. 
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7.3.4 Minimum detectable difference 
The MDD represents the smallest change in score of an instrument that falls outside the 
measurement error. The results of the randomised trial will be considered against the MDD 
for each measure. In instances where the MDD of the measures used within the doctoral 
program was not published, this was calculated using the formula: (SD*√1-ICC)*1.96* √2, 
where SD is standard deviation, ICC is the intra-class correlation coefficient. 
The MDD for functional strength testing was four repetitions for sit to stand, seven 
repetitions for lateral step ups (between 6.6 and 7.2 repetitions for left and right sides), and 
approximately three for half-kneel to stand (between 3.04 and 3.87 for left and right 
legs).{Verschuren, 2008 #1492}  For the 6MWT, a test-retest study demonstrated that in 
95% of cases, the second test would fall within 43.1 metres of the first 6MWT distance with 
the MDD was calculated to be 38.4 metres.18 
For physical activity performance measured with the ActiGraph® accelerometer, the MDD 
was 179 counts per minute for sedentary activity (see Chapter 4).  
The smallest detectable difference for the MobQues28 across two time points between the 
same rater is between 12.3 points for mothers and 13.6 points for fathers, meaning a 
change of 14 points is required. Intra-rater reliability was lower meaning that for 
MobQues28 questionnaires completed by different raters across time points, a change of 
25 points is required.75  
7.3.5 A priori sample size calculation 
Sample size for the larger overall Mitii™ study (49 in each group) is based on the study’s 
primary hypothesis comparison between the functional effects of Mitii™ compared to 
standard care at 20 weeks on the Assessment of Motor and Process Skills (AMPS).  
The primary outcome of this doctoral program is physical activity capacity, measured using 
functional strength (sit to stand, lateral step-ups, and half-kneel to stand) and sub-maximal 
aerobic capacity measured using walking endurance (6MWT). Therefore, for this doctoral 
program sample size calculations were based on functional strength at 20 weeks. Data 
from the Mitii™ pilot study was used to calculate the sample size.74 Large effect sizes 
(>0.8) were demonstrated in a group of nine independently ambulant children and 
adolescents with unilateral CP, which are presented in Chapter 2. Similar results would be 
expected in the current study given the similarity of the sample characteristics. Based on 
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an expected effect size of 0.8, 26 experimental subjects and 26 control subjects would be 
required to enable the null hypothesis to be rejected if the population means of the 
experimental and control groups are equal with probability (power) 0.8. Alternatively, 34 
experimental subjects and 34 control subjects would be required to enable the null 
hypothesis to be rejected if the population means of the experimental and control groups 
are equal with probability (power) of 0.9.   The Type I error probability associated with this 
tests of the null hypothesis is 0.05. This sample size matches similar examples of physical 
activity interventions within the literature investigating daily step counts using 
accelerometer devices.76, 77  
7.3.6 Post hoc power calculation 
Post hoc power calculations were performed using the outcome data from the 20 week 
assessment presented in Chapter 8. Recruitment exceeded original expectations and the 
sample included in the primary data analysis was 101. Given the sample size of 51 in the 
intervention and 50 in the control group, and the use of linear regression to determine the 
outcome between groups, and with α set at 0.05, the study had 99% power to detect the a 
large effect size (f2=0.35), 80% power to detect a moderate effect (f2=0.10) and 22% 
power to detect a small effect (f2=0.02).  
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Chapter 8. Move it to improve: can a web-based training program 
increase physical activity in children and adolescents with cerebral 
palsy? 
8.1 Introduction to Chapter 8 
This chapter consists of the paper entitled “A randomized control trial of web-based 
training to increase physical activity in children with cerebral palsy”. This paper reports the 
results of the randomised trial at the 20 week primary endpoint. This study addresses the 
primary aim of the thesis to determine the efficacy of Mitii™ training on physical activity 
capacity and performance, mobility limitations and recreational participation in 
independently ambulant children and adolescents with unilateral CP. 
8.2 Paper 7: ““A randomized control trial of web-based training to 
increase physical activity in children with cerebral palsy” 
This paper is currently under review in Journal of Pediatrics. 
 Mitchell L, Ziviani J, Boyd R. “A randomized control trial of web-based training to increase physical 
activity in children with cerebral palsy.” Submitted to Neurorehabilitation and Neural Repair. 
The material from this paper also formed part of a ‘late breaking’ free paper presentation at 
the 7th Biennial Conference of the Australasian Academy of Cerebral Palsy & 
Developmental Medicine, 11th to 14th March 2014, Hunter Valley, Australia; and has been 
presented as a free paper at the 68th American Academy of Cerebral Palsy and 
Developmental Medicine Meeting, 10th to 13th September 2014, San Diego, USA.  
Mitchell L, Ziviani J, Smith A, Boyd R. (2014) “Move it to improve it: using a web-based therapy program 
to increase physical activity in children and adolescents with congenital hemiplegia”. Developmental 
Medicine and Child Neurology. 56(S5): 64. 
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ABSTRACT  
Objective: To determine the efficacy of MitiiTM training, a novel web-based multimodal 
therapy program which is delivered remotely using ‘virtual’ therapists, on physical activity 
capacity and performance in children with unilateral cerebral palsy (CP). 
Study design: In a matched-pairs randomized waitlist control trial, independently 
ambulant children and adolescents with unilateral CP were allocated to receive 30 minutes 
of Mitii™ training (intervention) 6 days per week, or waitlisted receiving usual care (waitlist 
control) for 20 weeks. Physical activity capacity was assessed using maximal repetitions of 
functional strength tasks, and six minute walk test (6MWT); performance using four day 
ActiGraph®GT3X+ accelerometer records at baseline and 20 weeks. Secondary outcomes 
were mobility limitations (MobQues28) and recreational participation (Assessment of Life 
Habits recreational domain). Data were analysed by intention to treat comparing between 
groups using linear regression controlling for baseline score. 
Results: Participants were n=101, 52 males, mean age 11y3mo (2y4mo). Intervention 
participants completed 32.4 (SD 17.2) hours of training, which was associated with 
significant improvements in functional strength (mean difference: 20.9 repetitions; 95% 
confidence interval [CI]: 15.5-26.3; p<0.001), and 6MWT distance (mean difference: 40.3 
meters; 95%CI: 23.5-57.1; p<0.001) compared to control at 20 weeks. There were no 
significant differences in other outcomes (p>0.05). 
Conclusion:  Mitii™ training was effective at increasing functional strength and walking 
endurance in independently ambulant children with unilateral CP. This did not translate 
into improvements in physical activity performance, recreational participation, or reduce 
mobility limitations.  
Clinical Trial Registration: Australian New Zealand Clinical Trials Registry 
(www.anzctr.org.au): ACTRN12611001174976.  
  
 119 
 
INTRODUCTION 
Cerebral palsy (CP) describes a group of disorders of the development of movement and 
posture, causing activity limitations, attributed to non-progressive disturbances in the 
developing fetal or infant brain.1 Children with CP demonstrate reduced levels of anaerobic 
and aerobic fitness, reduced muscle strength and are less physically active compared to 
their typically developing peers.2, 3 As CP is the most common physical disability in 
childhood4, increasing levels of physical activity is an important health promotion 
consideration, particularly as patterns of physical activity acquired during childhood years 
are more likely to be maintained into adult life, providing the foundation for healthy lifestyle 
choices.5 Physical activity is described as any body movement using skeletal muscles that 
results in energy expenditure.6 When considering physical activity measurement, it is 
necessary to distinguish between an individual’s capacity (best effort in a standardized 
environment) and performance (actual activity in the real world).7, 8  Both of these 
constructs are important to consider among children with CP, as reduced strength or 
cardiovascular fitness can compromise daily function,9 potentially reducing their capacity 
to undertake physical activity. This may then contribute to high levels of inactivity, 
potentially placing them at risk of future health problems, such as increased blood 
pressure, blood glucose and cholesterol.10  
Evidence suggests that cardiovascular fitness training and progressive resistance training, 
are able to increase physical activity capacity in children with CP.11  One approach to 
increase physical activity is using active video games, which have the potential to deliver 
moderate to vigorous intensity exercise12 during otherwise sedentary screen time. Review 
studies present evidence which suggests that active video games can increase physical 
activity capacity and performance in children with CP, however to date the evidence is 
limited by small subject numbers and poor methodological quality.12, 13 Move it to improve 
it or Mitii™ (Mitii™ Development A/S, Copenhagen Denmark) is a novel, multi-modal, web-
based therapy program that combines upper-limb, visual-perceptual, lower-limb strength 
and balance training using a game-like design. A multidisciplinary team of therapists act as 
‘virtual trainers’ remotely accessing the program to set up a series of activities. These are 
graded regularly to deliver an incrementally challenging and individualized program 
delivered in the client’s home. The feasibility of delivering Mitii™ has been confirmed in a 
pilot study (n=9), with participants demonstrating significant gains in functional strength 
and cardiovascular endurance measured with the Bruce treadmill endurance protocol.14  
Further research is required to test the efficacy of this novel program. 
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This study aimed to determine the efficacy of Mitii™ training on physical activity capacity 
and performance in children with unilateral CP. Secondary aims were to determine if 
Mitii™ training could reduce mobility limitations and improve recreational participation. It 
was hypothesised that participants receiving Mitii™ training would demonstrate increased 
physical activity capacity and performance compared to a control group.  
METHODS 
The efficacy of Mitii™ was assessed using a matched-pairs randomized waitlist control 
trial compared to 20 weeks of standard care. The study methods and intervention are 
described in detail in the published protocol.15  The current study examines the efficacy of 
Mitii™ against secondary outcomes as reported in the published protocol.15  Ethical 
approval was obtained by the Medical Ethics Committee of The University of Queensland 
(2011000608), The Royal Children’s Hospital Brisbane (HREC/11/QRCH/35), Cerebral 
Palsy Alliance Ethics Committee (2013-04-01), and registered with the Australian clinical 
trials register (www.anzctr.org.au): ACTRN12611001174976. Written and informed 
consent was obtained from parents or guardians and participants greater than 12 years old 
before entering the trial.  
Participants: Children and adolescents aged 8-17 years with unilateral CP, classified at a 
Gross Motor Functional Classification System (GMFCS) level I-II16 and Manual Abilities 
Classification scale (MACS) I-III17 were recruited from population-based research 
databases within the Queensland Cerebral Palsy and Rehabilitation Research Centre, and 
Cerebral Palsy Alliance, Australia. Children were excluded from participation if they had 
unstable epilepsy or medical conditions which would preclude participation in the training. 
Children were delayed entry into the trial if they had undergone upper-limb Botulinum 
Toxin Type-A (BoNT-A) injections (±serial casting) or surgery in the previous two or six 
months respectively. Where children did not have access to a computer or internet, these 
were provided for the duration of the study. Standard care was not delivered by study 
personnel however concurrent therapies (including lower limb BoNT-A) were recorded via 
parent questionnaire at 20 weeks. 
Procedure: Children were matched in pairs according to age (within 12-month age 
bands), sex and level of upper-limb functional ability based on MACS level at screening. 
Children were randomized from sealed envelopes opened by non-study personnel before 
baseline assessment to allow for the provision of travel to Brisbane, and timetabling of 
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either one or two days of assessment. Participants were randomized within pairs to either: 
a) Intervention group: attend two days of assessment and training before returning home 
to commence Mitii™ training immediately for 20 weeks; or b) Waitlist control group: attend 
one day of assessment then continue care as usual for 20  weeks. Children attended re-
assessment between 20-22 weeks, after completion of the program. 
Intervention: Activities within Mitii™ program were combined in an individualized 
sequence to make a daily program of 30 minutes duration to be completed six days per 
week for 20 weeks (total potential dose of 60 hours). The level of difficulty was adjusted 
remotely by therapists (physiotherapist, occupational therapist and neuropsychologist) who 
were available to the participants and their families via email, phone or video-conferencing 
to provide encouragement and technical support. Each program was set up such that 
physical activity games were interspersed with upper-limb and visual-perceptual games 
which provided rest periods of at least 60-90 seconds.  Gross-motor exercises comprised 
approximately 40% of the overall program and included sequences of repetitive multi-joint 
body-weight functional exercises (such as sit to stand, alternate lunging, step ups or side 
steps onto a block, squatting, balancing on balance foam) to various interactive elements 
of the program, e.g. flying a spaceship while squatting and balancing on foam, or lunging 
to shoot a pirate ship with a cannon ball. The intensity of lower-limb strength exercises for 
week one were determined by setting tasks at approximately 75% of repetition maximum 
determined during baseline assessments. These were incremented weekly by the 
physiotherapist by increasing the repetitions, speed, step height and balance challenge in 
response to individual performance and feedback from the participants and their parents or 
caregivers.  Physical training varied based on the child’s individual needs, but on average 
commenced in week one with seven activities of between 5-10 repetitions lasting 
approximately 60 seconds per activity, and progressed to eleven games of up to 20 
repetitions lasting approximately 90 seconds with the addition of step blocks and balance 
foam.  
Outcomes: All outcomes were assessed by Physiotherapists trained in the data collection 
procedures. Strength was tested according to a protocol outlined by Verschuren et al.18 
which records maximal repetitions of sit to stand, lateral step up using a 20cm step, and 
half-kneel to standing for the dominant and non-dominant leg over a 30 second period. 
The minimum detectable difference (MDD) is four sit to stands, seven lateral step ups, and 
three half-kneel to standing repetitions.18 A composite score was created summing 
repetitions from each task which was used to create a single variable in the linear 
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modelling procedure. Walking endurance was measured using the simple field-based six-
minute walk test (6MWT), which measures the maximal distance walked in six minutes 
along a flat, straight, 10 meter corridor using standardized verbal encouragement with the 
MDD calculated to be 38.4 meters.19  
Physical activity performance was recorded using an ActiGraph®GT3X+ tri-axial 
accelerometer (ActiGraph® Corporation, FL, USA) initialized to record step counts and 
accelerations at a frequency of 100 Hz in 5 second epochs. Accelerometer units were 
fitted on an elastic belt worn at the level of the iliac crest on the mid-axilla line of the least 
impaired side of the body. Participants were instructed to wear the device for all waking 
hours for four consecutive days (including two weekend and two week days where 
possible). During this time, parents registered the wear time of the device on an activity 
diary. Once returned, acceleration data were downloaded to a personal computer and 
manipulated in ActiLife™ software v6 (ActiGraph® Corporation, FL, USA). All representative 
and complete data where at least eight hours of data were recorded each day was 
included. Vertical axis activity counts were converted to activity intensity using validated 
Evenson cut points (vertical counts∙min-1: Sedentary ≤100, light 101-2295, moderate 2296-
4011, vigorous ≥4012).20  
Secondary outcomes recorded a via a parent questionnaire were the 28-item Mobility 
Questionnaire (MobQues28), which scores mobility limitations on a scale of 0-100,21 and 
recreational participation measured using the Assessment of Life Habits (LIFE-H) 
recreation domain, determined a priori to be most relevant to physical activity. The LIFE-H 
assesses a person’s ability to perform everyday tasks producing a domain weighted score 
ranging from 0 to 10.22 Personal and environmental characteristics were described at 
baseline including demographic information relating to the household and school 
environment. Feedback on the Mitii™ program was also obtained from parents upon 
completion of the program using a subjective questionnaire designed for the trial 
(Supplemental Table 1). 
Statistical analysis 
Continuous data were examined for normality by visually inspecting histograms and with 
the Shapiro-Wilk test. All of these variables were normally distributed. Descriptive statistics 
were used to calculate participant demographic and clinical characteristics. To account for 
differences in accelerometer wear time, wear time was standardized to 12 hours using the 
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formula: (time spent in activity state/wear time)*12. Differences between groups for 
primary and secondary outcome variables were examined using linear regression models, 
where baseline score and group allocation (dummy coded: waitlist: 0; Mitii™: 1) served as 
independent variables within the model. Assumptions of the model were checked, 
including normality, co-linearity, homoscedasticity and Mahalanobois’ distance. To explore 
the influence of potential confounders, GMFCS (I: 0; II: 1), sex (male: 0; female:1), BoNT-
A status (0: not received; 1: received) and age were added stepwise into the model and 
where the variable was significantly associated with the dependent variable it was deemed 
to be a potential confounder. Where group allocation was found to be significantly 
associated with an outcome variable and not confounded by other variables, a further 
linear regression was run for Mitii™ participants with baseline score and training dose as 
independent variables.  Sample size for the larger overall Mitii™ study (49 in each group) 
is based on the study’s primary hypothesis comparison between the functional effects of 
Mitii™ compared to standard care at 20 weeks on the Assessment of Motor and Process 
Skills (AMPS).15 For this study, sample size calculations were based on functional strength 
at 20 weeks. Given the sample size of 51 in the intervention and 50 in the control group, 
and the use of linear regression to determine the outcome between groups, and with α set 
at 0.05, the study had 99% power to detect the a large effect size (f2=0.35), 80% power to 
detect a moderate effect (f2=0.10) and 22% power to detect a small effect (f2=0.02).  Data 
are mean (SD) and α was set at 0.05 for primary analyses. Bonferroni adjustment was 
applied due to multiple secondary analyses requiring p<0.005. Data were collated in 
Microsoft® Excel™ 2010 (Microsoft Corporation, USA). As missing data were less than 
20%, data were analyzed by intention to treat using IBM SPSS v22 (IBM Corp., NY, USA). 
RESULTS 
The recruitment and study period was January 2012 until March 2014. The flow of 
participants is presented in Figure 1. Of 179 eligible participants (mean age 13y 7mo [SD 
2y 0mo], 56% males), 102 participants (57%) enrolled in the study. Participants who 
proceeded to baseline assessments were children (n=101) with unilateral CP (52 males; 
mean age 11y3mo [SD 2y4mo], range 8-17 years). The personal and socio-demographic 
characteristics of participants at baseline are presented in Table 1. No differences were 
found between groups at baseline for any variable. In the intervention group, 47 
commenced training and were assessed at 20 weeks (92% retention); in the waitlist 
control group, 44 were assessed at 20 weeks (86% retention; Figure 1).  
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Insert Figure 1 about here 
On average, participants completed 32.4 (17.2) hours of Mitii™ training over the 20 week 
period, logging in for 24.2 (5.5) minutes on 77.7 (35.7) days. The total dose of therapy 
fluctuated, ranging from 3.7 hours to 74.7 hours (Supplemental Figure 1a). Over the 
course of the intervention, the number of participants logging into the program on a regular 
basis reduced, such that by the end of the 20 week period 10.7 logins were recorded on 
average, representing 23% of intervention participants (Supplemental Figure 1b). Limited 
concurrent therapy was provided to either group during the study period, including BoNT-A 
(Table 1). From the intervention group, 12 (23%) participants received Physiotherapy 
totalling on average 0.47 hours, and 15 (30%) of participants in the control group received 
Physiotherapy totalling on average 3.9 hours over the 20 weeks.  There were two potential 
adverse events recorded during the intervention. One participant reported knee pain 
during lunges and another reported neck pain. In both instances participants were 
instructed to modify the movement and were able to continue training with close 
monitoring. One participant in the intervention group had seizures but parents reported this 
was not related to training. Despite study personnel’s best attempts to resolve technical 
issues, some families reported frustration over the course of the intervention.  
Insert Table 1 about here 
Baseline and 20 week data are presented in Table 2. After 20 weeks, composite functional 
strength score was 20.9 repetitions higher in the intervention group than the control group 
after adjusting for baseline score (95% confidence interval [CI]: 15.5 to 26.3; p<0.001), and 
6MWT distance was 40.3 meters greater (95%CI: 23.5 to 57.1; p<0.001; Table 3). The 
increase in 6MWT distance was above the MDD. Sex, GMFCS, BoNT-A status and age 
were not significant confounders within the linear regression models (p>0.05). At 20 
weeks, 6MWT distance was significantly greater with increasing training dose (B=0.6, 
95%CI: 0.1 to 1.1; p=0.02) but functional strength composite score was not (B=0.2, 
95%CI: -0.1 to 0.4; p=0.06). There were no statistically significant differences between 
groups for physical activity performance, MObQues28 or LIFE-H (Table 3).  
Insert Table 2 about here; Insert Table 3 about here 
When asked to feedback on the program, top reasons ranked by parents (n=45) for not 
accessing the program were technical issues (n=14; 31%) including difficulties with 
internet connectivity (n=6; 13%), a lack of time (n=8; 18%), or reduced motivation from the 
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children (n=8; 18%). Parents reported liking the progressive nature of the program (n=18; 
40%), that it could be accessed online (n=11; 24%), the flexibility of the location (n=8; 
18%) and time of access (n=5; 11%). Overall, parents reported being satisfied with the 
Mitii™ program and felt their child had somewhat improved lower limb strength, physical 
activity and sport participation, though felt that the duration, frequency and length of the 
program was a little too long (Supplementary Table 2). 
DISCUSSION 
To our knowledge this is the largest randomized trial of an active video game in children 
with CP. Participants randomly assigned to the Mitii™ training group achieved statistically 
significant improvements in functional strength and walking endurance compared to the 
control group. This confirmed our hypothesis that participants receiving Mitii™ training 
would demonstrate increased physical activity capacity; however we were not able to 
demonstrate an increase in physical activity performance following training.  
The approach used in the current study is different to what has previously been presented 
in the published literature to increase physical activity capacity in children with CP.11, 13 
Typically, active video games examined in the literature are either low-cost commercially 
available consoles which are not easily individualized, or customisable rehabilitation-
specific systems where cost typically limits.13 In contrast, Mitii™ is delivered in the home 
environment and individualised using remote monitoring by a team of ‘virtual’ therapists in 
response to feedback and performance from each participant. The delivery of lower-limb 
and balance exercises to increase physical activity remotely using a web-based program 
has also not been previously explored. 
Looking at broad intervention approaches to increase physical activity capacity in children 
with CP, the strength of the evidence to support cardiovascular fitness training is strong.11 
While progressive resistance training shows promise, the evidence to support this 
approach is limited by the methodological quality of included trials which at times have 
produced conflicting results.11 Previous research using progressive resistance training has 
been criticized for a discrepancy between the training mode and the instrument employed 
within a study to measure an effect.9 The significant effects demonstrated in the current 
study reinforce the importance of training specificity, with significant gains potentially due 
to similarities between training and functional strength assessments. Training specificity 
cannot, however, explain the significant improvements demonstrated in walking endurance 
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with the 6MWT. This finding is particularly interesting as while increases in strength are 
typically shown following training, so far there has been limited translation into walking 
ability.11 It is unclear why Mitii™ training may have resulted in increased walking 
endurance despite not specifically training gait. While the Mitii™ pilot study demonstrated 
increases in cardiovascular endurance measured by the Bruce treadmill protocol, they 
were unable to demonstrate an increase in walking endurance with the 6MWT.14 While the 
actual training was individualized, and was therefore potentially different to that provided in 
the pilot, physical training was typically provided in intervals interspersed with upper-limb 
and visual-perceptual activities. These short intense bursts of activity may have increased 
cardiovascular fitness, contributing to improved walking endurance. Further evaluation of 
cardiovascular fitness in response to training and of cardiovascular load during game-play 
may be useful to determine the mechanisms underlying improvements in physical activity 
capacity demonstrated.  
Previous research of exercise programs has often failed to explore the effect on activity or 
participation in children with CP.9 In contrast, the current study provides a broad overview 
across the International Classification of Functioning, Disability and Health framework.7 
Despite improvements in physical activity capacity, these changes did not lead to 
significant improvements in physical activity performance or recreational participation, nor 
reduce physical inactivity or mobility limitations. While this may reflect ceiling effects due to 
the high physical capability of included participants, this finding is not unexpected. 
Research typically shows that ‘you gain what you train’ and improvements in capacity 
rarely translate into performance.23 This seems particularly relevant for physical activity, as 
the notion that increases in physical activity capacity will translate into improved 
performance without a targeted intervention does not account for the many determining 
factors which underpin physical activity performance. Numerous barriers to physical 
activity participation have been identified in the literature, including the influence of the 
school, community, family and home environments.24, 25 The findings in the current study, 
combined with previous research with limited results26, reinforce that overcoming these 
barriers is critical to translation of physical activity capacity changes into performance. 
Active video games may well have a role in increasing physical activity in children with CP, 
particularly as they are relatively cheap, enjoyed by children and can be completed in the 
home environment; however these need to be considered in the context of multi-
dimensional interventions which incorporate behavioural change strategies to overcome 
the barriers associated with participating in increased physical activity.24, 27 By 
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incorporating behavioural change strategies, interventions can be targeted according to 
the barriers which are most likely to be directly influencing their readiness to change.27 
This targeted approach seems particularly relevant for children and adolescents with a 
physical disability such as CP, where mainstream physical activity health promotion 
messages may not always resonate with children and their families. Additional information 
and strategies may be required to find and adapt physical activity opportunities to their 
child’s abilities and to fit into a busy lifestyle where school and therapy are often competing 
with leisure and recreational time. 
To our knowledge, this is the first randomized trial to test the efficacy of Mitii™. Despite 
completing only 54% of the potential dose, participants demonstrated significant 
improvements in physical activity capacity which increased with increasing training dose.  
While we had aimed for a training dose of 60 hours, on average, participants completed 
over 30 hours of training which has been suggested a previous study to be an effective 
dose for rehabilitation therapy in children with CP.28 Technical issues, primarily 
encountered due to the isolation of Australia from the server located in Denmark, and 
competing interests often resulted in a gradual decline in completing the program and in 
some instances limited the total training dose. Overall, parents and the children reported 
being satisfied with the intervention though some families reported frustration with 
technical issues encountered. Future research to determine which families respond best to 
a home-based system such as Mitii™ would be useful when prescribing the intervention. 
Future research should also explore the effect of a program of shorter duration or the 
impact of future developments within the program. Ongoing changes to the program may 
overcome some of the barriers encountered throughout the course of the intervention and 
it would be useful to explore if this changes a child’s motivation to complete the program.  
This study has utilised a strong design methodology, however it should be noted that study 
personnel were not able to be blinded to group allocation so there may have been the 
potential for bias influencing results, though adherence to standard protocols for the 
administration of these tests was maintained.18, 19 To limit assessment burden, where 
possible we utilised parent proxy reporting. This resulted in feedback on the program as 
well as the secondary outcomes being parent reported. Furthermore, this study was limited 
to independently ambulant children with unilateral CP meaning the results may not be 
generalizable to children with CP with more limited functional capacity or children with 
other disabilities. The current study reports the findings of the primary outcome at 20 
weeks immediately post intervention; future research will explore the retention effect of 
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training in the full cohort (n=101) after a further 20 weeks from the completion of training 
and to explore potential effects which may not have been realised immediately after 
completion of the Mitii™ training.   
Conclusion 
Delivering training to independently ambulant children with unilateral CP using the web-
based program Mitii™ and ‘virtual’ trainers was effective at increasing physical activity 
capacity, assessed using functional strength and walking endurance. However, 
improvements in physical activity capacity did not translate into improvements in physical 
activity performance or recreational participation, or reduce sedentary time or mobility 
limitations. This reinforces that physical activity capacity and performance represent 
separate constructs requiring different measurement techniques and different treatment 
approaches. 
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Table 1. Personal and socio-demographic characteristics of study participants at baseline and concurrent 
therapy provided during intervention period 
  Intervention N=51 Waitlist control N=50 
Personal characteristics 
         Right hemiplegia 23 45% 30 60% 
     Males 26 51% 26 52% 
GMFCS: 
         I 21 41% 25 50% 
     II 30 59% 25 50% 
MACS: 
         I 11 22% 13 26% 
     II 39 76% 37 74% 
     III 1 2% 0 0% 
Age; mean (SD) 11y 3mo (2y 4mo) 11y 4mo (2y 6mo) 
Comorbid conditions 
    Intellectual Impair. 4 8% 7 14% 
Learning difficulties 15 29% 12 24% 
ASD or Asperger’s 3 6% 1 2% 
ADHD 5 10% 7 14% 
Visual Impair. 5 10% 8 16% 
Hearing Impair. 1 2% 3 6% 
Epilepsy 12 24% 7 14% 
Concurrent therapy during intervention period 
   BoNT-A (UL) 1 2% 0 0% 
   BoNT-A (LL, calf) 5 9% 11 22% 
   Surgery 0 0% 0 0% 
Socio-demographic characteristics 
   School type: 
         Primary 30 59% 27 54% 
     Secondary 14 28% 18 36% 
     Special Education 3 6% 3 6% 
     Other 3 6% 1 2% 
     Missing 1 0% 1 2% 
Parent relationship: 
         Married/Defacto 45 88% 40 80% 
     Separated/Divorced 2 4% 7 14% 
     Never married 1 2% 2 4% 
     Other 2 4% 0 0% 
     Missing 1 2% 1 2% 
Household structure: 
         Original parents 35 69% 30 60% 
     Step family 8 16% 9 18% 
     Single parent 5 10% 7 14% 
     Other 2 4% 3 6% 
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     Missing 1 2% 1 2% 
Annual household income: 
         <$25,000 4 8% 8 16% 
     $25,000-$49,999 5 10% 7 14% 
     $50,000-$74,999 8 16% 9 18% 
     >$75,000 32 63% 22 44% 
     Missing 2 4% 4 8% 
Data are N (%) with exception of age and the PEM-CY which is mean (SD). KEY: GMFCS: 
Gross Motor Functional Classification System; ASD: Autism Spectrum Disorder; ADHA: 
Attention deficit hyperactivity disorder; BoNT-A: Botulinum Neurotoxin Type-A; UL: upper-
limb; LL: lower-limb; Annual household income are in AUD$. 
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Table 2.  Physical activity capacity, performance, activity limitations and recreational participation at baseline and 20 week assessments (immediately post 
intervention) 
Outcome measures 
Intervention 
 
Waitlist control 
n Baseline n 20 weeks 
 
n Baseline n 20 weeks 
Physical activity capacity 
         
Functional Strength composite, (reps) 51 43.7 (22.3) 46 63.5 (26.0) 
 
50 47.6 (20.8) 43 46.8 (18.3) 
Sit-to-stand 51 12.4 (3.9) 46 15.3 (4.4) 
 
50 12.7 (3.7) 43 12.7 (3.1) 
Lateral step, D 51 13.3 (7.4) 46 19.4 (8.0) 
 
50 13.8 (6.2) 43 14.1 (5.4) 
Lateral step, ND 51 12.0 (7.9) 46 18.5 (8.1) 
 
50 11.9 (6.7) 43 12.1 (5.5) 
Half-kneel, D 51 3.3 (3.5) 46 5.6 (5.5) 
 
50 4.7 (4.8) 43 4.2 (4.1) 
Half-kneel, ND 51 2.5 (3.1) 46 4.5 (4.9) 
 
50 3.8 (4.4) 43 3.6 (4.6) 
6MWT (meters) 51 366.0 (70.8) 46 404.4 (68.9) 
 
50 382.0 (85.8) 43 374.0 (64.9) 
Physical activity performance 
Counts/minute  48 432 (151) 43 419 (199) 
 
46 436 (179) 39 419 (158) 
Step counts  48 7775 (2416) 43 7558 (3404) 
 
46 7641 (3164) 39 6961 (2530) 
Wear time (hours) 48 11:36 (1:18) 43 11:23 (1:38) 
 
46 11:34 (1:30) 39 11:19 (1:54) 
Time sedentary  (hours) 48 8:35 (0:48) 43 8:36 (1:00) 
 
46 8:38 (1:03) 39 8:48 (0:53) 
Time light  (hours) 48 2:39 (0:38) 43 2:35 (0:43) 
 
46 2:36 (0:47) 39 2:34 (0:40) 
Time MVPA  (hours) 48 0:44 (0:17) 43 0:43 (0:25) 
 
46 0:44 (0:20) 39 0:42 (0:18) 
Weekend sedentary  (hours)  42 8:36 (1:07) 43 8:37 (1:28) 
 
36 8:38 (1:19) 35 8:54 (0:56) 
Weekend light  (hours) 42 2:41 (0:50) 41 2:48 (1:30) 
 
36 2:38 (0:57) 35 2:37 (0:42) 
Weekend MVPA  (hours) 42 0:41 (0:24) 41 0:41 (0:25) 
 
36 0:42 (0:29) 35 0:36 (0:18) 
Weekday sedentary (hours) 48 8:36 (0:48) 43 8:38 (1:12) 
 
46 8:38 (0:59) 39 8:54 (0:54) 
Weekday light (hours) 48 2:36 (0:38) 43 2:34 (0:55) 
 
46 2:35 (0:44) 39 2:24 (0:41) 
Weekday MVPA (hours) 48 0:47 (0:18) 43 0:49 (0:28) 
 
46 0:45 (0:18) 39 0:48 (0:18) 
MobQues28 (score/100) 49 89.4 (10.9) 47 90.8 (9.4) 
 
50 90.5 (7.7) 43 90.4 (11.4) 
LIFE-H  Recreation (score/10) 46 7.5 (2.36) 46 8.0 (2.3) 
 
48 7.6 (2.34) 42 7.4 (2.5) 
Data are mean (SD). Physical activity performance represents standardised time for 12hr wear time. Difference represents a difference 
between groups at 20 weeks. KEY: n: number; 95% CI: 95% confidence intervals; reps: repetitions; D; dominant leg; ND: non-dominant leg; 
6MWT: six-minute walk test; MVPA: moderate to vigorous physical activity; MobQues28: Mobility Questionnaire 28 item; LIFE-H Recreation: 
Assessment of Life Habits recreational domain. 
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Table 3.  Linear regression results for primary and secondary outcomes controlling for baseline score and 
treatment group allocation. 
 Outcome measure  B (95% CI)  t P-value   
Functional Strength 20.9 (15.5 to 26.3)  7.70 <0.001* 
6MWT 40.3 (23.5 to 57.1)  4.77 <0.001* 
Sedentary activity   -0.1 (-0.4 to 0.3)  -0.49 0.62 
Light activity 0.0 (-0.2 to 0.2)  0.01 0.99 
MVPA 0.3 (-0.1 to 0.2)  0.41 0.68 
Activity counts 12.1 (-46.6 to 70.8)  0.41 0.68 
Steps 576.8 (-540.1 to 1693.7) 1.03 0.31 
MobQues28  0.3 (-3.4 to 4.1)  0.18 0.86 
LIFE-H 0.6 (-0.2 to 1.4) 1.56 0.12 
 
* Denotes significant at p<0.05; Physical activity performance represents standardised time for 
12hr wear time. Group allocation dummy coded such that a positive association favours 
intervention group. 
KEY: B: Unstandardized coefficient; 95% CI: 95% confidence interval; t: t-statistic; MobQues28: 
Mobility Questionnaire 28 item; Functional strength: summed score of 30-second repetition 
maximum testing; reps: repetitions; 6MWT: six-minute walk test; MVPA: moderate to vigorous 
physical activity; LIFE-H: Assessment of Life Habits recreational domain.  
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Supplemental table 1: Parent reported satisfaction and improvements suggested with the intervention 
collected via questionnaire at 20 weeks 
  
Response 
Mean (SD) 
Would you return to Mitii™? (Not at all, Maybe, Yes definitely) 7.1 (2.2) 
Satisfaction: (Very dissatisfied, Quite Satisfied, Very Satisfied) 7.5 (1.6) 
How satisfied were you with the Mitii™ program? 7.4 (1.8) 
How satisfied were you with the quality of Mitii™ received? 7.7 (1.6) 
How satisfied were you with the support received? 7.5 (1.7) 
How satisfied were you with the type of help received? 7.5 (1.9) 
How satisfied were you with the amount of therapy received? 7.5 (2.0) 
How satisfied were you with the technical support received? 7.5 (2.0) 
How satisfied were you with accessing therapy online? 7.9 (1.3) 
Needs: (Not at all met, Needs somewhat met, All needs met) 
To what extent did the program meet the needs of your child? 6.9 (1.4) 
To what extent did the program meet your needs? 7.1 (1.5) 
Reported improvements: (Hasn’t helped at all, Helped somewhat, Helped 
a lot) 
 Has the program helped your child use lower limbs more?  5.3 (2.2) 
Has the program helped your child do more physical activity? 5.2 (2.3) 
Has the program helped your child to participate more in sports? 4.5 (2.3) 
Program duration: (Much too long , Just right, Much too short) 
 Please comment on the overall length (20 weeks) 4.1 (1.8) 
Please comment on the frequency (up to daily) 4.3 (0.8) 
Please comment on the daily duration (20-30 minutes) 4.1 (1.0) 
 
Data is mean (SD). Response was scored in a nine-point likert scale from 1 representing the lowest score to 
9 the highest score, with the extreme range (1 and 9) and middle (5) responses provided for each question.  
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Figure 1. CONSORT flowchart of participants and assessments for analysis through the study  
Baseline n=51 Baseline n=50 
Enrolled in study n=102 
Matched in pairs 
 
Randomisation in pairs 
Intervention group 
n=51 
Waitlist control 
n=51 
20 week n=47 
Retention 92.2% 
20 week n=44 
Retention 86.3% 
Withdrew n=4  
(Medical n=1 
Personal 
reasons n=3) 
Failure to 
proceed n=1 
Withdrew n=6 
(Personal 
reasons = n=6) 
Mitii™ intervention 
n=47 
Control period 
 
Potential participants n=270 
Self-referral or other contact n=72 
Identified from database n=198 
Excluded n=77 
Declined n=40 
Other n=37 (Undecided 
n=12; Target recruitment 
reached n=25) 
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Analysis 
 Capacity n=46 
Performance n=43 
MobQues28 n=47 
LIFE-H n=46 
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Analysis 
 Capacity n=43 
Performance n=39 
MobQues28 n=43 
LIFE-H n=42 
Baseline measures 
Classification: Gross Motor Functional 
Classification System (GMFCS) 
Capacity: Six-minute walk test; 
functional strength assessment 
Performance: Accelerometer 
Questionnaires:  
Mobility Questionnaire (MobQues28) 
Assessment of Life Habits (LIFE-H) 
Demographic Questionnaire 
20 week measures 
Capacity: Six-minute walk test; 
functional strength assessment 
Performance: Accelerometer 
Questionnaires:  
Mobility Questionnaire (MobQues28) 
Assessment of Life Habits (LIFE-H) 
Demographic Questionnaire 
Eligible participants n=179 
Ineligible n=91 
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Supplemental figure 1. a) Total training dose for intervention group particpants; b) average 
number of participants logging into program over the 20 weeks, n=47 
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8.3 Summary and conclusions 
This study concluded that delivering training to independently ambulant children and 
adolescents with unilateral CP using the web-based program Mitii™ and virtual trainers 
was effective at increasing physical activity capacity. This increase in capacity did not 
translate into improvements in physical activity performance, reductions in parent reported 
mobility limitations, or enhanced recreational participation. When considering this evidence 
in the context of this doctoral program: 
i) The significant effects demonstrated in the current study highlights the importance of 
training specificity, with large gains potentially demonstrated due to similarities 
between the Mitii™ training and functional strength assessments. It should be noted, 
that while large effects and statistically significant improvements in physical activity 
capacity were demonstrated, those for functional strength were below the MDD 
determined by a previous test-retest reliability study and as such results should be 
interpreted with some caution. 
ii) It would be useful to look at testing the level of anaerobic and aerobic fitness pre and 
post Mitii™ in future research to determine the mechanisms underlying 
improvements in walking endurance. 
iii) Despite improvements in physical activity capacity, these changes did not lead to 
significant improvements in physical activity performance, a decrease in physical 
inactivity, reductions in parent reported mobility limitations or improved recreational 
participation. These findings corroborate the view that physical activity capacity and 
performance represent separate constructs requiring different measurement 
techniques and different treatment approaches. 
iv) Overall, parents and the children reported being satisfied with the Mitii™ intervention 
though some families reported frustration due to the technical issues encountered. 
Future research to determine which families respond best to a home-based system 
such as Mitii™ would be useful when prescribing the intervention. 
v) Despite completing only 54% of the potential dose of Mitii™ on average, participants 
demonstrated significant improvements in physical activity capacity which increased 
with increasing Mitii™ dose. Future research which looks at the impact of a program 
of shorter duration and intensity would be useful, as this may overcome some of the 
barriers to ongoing completion of the program throughout the course of the 
intervention. Parents indicated that they felt the program length and duration were a 
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little too long and typically the frequency of accessing the program reduced over the 
course of the intervention.  
vi) The cross sectional study looking at the association between physical, personal and 
environmental characteristics and physical activity (Chapter 6) had suggested that 
there may have been a difference in physical activity outcomes between participants 
on the basis of age and sex. Linear regression analysis did not find any significant 
associations between age or sex on the effectiveness of Mitii™ training. Future 
research would be useful to further explore this effect in a larger sample. 
vii) The current study reports the findings of the primary outcome at 20 weeks 
immediately post intervention. Future research should explore the retention effect of 
Mitii™ training in the full cohort (n=101) after waiting an additional 20 weeks after 
completion of the intervention deemed to be beyond the scope of this doctoral 
program. 
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Chapter 9. Discussion and conclusion 
In this final chapter the major findings from the systematic reviews and experimental 
studies undertaken in this doctoral program will be examined in relation to the current 
published literature. The limitations and generalisability of the findings will be discussed. 
The feasibility of implementing a program such as Mitii™ into clinical practice will be 
explored and future clinical research directions recommended. 
The main aims of the studies described in this thesis were to determine the efficacy of 
active video game technologies, specifically the web-based therapy program Mitii™, to 
increase physical activity capacity and performance in children and adolescents with 
unilateral CP; to investigate measurement of physical activity performance in children and 
adolescents with unilateral CP; and to describe patterns and characteristics associated 
with physical activity in this population. This doctoral program presents results from the 
first randomised trial of Mitii™ in children with unilateral CP with comprehensive evaluation 
of physical activity capacity and performance across broad domains of the ICF.4 In 
addition, profiles of physical activity undertaken by children with unilateral CP and 
characteristics associated with physical activity have been presented. This doctoral 
program strengthens the evidence base for using accelerometers in independently 
ambulant children and adolescents with unilateral CP. 
9.1 Overview of findings 
The following presents the findings in relation to the proposed hypotheses formulated at 
the conception of this doctoral program. 
9.1.1 Hypothesis 1: There will be emerging evidence that active video game 
interventions can increase physical activity capacity and performance. 
Prior to the commencement of the randomised trial, a systematic review was undertaken 
to determine the current level of evidence to support the use of virtual reality technology as 
a tool to increase physical activity capacity and performance in children with CP. The 
systematic review is reported in Chapter 2. At the time of conducting the review, virtual 
reality was a new and emerging technology and as such systematic searching yielded only 
four studies of limited methodological quality which explored the effect of virtual reality 
interventions on physical activity capacity or performance in children with CP or an early 
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brain injury. This meant that firm conclusions were unable to be drawn, but nonetheless, 
there appeared to be a small positive effect for active video game technologies to increase 
physical activity capacity and performance in children with CP or early brain injury. Few 
studies had assessed outcomes relating to both physical activity capacity and 
performance, or included measures across all domains of the ICF.4 The findings from this 
systematic review were useful for highlighting deficiencies in the evidence base at the time 
as well as informing the design of the Mitii™ randomised trial. A matched pairs, waitlist 
controlled trial was chosen to provide a strong design methodology to overcome limitations 
in the published literature. Outcomes were chosen which would explore the efficacy of 
Mitii™ on physical activity across the ICF.4 These findings support our first hypothesis that 
existing literature would provide weak but emerging evidence to support virtual reality 
technologies to increase physical activity capacity and performance in children with CP or 
early brain injuries. 
9.1.1 Hypothesis 2: The evidence of the validity or reliability of measures of 
physical activity performance will be of limited methodological quality and 
not specific to this population. 
Prior to the commencement of the randomised trial, a second systematic review was 
undertaken to determine how best to measure physical activity in children with CP. This 
systematic review is reported in Chapter 3, and yielded 12 studies assessing the 
clinimetric properties of ten measures of physical activity in children with CP. There was a 
paucity of research to support the validity or reliability of measurement instruments to 
assess physical activity performance in children with CP. With the exception of evidence to 
support the validity of accelerometers, evidence was generally of poor methodological 
quality and limited by small subject numbers. Accelerometers had the greatest volume of 
evidence to support their validity in this population, having been validated against oxygen 
consumption78, heart rate monitoring 79 and direct observation.80 In combination with 
excellent clinical utility, this review concluded that accelerometers seem an ideal tool for 
the measurement of physical activity in children with CP but further research was required 
to confirm their reliability in this population. These findings support the second hypothesis 
that existing literature for the clinimetric properties of measures of physical activity in 
children with CP would be of limited quality and non-specific to the population.  
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9.1.2 Hypothesis 3: Accelerometers will demonstrate good to excellent reliability in 
independently ambulant children and adolescents with unilateral CP. 
The systematic review presented in Chapter 3 confirmed accelerometers were commonly 
used to measure physical activity in children with CP but there was limited evidence to 
support their reliability in this population. This prompted the study presented in Chapter 4 
which investigated the reliability of accelerometers in independently ambulant children and 
adolescents with CP. Overall, accelerometers had good reliability with three to four days of 
monitoring in the community (R>0.70) and good agreement between repeated measures 
conducted in a controlled environment during light and MVPA standardised tasks 
(ICC=0.80). Agreement measures were somewhat lower during stepping tasks, with ICC 
values of 0.66, though MVPA tasks combined produced adequate reliability with the ICC = 
0.80. This confirmed our third hypothesis that accelerometers will demonstrate good 
reliability in independently ambulant children and adolescents with unilateral CP. To our 
knowledge this paper presents the first evidence to confirm the reliability of accelerometers 
in independently ambulant children and adolescents with unilateral CP. This study in 
combination with evidence of validity and clinical utility presented in Chapter 3, confirmed 
that accelerometers should be used to objectively measure physical activity performance 
over four consecutive days in the Mitii™ randomised trial. While the agreement between 
repeated measures was good, there were large variations in activity counts between days 
which resulted in wide standard errors and consequently large minimum detectable 
differences. This meant that large effect sizes would be required in the Mitii™ randomised 
trial to be sensitive to changes in MVPA following the Mitii™ intervention.  
9.1.3 Hypothesis 4: Independently ambulant children and adolescents with 
unilateral CP will perform physical activity at insufficient levels to meet the 
national recommendations 
Cross-sectional analyses of 101 baseline assessments from the Mitii™ randomised trial 
were undertaken to characterise physical activity performance in children with CP. 
Children in the study on average participated in 2:38 (SD 0:51)  hours light activity and 
0:44 (SD 0:26)  hours MVPA daily. Alarmingly, high levels of inactivity were demonstrated, 
with participants inactive for 8:36 (SD 1:09) hours daily. Only 25% of participants met the 
recommended level of MVPA of 60 minutes daily. In this study, profiles of physical activity 
were described which for the first time in independently ambulant children and adolescents 
with unilateral CP, looked beyond a single descriptor of MPVA or inactivity to describe 
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hourly patterns of activity across a typical day. The patterns of physical activity 
demonstrated in independently ambulant children and adolescents with unilateral CP were 
similar to those of typically developing children, with males participating in more physical 
activity than females and children more than adolescents throughout the day. Weekday 
activity was characterised by peaks of activity interspersed with periods of inactivity 
compared to weekend activity which was more consistent. Physical activity was similar 
between children classified at GMFCS levels I and II, suggesting gross motor functional 
limitations are not a determinant of physical activity in this group of independently 
ambulant children with CP. This study, presented in Chapter 5, confirmed our fourth 
hypothesis that independently ambulant children and adolescents with unilateral CP 
perform physical activity at insufficient levels to meet the national recommendations, which 
outline that all children and adolescents complete at least 60 minutes of MVPA daily.38, 39 
9.1.4 Hypothesis 5: Physical, personal and environmental characteristics will be 
associated with physical activity. 
To further the understanding of physical activity in independently ambulant children and 
adolescents with CP, additional analyses of 101 baseline assessments from the 
randomised trial were undertaken which aimed to describe the characteristics associated 
with physical activity. This was conducted in order to identify potentially modifiable factors 
which may influence physical activity performance. While limited to measures included in 
the randomised trial, this analysis provided a selection of assessments including physical, 
personal, and environmental characteristics for comparison to physical activity. Presented 
in Chapter 6, this study confirmed our fifth hypothesis that there was a significant 
associated between increased physical activity capacity (walking endurance using the 
6MWT) and increased physical activity performance; and between increased participation 
in the home and community environment (measured using the PEM-CY) and increased 
physical activity performance. In addition, non-modifiable characteristics associated with 
increased physical activity were younger age and male sex. Association between mobility 
limitations (measured using the MobQues28) or recreational participation (recreation 
domain of the LIFE-H) and physical activity performance were not identified. Looking more 
specifically at participants recording high levels of physical activity or inactivity, high levels 
of MVPA were associated with younger age, male sex, and increased community 
participation measured using the PEM-CY; whereas high levels of inactivity were 
associated with older age, and reduced community participation. Chapters 5 and 6 
confirmed that physical inactivity is a significant issue in independently ambulant children 
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and adolescents with unilateral CP, particularly in females and adolescents, and that 
interventions targeting an increase in physical activity appeared warranted. During pilot 
testing the Mitii™ intervention demonstrated increases in physical activity capacity, 
including walking endurance during the Bruce treadmill endurance protocol.74 If similar 
improvements could be achieved in the Mitii™ randomised trial, improvements may 
manifest in physical activity performance.  
9.1.5 Primary hypothesis: Physical activity capacity and performance will increase 
immediately following the Mitii™ training (20 weeks) compared to standard 
care.  
One-hundred and two children and adolescents were recruited to the randomised trial, of 
which 101 underwent baseline assessments. Children were matched for age, sex and 
upper-limb function (MACS) and randomised within pairs to receive 20 weeks of daily 
Mitii™ training (intervention) or waitlisted, receiving standard care (waitlist control). Of 51 
children allocated to the intervention group, 47 underwent the training (92% retention). 
Despite completing only 54% of the potential dose of Mitii™ (32.4 hours [SD 17.2 hours]), 
the results demonstrate that delivering training to independently ambulant children and 
adolescents with unilateral CP using the web-based program Mitii™ and virtual trainers is 
effective at increasing physical activity capacity, measured using maximal repetitions of 
functional tasks during 30-seconds and 6MWT. This did not translate into improvements in 
physical activity performance recorded using accelerometers, reductions in mobility 
limitations on the MobQues28, or improved recreational participation measured using the 
LIFE-H recreation domain. The lack of improvement in these measures may reflect ceiling 
effects due to the high physical capabilities of the sampled children. There were a number 
of children classified at GMFCS level I who reported few mobility limitations and high 
levels of recreational participation at baseline. Similarly, children with unilateral CP 
represent some of the most physically capable children with CP and physical activity 
participation appears to be highest in this group compared to children with CP presenting 
with other motor types or distributions. Alternatively, research typically shows that ‘you 
gain what you train’ and improvements in capacity rarely translate automatically into 
performance and perhaps the Mitii™ training did not contain sufficient ingredients to train 
these constructs.81 This seems particularly relevant for physical activity, as the notion that 
increases in physical activity capacity as a result of the intervention will translate into 
improved performance without a targeted intervention does not account for the many 
determining factors which underpin physical activity performance. Results of the 
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randomised trial partially supported our primary hypothesis, that physical activity capacity 
(functional strength and 6MWT) will increase in independently ambulant children and 
adolescents with unilateral CP immediately following the Mitii™ training (20 weeks) 
compared to standard care. We did not find sufficient evidence to support improvements in 
physical activity performance (physical activity) or recreational participation (LIFE-H), nor 
reductions in mobility limitations (MobQues28). 
9.2 Contextualising findings 
The results of the studies presented in this doctoral program will be considered with 
published evidence assessing physical activity in children and adolescents with CP and 
the potential for interventions to increase physical activity capacity and performance in this 
population.   
9.2.1 Physical activity in children with cerebral palsy 
Modern lifestyles mean that children and adolescents spend an increasing amount of time 
sedentary, engaged in activities such as watching TV, using computer and game-
consoles, and sitting in an automobile, all of which typically displace more active 
behaviours. This is concerning as regular physical activity is essential for children and 
adolescents and because patterns of physical activity acquired during childhood are more 
likely to be maintained in adult life.13 As a result, many countries have adopted physical 
activity guidelines which advocate that all children and adolescents, including where 
possible those with disabilities, should engage in at least 60 minutes of MVPA every day 
and limit sedentary screen time to less than two hours.38, 39 The adoption of 
recommendations for both MVPA and sedentary time reflects the independent risks 
associated with these behaviours. While insufficient physical activity and increased 
sedentary time are often found in tandem they represent different constructs.57 
Furthermore, it appears that the detrimental health consequences associated with 
prolonged sedentary behaviours are independent of the protective effect of regular 
MVPA.57 This means that even if a person performs sufficient MVPA to meet the 
recommended guidelines, if the remaining time is spent sedentary they can be still be at 
risk of poor health due to inactivity.57  Despite these recommendations and the known 
health benefits of engaging in regular physical activity, people with CP are generally less 
physically active compared to typically developing children82  or children with other 
physical disabilities.45  
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Only 25% of children and adolescents with unilateral CP participate in 60 minutes of 
MVPA on at least one day of monitoring and on average record only 0:44 hours in MVPA. 
In previous research, only 7-11% of children with CP reported sufficient physical activity to 
meet the recommend level .46-48, 58 While the findings presented in the cross-sectional 
physical activity study (Chapter 5) suggest an improvement in the proportion of children 
with CP meeting the recommended level of physical activity, the reality is that the majority 
of independently ambulant children and adolescents with unilateral CP are not sufficiently 
physically active to meet the recommended level. Despite including some of the most 
physically capable children classified at GMFCS levels I and II, these results are 
comparable to a study which also utilised accelerometers in adolescents classified 
GMFCS II-IV, where 26% of children engaged in more than 60 minutes of MPVA on at 
least one day of monitoring.83 The increase in the proportion of children meeting the 
recommendations in these two studies could represent ability of accelerometers to capture 
physical activity objectively and in real time. Previous research had utilised subjective 
recall questionnaires, which are prone to recall bias and tend to under-report incidental 
activity.50 Subjective questionnaires are dependent on accurate observation and recall of 
physical activity and while formal structured activities, such as organised sport or physical 
education classes, may be accurately captured using this method, incidental or 
unstructured physical activity can be missed.50 This is particularly important when 
measuring physical activity in children, who typically engage in very short bursts of intense 
physical activity interspersed with varying intervals of low to moderate activity.50 It may be 
that parents had previously under-estimated children’s incidental activity resulting in fewer 
meeting the recommended levels, and accelerometers were able to capture this activity.  
Nonetheless, physical inactivity remains a considerable issue in children and adolescents 
with CP. Physical activity levels demonstrated in the cross-sectional physical activity study 
(Chapter 5) indicate that independently ambulant children and adolescents with unilateral 
CP, who represent some of the most physically capable children with CP, participate in 
less physical activity than typically developing children84, and in fact participate in lower 
levels of physical activity than children who are obese.85 This is concerning as a recent 
study found that almost 19% of ambulatory children with CP are overweight or obese and 
22% present with hypertension, which was associated with reduced levels of MVPA.86  
Increasing evidence details the negative effects that prolonged inactivity has on 
cardiovascular and metabolic systems which appears to be independent of the amount of 
exercise a person undertakes.56, 57 In adulthood, the negative health consequences of 
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prolonged sedentary behaviour include increased waist circumference, systolic blood 
pressure, plasma glucose, and cholesterol.87 Therefore in addition to physical activity, 
physical inactivity is important to consider in children with CP.37 Sedentary behaviour 
refers to any waking activity characterised by a low energy expenditure (≤1.5 METS) while 
in a seated or reclining posture.88 This definition requires particular consideration when 
describing inactivity in children with CP. The motor disorders of CP are characterised by 
postural instability so there is potential that the muscle activation required in maintaining 
an upright seated position could result in an energy output of greater than 1.5 METS.37 
This would mean that according to the definition of sedentary behaviour, even in a seated 
position a person with CP may not truly be sedentary.37 The definition also specifies that 
sedentary behaviour is limited to a seated or reclining posture. Many accelerometer 
devices, including the ActiGraph®, are not able to distinguish between sitting or standing 
positions which would make accurate classification of sedentary behaviour difficult. As an 
example, a child wearing an ActiGraph® device in static standing would record zero 
acceleration counts, which according to the device could be interpreted as sedentary 
behaviour but according to the definition is not sedentary.37  
While more research is required to define sedentary behaviour in children with CP, the 
cross-sectional physical activity study (Chapter 5) provides important insights on physical 
inactivity in this population. In this study, participants were inactive for 8:36 hours daily or 
44 minutes per hour, constituting 72% of a typical day, with inactivity highest in 
adolescents (9:14 hours, 77% of day) and females (8:50 hours, 74% of day). These levels 
are alarming when combined with the low levels of physical activity, especially in the 
context of these children representing some of the most physically able children with CP. 
Children classified at GMFCS level III or with diplegia are likely to be at greater risk of 
physical inactivity. Previous studies have found similar findings of physical inactivity, 
reporting ambulatory children and adolescents with CP are significantly more inactive and 
take fewer breaks from sedentary time than age, gender and season matched typically 
developing controls.89  Youth with CP have been found to record significantly less 
ambulatory physical activity and take fewer steps than typically developing children.52 Two 
other studies have explored physical inactivity in older adolescents and young adults with 
CP: the first study, conducted in the Netherlands in ambulatory adolescents, identified that 
only 9% of a 24 hour period was spent physically active with almost 80% of that time spent 
inactive, which was significantly less than able-bodied controls90; the second, conducted in 
the Middle East with a sample of 222 adolescents classified at GMFCS levels II-IV, found 
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that in ambulatory adolescents 3-6% was of a day was spent active and 82-87% was 
inactive, but this reduced significantly for non-ambulatory adolescents who spent  98% of 
their time inactive and recorded only 120 steps per day.91  
As presented in the cross-sectional physical activity study (Chapter 5), physical inactivity in 
independently ambulant children and adolescents with CP appears to be most problematic 
on weekends, with fewer step counts recorded and participants less likely to meet the 
recommended level of MVPA. This is consistent with previous evidence in children with 
CP53 and typically developing children.92 Similar to evidence in typically developing 
children85, the daily pattern of physical activity also differed by day type. In the cross-
sectional physical activity study (Chapter 5), hourly activity counts illustrate that weekday 
physical activity is characterised by deep peaks and troughs, most likely representing 
periods sitting sedentary in a classroom, interspersed with free play opportunities during 
breaks as well as before or after school. Males appear to be more active during these 
breaks, with higher peaks than females, returning to similar levels of activity during 
sedentary periods. In contrast, weekend activity fluctuates less throughout a typical day, 
representing less structured activity compared to weekdays, though males do exhibit 
higher weekend activity levels between 8am and 11am, suggestive of organised sport or 
active tasks being performed at this time. 
In the physical activity association study (Chapter 6), younger age and male sex were 
associated with increased physical activity performance in independently ambulant 
children and adolescents with unilateral CP. This is consistent with previous research in 
children with CP53, 93, 94 and typically developing children.95 Interestingly, while male sex 
was associated with increased physical activity it did not appear to influence physical 
inactivity in a secondary analysis of highly inactive participants. This is similar to evidence 
from typically developing children, where it is unclear whether females or males are more 
sedentary.96   Objective data suggests that teenage females are more sedentary than 
teenage males, but surveys indicate that males spend more time playing sedentary video 
games.96 In the group of independently ambulant children and adolescents with unilateral 
CP studied, mobility limitations (measured using MobQues28) and activity capacity 
(functional strength) were not associated with levels of physical activity. Increased walking 
endurance measured using the 6MWT was however associated with increased physical 
activity. While the physical activity association study (Chapter 6) was cross-sectional 
meaning causal associations cannot be made, this suggests that targeting an increase in 
physical capability may produce modest increases in physical activity. This finding is of 
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interest given independently ambulant children are likely to achieve the majority of their 
physical activity through ambulatory activity, for example walking or running for play, or 
moving within a school environment. Previous research has confirmed higher energy costs 
of walking were associated with levels of physical activity in children with CP79 and 
reduced levels of cardio-vascular fitness are typical in this population.37 These factors may 
result in decreased walking endurance which in turn could reduce ambulatory physical 
activity. Potentially, gains in physical activity could be made by increasing walking 
capacity, by reducing the energy cost of walking through improved biomechanics and/or 
increasing cardio-vascular fitness. Conversely, increased cardio-vascular fitness and 
walking endurance would be a desired outcome of increased participation in physical 
activity, highlighting the multidimensional nature of physical activity.  
In addition to the physical characteristics associated with physical activity listed above, 
increased frequency of participation in home and community activities was associated with 
increased physical activity. In the physical activity association study (Chapter 6), the 
relationship with community participation was particularly strong (B=54.3), contributing a 
larger increase in physical activity in the regression model than age (B=-22.6) and at a 
similar level to sex (B=-60.3). Community participation also demonstrated an inverse 
relationship with inactivity in those participants who spent the majority of their time 
inactive. While this is a new finding, this is not overly surprising when one considers that 
the community section of the PEM-CY (Appendix 11.7.4) asks about the frequency of 
participation in activities such as neighbourhood outings, organised physical activity, 
unstructured physical activity, or getting together with other children. While not measuring 
physical activity per se, it is logical that a child with increased participation in these 
activities is likely to be typically more active and record a higher level of both planned and 
incidental physical activity, and conversely children who do not typically engage in these 
activities are likely to be more inactive. This finding highlights that exploring the barriers to 
participation in the home and community environments is critical to increasing a child’s 
participation and consequent physical activity. While non-significant, there was a negative 
association between lower socio-economic status and physical activity performance. This 
aligns with the research in typically developing children, where children from low socio-
economic status demonstrated a trend toward increased sedentary time and lower 
physical activity than children with higher socio-economic status, however this was found 
to be non-significant when body mass index was considered.97 As cost and community 
support are likely to influence access to physical activity opportunities this is important to 
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consider in children with CP. Home based active video game systems may provide a 
viable option to overcome restrictions to accessing physical activity opportunities. 
Consistent with published literature79, 86, 90, in the physical activity association study 
(Chapter 6) there does not appear to be a difference in physical activity between children 
classified at GMFCS levels I and II. However, previous research has demonstrated that 
physical activity levels reduce with increasing GMFCS level (GMFCS III-IV)53, 83, 93 and with 
bilateral distribution of motor impairment.53 These findings suggest that physical inactivity 
and the potential for secondary health consequences are likely to represent a much larger 
problem in these children than what has been presented in the group of independently 
ambulant children and adolescents with CP studied within this doctoral program. 
In summary, it appears that even independently ambulant children and adolescents with 
unilateral CP, who represent some of the most physically capable children with CP, are not 
performing sufficient physical activity to meet the recommended level of MVPA. This, 
combined with high levels of inactivity, may place them at risk of future health problems, 
such as increased blood pressure, blood glucose and cholesterol.87 High levels of physical 
activity in this population were associated male sex, younger age, increased walking 
endurance and increased home and community participation. Physical inactivity appears 
to be most problematic in females, adolescents and on weekend days. Interventions 
targeting an increase in physical activity should ideally target these more vulnerable 
groups. 
9.2.2 Using virtual reality to increase physical activity 
Since the completion of the systematic review of virtual reality technologies presented in 
Chapter 2, there has been a growing interest in the use of virtual reality and active video 
games for rehabilitation in children with CP. Despite this interest, there have been no 
additional published systematic reviews exploring the effect of active video game 
technologies on physical activity in children with CP or early brain injuries.  With the 
exception of the Mitii™ randomised trial (Chapter 8) there are no published studies or 
randomised trials which have looked at the ability of active video games to increase both 
physical activity capacity and performance in independently ambulant children and 
adolescents with CP.  A recent scoping review was conducted which identified many of the 
same studies included in our systematic review (Chapter 2).98 As can be expected, similar 
conclusions to our systematic review were formulated: that there is inadequate evidence 
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for the use of active video games to improve cardiovascular fitness in children with CP, 
however the results appears promising.98 Another systematic review looked broadly at the 
use of virtual reality in conjunction with conventional therapy for rehabilitation of children 
with CP, which also concluded that due to poor methodological quality and small subject 
numbers, evidence-based conclusions are unable to be made from the available 
evidence.99  
Since the publication of the systematic review presented in Chapter 2, there have been 
some studies which support the premise that active video games can increase physical 
activity in children with CP. These were included in the recent review studies mentioned 
above.98, 99 In a study of ten independently ambulant children with spastic diplegia, a 
moderate intensity of exercise was achieved during Nintendo® Wii™ bicycling and jogging 
games, which was a similar to that demonstrated in typically developing children.100 Also, 
in 17 independently ambulant children with CP, energy expenditure during video game 
play using Nintendo® Wii™ Sports and Dance Dance Revolution™ was found to be 
comparable to moderate intensity physical activity, particularly if games required 
movement of the lower body (e.g. Dance Dance Revolution) or high-frequency bilateral 
upper-limb movements (e.g. Wii™ Boxing).101 These findings are similar to evidence in 
adults with CP, where energy expenditure whilst playing Nintendo® Wii™ Sports tennis 
and was found to provide moderate-intensity exercise.70 Energy expenditure during Mitii™ 
has not been determined, but given it uses movement of the lower body, including 
repeated squats and lunges, one could assume that it would result in similar energy 
expenditure to published evidence during Nintendo® Wii™ games requiring lower limb 
movement. Despite these promising studies, the evidence remains inconclusive as to the 
effect of active video games to increase physical activity capacity and performance in 
children and adolescents with CP.  
In the absence of solid evidence in children with CP, the literature from typically 
developing children can be used to inform how children with CP are likely to perform. The 
results appear promising: a systematic review for typically developing children has been 
published which contains substantially more evidence (with 15 systematic reviews and 117 
original studies included) than what is currently published in children with CP.102 This 
review suggests that heart rate and energy expenditure increases to moderate to vigorous 
levels during active video game play;102 in some instances rising by 222 per cent (SD 100 
per cent) and up to 5.0 METs (for XivavX® J-Mat and Platstation® EyeToy™ Knockout).102, 
103 The results of this review were unable to determine conclusively if active video games 
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promoted long term increases in physical activity.102 Special populations, for example 
children with CP, are thought to have the potential to benefit more from active video 
games as a method to increase physical activity,104 though there is insufficient evidence to 
support this claim. In a randomised trial of a paediatric weight management program in 
typically developing children, the addition of active video games resulted in significantly 
increased MVPA (mean 7.4 [SD 2.7] min/day) and resulted in increased weight loss.105 In 
another randomised trial with a cross over design, replacing traditional electronic games 
with active video games resulted in a similar increase in MVPA to the removal of all 
electronic games.106 This evidence from children with typical development suggests that 
active video games may well have a role in increasing physical activity in children with CP, 
particularly as they are relatively cheap, enjoyed by children and can be completed in the 
home environment; however more research is required to substantiate this claim. 
9.2.3 Increasing physical activity in children with cerebral palsy 
Looking beyond active video games, systematic reviews and meta-analyses exploring the 
efficacy of strength training and fitness interventions have so far been inconclusive.68, 107  
According to the Evidence Alert Traffic Light system (which grades an intervention into red, 
yellow or green based on the strength of evidence supporting its use)108 the evidence for 
lower limb strength training provides this intervention with a ‘yellow-light’, directing 
clinicians to ‘probably to do’ but to use validated outcome measures to assess the effect of 
the intervention.107 This conclusion was based upon low quality evidence suggesting that 
lower limb progressive resistance training is effective in the short term at increasing 
muscle strength in the targeted muscle groups, though strength gains are typically lost 
once training ceases.107  
One potential reason which has been cited as an explanation for the limited results 
demonstrated in many of the strength training studies is a discrepancy between the 
training mode and the instrument employed within the study to measure an effect.68 
Isometric based muscle tests have been commonly used in the literature following strength 
based interventions. These tests measure the ability of a muscle group to generate force 
in an open-chain position without a change in muscle-tendon length.23 This is commonly 
assessed by manual muscle testing (using an ordinal scale), or with hand-held 
dynamometry. Though typically interventions targeting an increase in physical activity 
capacity in children with CP do not train isometric, open chain, isolated muscles of the 
lower limb. The majority of interventions use free weight or machine weights during closed-
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chain exercises.68 Evidence supports exercise-type specificity, which suggests that the 
greatest training effects occur when the same exercise type is used for both testing and 
training.24 This principle therefore suggests that a closed-chain multi joint test may be 
more appropriate to test strength in children with CP following an intervention of this type. 
Dynamic closed-chain, functional muscle strength tests record the maximum number of 
repetitions performed during a 30-second time period of a functional movement, for 
example sit to stand or step ups.23 The randomised trial presented in Chapter 8 used 
closed-chain body weight exercises delivered using the Mitii™ program and consequently 
used a similar outcome measure to demonstrate increases in functional strength. The 
significant results demonstrated for physical activity capacity highlights the importance of 
training specificity, with large gains potentially due to similarities between Mitii™ training 
and functional strength assessments.  
There is some suggestion that improvements in function can be made using resistance 
training during functional tasks, such as sit to stands, but the evidence supporting this 
claim is again of low quality.107 The use of this training approach should also be carefully 
considered, as multi-joint functional strength training has recently been cautioned in 
children with CP.109 The authors proposed that non-specific ‘whole-limb’ exercises 
employed during functional strength training may result in non-selective strengthening and 
exacerbate muscle imbalances.109  Instead it is recommended that single-joint training 
protocols be used in children with CP instead.109 Typically, weights were not used during 
the Mitii™ training, instead utilising body weight exercises, so it is unclear if such caution is 
warranted in this situation but this is an important consideration for the development of 
future training protocols.  
The evidence from the systematic review of interventions for children with CP suggests 
that improved strength following resistance training does not necessarily carry over into 
functional improvements or increased walking ability without more specific treatment 
approaches.107 The results of the Mitii™ randomised trial (Chapter 8) however, suggest an 
improvement in walking endurance measured using the 6MWT despite not specifically 
training gait. It is unclear what mechanisms would be responsible for the potential 
improvement in walking endurance with Mitii™ training. While Mitii™ training was not 
designed to deliver cardiovascular training, the program was set up such that physical 
training was typically provided in intervals of up to 90 seconds and interspersed with ‘rest’ 
periods of upper-limb and visual-perceptual activities. Evidence in adults suggests that 
high intensity training, consisting of short intense bursts of exercises, results in equal or 
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greater increases in aerobic fitness compared to continuous  moderate intensity 
exercise.110 Fitness training has also been awarded a ‘green-light’ according to the 
Evidence Alert Traffic Light system108, with sufficient evidence to support short term 
increases in aerobic fitness with training in children with CP.107 The short intense bursts of 
activity during the Mitii™ training may have resulted in improvements in cardiovascular 
fitness, contributing to improved sub-maximal walking endurance. Further evaluation of 
anaerobic and/or aerobic fitness17 in response to Mitii™ training may determine the 
mechanisms underlying improvements in physical activity capacity.  
While the Mitii™ randomised trial (Chapter 8) demonstrated increases in physical activity 
capacity at 20 weeks, we were unable to demonstrate significant increases in physical 
activity performance. This finding is not unexpected, as research typically shows that ‘you 
gain what you train’ and improvements in motor capacity rarely translate into improved 
motor performance.81 Evidence based intervention approaches to increase physical 
activity in children with CP are currently limited. If the published literature on this topic for 
children with CP is considered, interventions targeting an increase in physical activity 
performance thus far have been varied in their content, measurement and study design. 
This means that there is limited evidence to guide intervention choice for children with CP. 
There is only one systematic review evaluating interventions to increase physical activity in 
children and adolescents with CP, and this is itself quite limited.69 This comprehensive 
review identified only five studies (three randomised trials, one pre-post and two qualitative 
studies) which assessed habitual physical activity following an intervention, noting a small 
but significant effect supporting physical activity interventions (δ = 1.0; 95% confidence 
interval 0.28 to 1.72).69 This effect must be considered cautiously as only two of the 
included interventions were pooled and the interventions were very different (ranging from 
six weeks of twice weekly closed-chain circuit training compared to nine months of aerobic 
training four times a week) and were assessed using measures which are difficult to 
compare (time spent in an upright position compared to total energy expenditure). Despite 
these limitations, this review provides preliminary evidence that structured exercise 
programs (either group or individual) and online educational support programs can 
increase physical activity in children and adolescents with CP, but further research is 
required to support this claim.  
Since the publication of this review in 2011,69 there have been few published examples of 
interventions targeting an increase in children and adolescents with CP which have 
recorded physical activity performance as an outcome measure. The notable exception is 
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the ‘LEARN 2 MOVE’ program conducted in the Netherlands, which aimed to increase 
physical activity in children and adolescents with CP.111 This was a randomised controlled 
trial which investigated the effect of combined fitness training and motivational interviewing 
program in a group of 50 children classified GMFCS I-III presenting with a mix of bilateral 
and unilateral spastic CP.111 The program included fitness training, comprising anaerobic 
exercise and muscle strengthening exercises, combined with home based physiotherapy 
and motivational interviewing for four months, which then reduced to motivational 
interviewing and home-based physiotherapy until six months, followed by ‘usual 
physiotherapy’ until 12 months; which was compared to a control group receiving ‘usual 
physiotherapy’ for 12 months.111  Despite this comprehensive intervention, there were no 
significant improvements in walking activity measured using the StepWatch™ monitor 
across all time points, though parents reported an increase in MVPA using the Activity 
Questionnaire for Adults and Adolescents.112 There were no improvements in physical 
activity capacity, measured using a one-minute walking test and functional strength testing 
using the maximal repetitions of functional tasks recorded over 30-seconds, at 6 or 12 
months.112 Walk distance on the one-minute walk test improved in the intervention group 
at four months but this was not maintained over subsequent follow ups.112 Finally, there 
were no improvements in social participation during recreation and leisure (LIFE-H and the 
Children’s Assessment of Participate and Enjoyment questionnaires).113  
Given the breadth of the intervention, these findings are initially somewhat surprising. The 
authors postulate a number of potential explanations for their results, including the 
duration of the program being too short to elicit changes in as complex a behaviour as 
physical activity; selection bias of the sample whereby the participants inadvertently 
participated in more physical activity simply by being interested and involved in the study; 
and that therapists in the control arm may have delivered a similar program of fitness and 
strength training.112 The authors of this study do not describe the intensity of the ‘usual 
physiotherapy’ which was received by the control group, but this could offer a potential 
explanation. Participants in the control group were still able to access their regular 
physiotherapy, which as the authors suggest could have been utilised to provide a similar 
training program. In contrast, in the randomised trial presented in Chapter 8, the waitlist 
control received little to any concurrent physiotherapy over the course of the Mitii™ 
intervention and significant improvements were demonstrated in physical activity capacity. 
Compared to the ‘LEARN 2 MOVE’ group, the waitlist control group in the Mitii™ 
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randomised trial (Chapter 8) acted as a true control group with which to compare the 
Mitii™ intervention.  
In conclusion, while strength and fitness training to enhance physical activity capacity in 
children with CP appears promising, the current literature limits strong evidence based 
conclusions to be made. Improvements in physical activity performance levels, however, 
appear to be more difficult to elicit and current intervention strategies need to be 
reconsidered. 
9.2.4 Future directions for interventions targeting an increase in physical activity 
The lack of translation into physical activity performance demonstrated in the randomised 
trial (Chapter 8) and in previous studies69, 112, suggests that a different approach to 
increasing physical activity performance is needed among children with CP. While active 
video games have the potential to motivate children resulting in moderate to vigorous 
intensity exercise, solely relying on them for self-directed use and without a structured 
program does not seem to result in the long term promotion of physical activity.114 Instead, 
strong evidence in typically developing children supports multi-component school based 
interventions that involve the family or community.115  While interventions such as these 
would require adaptation to tailor them for a child with a disability, a similar intervention in 
combination with active video games such as Mitii™ could be effective to increase 
physical activity in independently ambulant children with unilateral CP. In addition, 
interventions targeting an increase in physical activity may need to incorporate behavioural 
change strategies to overcome the barriers, perceived or real, associated with participating 
in increased physical activity.64, 116  
Numerous barriers to physical activity participation have been identified in the literature 
which describe the influence of the school, community, family and home environments on 
a child’s participation in physical activity.63, 64, 117 A systematic search identified a lack of 
knowledge or skills, the child’s preference for physical activity, fear, parental behaviours 
and attitudes to physical activity, negative attitudes to disability, inadequate facilities, a 
lack of transport, programs or staff capacity, and the cost of such activities as potential 
barriers to physical activity in children with CP.117 Conversely, facilitators of physical 
activity in children with CP included the child’s desire to be physically active, practising 
skills to encourage competence, the involvement of peers, family support, accessible 
facilities which are nearby, better opportunities for physical activity and the availability of 
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skilled staff and the provision of information.23  In focus group interviews with 33 
ambulatory children with CP and their parents many of the same themes emerged, with 
the physical abilities of the child, child-related psychological factors, parental factors, 
opportunities for sport and physical activity, practical feasibility, social environment and 
facility factors recognised as both barriers and facilitators of physical activity.64 When the 
outcomes of the randomised trial (Chapter 8) are considered within the context of these 
barriers and facilitators, it is not unexpected that improvements in physical activity capacity 
during the intervention period did not translate into increased physical activity performance 
without first addressing the barriers to participation in physical activity.  
Qualitative studies are useful in informing why and how children with CP participate in 
physical activity, which can then be used to determine the essential components of 
physical activity interventions. In a small group of 16 children with CP across the spectrum 
of GMFCS levels, children described wanting to be physically active with friends and family 
in a fun, supportive and autonomous environment.118 This statement is perhaps best 
summarised by considering the ‘F-words’ proposed by Rosenbaum and Gorter,119 where 
‘function’ sits alongside ‘family’, ‘fitness’, ‘fun’ and ‘friends’ in a reconsidered version of the 
ICF model. The focus of the Mitii™ intervention is on ‘function’ (increasing strength and 
walking endurance) and potentially ‘fitness’, but children in the study by Lauruschkus et 
al.118 feel that the ‘family’, ‘fun’ and ‘friends’ elements of this model are more important to 
participation in physical activity. It may be useful in further developments of the Mitii™ 
program to encourage positive social interactions during the intervention period, perhaps 
using an online social forum or introducing a competitive scoreboard, as this appears to be 
an important consideration if wanting to engage children and promote long term increases 
in physical activity. 
One potential approach to changing physical activity behaviours in children and 
adolescents with CP is the delivery of individually adapted health behaviour change 
programs.120 This approach is strongly recommended by the Centers for Disease Control 
and Prevention for increasing physical activity in typically developing children and 
adults.120 This approach tailors a program to an individual’s specific interests and their 
readiness to change, by teaching behavioural skills such as goal setting and self-
monitoring, building social support, behavioural reinforcement, problem-solving and 
relapse prevention, to help participants incorporate physical activity into their daily life.120 
This intervention approach is based on the stages of change theoretical model, which 
suggests that as people attempt to adopt healthy behaviours (e.g. regular physical activity) 
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or eliminate unhealthy behaviours (e.g. watching television) they move through a series of 
stages related to their readiness to change. 121, 122 These stages are pre-contemplation, 
contemplation, preparation, action and maintenance.121, 122 At each stage, a different 
intervention approach is required to help a person progress through to the next stage, 
meaning it is imperative to understand where a person is in their readiness to change in 
order to tailor the intervention appropriately.122 The delivery of healthy lifestyle and 
physical activity interventions using these approaches has been used successfully for 
health promotion in adults and typically developing children.122  
This concept has recently been explored in independently ambulant children and 
adolescents with CP.116 This study expanded on previous research64 to categorise barriers 
and facilitators to physical activity in children and adolescents with CP according to three 
stages common to behavioural change theories: 1)  pre-intention, where persons are not 
fully informed about physical activity and its benefits or consequences and have not 
decided to act; 2) an intention stage, where persons intend on completing physical activity 
but have not yet acted upon this intention; and 3) an action stage, where persons act 
according to their behavioural intentions and participate in physical activity.116 This study 
found that in the pre-intention stage, barriers to physical activity were more likely to relate 
to the child and views of the parent, whereas persons in the intention and action stages 
were more likely to identify social and environmental barriers to physical activity.116 This 
information allows interventions to be targeted according to the barriers which are most 
likely to be directly influencing their readiness to change. Families at the pre-intention 
stage may benefit from information on the benefits of physical activity to create awareness 
about the need to change; families at the intention stage should be encouraged to 
maintain their commitment to physical activity and counselled to develop self-efficacy; and 
families in the action phase would benefit most from advocacy to address external barriers 
to physical activity.116 This targeted approach seems particularly relevant for children and 
adolescents with a physical disability such as CP, where mainstream physical activity 
health promotion messages may not always resonate with children and their families. 
Additional information and strategies may be required to find and adapt physical activity 
opportunities to their child’s abilities and to fit into a busy lifestyle where school and 
therapy are often competing with leisure and recreational time.  
It is important to note, however, that individual based approaches are just one intervention 
type recommended to increase physical activity in typically developing children and adults. 
One way to conceptualise approaches to promote physical activity is in terms of upstream 
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and downstream interventions.123 Downstream approaches focus on direct behavioural 
change interventions, focusing on physical activity behaviour at an individual level which 
are often delivered by health care professionals’.123 To date, the majority of physical 
activity research and interventions in children and adolescents with CP have been focused 
at this level. Midstream approaches to physical activity promotion are more widespread 
and target a larger number of people.123 These include community-wide campaigns which 
promote physical activity behaviour through mass media, school-based physical education 
programs, and social support interventions delivered in the community.124 Finally, 
upstream approaches attempt to address the problem behaviour at their source.123 These 
approaches encompass environmental and policy change to create or enhance access to 
places for physical activity.124  
While more research is needed to determine the best approach to increasing physical 
activity in children and adolescents with CP, perhaps it is time to move further upstream? It 
may be that change needs to occur not just at the individual level, through individual 
physical activity capacity and behavioural change interventions, but approaches may need 
to shift upstream to consider the boarder social and physical environments in which the 
individual is to participate. In addition to the downstream health interventions currently 
being trialled in children with CP, other potential intervention approaches which may be 
relevant include the creation of disability friendly public health messages, inclusive 
physical education programs in schools and communities, community education and 
training to support physical activity in a child with a disability, and creating accessible 
community environments which enhance participation in physical activity. These 
approaches should ideally incorporate ‘family’, ‘friends’ and ‘fun’ to promote long term 
changes in physical activity behaviours and potentially enhance participation and quality of 
life. 
9.2.5 Summary 
Independently ambulant children and adolescents with unilateral CP, who represent some 
of the most physically capable children with CP, are not performing sufficient physical 
activity to meet the recommended level of MVPA (60 minutes daily). This, combined with 
high levels of inactivity, may place them at risk of future health problems such as 
increased blood pressure, blood glucose and cholesterol.87 High levels of physical activity 
in this population were associated with male sex, younger age, increased walking 
endurance and increased home and community participation. Physical inactivity appears 
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to be most problematic in females, adolescents and on weekend days. Interventions 
targeting an increase in physical activity should ideally target these more vulnerable 
groups. 
The use of active video games, including Mitii™, to deliver strength and fitness training to 
enhance physical activity capacity in children with CP appears promising. The current 
literature, however, limits strong evidence based conclusions to be made about the use of 
active video games to increase physical activity capacity and performance in children with 
CP. In contrast, there is strong evidence in typically developing children which suggests 
that heart rate and energy expenditure increases to moderate to vigorous levels during 
active video game play102, however, solely relying on them for self-directed use and 
without a structured exercise program does not seem to result in the long term promotion 
of physical activity.114 Improvements in physical activity performance appear to be more 
difficult to elicit and current intervention strategies need to be reconsidered. 
One potential approach to changing physical activity behaviours in children and 
adolescents with CP is the delivery of individually adapted health behaviour change 
programs.120 This concept has recently been explored in independently ambulant children 
and adolescents with CP, where barriers and facilitators to physical activity were 
categorised according to behavioural change stages.116 This information allows 
interventions to be targeted according to the barriers which are most likely to be directly 
influencing their readiness to change and seems particularly relevant for children and 
adolescents with a physical disability such as CP, where mainstream physical activity 
health promotion messages may not always resonate with children and their families. In 
addition to individually targeted interventions, health promotion messages targeted at 
midstream and upstream levels, encompassing changes in the social and physical 
environments in which the individual with CP is to participate, appear necessary.  
9.3 Study strengths, limitations and generalisability of findings 
The systematic reviews presented in Chapters 2 and 3, utilised a strong systematic 
methodology, studies were assessed against quality evidence based checklists, and 
search criteria were considered to provide a comprehensive overview of interventions and 
measurement tools respectively. Despite strong study designs, these review studies 
highlighted a paucity of evidence on both topics limiting the conclusion which could be 
drawn. For the systematic review (Chapter 2), virtual reality was acknowledged as a new 
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and emerging technology meaning only four studies were identified which were pre-post 
pilot studies without a control group or single participant designs. For the clinimetric review 
(Chapter 3), criterion validity was of low methodological quality when assessed against the 
COSMIN checklist, and there was little evidence to support the reliability of selected 
measures of habitual physical activity in children with CP. Consequently, the selection of 
measurement tools and study design for the randomised trial reported in this thesis were 
based upon preliminary evidence. As evidence for the psychometric properties was 
limited, we subsequently undertook a study investigating the reliability of accelerometers. 
The reliability study (Chapter 4) strengthened the evidence to support the use of 
accelerometers to measure physical activity in children with CP in the Mitii™ randomised 
trial. To overcome limitations identified in the literature from our clinimetric review (Chapter 
3), we ensured a large sample size justified with a power calculation, and a strong-test 
retest methodology using standardised tasks. Some potential limitations include the 
decision to not use oxygen consumption to confirm exercise intensity during the 
standardised tasks. To minimise this potential limitation we used a similar design 
methodology to that which had been used to validate accelerometers using oxygen 
consumption in children with CP78, choosing to repeat this series over two consecutive 
days to determine the agreement between repeated measures in a controlled 
environment. Within the community, participants wore the accelerometer for a maximum of 
four days. This means that the reliability of physical activity measurement with increasing 
days cannot be established. It would be useful to repeat measurement in the community 
with a larger sample of days, such as seven days, to determine if the reliability of 
measurement increases with more than four days. These decisions were made in order to 
limit the overall burden of assessment for children in the Mitii™ randomised trial. To our 
knowledge, the reliability study (Chapter 4) provides the first evidence to support the 
reliability of accelerometers in independently ambulant children and adolescents with CP 
and represents a strong foundation for the use of accelerometers to assess physical 
activity in the Mitii™ randomised trial.  
While a large sample was selected, using cross sectional studies to describe physical 
activity in children with CP does not allow for conclusions to be make about the stability of 
physical activity over time or seasons (Chapter 5), nor does it not allow for causal 
associations to be made between physical, personal or environmental characteristics and 
physical activity (Chapter 6). A prospective cohort study would enable these conclusions to 
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be made and should be considered for future research but was considered beyond the 
scope of this doctoral program. 
The sample of 101 children included in the cross sectional analyses (Chapters 5 and 6) 
and in the Mitii™ randomised trial (Chapter 8) represents one of the largest sample sizes 
to date to describe physical activity in children with CP and to explore the effect of active 
videos games in a randomised trial in this population. The sample selected for the studies 
within this doctoral program was limited to independently ambulant children and 
adolescents with unilateral CP. This criterion was selected to ensure homogonous sample 
and to test the efficacy of the Mitii™ program in a sample of children for which it was 
designed. While the Mitii™ program includes a lower limb strengthening component and 
could be adapted for a child with diplegia, the program was designed to challenge 
participants with asymmetric upper-limb impairment. Were the inclusion criteria to be 
expanded, the delivery of the Mitii™ program would require significant adaption and 
additional assistance would need to be provided. While this criterion allowed for a strong 
study design, children with bilateral distribution of motor impairment and with more severe 
gross motor impairments (classified at GMFCS levels III-V) are likely to be less physically 
active than the children studied in this doctoral program. This may have resulted in ceiling 
effects whereby the children selected for the Mitii™ randomised trial participated in high 
levels of physical activity at baseline and therefore had less room for improvement 
following the intervention. Certainly, this appears to have been the case with the 
MobQues28, where many scored the maximum score at baseline (11.9% of participants). 
However, despite representing some of the most physically capable children with CP, 
independently ambulant children with CP present with reduced cardiovascular fitness and 
muscle strength37,  meaning increasing physical activity capacity and performance is still 
important even they have the smallest potential for improvement. Overall, a tight sample of 
children with CP was selected to increase the internal validity of the study; however this 
may limit the study’s generalisability. Future research would be useful to look at the 
application of a modified version of Mitii™ in children with more severe motor impairments, 
a bilateral distribution of motor impairments or with other disabilities (e.g. autism spectrum 
disorder, developmental coordination disorder, children born preterm). 
This doctoral program was nested within a larger clinical trial, meaning children were not 
only completing assessments relating to the physical activity component of the trial but 
also assessment of upper limb function, executive function, and in some cases MRI, as 
presented in the study protocol paper (Chapter 7). This required almost a full day of 
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assessment and Mitii™ training. To limit assessment burden, outcome measure selection 
was carefully considered. Measurement of habitual physical activity was prioritised, and 
capacity measures that were thought likely to contribute to this; namely lower limb 
functional strength, walking endurance and mobility limitations. Parent report participation 
and mobility limitations were also selected rather than using child report, mainly to reduce 
the overall burden of assessment. The validity and reliability of these respective 
instruments is high.75, 125, 126 Initially, it was decided that the inclusion of maximal aerobic 
and anaerobic fitness assessments would be too burdensome and it was thought the 
Mitii™ training would be sub-maximal, meaning that changes would not necessarily be 
seen with these measures. In retrospect, we may have under-estimated the intensity of the 
Mitii™ training and the assessments of cardiovascular fitness would have been useful to 
determine the underlying mechanisms for improvements in walking endurance. Also, the 
physical activity association study (Chapter 6) was conducted as a secondary cross-
sectional analysis of baseline assessments taken from the randomised trial. This meant 
that variables which may have been useful were not included in the modelling, as only 
33% of the variance was explained by the variables selected in the model. It would be 
useful in future research to include variables more commonly cited as barriers or enablers 
to physical activity, including perceived competence, parental attitudes, and the availability 
and proximity of parks and equipment.127-129 Nonetheless even without attending to these 
aspects significant results were demonstrated using the selected outcome measures. 
The use of accelerometers within the studies incorporated into this doctoral program 
allowed the physical activity of children with CP to be compared to the recommended level 
of MVPA as well typically developing children, as these devices are frequently used to 
record physical activity in this population. While comparisons of physical activity levels are 
made to typically developing children without a reference sample, there is a substantial 
amount of published literature to enable comparisons between populations to be made. 
One potential limitation of using accelerometers is the inability to capture swimming or 
other water sports. As accelerometers are not waterproof participants were requested to 
remove them for swimming or water sports. While there is potential that physical activity 
was missed during these periods of time, on average wear time was over 11 hours daily so 
this is likely to be minimal. Overall, the measures selected for the Mitii™ randomised trial 
were carefully selected based in their evidence of validity and reliability, and to consider 
the potential assessment burden of the participants within the trial.  
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9.3.1 Considerations with the Mitii™ program 
Given the web-based nature of the intervention, recruitment targeted children from rural 
and remote areas in order to provide intensive therapy where services are currently 
limited. While this is a definite strength of the randomised trial, this also presented some 
challenges delivering the program. Technical and internet connectivity issues were 
common, primarily encountered due to the isolation of Australia from the Mitii™ server 
located in Denmark. This tended to be more problematic where participants lived in more 
rural areas and therefore had slower internet connectivity speeds (resulting in long upload 
and download times). This in turn resulted in frustration with the Mitii™ program and often 
resulted in a gradual decline in completing the program. On average, participants recorded 
only 54% of the total potential dose. At the time of commencing the randomised trial, the 
development of the Mitii™ program was in its infancy and a large scale project using the 
intervention had not been completed outside of Europe. As the program continues to be 
developed it is thought that many of the technical issues encountered during the 
randomised trial will be addressed, which should increase compliance with the 
intervention.  
In the initial phases of testing the Mitii™ program, we determined that it would lend itself 
more to younger children than adolescents. During recruitment often adolescents seemed 
more likely to be busy with school and extra-curricular activities meaning they declined 
participation due to these competing demands. In instances where adolescents were 
already engaged in a lot of video game-play, questioning during recruitment often revealed 
that the Mitii™ intervention would be less appealing for this older age group and they 
declined participation. As a result, within the sample of participants, there were a larger 
number of children (8-12 years) to adolescents (>13 years) (66 children vs 35 
adolescents). This is potentially counterintuitive to the recommendations of the physical 
activity association study (Chapter 6) where it was suggested that physical activity 
interventions target adolescents. Again, as the Mitii™ program continues to be developed, 
new modules tailored to adolescents should be added which would increase interest 
among this age group.  
Since the commencement of the randomised trial, there has been a newer Mitii™ version 
released which uses a Microsoft® Kinect® camera. This provides more flexibility in adding 
new graphics and manipulating the program to meet the skills of the clients. The use of the 
Kinect® camera rather than the green tracking bands used in the Mitii™ randomised trial 
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(Chapter 8) also allows the therapist to identify a body part for tracking, for example, 
identify the head as the controller during squats. This should eliminate the potential for 
‘cheating’ which was sometimes encountered with the green band version.  
Being a home based program, it is unclear what percentage of time was spent doing the 
actual prescribed tasks or whether children found easier ways to complete the exercises. 
While the program has the ability to record the number of repetitions and the speed of the 
exercises, it does not have the ability to control the location of the green bands or monitor 
movement quality. For example, a child may have the band on their hand and used this as 
the controller rather than swapping the band to their head and doing squats as prescribed. 
Parent supervision was encouraged during the training period but it is unclear if this 
occurred in all instances. While the Mitii™ program will not have the ability to control 
movement quality in the way that conventional therapy with ‘hands on’ therapists would be 
able to achieve, the new Kinect® system should help guide movements more effectively. In 
saying this, the Mitii™ program was designed to be a hands-off home based program in 
order to provide cost effective yet intensive therapy with only remote monitoring by 
therapists. This represents a new method of delivering therapy; therefore to compare it to 
conventional ‘hands on’ therapy may be against the original program design.  
In light of the positive results following the Mitii™ randomised trial (Chapter 8) and despite 
these potential limitations, the children in the Mitii™ randomised made significant 
improvements in physical activity capacity immediately following the intervention. The 
study was sufficiently powered to changes in these outcomes. The inclusion of a waitlist 
control group was decided upon to provide equity of access to this new and novel therapy 
program yet still allow a comparison to usual care. During the control period, minimal 
concurrent therapies were provided. As a result, the internal validity of the randomised trial 
is strong and results can be interpreted with confidence. While statistically significant, it 
should be noted that improvements in functional strength were not above the minimum 
detectable difference which has been previously reported, and as such results should be 
interpreted with caution. It should also be noted that study personnel were not blinded to 
group allocation so there may have been the potential for bias influencing results, though 
adherence to standard protocols for the administration of these tests was maintained. 
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9.4 Considerations for future research and implementation into clinical 
practice 
Overall, delivery of the Mitii™ therapy program using virtual therapists over the internet 
was successful, but lessons have been learnt from this process that would potentially be 
useful for future clinicians or researchers. The Mitii™ program was able to be delivered in 
the home environment without direct supervision from therapists. This offers a potential 
cost saving compared to regular physical activity interventions, often requiring significant 
staffing with a small ratio of physiotherapists to clients and potentially costly equipment, 
including treadmills or weights machines. These can ultimately be a limiting factor for 
translating programs into clinical practice, as many therapy centres would be unable to 
provide sufficient staffing or equipment to support such a program. In many instances, 
parents and families would also be unable to attend such a large number of outpatient 
appointments. In contrast, the Mitii™ program can be accessed at the family’s 
convenience and uses only minimal equipment, requiring only an internet connected 
computer, green tracking bands, and then a wobble board or step block for additional 
physical challenges. 
In saying this, delivery of a web-based intensive therapy program in the home environment 
without direct physiotherapy supervision presented its own unique challenges. Without 
direct supervision, therapists rely on either self-monitoring from clients or their parents to 
ensure the exercises are completed correctly. There was initially some concern that this 
would result in injury and for this reason loaded exercises were not prescribed, and 
instead were progressed with increasing the speed or the number of repetitions. 
Therapists also spent a considerable amount of time teaching parents and children the 
correct exercise technique and provided pictorial and video instructions of exercises to 
assist parents and children once at home. There were two potential adverse events 
reported during the intervention period, which were minor musculoskeletal injuries likely as 
a result of poor training technique. These then resolved when the technique was corrected 
over the phone and the number of repetitions was reduced. General concerns have been 
raised about the safety of resistance training programs, but properly designed and 
supervised resistance training have been deemed safe for youth.130 Concerns also appear 
warranted with home based programs using active video games, with case-study 
examples of strain and injury associated with active video game play in typically 
developing children, often termed ‘Wiiitis’.131 Muscle activation during Wii™ in children with 
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CP is generally at levels deems to be a low risk for muscle strain101 though overuse injury 
is still possible. To limit adverse events, and also to provide technical support and general 
encouragement during the study period, study personnel were in frequent contact with 
participants and their families to help monitor concerns and make adjustments as needed. 
This would be an important consideration if implementing a program such as Mitii™ into 
clinical practice. Clinical staff would need to ensure sufficient time was provided for initial 
training with the Mitii™ program and to monitor progress over the course of the 
intervention.  
Parents and the children reported being satisfied with the Mitii™ intervention though some 
families reported frustration due to the technical issues encountered. This is an important 
consideration for the selection of clients who may be suitable to participate in a web-based 
intervention. Where a strong internet connection is unable to be obtained, clients and their 
families should be forewarned about potential delays in loading the program. Oftentimes 
when parents and children were told about the reason for such delays they were better 
able to cope with any frustration. Competing interests also meant that children’s interest in 
the Mitii™ program declined over time, evidenced by reducing program logins over the 20 
week intervention period. This is comparable to information from systematic reviews of 
active video games in typically developing children, which found that usage of active video 
games declined after the initial intervention period, with games reported as ‘boring’ within 4 
weeks if unchanged.114 Future research which looks at the impact of a Mitii™ program of 
shorter duration would be useful, as this may overcome some of the barriers to ongoing 
completion of the program throughout the course of the intervention. As the Mitii™ 
program continues to be developed and new features are added, it would be interesting to 
see if engagement improves resulting in an increased training dose. To maintain 
engagement and potentially encourage long term increases in physical activity, it is 
recommended that greater choices of games and flexibility be provided, and explore ways 
to increase social engagement with other Mitii™ users.  
The current study reports the findings of the primary outcome at 20 weeks, despite the 
broader Mtii™ trial capturing retention of effects 20 weeks after the completion of training. 
Future research should explore the retention effect of Mitii™ training in the full cohort 
(n=101) a further 20 weeks beyond the completion of the Mitii™ intervention. This is an 
important aspect to consider given the intensity of the training period. This was determined 
to be beyond the scope of this doctoral program.  
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This doctoral program has presented new evidence for physical activity in independently 
ambulant children and adolescents with unilateral CP, and the efficacy of the new web-
based multimodal training program Mitii™. While the delivery of an intervention such as 
Mitii™ requires individualisation, specific recommendations for clinical practice are: 
 Physical inactivity represents a growing concern among children and adolescents with 
CP, even among the most physically capable children with congenital hemiplegia 
classified at GMFCS levels I and II. Measurement of physical activity capacity and 
performance should therefore be included within a comprehensive assessment at 
critical periods of development as well as before and after interventions. 
 Accelerometers have the greatest evidence to support their use for measuring physical 
activity in independently ambulant children and adolescents with CP. They have been 
validated against oxygen consumption, heart rate and direct observation; they have 
good reliability in both the community and controlled laboratory environment; and 
excellent clinical utility. 
 Active videos games, including Mitii™, appear to be able to improve physical activity 
capacity and provide immediate increases in energy expenditure to moderate to 
vigorous intensities. They can therefore be used to increase physical activity capacity. 
 Mitii™ does not have evidence to suggest that it can increase physical activity 
performance. This in combination with inconclusive evidence from systematic reviews 
in typically developing children suggests that future research studies or clinical 
programs should evaluate physical activity performance to provide additional evidence 
to either support or refute this claim. 
 The delivery of Mitii™ may be enhanced by a multi-component intervention providing 
an individualised and tailored approach to change physical activity behaviours and 
identify strategies to overcome barriers to participation in physical activity.  Future 
research is needed to confirm this.  
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9.5 Conclusion 
This thesis examined the effect of Mitii™ on physical activity capacity and performance in 
independently ambulant children and adolescents with unilateral CP.  
The main conclusions are summarised: 
i) A systematic review found low quality evidence supporting virtual reality 
interventions to increase physical activity capacity and performance in children 
and adolescents with CP. 
ii) A systematic review of the clinimetric properties of measures of physical activity 
in primary school aged children with CP identified accelerometers to be the most 
valid and clinically useful tool to measure physical activity; however, evidence 
for their reliability in children with CP was lacking. 
iii) A reliability study found that three days of monitoring using accelerometers was 
required to produce reliable estimates of MVPA in children and adolescents with 
unilateral CP and established the agreement between repeated measures. 
iv) A cross sectional analysis of data collected during baseline assessments for the 
randomised trial found that independently ambulant children with unilateral CP 
perform insufficient MVPA to meet national recommendations, and that they 
spend a significant proportion of their day inactive, which may place them at risk 
of health problems associated in inactivity.  
v) A secondary analysis of cross sectional data collected during baseline 
assessments for the randomised trial indentified younger age, male sex, 
increased walking endurance, and increased frequency of participation in home 
and community environments were significantly associated with increased 
physical activity performance.  
vi) A matched pairs, waitlist controlled randomised trial found a significant 
difference favouring the Mitii™ intervention group at 20 weeks on assessment of 
functional strength and walking endurance, but not physical activity 
performance, recreational participation or mobility limitations. The response for 
walking endurance was dose dependent, indicating a positive training effect. 
 
These findings suggest that delivering training using the web-based program Mitii™ and 
virtual trainers was effective at increasing physical activity capacity in independently 
 171 
 
ambulant children and adolescents with unilateral CP. Improvements in physical activity 
capacity did not translate into improvements in physical activity or reduce sedentary time. 
This reinforces that physical activity capacity and performance represent separate 
constructs requiring different treatment approaches. Mitii™ may have a role in increasing 
physical activity in children with CP; however may need to be considered in the context of 
multi-dimensional interventions which incorporate behavioural change strategies to 
overcome the barriers associated with participating in increased physical activity. 
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Queensland 
Government 
Queensland Health 
Enquiries to: 
Telephone: 
Facsimile: 
Om· Ref: 
CHILDREN'S HEALTH SERVICES Linda Hardy 
3636 7591 
3636 7215 
Executive Administration 
24
th 
June 2011 
Associate Professor Roslyn Boyd 
Scientific Director 
QCPRCC 
3rd Floor Foundation Building 
Royal Children's Hospital 
HERSTON  QLD 4029 
Dear Assoc Professor Boyd 
Re: Research Project: MiTii: A randomised trial of novel upper limb  training for children with 
congenital hemiplegia 
Please be advised the above mentioned research project has successfully received Institutional 
approval following Executive review on the 23rd June 2011. 
May  I  take  this  opportunity  to  wish  you  every  success  with  your  research  project and 
contribution it will make to Children's Health Services and the broader research community. 
the 
Yours Sincerely 
Linda Hardy 
Chief Operating Officer 
Royal Children's Hospital 
Children's Health Services 
Phone 
3636 8262 
Fax 
3636 7215 
Office 
Chief Operating Officer 
Level l -North Tower- RCH 
Postal Herston Rd Herston 
Qld 4029 
11.1.1 Royal Children’s Hospital Approval letters 
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Queensland 
Government 
Queensland 
Health 
MEMORANDUM 
To: Sue McKee 
 
A/COO 
 
Assoc Professor Roslyn 
Boyd 
Copies to: 
From: Professor Ross 
Pinkerton 
 
A/Director Research 
 
Children's Health 
Service 
Tel No: 
Fax No: 
File 
Ref: 
07 3636 
9024 
 
07 3636 
9432 
Date: 28th March 
2013 
For Noting: Amendments to Protocol 
Research application- HREC/11/QRCH/35/AM01: MiTii -A  
randomised trial of novel web-based  upper limb intervention for 
congenital hemiplegia. Principal Investigator: A/Professor  Roslyn 
Boyd 
Subject: 
I have reviewed the above documentation and confirm that the amendments relate 
only to: 
• 
• 
• 
Recruitment changes 
Editorial or administrative 
changes 
Scientific changes 
There is no  ariance of any relevance to the CHS. Authorisation to implement 
amendments has been 
gr 
e  . 
ctor 
Research 
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Queensland 
Government 
QLD CHILDREN'S HEALTH SERVICES (RCH) 
HUMAN RESEARCH ETHICS COMMITTEE 
 
Professor John Pearn (Chair) 3365 5323 
Mrs A manda Smit h (Co-ordinator) 3636 9167 
Queensland Health 
Level 3, RCH Foundation Building 
Royal Children's Hospital 
Herston QLD 4029 Australia 
Tele phone (07) 3636 91 67 
Facsimile (07) 3365 5455 
 
1 3th May 2011 
Assoc Prof Roslyn Boyd 
Scientific Director 
QCPRCC 
3rd Floor, Foundation Building 
ROYAL CHILDREN'S HOSPITAL  QLD  4029 
Dear Assoc Prof Boyd 
HREC  Reference number·: HREC/11/QRCH/35 
Project title: MiTii: A randomised trial of novel web based  upper  limb intervention for 
congenital 
hemiplegia 
Many thanks for your application of the above project for review  by the QLD Children's  Health Services 
(RCH) Human Research Ethics Committee (HREC) at its meeting held on 9th
 
May 2011. 
This HREC is constituted and operates in accordance with the National Health and Medical    
Research 
Council's  (NHMRC) National  Statement  on  Ethical  Conduct  in  Human  Research  (2007),  NHMRC and 
Universities Australia Australian Code for the Responsible Conduct  of Research (2007) and the CPMPIICH 
Note for Guidance on Good Clinical Practice. 
I  a m  pleased to advise the proposal meets the requirement  of the National Statement on Ethical Conduct in 
Human Research and the Committee has granted approval for this research 
project. 
and approved include: 
The documents reviewed 
  J:\Ethics\Ethics\20L I  Projccts\HREC-11 -QRCH-
35\boyd130511.rtf 
Document Version Date 
Master Participant Informat ion Sheet: Parent/Guardian Version 1.0 18 March 2011 
Master Participant Information Sheet: Pa tticipant (child) version 1.0 18 March 2011 
Master Consent Form: Parent/Guardian Version 1.0 1 8 March 2011 
Master Consent Form: Participant (child) version 1.0 18 March 201 1 
Letter of invitation to patticipant: Study Flyer 1.0 18 March 2011 
Questionnaire: BRIEF-PARENT VERSION 1.0 22 March 20 II 
Questionnaire: TEA-CH 1.0 22 March 20 II 
Questionnaire: CP-QOL CHILD - CAREGIVER QUESTIONNAlRE  22 March 20 II 
Questionnaire: D-KEFS Color-Word Interference Test  22 March 20 II 
Questionnaire: D-KEFS Trail Making Test  22 March 20 II 
Quest ionnaire: Jebsen_Taylor Test Hand Function  22 March 20 II 
Questionnaire: LIFE-H  22 March 20 II 
Questionnaire: WISC-IV Digit Span Test  22 March 20 II 
Questionna ire: CP-QOL CHILD- CHILD QU ESTIONNAIRE  22 March 20 I  I 
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Please note the following conditions of approval: 
I. We require an annual progress report (or sooner if the project is completed) concerning the study.  This must 
include progress to elate or outcome in the case of completed research. (In accordance with National Statement 
5.5.3) 
2. HREC approval is valid from 13/05/11 to 13/05/14. 
3. In accordance with the National Statement (3.3.12),  before beginning the clinical  phase of  the research, 
researchers should register clinical trials in a publicly accessible domain. 
4. If the project does not proceed, the Committee must be informed as soon as possible. (In accordance with 
National Statement 5.5.6) 
5. The Committee must be informed of any potential or realised problem with bioethical implications, if such 
occurs during the conduct of the research project. 
6. Any serious  adverse event  (SAE)  that arises  in  the context of  this  research, or  involving a  researcher 
conducting this research, must be reported to the Ethics Committee within 72 hours and reported to the sponsor 
(if applicable) within the stipulated time frame. 
Serious Adverse Event Reports that are generated off-site may be (a) Serious Unexpected Adverse Reactions 
or (b) Serious Events which the Research Team believes cannot be related to the research intervention.  The 
Research team must report incidents of (a) during multi-centre trials.  Such are required to be submitted to the 
Chair of the QLD Children's Health Services District Ethics Committee (RCH) on receipt by the researcher. A 
summary of the SAE reports is to accompany the submission.  Information required includes; patient details 
(age & sex), adverse event, outcome and the likelihood of the event being related to the study 
drug/device/procedure. 
With  respect   to all SAEs,  the  researcher must  provide his  or  her  opinion as  to  whether the  SAE  is 
directly related to the  research intervention.  A copy of the SAE Summary must  be provided. (This can be 
obtained from  the Ethics Officer) 
7. Amendments to the research project which may affect the ongoing ethical acceptability of a project must be 
submitted to the HREC for review. Major amendments should be reflected in a revised online NEAF 
(accompanied by all relevant updated documentation and a cover  letter from the principal investigator, 
providing a  brief description of the changes, the rationale for the changes, and their implications for the 
ongoing conduct of the study). Hard copies of the revised NEAF, the cover letter and all relevant updated 
documents with tracked changes must  also be submitted to the HREC coordinator as per standard HREC 
SOP. Further advice on submitting amendments is a ailable
from: 
http://www.health.qld.gov.au/cpic/documents/ethics/rescarcher  userguide.pdf 
8. The Ethics Committee will conduct a randomly identified audit of a proportion of research projects approved 
by the Committee. That audit process will look at such issues as; 
a. 
b. 
c. 
d. 
e. 
Security of Documents 
Consent Form Register 
Serious Adverse Events Register 
Withdrawal of Participants - who and why 
The de- identification of data 
J:\Ethics\Ethic \2011 Projccts\HR EC-11-QRCH-35\boyd 13051l.rtf 
Questionnaire: COPM  22 March 20 II 
Questionnaire: AMPS SCORE FORM  22 March 20 II 
Questionnaire: AHA  22 March 20 II 
Questionnaire: MOBQUES  22 March 20 I I 
Covering Letter: principal investigator to HREC cover letter  23 March 20 II 
Protocol: protocol  I 8 March 2011 
LETTER OF SUPPORT  23 March 20 II 
Institutional approval  23 March 20 II 
Application   
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9. We require researchers  to give a declaration of intention to publish their findings in a refereed journal or 
similar peer-reviewed forum .  Your work must be in accordance with the following: 
• National Statement on Et hical Conduct in Human Research: 
htt p://www.nhmrc.gov.au/pub1 icat ion s/sy nopses/  files/e72.pdf 
• Queensland Hea lth Management Resea rch Policy: 
htt p://www.heal th.gld.gov.au/cpic/documents/ethics/research  policy.pdf 
• Joint NHMRC I AVCC Statement a nd Guidelines on Research Pract ice (1997): 
http://www.nhmrc.gov.au/funding/policy/research prac.ht m 
Declaration of Helsinki: 
htt p://www.health .g ld.gov.au/et h ics/Documents/24938 pol i cy.pdf 
• 
• G u idel ines under Section 95 of the Privacy Act 1 995 and Guidelines approved under Section 95A of 
the Privacy Act 1995. 
http://www.com law.gov.au/ComLaw/Legislation/ActCom pi lationl.nsf/OII3471 AB909A 180172CA2572 
5C0083858A/$file/Privacy1988  WD02HYP.pdf 
Queensland Health Privacy Guidelines IS42 & IS42A: 
http:// ps.healt h.g ld .gov.au/privacy/resources.htm 
• 
10. Resea rchers should note, if not QLD Health employees, a Blue Card may be requ ired for contact w ith ch ild 
ren. 
II. The Researcher must send the 'Notification  of Commencement  of Research  Protocol' as soon as resea rch 
begins. Stat us of the project will remain as 'Not Sta rted ' until t his form is received. 
Should you have any queries about the HREC's considerat ion of your project please contact Amanda Smith 
(Co-ordinator) or Professor John Pearn (Chairperson). The HREC terms of Reference, Standard Operating 
Proced ures, membership and standard forms are ava ila b le from: 
htt p://www.health.q ld .gov.a u /cp ic/et h ics/reagu  homepage.asp 
You are reminded that this letter constitutes ethical approval only. You must not commence this research 
project  at a site until separate  authorisation  from  the District  CEO  or· Delegate of that site has been 
obtained. 
A copy of this approval  must  be submitted  to the District  Executive with  a  completed  Institutional 
Approval  Form   for  authorisation   from  the  CEO  or  Delegate  to  conduct  this  research 
Children's Health Service District. 
within the 
This approval is applicable to the following Queensland Health 
sites: 
Royal Children's Hospital, Brisbane 
Cairns Base Hospital, Cairns 
The Townsville Hospital, Townsvi lle 
The HREC wishes you every success in your research. 
Yours Sincerely, 
J:\Ethics\Ethic.s\20 I I Projects\HREC-11 -QRCH-35\boyd 1 305 II.rtf 
 
 
 
 
  
Professor Alan Isles 
Deputy Chair· 
Queensland Children's Health Services (RCH) Human Research Ethics Committee 
cc: Eth ics Committee 
Files 
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Queensland 
Government 
QLD CHILDREN'S HEALTH SERVICES (RCH) 
HUMAN RESEARCH ETHICS COMMITTEE 
 
Professor John Pearn (Chair) 3365 5323 
Mrs Amanda Smith (Co-ordinator)  3636 9167 
Queensland Health 
Level 3, RCH Foundation Building 
Royal Children 's Hospital 
Herston QLD 4029 Austral ia 
Telephone (07) 3636 91 67 
Facsi mile (07) 3365 5455 
25th August 2011 
Associate Professor Rosl yn Boyd 
Scientific Director 
Queensland Cerebral Pa lsy & Rehabilitation Centre 
The University of Queensland 
Level 7, Block 6 
Roya l Brisbane Women's  Hospital 
Herston  QLD  4029 
Dea r Professor Boyd, 
HREC Reference number: HREC/11/QRCID35 
Project title: MiTii: A randomised  trial of novel web-based upper limb intervention for congenital 
hemiplegia 
Amendment number·: HREC/11/QRCID35/AM01 
Many thanks for your letter of the 22"d August regarding an amendment to the above st udy.  This has now 
been reviewed. I am pleased to advise that the amended documents reviewed and approved were: 
The QLD Children's Health Serv ices (RCH) Human Research Ethics Committee (HREC)  is constituted and 
operates in accordance with  the National Health and Medical  Research  Council's "National Statement on 
Ethical Conduct in Human Research (2007), NHMRC and Universities Australia Australian Code for the 
Responsible  Conduct  of  Research  (2007) and  the "CPMPIICH  Note  for Guidance  on Good Clinical 
Practice". 
A copy of this letter must be forwarded to the Research Governance Officer. 
It should be noted that all requirements of the original approval still apply. 
Yours sincerely, 
Professor Alan Isles 
Deputy Chair 
Queensland Children's Health Services (RCH) Human Research Ethics Committee 
Cc: Ethics Committee Fi les 
J:\Ethics\Ethics\201 1  Projects\HREC-l l-QRCH-35\boyd250811.rtf 
Document Version Date 
Patient/Participant  Information Sheet and Consent Form   
Notification of amendment   
Covering Letter  22 August 20II 
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QLD CHILDREN'S HEALTH SERVICES (RCH) 
HUMAN  RESEARCH ETHICS COMMITTEE Queensland 
Government Professor John Pearn  (Chair) 3365 5323 
Mrs Amanda Smith (Co-ordinator) 3636 9167 
Queensland Health 
Level 3, RCH Foundation Building 
Royal Children's Hospital 
Herston  QLD  4029  A ustralia 
Telephone (07) 3636 9167 
Facsimile (07) 3365 5455 
8th March 2012 
Associate Professor Roslyn Boyd 
Scientific Director 
Queensland Cerebral Palsy & Rehabilitation Research Centre 
Royal Brisbane & Women's  Hospital 
Level 7, Block 6 
Herston  QLD  4029 
Dear Professor Boyd, 
HREC Reference number·: HREC/11/QRCW35 
Project title: MiTii: A randomised trial of novel web-based upper limb intervention  for congenital 
hemiplegia Amendment  number: HREC/11/QRCH/35/AM02 
Many thanks for your letter of the 2"d March regarding an amendment to the above study.  This has now been 
reviewed.  I am pleased to advise that the amended documents reviewed and approved were: 
The QLD Children's Health Services (RCH) Human Research  Ethics Committee (HREC)  is constituted and 
operates  in accordance  with the National  Health  and Medical  Research  Council's "National Statement on 
Ethical Conduct in Human Research (2007}, NHMRC and Universities Australia Australian Code for the 
Responsible Conduct  of  Research  (2007)  and  the "CPMPIICH  Note for  Guidance  on  Good  Clinical 
Practice". 
A copy of this letter must  be forwarded  to the Research Governance  Officer.    It should  be noted that all 
requirements of the original approval still apply. 
Yours sincerely, 
 
Professor Alan Isles 
Deputy Chair 
Queensland Children's Health Services (RCH) Human Research Ethics Committee 
Cc: Et hics Committee Files 
J:\Ethics\Ethics\20 II  Projects\HREC-11-QRCH-35\boyd080312.rtf 
Document Version Date 
Parent/Guardian Information Sheet and Consent Form  02 March 2012 
Advertising Flyer   
Notification of amendment   
Letter of invitation to participant  03 February 2012 
Covering Letter  02 March 2012 
Participation & Environment Measure- Children & Youth   
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Queensland 
Government 
QLD CHILDREN'S HEALTH SERVICES (RCH) 
HUMAN  RESEARCH ETHICS COMMITTEE 
Professor John Pcnrn (Chair) 3365 5323 
Mrs Amanda Smith (Co-ordinator)  3636 9167 
Queensland Health 
Level 3, RCH Fou nda tion Buildi ng 
Royal Children 's Hospital 
Herston QLD 4029 Australia 
Telephone (07) 3636 9167 
Facsimile (07) 3365 5455 
8111 August 201 2 
Professor Roslyn Boyd 
Scientific Director 
Queensland Cerebral Palsy & Rehabilitation Research Centre 
Level 7, Block 6 
Royal Brisbane and Women's Hospital 
Herston, QLD 4029 
Dear Professor Boyd, 
HREC  Reference number: HREC/11/QRCH/35 
Project title: MiTii:  A randomised trial  of novel web-based upper limb intervention for congenital 
hemiplegia. 
Amendment number: HREC/11/QRCH/35/AM03 
Many thanks for your letter of the 31st July regarding an amendment to the above study.  This has now been 
reviewed and I am pleased to advise that the amended documents reviewed and approved were: 
The QLD Children's Health Services (RCH) Human Research Ethics Committee (HREC) is constituted and 
operates in accordance with the National Health and Medical Research Council's "National Statement on 
Ethical Conduct in Human Research (2007), NHMRC and Universities Australia Australian Code for the 
Responsible Conduct of Research (2007) and the "CPMPIJCH Note for Guidance on Good  Clinical 
Practice". 
A copy of this letter must  be forwarded to the Research Governance Officer.   It should be noted that all 
requirements of the original approval still apply. 
Yours sincerely, 
Professor John Pearn 
Chair 
Queensland Children's Health Services (RCH) Human Research Ethics Committee 
Cc: Ethics Committee Files 
J:\Ethics\Ethics\201 1  Projects\HREC-I l -QRCH-35\boyd080812.rtf 
Document Version Date 
Pat1icipant Information Sheet and Consent Form  23 July 2012 
Parent/Guardian Information Sheet and Consent Form  23 July2012 
Notification of amendment   
Covering Letter  23 July201 2 
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Queensland QLD CHILDREN'S HEALTH SERVICES (RCH) 
HUMAN RESEARCH  ETHICS COMMITTEE 
Professor John Peam  (Chair) 3365 5323 
Mrs Amanda Smith (Co-ordinator)  3636 9167 
Level 3, RCH Foundation Building 
Professor Roslyn Boyd 
Scientific Director 
Queensland Cerebral Palsy & Rehabilitation Research Centre 
Level 7, Block 6 
Royal Brisbane and Women's Hospital 
Herston, QLD  4029 
Dear Professor Boyd, 
HREC Reference number: HREC/ll/QRCW35 
Project title: MiTii: A randomised trial of novel web-based upper limb intervention for congenital 
hemiplegia. 
Many  thanks  for  your  letter  of the  28°' August  regarding  the  addition  of  the Cerebral Palsy  League  of 
Queensland as a site for the above study.  This has now been noted by the Committee. 
Please do not hesitate to contact me should you have any queries. 
Yours sincerely, 
Professor Alan Isles 
Deputy Chair 
Queensland Children's Health Services (RCH) Human Research Ethics Committee 
Cc: Ethics Committee  Files 
J:\Ethics\Ethics\2011 Projects\HREC-ll-QRCH-35\bod y l 20912.rtf 
 
 
 
 
 
 
 
Government 
 
Queensland Health 
 
 
Royal Children's Hospital 
Herston QLD 4029  Australia 
Telephone (07) 3636 9167 
Facsimile (07) 3365 5455 
 
12
th
 September 2012 
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Queensland 
Government 
CH ILDR EN'S HEALTH SERVICES QUEENSLAND 
HUMAN  RESEARCH ETHICS COMMITTEE 
 
Professor John Pcarn (Chair) 3365 5323 
Mrs A ma nda Smith (Co-ordi nator) 3636 91 67 
Queensland Health 
Level 3, RCH Fou ndation Building 
Royal Child ren 's Hos pital 
Herston  QLD 4029 Australia 
Tele phone (07) 3636 91 67 
Facs imile (07) 3365 5455 
 
17
111 
January 2013 
Professor Roslyn Boyd 
Scientific Director 
Queensland Cerebral Palsy & Rehabilitation Research Centre 
Level 7, Block 6 
Royal Brisbane and Women's Hospital 
Herston, QLD 4029 
Dear Professor Boyd, 
HREC Reference number: HREC/11/QRCH/35 
Project title: V2(CPLQ)- Mitii: A randomised trial of novel web-based upper limb intervention for 
congenital hemiplegia 
Amendment number: HREC/11/QRCH/35/AM04 
Many tha nks for your letter of the 19'11 December  regarding an amendment to the above study. Thi s has now 
been reviewed a nd the Committee is pleased to advise that the amended documents reviewed a nd approved 
were: 
The QLD Children 's Health Services (RCH) Human Resea rch Ethics Comm ittee (HR EC) is constituted and 
operates in accordance with the National Health and Medical Research Council 's  "National Statement on 
Ethical Conduct in Human Research (2007), NHMRC and Universities Australia Australian Code for the 
Responsible Conduct  of  Research  (2007)  a nd  the "CPMPI!CH  Note  for  Guidance  011   Good  Clinical 
Practice". 
A copy of this letter  must be forwarded to the Research Governance Officer.   It should be noted that all 
requirements of the original approval still apply. 
 
Professor John Pearn 
Chair 
Children 's Health Services Queensland Human Research Ethics Committee 
Cc: Ethics Committee files 
J:\Et hics\Ethics\2011  Projccts\I-I REC-11 -QRCII-35\boyd1 701 1 3.rtf 
Document Version Date 
Covering Letter  19 December 201 2 
Pa rticipa nt Information Sheet and Assent Form 4 1 4 December 2012 
Parent/Guardian Information Sheet and Consent Form 4 1 7 December 2012 
Invest igator CV - Professor Paul Scuffam   
Application AU/I ll FAOII 2  
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CHILDREN'S HEALTH SERVICES  QUEENSLAND 
HUMAN RESEARCH ETHICS COMMITTEE 
 
Professor John Pearn (Chair) 3365 5323 
Mrs Amanda Smith (Co-ordinator)  3636 9167 
Level 3, RCH Foundation Building 
Royal Children's Hospital 
Herston QLD 4029 Australia 
Telephone (07) 3636 9167 
Facsimile (07) 3365 5455 
 
7th August 2013 
Professor Roslyn Boyd 
Scientific Director 
Queensland Cerebral Palsy & Rehabilitation  Research Centre 
Level 7, Block 6 
Royal Brisbane and Women's Hospital 
Herston, QLD  4029 
Dear Professor Boyd, 
HREC Reference number: HREC/11/QRCW35 
Project title: Mitii: A randomised trial  of novel web-based upper  limb intervention for children with 
congenital hemiplegia 
Amendment number: HREC/11/QRCW35/AM07 
Many thanks for your letter of the 1st August regarding an amendment  to the above study.   This has now 
been reviewed and I am pleased to advise that the amended documents reviewed and approved were: 
The QLD Children's Health Services (RCH) Human Research Ethics Committee (HREC)  is constituted and 
operates  in accordance  with the National  Health and Medical Research  Council's "National Statement on 
Ethical Conduct in Human Research (2007), NHMRC and Universities Australia Australian Code for the 
Responsible Conduct  of  Research (2007)  and  the "CPMPIICH  Note for  Guidance  on  Good  Clinical 
Practice". 
A copy of this letter must be forwarded  to the Research  Governance  Officer.   It should  be noted that all 
requirements of the original approval still apply. 
Yours sincerely, 
 
Professor John Pearn 
Chair 
Children's  Health Services Queensland Human Research Ethics Committee 
Cc: Ethics Committee Files 
J:\Ethics\Ethics\2011 Projects\HREC-ll-QRCH-35\boyd070813.rtf 
Document Version Date 
Parent/Guardian Information Sheet and Consent Form 6 0 I  August 2013 
Notification of amendment   
Covering Letter  0 I August  2013 
Application AU/1/5103110  
Pmticipant Information Sheet and Consent Form 6 0 l August 2013 
 
 
 
 
 
 
Queensland 
Government 
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CHILDREN'S HEALTH SERVICES  QUEENSLAND 
HUMAN RESEARCH ETHICS COMMITTEE 
 
Professor John Pearn (Chair) 3365 5323 
Mrs Amanda Smith (Co-ordinator) 3636 9167 
Level 3, RCH Foundation Building 
Royal Children's Hospital 
Herston QLD 4029 Australia 
Telephone (07) 3636 9167 
Facsimile (07) 3365 5455 
3'' September 
Professor Roslyn Boyd 
Scientific Director 
Queensland Cerebral Palsy & Rehabilitation Research Centre 
Level7, Block 6 
Royal Brisbane and Women's Hospital 
Herston, QLD  4029 
Dear Professor Boyd, 
HREC Reference number: HREC/11/QRCH/35 
Project title: Mitii: A randomised  trial of novel web-based upper limb intervention for children with 
congenital hemiplegia 
Amendment number: HREC/11/QRCH/35/AMOS 
Many thanks for your letter of the 29'" August regarding an amendment  to the above study.   This has now 
been reviewed and I am pleased to advise that the amended documents reviewed and approved were: 
The QLD Children's  Health Services (RCH) Human Research Ethics Committee (HREC)  is constituted and 
operates  in accordance  with the National Health and Medical Research’s Council's "National Statement on 
Ethical Conduct in Human Research (2007), NHMRC and Universities Australia Australian Code for the 
Responsible Conduct of Research (2007) and the "CPMPIICH Note for Guidance on Good Clinical 
Practice". 
A copy of this letter must be forwarded  to the Research Governance  Officer.   It should  be noted that all 
requirements of the original approval still apply. 
Yours sincerely, 
Professor John Pearn 
Chair 
Children's  Health Services Queensland Human Research Ethics Committee 
Cc: Ethics Committee Files 
J:\Ethics\Ethics\2011 Projects\HREC-11-QRCH-35\boyd030913.rtf 
Document Version Date 
Parent/Guardian Information Sheet and Consent Form 7 28 August 2013 
Notification of amendment  29 August 2013 
Covering Letter  29 August 2013 
 
 
 
 
 
 
Queensland 
Government 
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CHILDREN'S HEALTH SERVICES QUEENSLAND 
HUMAN RESEARCH ETHICS COMMITTEE 
Professor John Pearn (Chair) 3365 5323 
Mrs Amanda Smith (Co-ordinator) 3636 9167 
Level3,  RCH Foundation Building 
Royal Children's Hospital 
Herston QLD 4029 Australia 
Telephone (07) 3636 9167 
Facsimile (07) 3365 5455 
1st April2014 
Professor Roslyn Boyd 
Queensland Cerebral Palsy and Rehabilitation Research Centre 
Level 7, Block 6 
Royal Brisbane & Women's  Hospital 
Herston  QLD  4029 
Dear Professor Boyd, 
HREC Reference number: HREC/11/QRCH/35 
Project title: Mitii: A randomised trial  of novel web-based upper  limb intervention for children with 
congenital hemiplegia 
Amendment number: HREC/11/QRCH/35/AMl0 
Many thanks for your letter of the 26'h March regarding an amendment  to the above project.  This has now 
been reviewed and I am pleased to advise that the amended documents reviewed and approved were: 
The QLD Children's Health Services (RCH) Human Research Ethics Committee (HREC)  is constituted and 
operates  in accordance  with the National  Health and Medical Research  Council's "National Statement  of 
Ethical Conduct in Human Research (2007), NHMRC and Universities Australia Australian Code for the 
Responsible Conduct  of  Research (2007)  and  the "CPMPIICH  Note for  Guidance  on  Good Clinical 
Practice". 
A copy of this letter must be forwarded to the Research Governance  Officer.   It should be noted that all 
requirements of the original approval still apply. 
Yours sincerely, 
 
Professor John Pearn 
Chair 
Children's Health Services Queensland Human Research Ethics Committee 
Cc: Ethics Committee Files 
J:\Ethics\Ethics\2011 Projects\HREC-11-QRCH-35\amendment approval 01 0414.rtf 
Document Version Date 
Parent/Guardian Information Sheet 8 25 March 20 I 4 
Participant Information Sheet 8 25 March 2014 
Notification of amendment  26 March 2014 
Investigator CV Kelly Hentsehke  
Covering Letter  26 March 2014 
Investigator CV Adina Piovesana  
 
 
 
 
 
 
Queensland 
Government 
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Professor Ros Boyd 
Queensland Cerebral Palsy and Rehabilitation Research Centre 
Department of Paediatrics and Child Health 
The University of Queensland 
Harston OLD 4029 
Formerly  known as The Spastic Centre 
April41 h 2013 
Dear Prof Boyd 
RE: "MiTii: A randomised trial of novel web- based upper  limb intervention for 
congenitalhemiplegia." 
Thank you for your application of the above project for consideration by the Cerebral 
Palsy Alliance's Human Research Ethics Committee (HREC) at its meeting held on 
3ro April2013. 
Our HREC is constituted and operates in accordance with the National Health and 
Medical Research  Council's (NHMRC) National Statement on Ethical Conduct  in 
Human Research (2007). 
I am pleased to inform you that your project meets the requirements of the National 
Statement on Ethical Conduct in Human Research and our Committee has granted 
approval for this project. 
The Committee also provides the following comments for your consideration: 
• The  Committee notes that Version 4  of the Standard Participant  Information 
Statement  and Assent Form is 10  pages long and expressed some concern 
about this length and expectation that a young person would be able to fully 
comprehend such a statement. 
• Additionally, on page 29 of  the NEAF, the Committee noted that  not all the 
columns on table were completed for the participants. It has assumed that this is 
an oversight and that people with cognitive impairment/intellectual disability or 
mental illness are the only participants that this project specifically excludes. 
Details of the approval are as follows: 
Project approval number:  2013-04-01. Please use this number in all subsequent 
correspondence to the Committee. 
Approval period: April 2013 to April 2016 
 
T 61 2 9975 8000 1 F 61 2 9451 5209  1 
PO Box 184  Brookvale NSW 2100 ABN 45 000 062 288 
E info@cerebralpalsy.org.au  1   W cerebralpalsy.org.au 
187 Allambie Road,Allambie He1ghts,NSW 2100 
11.1.2 Cerebral Palsy Alliance Approval letters 
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Authorised research personnel: 
Principal researchers/investigators 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
Prof Ros Boyd 
Prof Jenny Ziviani 
A/Prof Steven Rose 
Dr Robert Ware 
Dr Leanne Sakzewski 
A/Prof Anthony Smith 
Dr David Abbott 
Prof Richard MacDonnell 
Dr Tracy Comans 
Prof Paul Scuffam 
Associate researchers/investigators 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
Prof Jens BoNielson 
Dir Peder Esben Bilde 
Dr Koa Whittingham 
Ms Sarah James 
Ms Louise Mitchell 
Ms Melinda Lewis 
Ms Rachel Thomas 
Ms Laura Pareezer 
Dr Lynne McKinlay 
Ms Stephanie Ross 
Mr Henry Tsao 
Approved documentation: 
Please attach a footer "This study has been approved by the Cerebral Palsy Alliance 
Human Research Ethics Committee. If  you have any complaints or reservations 
about the ethical conduct of this research you may contact the Ethics Committee on 
(02) 9975 8776 or ethics@cerebralpalsy.org.au" to the information statements and 
consent forms, labelling this version 1. 
Please send a copy of the final updated documents to the Ethics Committee. If you 
wish to change these in the future please send a copy to the Ethics Committee for 
review. 
The approval of this project is conditional upon your continuing compliance with the 
National Statement. 
Accordingly, it is the responsibility of the principal investigator/s to: 
• Provide a summary  of your progress on a yearly basis to the committee 
commencing April 2014. A final report on completion and notification of any 
publications from this project is also requested. Failure to submit required 
reports will result in withdrawal of consent for the project to continue. 
Advise  the  HREC  immediately  in  writing of  any  serious  adverse  events 
occurring during the course of the research. 
Advise  the  HREC  immediately  of  all  unforseen  events  that  might  affect 
continued ethical acceptability of the project. 
Advise the HREC of any proposed changes to the research protocol, research 
personnel, information statement or consent form. All proposed amendments 
• 
• 
• 
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must be addressed in writing to the HREC and must be approved by the 
HREC before continuation of the project. 
Advise  the   HREC  immediately,  providing   reasons,  if  the   research  is 
discontinued prior to its completion. 
Request an extension of ethics approval should the project not be completed 
within the time period specified above. 
Ensure  that  copies  of  all  signed  consent  forms  are  retained and  made 
available to the HREC on request. 
Provide a  copy  of  this  letter  to any internal/external granting agencies if 
requested. 
• 
• 
• 
• 
The Ethics Committee and Board  of Directors wish you well with this important 
project. 
Yours sincerely 
Dr Neroli Best 
Chair, Ethics Committee 
Cerebral Palsy Alliance Ethics Committee is a NHMRC HREC: EC00402 
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THE UNIVERSITY OF QUEENSLAND 
 
 
 
 
Institutional  Approval Form For Experiments On Humans 
Including Behavioural Research 
 
 
 
 
 
Chief Investigator:         A/Prof Roslyn Boyd, Prof Jenny Ziviani, Dr David Abbott, 
A/Prof Stephen rose, Prof Richard Macdonell, Dr Leanne 
Sakzewski, Dr Robert; Ware, A/Prof Anthony Smith 
 
Project Title:                   MiTii: A Randomised Trial Of Novel Web-Based Upper 
Limb Intervention For Congenital Hemiplegia 
 
Supervisor:                       A/Prof Roslyn Boyd, Prof Jenny Ziviani 
 
Co-Investigator(s): Prof Jens Bo Nielson, Director Peder Esben Bilde,Dr 
Radwa Badawy, Dr Koa Whittingham, Ms Kate Hunt, Ms 
Louise Mitchell 
 
Department(s):               Queensland Cerebral Palsy Rehabilitation and Research 
Centre, Royal Children's Hospital, School of Medicine 
 
Project Number:              2011000608 
 
Granting Agency/Degree:NHMRC 
Duration: 1st March 2014 
Comments: 
 
Expedited review on the basis of approval from the Queensland Children's Health 
Services (RCH) HREC, dated 13/05/2011. 
 
 
Name of responsible Committee:- 
MedicalResearch Ethics Committee 
This project complies with the provisions contained in the National Statement on 
Ethical Conduct in Human Research and complies with the regulations governing 
experimentation on humans. 
Name of Ethics Committee representative:- 
Professor Bill Vicenzino 
Chairperson 
Medical Research Ethics Committee 
 
 
 
 
 
Date:                                                           Signature: 
 
  
 
 
 
 
 
11.1.3 The University of Queensland Approval letters 
  
 205 
 
THE  UNIVERSITY OF QUEENSLAND 
 
 
 
Institutional Human Research Ethics Approval 
 
 
Project Title:  MiTii: A Randomised Trial Of Novel Web-Based Upper Limb 
Intervention For Congenital Hemiplegia- 21/03/2013- 
AMENDMENT 
 
Chief  Investigator: Prof Roslyn Boyd 
 
Supervisor: Prof Roslyn Boyd, Prof Jenny Ziviani 
 
Co-lnvestigator(s): Prof Jenny Ziviani, Dr David Abbott, A/Prof Stephen Rose, 
Prof Richard Macdonell, Dr Leanne Sakzewski, Dr Robert 
Ware, A/Prof Anthony Smith, Prof Jens Bo Nielson, Director 
Peder Esben Bilde, Dr Radwa Badawy, Dr Koa Whittingham, 
Ms Louise Mitchell, Laura Pareezer, Ms Sarah James, 
Rachel Thomas, Laura Pareza, Dr Lynne McKinlay, Henry 
Tsao, Dr Tracy Coman, Prof Paul Scuffam, Stephanie Ross, 
Carly Mayberry 
 
School(s): Queensland Cerebral Palsy Rehabilitation  and Research 
Centre, Royal Children's Hospital, School of Medicine 
 
Approval Number: 2011000608 
 
Granting Agency/Degree: Smart Future Co-investment Funds, Foundation for Children 
Grant 
 
Duration: 1st March 2014 
 
Comments: 
 
 
 
 
 
Note: if this approval is for amendments to an already approved protocol for which a UQ 
Clinical Trials Protection/Insurance Form was originally submitted, then the researchers must 
directly notify the UQ Insurance Office of any changes to that Form and Participant 
Information Sheets & Consent Forms as a result of the amendments, before action. 
Name of responsible Committee: 
Medical Research Ethics Committee 
This project complies with the provisions contained in the National Statement on Ethical 
Conduct in Human Research and complies with the regulations governing experimentation on 
humans. 
Name of Ethics Committee representative: 
Professor Bill Vicenzino 
Chairperson 
Medical Research Ethics Committee 
 
 
 
 
 
 
Signature   Date  
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THE UNIVERSITY OF QUEENSLAND 
 
Institutional Human Research Ethics Approval 
Project Title: MiTii: A Randomised Trial Of Novel Web-Based Upper  Limb 
Intervention For Congenital Hemiplegia- 05/09/2013- 
AMENDMENT 
Chief Investigator: Prof Roslyn  Boyd 
Supervisor: Prof Roslyn  Boyd, Prof Jenny  Ziviani 
Co-lnvestigator(s): Prof Jenny  Ziviani,  Dr David  Abbott,  A/Prof  Stephen Rose, 
Prof Richard Macdonell, Dr Leanne Sakzewski, Dr Robert 
Ware, A/Prof Anthony Smith,  Prof Jens Bo Nielson, Director 
Peder Esben  Bilde, Dr Radwa Badawy, Dr Koa Whittingham, 
Ms Louise  Mitchell,  Laura  Pareezer, Ms Sarah James, 
Rachel Thomas, Laura Pareza, Dr Lynne  McKinlay, Henry 
Tsao,  Dr Tracy Coman, Prof Paul Scuffam, Stephanie Ross, 
early  Mayberry 
School(s): Queensland Cerebral Palsy Rehabilitation and Research 
Centre,  Royal  Children's Hospital, School of Medicine 
Approval Number: 2011000608 
Granting Agency/Degree: Smart Future  Co-investment Funds, Foundation for Children 
Grant 
Duration: 1st March  2014 
Comments: 
• ParenUGuardian Information Sheet  Version  7 
• Participant Information Sheet Version  7 
Note: if this approval is for amendments to an already  approved protocol for which a UQ 
Clinical Trials Protection/Insurance Form  was originally submitted, then the researchers must 
directly  notify the UQ Insurance Office  of any changes to that Form  and Participant 
Information Sheets  & Consent Forms  as a result of the amendments, before action. 
Name of responsible Committee: 
Medical Research Ethics Committee 
This project  complies with the provisions contained in the National Statement on Ethical 
Conduct in Human Research and complies with the regulations governing experimentation on 
humans. 
Name of Ethics Committee representative: 
Professor Bill Vicenzino 
Chairperson 
Medical Research Ethics Committee 
Signature Date      
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11.1.4 Australian New Zealand Clinical Trials Registration 
 
 
 
 
 
Request Number:  336683 
 
ACTR  Number:  ACTRN12611001174976 
 
Trial Status:  Registered 
 
Date  Submitted: 11/07/2011 
 
Date  Registered: 10/11/2011 
 
Date  Last  Updated:  05/03/2012 
 
Registration Type:  Prospective registered 
 
 
 
Page 1 
 
 
Public title:  MiTii: A randomised trial of novel web-based 
upper limb intervention for congenital hemiplegia 
 
ANZCTR registration 
title: 
 
A randomised control trial evaluating the 
functional, neurological and participation 
outcomes of the "Move it To improve it" program 
for children with congenital Hemiplegia 
 
Secondary ID: Nil 
 
UTN: 
 
Trial acronym: MiTii 
 
 
 
Page 2 
 
 
Health condition(s) or problem(s) studied: 
 
Congenital Hemiplegia 
Cerebral Palsy 
 
Condition category: Condition code: 
 
Neurological Other neurological disorders 
 
Physical Medicine / Rehabilitation Other physical medicine / rehabilitation 
 
 
 
Page 3 
 
 
 
Description of 
intervention(s) / 
exposure: 
MiTii (“Move it To improve it”) is an internet- 
based multimodal therapy which combines 
upper-limb training within the context of 
meaningful physical activity that can be accessed 
in children's homes. Inherent in this approach is 
the ability to scaffold visual perception skills and 
cognitive challenge, both important aspects of 
activity engagement and participation in a virtual 
training environment. The program is potentially 
cost effective as only three centre-based 
therapists (Physiotherapist, Occupation 
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Therapist, and psychologist) are required to 
provide initial assessment, goal setting and 
training for families and participating children. 
Each therapist then spends 30 minutes each 
week to remotely modify the individualised 
program. This current application proposes to 
test the efficacy of MiTii in a wait list randomised 
controlled trial. We propose to provide MiTii at an 
intensity of 30 minutes per day, 6 days/week for 
20 weeks (total dose 60 hours). All children will 
therefore receive the therapy within 10 months 
of being randomised either to commence MiTii 
immediately or waitlisted for 20 weeks before 
receiving the same Mitii therapy as the 
Immediate invention group. Retention of effects 
will be tested at 10 months. As current therapy 
programs are resource intensive and time 
consuming it is important to determine if gains 
from MiTii are sustained over a 10 month period 
as this could offer a cost effective model of care, 
particularly for rural, remote and isolated 
children with CP. 
 
Intervention code:  Rehabilitation 
 
 
Comparator / control 
treatment: 
 
The delayed intervention or waitlist group will act 
as a control group. These children will undergo 
baseline assessment and then be sent home for 
20 weeks receiving standard Treatment/Care as 
Usual. After the 20 weeks, assessments will be 
repeated and they will then receive the same 20 
week Mitii training as the Immediate 
Intervention group. Standard care is considered 
Physiotherapy, Occupational Therapy or 
Psychology that the child would otherwise 
receive without the intervention, excluding 
splinting, casting or surgery management. 
Should children normally received Botox, their 
inclusion in the study will be delayed until after 
their Botox and standard follow up care has been 
completed. Standard care will be assessed using 
a parent questionnaire which documents the 
types of therapies and frequency received 
 
Control group:  Active 
 
 
 
Page 4 
 
 
Primary outcome:  Motor and Process Skills in daily living activities 
as demonstrated by a 0.5 logit score on the 
Assessment of Motor and Process Skills (AMPS) 
 
Timepoint: 
 
immediately post-intervention (at 20 weeks) and 
retained at 40 weeks post intervention 
commencement 
 
Secondary outcome 1: Activity limitations (unimanual capacity and 
bimanual performance) by mean difference of 5 
points on the Assisting Hand Assessment (AHA) 
and 10% decrease in time on the Jebsen-Taylor 
Test of Hand Function (JTHF) 
 
Timepoint: 
 
immediately post-intervention (at 20 weeks) and 
retained at 40 weeks post intervention 
commencement. 
 
Secondary outcome 2: Neuroplasticity determined on the Motor Evoked 
Potential (MEP) curves using Transcranial 
Magnetic Stimulation (TMS) 
 
Timepoint: immediately post-intervention (at 20 weeks) and 
retained at 40weeks post intervention 
commencement. 
 
Secondary outcome 3: Visual perception (visual discrimination, visual 
memory and visual sequential memory) 
 
Timepoint: immediately post-intervention (at 20 weeks) and 
retained at 40 weeks post intervention 
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commencement. 
 
Secondary outcome 4: Executive functioning (sustained attention, 
working memory and cognitive flexibility) 
 
Timepoint: immediately post-intervention (at 20 weeks) and 
retained at 40 weeks post intervention 
commencement. 
 
Secondary outcome 5: Executive functioning in everyday life (measured 
by the BRIEF) 
 
Timepoint: immediately post-intervention (at 20 weeks) and 
retained at 40 weeks post intervention 
commencement. 
 
Secondary outcome 6:               Participation (LIFE-H) by 0.5 weighted score for 
categories of personal care, nutrition, education 
and recreation 
 
Timepoint: immediately post-intervention (at 20 weeks) and 
retained at 40 weeks post intervention 
commencement. 
 
Secondary outcome 7: Occupational performance (COPM performance 
and satisfaction) by 2 points 
 
Timepoint: immediately post-intervention (at 20 weeks) and 
retained at 40 weeks post intervention 
commencement. 
 
Secondary outcome 8: Functioning and participation domains of quality 
of life (CP-QOL-child/CP-QOL-Teen) by 5 points 
on specified domains 
 
Timepoint: immediately post-intervention (at 20 weeks) and 
retained at 40 weeks post intervention 
commencement. 
 
Secondary outcome 9: MiTii will be more cost-effective compared with 
Usual Care as shown by resource use and 
effectiveness based on function (AMPs) and 
quality of life (CPQOL) 
 
Timepoint: immediately post-intervention (at 20 weeks) and 
retained at 40 weeks post intervention 
commencement. 
 
Secondary outcome 10: MiTii will increase physical activity capability 
(measured using the functional strength 
assessments, walking tests and modified shuttle 
run test) and performance (measured using a 
physical activity questionnaire and 
accelerometers over >3 days) 
 
Timepoint: immediately post-intervention (at 20 weeks) and 
retained at 40 weeks post intervention 
commencement. 
 
 
Page 5 
 
 
Key  inclusion 
criteria: 
i. Gross Motor Function Classification (GMFCS) I 
or II; Manual Abilities (MACs) I, II, III. ii. 
Sufficient co-operation and cognitive 
understanding to perform the tasks and access 
the computer equipment; iii. Are able to attend 3 
appointments in Brisbane for initial 
assessment/training and follow-up assessments. 
iv. Able to access the internet at home (phone 
line or internet access). Note; laptops will be 
loaned for those require them and camera’s 
provided for all children with the treatment 
phase. 
 
Minimum Age:  8 Years 
 
Maximum Age:  18 Years 
 
Gender:  Both males and females 
 
Healthy volunteers? No 
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Key  exclusion 
criteria: 
i. received upper limb surgery in the last 6mths; 
ii. unstable epilepsy (i.e. not controlled by 
medication) is a precaution for TMS. Where 
children have received BoNT-A or upper limb 
casting in the previous 1 month, inclusion in the 
study will be delayed until after treatment and 
standard follow up. 
 
 
Page 6 
 
Study  type:  Interventional 
Purpose of the  study:  Treatment 
Allocation to 
intervention: 
Randomised controlled trial
 
 
Describe the procedure for 
enrolling a subject and 
allocating the treatment 
(allocation concealment 
procedures): 
 
Screening phone call to ensure participant's 
suitability. Rolling recruitment in blocks of 10-15 
children. Matching pairs for age/gender/MACS 
scores Once baseline assessments have been 
completed, children will be randomised within 
pairs from concealed envelopes opened by non- 
study personnel. Treatment allocation will be 
recorded on a piece of folded paper inside each 
envelope in random order (computer generated). 
The randomisation process will involve allocating 
a number “1” or “2’ to each member of the pair 
which will be written on the paper inside the 
envelope. As each pair is entered, they will be 
allocated the next consecutive envelope, which 
will be opened by the non-study personnel who 
will read and record the treatment allocation 
from the paper inside the envelope. Study 
personnel will be informed of group allocation. 
 
Describe the methods used 
to generate the sequence 
in which subjects will be 
randomised (sequence 
generation): 
 
 
randomisation within pairs by computer number 
generation of 1 or 2 alternatives within the pairs. 
 
Masking / blinding: Blinded (masking used) 
 
Who is/are 
masked/blinded: 
The people assessing the outcomes 
The people analysing the results/data 
 
Assignment: Parallel 
 
Other design features 
(specify): 
Nil
 
 
Type of endpoint(s): Efficacy 
 
 
 
Page 7 
 
 
Phase Not Applicable 
 
Anticipated or actual 
date  of first participant 
enrolement: 
 
1/04/2012 
 
Target sample size:  98 
 
Recruitment status:  Not yet recruiting 
 
 
 
Page 8 
 
 
Funding source 1: Government funding body e.g. Australian 
Research Council 
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Name:  National Health and Medical Research Council 
(applied March 2011) 
 
Address:  National Health and Medical Research Council 
GPO Box 1421 
Canberra ACT 2601 
 
Country:  Australia 
 
Funding source 2: Charities/Societies/Foundations 
 
Name:  Royal Childrens Hospital Foundation 
 
Address:  Foundation Building 
Royal Childrens Hospital 
Herston Road 
Herston 
Qld 
4029 
 
Country:  Australia 
 
Primary sponsor:  Government funding body e.g. Department of 
Health 
 
Name:  Smart Futures Coinvestment Fund 
 
Address:  Queensland Government 
 
Country:  Australia 
 
Secondary sponsor:  Charities/Societies/Foundations 
 
Name:  Foundation for Children 
 
Address:  Foundation for Children 
GPO Box 3655 
Sydney NSW 2000 
 
Country:  Australia 
 
Other collaborator: 
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Has  the  study received 
approval from  at least  No 
one  ethics committee? 
 
Ethics Committee name 1: Royal Childrens Hospital and Health Services 
District 
 
Address: Department of Pediatrics and Child Health 
3rd Floor, Foundation Building, 
Royal Childrens Hospital, 
Herston Rd, 
Herston 
QLD 4029 
 
Country: Australia 
 
Date submitted/Date which 
intend to submit to ethics 
committee: 
 
26/03/2011 
 
Ethics Committee name 2: University of Queensland 
 
Address: Medical Ethics Committee, 
University of Queensland, 
Research and Graduate Studies Office, 
St Lucia, 
QLD 4072 
 
Country: Australia 
 
Date submitted/Date which 
intend to submit to ethics 26/03/2011 
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committee: 
 
Countries of 
recruitment: 
Australia
 
 
Brief summary: This randomized comparison trial will test the 
efficacy of a novel rehabilitation (MiTii: Move it 
To improve it) which involves the use of a web- 
based, intensive and individualized, multimodal 
therapy program with therapists acting as 'virtual 
trainers', over a 20 week period, and comparing 
this approach to standard care received in 
children with congenital hemiplegia. 
 
Trial website: Nil 
 
Presentations / publication 
list: 
Nil
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Contact person for  public queries 
 
Name:  A/Professor Roslyn Boyd 
 
Address:  Queensland Childrens Cerebral Palsy and 
Rehabilitation Research Centre 
School of Medicine, Department of Paediatrics, 
University of Queensland, 
Level 7, Block 6, 
Royal brisbane And Women's Hospital 
Bowen bridge Road 
Herston, QLD, 4029 
 
Country:  Australia 
 
Tel:  +617 3365 5315 
 
Fax: +6173365 5538 
 
Email:  r.boyd@uq.edu.au 
 
 
Contact person for  scientific queries 
 
Name:  A/Professor Roslyn Boyd 
 
Address:  Queensland Childrens Cerebral Palsy and 
Rehabilitation Research Centre 
School of Medicine, Department of Paediatrics, 
University of Queensland, 
Level 7, Block 6, 
Royal brisbane And Women's Hospital 
Bowen bridge Road 
Herston, QLD, 4029 
 
Country:  Australia 
 
Tel:  +6173365 5315 
 
Fax: +6173365 5538 
 
Email:  r.boyd@uq.edu.au 
 
 
Contact person responsible for  updating information 
 
Name: Louise Mitchell 
 
Address: Queensland Childrens Cerebral Palsy and 
Rehabilitation Research Centre 
School of Medicine, Department of Paediatrics, 
University of Queensland, 
Level 7, Block 6, 
Royal brisbane And Women's Hospital 
Bowen bridge Road 
Herston, QLD, 4029 
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 Country:  Australia 
 
 Tel: +61733655315 
 
 Fax: +61733655538 
 
 
 Email:  louise.mitchell@uq.edu.au 
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11.2  Parent/Guardian information and consent forms 
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Queensland Cerebral Palsy & Rehabilitation Research Centre 
Royal Children’s Hospital 
Herston Road 
HERSTON QLD 4029 
Tel: (07) 3636 5542 
Fax: (07) 3636 5538 
 
STANDARD PARENT/GUARDIAN INFORMATION STATEMENT AND CONSENT FORM 
  
Project Number:  Royal Children’s Hospital: HREC/11/QRCH/35 
University of Queensland: 2011000608                                                                                
  
Title of Project: Mitii – “Move it to improve it”: A Randomised Trial of Novel Internet-based 
Multimodal Therapy for Children with Congenital Hemiplegia. 
 
Chief Investigators: Professor Roslyn Boyd, Professor Jenny Ziviani, A/Professor Stephen 
Rose, Dr Robert Ware, Dr Leanne Sakzewski, A/Professor Anthony Smith, Professor 
Richard MacDonnell, Dr David Abbott, Dr Tracy Comans, Professor Paul Scuffam. 
Associate Investigators: Louise Mitchell, Sarah James, Prof Jens Bo Neilsen, Peder Esben 
Bilde, Dr Koa Whittingham, Melinda Lewis, Rachel Thomas, Dr Lynne McKinlay, Stephanie 
Ross Naomi Westwood, Julien Savina, Lee Reid, Kelly Hentschke and Adina Piovesana. 
 
You are invited to participate in a Research Project that is explained below. 
 
Thank you for taking the time to read this Information Statement. 
This information statement and consent is 9 pages long.  Please make sure you have all the 
pages. 
 
For people who speak languages other than English: 
If you would also like information about the research and the Consent Form in your language, 
please ask the person explaining this project to you. 
 
What is an Information Statement? 
These pages contain a lot of information about a research project we are inviting your child to take 
part in. Please read this information carefully as it explains clearly and openly what is involved in 
participating in this project. This information is to help you to decide whether or not you would like 
your child to take part in the research.  
 
Before you decide to take part or not, you can ask us questions you have about the project.   You 
may want to talk to about the project with your family, friends or one of your child’s therapists.  
 
If you would like your child to take part in the research project, please sign the consent form at the 
end of this information statement. By signing the consent form you are telling us that you: 
 understand what you have read 
 had a chance to ask questions and receive satisfactory answers 
 consent to your child taking part in the project. 
We will give you a copy of the information and consent to keep. 
 
What is the Research Project about? 
Hemiplegia is a type of cerebral palsy that involves just one side of the body – impacting on 
function of the arm and the leg. Many children who have a hemiplegia attend regular school but 
may have physical and cognitive (eg. thinking, memory, attention, planning) difficulties. This might 
mean that children with a hemiplegia find it difficult to participate in the things that they would like to 
do at school, home or in the community. In this study we want to see if a new form of therapy (Mitii 
– Move it to improve it) is effective at improving some physical, manipulation, coordination & 
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cognitive difficulties in children with Hemiplegia. Mitii is delivered over the internet and uses a web-
cam to pick up movements of your child’s arm, leg or head which allows you to play computer 
games on the screen. The therapy can be completed at any time at home. 
 
 
This project has two parts.  Part A is the Assessment and treatment component.  Part B is 
the neuroscience component.  
 
In Part A we want to see if Mitii can help children with hemiplegia improve their physical and 
cognitive skills. We do this by comparing two groups – one who will receive the Mitii training 
straight away for 20 weeks and one who will continue with normal therapy and receive Mitii after 20 
weeks. 98 families will join the study and your child will be allocated randomly to one of two groups. 
The group that they are in is decided by chance – like a flip of a coin. No one is able to influence 
which group your child will be in, however they will receive Mitii despite which group they are in. 
 
When doing the Mitii training we would like your child to do it at home every day for 20 weeks – this 
will mean they get to access up to 60 hours of therapy. The Mitii program is completed at home 
using the internet and a webcam – if you don’t have these things we can loan them to you. The 
webcam picks up the movements of green bands and your child plays the games by moving their 
arm, leg or your head. The Mitii therapists back in Brisbane (occupational therapist, physiotherapist 
and neuropsychologist) will be your child’s ‘virtual trainers’. They will log on and see how your child 
is going and make sure that the program is just right for them by making it harder or easier. If we 
can prove that Mitii does help children with hemiplegia it will mean that children who don’t receive a 
lot of therapy or who live a long way away, will be able to access it at home.  
 
If your child participates in the first part of the study (Part A Assessment and Mitii Training) we will 
also ask you if you want them to be in the second part (Part B the Neuroscience). In this part we 
want to find out how their brain actually controls their hand movements and whether this might 
change after the training. The tests we use are: 
(i) Functional Magnetic Resonance Imaging (fMRI) which shows the parts of the brain that are 
active when you move your hand.  
(ii) Transcranial Magnetic Stimulation (TMS) which measures which side of the brain controls each 
hand. 
 
Both fMRI and TMS are safe to receive as there is no radiation (unlike X rays).  In our study we will 
involve children with a hemiplegia aged 8 to 16 years. We will do the assessments and training at 
the University of Queensland. 
 
Who are the Researchers? 
1. Professor Roslyn Boyd is a Paediatric Physiotherapist. She is the lead investigator of the study 
and will coordinate the project and supervise the staff conducting the assessments and training 
in the program. 
2. Professor Jenny Ziviani is an Occupational Therapist at the University of Queensland who will 
be involved in the study design and analysis. 
3. Associate Professor Stephen Rose, Dr Jens Bo Neilsen are all experienced neurologists and 
neuroscience researchers who are involved in the neuroscience part of the study (the brain 
imaging and measures of brain activity). 
4. Dr Robert Ware is a biostatistician from the School of Population Health, University of 
Queensland who will provide expert opinion on biostatistical analyses. 
5. Sarah James (Occupational Therapist), Stephanie Ross (Psychologist), Louise Mitchell 
(Physiotherapist), Kelly Hentschke (Occupational Therapist) and Adina Piovesana 
(Psychologist) are therapists conducting research. They will do assessments and run the online 
treatment programs. 
6. Dr Leanne Sakzewski is an Occupational Therapist who will assist with the research process 
and conduct some of the analysis. 
7. Peder Esben Bilde is part of the team in Denmark who devised the Mitii program and will 
provide expert assistance with the program implementation and technical support. 
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8. Dr Koa Whittingham is a psychologist who will provide guidance and assistance with measures 
of Executive Functioning. 
9. A/Professor Anthony Smith is the Deputy Director of the Centre for Online Health. He will 
provide technical assistance for the web-based program delivery. 
10. Melinda Lewis is an Occupational Therapist experienced in working with children with CP and 
is the study clinical co-ordinator. 
11. Rachel Thomas (physiotherapist) and Dr Lynne McKinlay work within the Department of 
Paediatric Rehabilitation. They provide clinical support to the Mitii project. 
 
Why is my child being asked to be in this research project? 
They are  
- between 8 and 16 years old and  
- have hemiplegia 
- do not have uncontrolled seizures  
 
What are my child’s alternatives to participating in this project? 
Your child does not have to take part in this project if you do not want them to.  If you decide for 
your child not to participate they will still have access to their normal care and treatment in the 
Department of Paediatric Rehabilitation at the Royal Children’s Hospital, Brisbane. 
You might decide for your child to take part in Part A (the individual assessment and training) but 
not do Part B (the fMRI and TMS). If you decide you don’t want your child to do Part B it won’t 
impact on them doing the Mitii assessment and training (part A).  
 
What do I need to do for my child to be in this research project? 
Before your child is accepted into the study we will call you to do a screening checklist. This will 
help us work out if this study is one that your child can participate in. This is also a chance for us to 
answer any questions or concerns that you or your child might have.  
 
Part A: Assessment Treatment Component 
Once you have consented for your child to participate and they have been accepted into the study, 
you and your child will need to come to the University of Queensland at St Lucia for 3-4 
assessment sessions. Your child will have the opportunity to complete the Mitii training either 
immediately or after a 20 week wait. They will be randomly allocated to either the IMMEDIATE or 
the WAITLIST group using the toss of a coin.  
 
All children will be assessed at baseline and then at 20 weeks (straight after the first group finishes 
training) and 40 weeks after this baseline assessment. If your child is in the WAITLIST group they 
will come back for one further assessment at 60 weeks. 
 
What is the Mitii training – “Move it to improve it”? 
 A web-based, intensive and individualized therapy program; 
 Completed at home using a webcam and computer; 
 Involves a series of interactive, game-like activities that will take approximately 30 minutes 
to complete each day.  
 Uses green band technology to track the movements of the hand/head bands you child 
wears. 
 We ask your child to use the Mitii program each day, over 20 weeks (total of 60 hours 
training).  
 Is Multimodal – uses your child’s physical and thinking skills at the same time.  
 Can be made more challenging each week 
 
You and your child will discuss their progress with the research staff on a weekly basis by email, 
computer skype or phone contact. As this is a new type of treatment we are very interested to find 
out what you and your child think about it.  
 
All assessments will be completed by an Occupational Therapist, Physiotherapist and/or 
Neuropsychologist. The following flow chart outlines the assessments you and your child would do: 
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BASELINE ASSESSMENT: 
 All children come to UQ for an assessment looking at: 
- hand and arm skills 
- physical skills and activity levels 
- attention, memory and other thinking skills. 
- we will also give your child a device called an accelerometer – which is similar to wearing a 
watch on a belt around their waist. This will measure your child’s physical activity and they 
will wear it for 4 days 
IMMEDIATE GROUP comes for two days so they can do the Mitii training 
WAITLIST GROUP comes for one day of assessment.  
We will support travel and overnight accommodation for you and your child if you need it. 
IMMEDIATE GROUP (48 children) 
Starts 20 weeks of Mitii training. 
If your child trains every day they will get access 
to up to 60 hours of therapy. 
 
WAITLIST GROUP (48 children) 
Continue with usual therapy for 20 weeks 
ASSESSMENT 2 at 20 weeks 
All children come back to UQ for an assessment  
We will do a lot of the same assessments that were done with your child at the first assessment to 
see if there have been any changes. 
 
WAITLIST GROUP comes for two days so they can do the Mitii training 
IMMEDIATE GROUP comes for one day of assessment.   
We will support travel and overnight accommodation if you need it. 
IMMEDIATE GROUP 
Continue with usual therapy for 20 weeks 
WAITLIST GROUP 
Starts 20 weeks of Mitii training. 
If your child trains every day you will get access 
to up to 60 hours of therapy. 
 
ASSESSMENT 3 at  40 weeks 
All children come back to UQ for an assessment  
We will do a lot of the same assessments that were done with your child at the first assessment to 
see if there have been any changes. 
BOTH GROUPS come for one day of assessment. We will support travel if you need it. 
 
ASSESSMENT 4 at 60 weeks 
WAITLIST GROUP ONLY will come back to UQ for an assessment for one day 
 
Part B: Neuroimaging Component 
The Neuroimaging component of the assessment will take 1½ - 2 hours and will occur at the same 
visits as the functional assessments.  
 
Whole-brain functional MRI studies (fMRI)  
MRI stands for Magnetic Resonance Imaging. A MRI scanner is a machine that uses 
electromagnetic energy (from strong magnets) to take pictures of the inside of the body. MRI is 
safe and is not the same as ionising radiation, for example, in X-rays. 
Functional MRI (or fMRI) measures the change in blood flow that is related to a change in brain 
activity. This change in brain blood flow is directly related to the hand movements that your child 
will perform while you are in the MRI scanner.  
 
We will ask your child to lie on a firm bed which moves inside the MRI scanner tunnel. The 
scanner will take pictures of the brain. It is very important that your child keeps very still during 
the scanning so that the pictures are not blurry. We will make sure that your child is in a 
comfortable position so that they can keep still. To help keep your child’s head still we will place 
some padding around their head. We will also use some Velcro straps and padding to help 
them keep their body still. The MRI scanner can be very noisy and we will give your child 
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special earphones to reduce the noise and so that they can hear the radiographer explaining to 
them what will happen next. A member of the research team can stay with your child at all times 
and you can wait just outside. You child can talk to the team at any time through a special 
microphone in the headpiece. For some of the scan your child will be able to watch a favourite 
movie or DVD of their choice.  The test should take approximately 1-1.5 hours to complete, but 
only 30-45 minutes of this time will be spent inside the MRI scanner. 
 
There are no proven long-term risks related to MRI scans as used in this research project. MRI is 
considered to be safe when performed at a centre with appropriate procedures. However, the 
magnetic attraction for some metal objects can pose a safety risk, so it is important that metal 
objects are not taken into the scanner room. 
 
We will thoroughly examine your child to make sure there is no reason for them not to have the 
scan. You must tell us if they have had metal, electronic, magnetic or mechanical implants, devices 
or objects in their body, such as a pacemaker, brain clip, ventricular shunt or metal pins. You must 
advise in advance if they have had any previous procedures involving surgery or a general 
anesthetic, so that any devices or objects inside their body can be checked that they are safe for 
use with the 3T MRI scanner. The magnet used in the research MRI scanner is very strong (called 
3 Tesla or 3T), and is twice as strong as the magnet normally used in hospitals. So even if your 
child has had a clinical MRI previously, it is important that we check all past procedures again to 
ensure safety for your child in this higher strength MRI scanner. You will be asked to counter-sign 
an MRI screening form that lists all previous procedures involving surgery or general anesthetic 
since birth in order for MRI compatibility of devices or objects to be checked.  
 
 
Transcranial Magnetic Stimulation (TMS): is a non-invasive method of measuring how the 
brain works, which will involve your child sitting very still in a chair. The researcher will place a 
special metal coil above their head. The coil will send a message to their brain – this is called a 
stimulus. This will cause a slight twitch in the muscle in your child’s hand. The twitch in their 
muscle will be measured by a small metal disc on their skin (a small electrode). At the same 
time as the twitch in their hand, your child might feel the muscles of their scalp tighten. They will 
also hear a click.  This may cause surprise and sometimes people find this uncomfortable. At 
the start the coil will deliver a very small stimulus. We will try and find the smallest message or 
stimulus that is needed to make the twitch. This is called the threshold stimulus. Some children 
may get a slight headache by the end of the procedure. The test will take about an hour. Your 
child does not need to do anything during the test and again they can choose a video to watch 
during the test.  
 
All assessments for Part A and Part B are outlined in the following table: 
 Assessment Table 
Visit 1 :  
BASELINE 
ASSESSMENT  
 
 
Assessments you’re your 
child will take 
approximately 3-4 hours 
 
 
 
 
 
 
 
 
Part A: Clinical Tests: 
Assessments your child will do: 
 Upper-limb and lower-limb passive range of motion  
 Sensory Assessments 
 Grip Strength 
 Assisting Hand Assessment (AHA) 
 Assessment of Motor and Process Skills (AMPS) 
 Melbourne Assessment of Unilateral Upper limb Function 
(MUUL) 
 Jebsen-Taylor Test of Hand Function (JTTHF) 
 Wechsler Intelligence Scale for Children – Version IV 
(WISC-IV) 
 Executive functioning tests 
 Test of Visual Perception Skills (TVPS)  
 Functional strength testing 
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The questionnaires for 
you to complete will take 
between 1-2 hours. They 
are done while your child 
is doing the other 
assessments.  
 
 
 Six-minute walk test 
 4 day Actigraph physical activity recording with written 
record 
 
Questionnaires for you to complete 
 Canadian Occupational Performance Measure (COPM) 
 Brief Rating Inventory of Executive Function (BRIEF) 
 Assessment of Life Habits – modified questionnaire (LIFE-
H) 
 Mobility Questionnaire (Mobques47) 
 Participation and Environment (PEM-CY) 
 Strengths and Difficulties Questionnaire (SDQ) 
 Baseline study questionnaire 
 
Part B: NeuroscienceTests:  
 Functional Magnetic Resonance Imaging (fMRI) 
 Transcranial Magnetic Stimulation (TMS) 
 
ALLOCATION to either 
WAITLIST OR 
IMMEDIATE MITII 
GROUP is revealed to 
each family.  
 
 
WAITLIST MITII GROUP is waitlisted for 20 weeks and 
continues usual care at home. They then return for re-
assessment and training in the Mitii system 
Families allocated to the Immediate Mitii group will receive: 
 Training in the Mitii system  
 Training in the activity log and accelerometer 
measurements 
 They will then receive all equipment required to return home 
and complete the 20 weeks intervention. 
 
Visit 2  
 
20 WEEK FOLLOW-UP 
ASSESSMENT 
 
20 weeks after the 
baseline assessment. 
  
Assessments with your 
child will take 
approximately 3-4 hours 
 
 
 
The questionnaires for 
you to complete will take 
between 1-2 hours. They 
are done while your child 
is doing the other 
assessments. 
 
 
 
 
Part A: Assessment and Training Clinical Tests: 
Assessments your child will do: 
 Assisting Hand Assessment (AHA) 
 Assessment of Motor and Process Skills (AMPS) 
 Melbourne Assessment of Unilateral Upper limb Function 
(MUUL) 
 Jebsen-Taylor Test of Hand Function (JTTHF) 
 Executive functioning tests 
 Test of Visual Perception Skills (TVPS)  
 Functional strength testing 
 Six-minute walk test 
 4 day Actigraph physical activity recording with written 
record 
 
Questionnaires for you to complete 
 Canadian Occupational Performance Measure (COPM)  
 Brief Rating Inventory of Executive Function (BRIEF) 
 Assessment of Life Habits – modified questionnaire (LIFE-
H) 
 Mobility Questionnaire (Mobques47) 
 Participation and Environment (PEM-CY) 
 Strengths and Difficulties Questionnaire (SDQ) 
 Study Questionnaire 
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 Part B: Neurological Tests:  
 Functional Magnetic Resonance Imaging (fMRI) 
 Transcranial Magnetic Stimulation (TMS) 
 
Visit 3:  
40 WEEK FOLLOW-UP 
ASSESSMENT 
 
 
40 weeks after the 
baseline assessment 
 
Assessments with your 
child will take 
approximately 3-4 hours 
 
 
The questionnaires for 
you to complete will take 
between 1-2 hours. They 
are done while your child 
is doing the other 
assessments. 
 
Part A: Clinical Tests: 
Assessments your child will do: 
 Assisting Hand Assessment (AHA) 
 Assessment of Motor and Process Skills (AMPS) 
 Melbourne Assessment of Unilateral Upper limb Function  
 Jebsen-Taylor Test of Hand Function (JTTHF) 
 Executive functioning tests 
 Test of Visual Perception Skills (TVPS)  
 Functional strength testing 
 Six-minute walk test 
 4 day Actigraph physical activity recording with written 
record 
 
Questionnaires for you to complete 
 Canadian Occupational Performance Measure (COPM) 
 Brief Rating Inventory of Executive Function (BRIEF) 
 Assessment of Life Habits – modified questionnaire (LIFE-
H) 
 Mobility Questionnaire (Mobques47) 
 Participation and Environment (PEM-CY) 
 Strengths and Difficulties Questionnaire (SDQ) 
 Study questionnaire  
 
Part B: NeuroscienceTests:  
 Functional Magnetic Resonance Imaging (fMRI) 
 
 
Visit 4:  
60 WEEK FOLLOW-UP 
ASSESSMENT 
WAITLIST GROUP 
ONLY 
 
60 weeks after the 
baseline assessment 
 
Assessments with your 
child will take 
approximately 3-4 hours 
 
 
The questionnaires for 
you to complete will take 
between 1-2 hours. They 
are done while your child 
is doing the other 
assessments. 
Part A: Clinical Tests:  
Assessments your child will do: 
 Assisting Hand Assessment (AHA) 
 Assessment of Motor and Process Skills (AMPS) 
 Melbourne Assessment of Unilateral Upper limb Function  
 Jebsen-Taylor Test of Hand Function (JTTHF) 
 Executive functioning tests 
 Test of Visual Perception Skills (TVPS)  
 Functional strength testing 
 Six-minute walk test 
 4 day Actigraph physical activity recording with written 
record 
 
Questionnaires for you to complete 
 Canadian Occupational Performance Measure (COPM) 
 Brief Rating Inventory of Executive Function (BRIEF) 
 Assessment of Life Habits – modified questionnaire (LIFE-
H) 
 Mobility Questionnaire (Mobques47) 
 Participation and Environment (PEM-CY) 
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  Strengths and Difficulties Questionnaire (SDQ) 
 Study questionnaire  
 
 
Descriptions of the Assessment Measures  
1) Range of motion, spasticity (stiffness), sensation and strength of your child’s impaired arm 
and lower leg. 
2) Assisting Hand Assessment (AHA) – a measure of skill in using both hands together.  
This assessment will be videotaped then scored by an independent rater masked to the 
group allocation.   
3) The Assessment of Motor and Process Skills (AMPS) – your child will be asked to 
complete an activity that they might complete during daily life so that it can be used to 
measure the way they use motor and thinking skills to do daily tasks.  The Occupational 
therapist will measure the quality (by rating the effort, efficiency, safety, and independence 
of motor and process skill items 
4) The Melbourne Assessment of Unilateral Upper limb function (MUUL) - is a videotaped 
measure of arm and hand skills.  It looks at movement quality during tasks which will be 
videotaped and scored by an occupational therapist. 
5) Jebsen-Taylor Test of Hand Function (JTTHF) – is a measure of speed of hand dexterity. 
6) The Wechsler Intelligence Scale for Children (WISC-IV) will be used to measure intellectual 
functioning at baseline to see if it has an impact on your child’s results with Mitii.  
7) Executive Functioning will be assessed with a selection of neuropsychological tests: (i) The 
Colour-Word Interference Test, Trail Making Test and the Tower Test from the Delis-Kaplan 
Executive Function System (DKEFS) to measure cognitive flexibility and response inhibition; 
and (ii) Digit Span, Coding and Symbol Search from the (WISC-IV) to measure working 
memory. Executive Functioning in Everyday Life will be assessed using the parent-report 
questionnaire the Brief Rating Inventory of Executive Function (BRIEF). 
8) Test of Visual Perceptual Skills (TVPS) will be performed on 7 subtests (visuo-spatial 
relationships, visual discrimination, visual memory, visual sequencing memory, visual 
closure, visual constancy and visual figure ground).  
9) Functional strength testing measures how many repetitions of sit to stand and step ups 
your child can do in 30 seconds. 
10) Six-minute walk test (6MWT) will measure the maximum distance walked over a six minutes. 
11) An Activity diary will be used to report on your child’s physical activities. The ActiGraph 
GT3M triaxial accelerometer will also be used and log accelerations of movement. This 
will be worn in the centre of your child’s back and will be worn for 4 days pre-intervention 
and 4 days post-intervention 
12) Canadian Occupational Performance Measure (COPM): asks you and your child to 
identify some things they find difficult in everyday life. You will score how they are going and 
how satisfied you are with how they do those things. This helps to identify goals and 
whether or not the Mitii training has helped your child meet these goals. 
13) Assessment of Life Habits (LIFE-H) is designed to habits in home, school and community 
as appropriate. Four categories will be tested: nutrition (mealtimes), personal care (dressing), 
education and recreation.  
14) Mobility Questionnaire (Mobques47) is a questionnaire that measures mobility limitations 
based on caregiver-reported items.  
15) Participation and Environment (PEM-CY) provides important information about how the 
environment influences participation in the home, school and community.  
16) The Strengths and Difficulty Questionnaire (SDQ) will be used to measure your perceptions 
of prosocial and difficult behaviours in your child. 
17) Neuroimaging tests: 
(i) Whole-brain functional MRI studies (fMRI) is a non-invasive procedure that measures the 
haemodynamic response (change in blood flow) related to neural activity in the brain.  
(ii) Transcranial Magnetic Stimulation (TMS) measures which side of the brain controls each 
hand. 
 
Assessment of Motor and Process Skills (AMPS) test-retest sub-study 
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If your child is having assessments over a two day period, they will be asked if they are happy to 
participate in the AMPS test-retest sub-study.  This involves completing the same two daily tasks 
on DAY TWO that they completed on DAY ONE.  These tasks are chosen on day one 
collaboratively with the child and Occupational Therapist and are tasks that the child is familiar with 
but finds somewhat challenging.  The AMPS assessment takes approximately 10-20 minutes per 
day  The AMPS has shown good test-retest reliability (that is, people typically achieve the same 
score when they complete the test again in a short time period) in adults, yet there is no evidence 
of the test-retest reliability in children with CP.  It is important to carry out this study to ensure that 
the AMPS is a reliable test of daily living skills for children with CP.  If your child does not want to 
participate in the retest component of this study, it will not affect their participation or treatment in 
the overall Mitii study in any way.   
 
Mitii Exit Interviews  
Children and their caregivers who are returning for an appointment after finishing their Mitii training 
will be invited to participate in an exit interview with a Chief Investigator on the project (who you will 
not have met before at your previous visit/s).  These interviews can be done separately or with the 
child and caregiver together, and will be audio recorded to allow for analysis of the interview 
content.  The interviews will take approximately 10 minutes each, or 20 minutes as a combined 
child/caregiver interview.  The Chief Investigator will ask simple questions for example, (i) How did 
you find participating in an online program delivered at home? (ii) Did you have any challenges 
over the 20 weeks? (iii) How does this therapy compare to standard face-to-face therapy? 
Information gained from these interviews will help us as therapists to understand the benefits and 
challenges of delivering online therapy. If you or your child does not wish to do an interview, this 
will not affect your child’s participation in the overall Mitii study in any way.   
 
Is there likely to be a benefit to my child? 
All participants will receive the Mitii Program in the study. If your child logs on to the program for 30 
minutes a day they will have the opportunity to access around 60 hours of an online, interactive, 
multimodal therapy program. Based on information from previous studies you might see 
improvements in their physical skills (strength and endurance), motor processing and task 
performance, and visual perception skills. With these improvements it might lead to more self-
confidence and self-esteem. They might also be able to participate and enjoy more things at 
school, home and in the community. 
  
Is there likely to be a benefit to other people in the future? 
We hope that the results of our project will help other children with hemiplegia and their families in 
the future.  If we find that this type of therapy has better and longer lasting effects on physical and 
cognitive skills, it may change the way we provide treatment in the future.  Better outcomes for 
physical and cognitive training may improve these children’s ability to participate in activities at 
home and school. 
 
11.2.1.1.1.1.1 What are the possible risks and/or side effects? 
We do not think that there will be any risks or side effects from completing the Mitii program. If you 
or your child would like, we can give you information about making sure they have a good balance 
of sedentary ‘screen time’ with electric media and more ‘active’ leisure activities. (Australian 
Government’s National Guidelines for Physical Activity for all children)  
 
There is no known health risks associated with the magnetic radiation in MRI scans. MRI is 
considered a safe procedure when performed at a centre with appropriate guidelines. However, the 
electromagnetic attraction for some metal objects can pose a safety risk, so it is important that 
metal objects are not taken into the scanner room. We will thoroughly examine your child to make 
sure there is no reason for them not to have the scan. You must tell us if your child has metal in 
their body such as a pacemaker, or metal pins/plates after surgery.  The MRI could be mildly 
inconvenient as your child has to remain very still while in the scanner. The noise during the fMRI 
test can be loud but we use high-quality headphones to make sure this is comfortable. Keeping still 
during the fMRI is important, so we will use Velcro strapping to keep your child’s head still - this 
can be a little uncomfortable after 30-45 minutes of scanning.  Your child will receive a practice 
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session in a mock scanner before the real fMRI.  At this time they can try lying in a mock scanner 
and ask any questions. The research team has safely performed over 150 functional MRIs with 
children with cerebral palsy.  
 
The MRI scans taken are for research purposes. They are not intended to be used like brain scans 
taken for a full clinical examination. The scans cannot be used to help diagnose, treat or manage a 
particular condition. A specialist will look at the MRI scans for features relevant to the research 
project. On rare occasions, the specialist may find an unusual feature that could have a significant 
risk to a participant’s health. If this happens, we will contact families to talk about the findings. In 
the unlikely event that we find an unusual feature, it could have consequences for a participant. It 
may impact on their ability to work in certain professions, or get life or health insurance. However, if 
we do find an unusual feature, a participant may be able to get treatment that might be of benefit. 
We cannot guarantee that we will find any/all unusual features. Participants will be notified of these 
issues when they are considering being in the study.  
 
Transcranial Magnetic Stimulation (TMS) is a safe procedure. We do not anticipate any adverse 
side effects.  Some children may get a slight headache by the end of the procedure.  There is an 
extremely low (0-3.6%) risk of TMS causing a seizure. It should be noted that in all the reports in 
which seizures have been associated with TMS, it was unclear whether this really was due to TMS 
or a coincidental finding in patients already having frequent seizures.  
 
What are the possible discomforts and/or inconveniences? 
You will have 3-4 visits with your child to the university to do the assessments. We will do our best 
to make sure that you have a lot of time to plan for these visits. The only inconvenience to you and 
your family will be the time of the assessments.  The assessments will take approximately 5 hours 
in total (3-4 hours for the clinical assessments, and 1-2 hours for the neurological assessments 
with a break in between). You will do this with your child on three separate occasions over the 10 
months of the study at UQ. Your child can do your Mitii training at home at any time that suits you 
and your family.  
  
What will be done to make sure the information is confidential?   
All results of assessments will be stored without your child’s name on them. A number will be used 
to identify them. This number will be linked to your child’s name but the linking file will be kept 
confidential, separate to their data and only made available to the researchers.  Data collection 
sheets recording the assessment scores and the videotapes of the assessments and group 
program will be stored in a secure filing cabinet and only the researchers will have access to this 
information. On the video files, your child will be able to be identified and these files will be used for 
assessment purposes only for this study.  These video files would not be used for teaching or 
promotional material for the project without directly seeking your permission separate to your child 
participating in this study. These data sheets and video CDs/files will be kept at the RCH in a 
locked filing cabinet or in a password-protected digital file on a secure server that is only able to be 
accessed by the researchers until the youngest child in the study turns 21 years of age, and then 
destroyed. If we give presentations or write about the results of this project, we will not use any 
names or identifying details. 
 
Will I be informed of the results when the research project is finished? 
If at any time you would like information about your child’s results, an appointment will be 
organised with one of the researchers.   A newsletter will also be sent to you about the progress of 
the study every 6 months. At the end of the study, all families will be sent a summary of the results. 
The newsletter and final summary will talk about the children as a group and your child will not be 
identified in person.  
 
You can decide whether or not to give permission for your child to take part in this research 
project.  You can decide whether or not you would like to withdraw your child at any time 
without explanation. 
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You can talk to your family or other people about this study. You can ask for any information 
before you decide if you would like your child to participate.  If you would like more information 
about the study or if you need to contact a study representative in an emergency, the person to 
contact is:                                      
 
Name:    Professor Roslyn Boyd   Melinda Lewis 
                                     Chief Investigator                                           Study Co-coordinator 
Contact telephone:   + 61 (7) 3365 5315    +61 (7) 3646 6423 
QCPRRC Administration:   + 61 (7) 3646 5542   
 
What are my rights as a participant? 
 I am informed that except where stated above, no information regarding my medical history will 
be released.  This is subject to legal requirements. 
 I am informed that the results of any tests involving me will not be published so as to reveal my 
identity.  This is subject to legal requirements. 
 The detail of the procedure proposed has also been explained to me.  This includes how long it 
will take, how often the procedure will be performed and whether any discomfort will result. 
 It has also been explained that my involvement in the research may not be of any benefit to 
me.  I understand that the purpose of this research project is to improve the quality of medical 
care in the future. 
 I have been asked if I would like to have a family member or a friend with me while the project 
is explained to me. 
 I understand that this project follows the guidelines of the National Statement on Ethical 
Conduct in Research Involving Humans (2007). 
 I understand that this research project has been approved by the Royal Children’s Hospital 
Ethics in Human Research Committee on behalf of the Royal Children’s Hospital Board. 
 I have received a copy of this document. 
 
Ethics Contact:  
The Human Research Ethics Committee of the Royal Children’s Hospital and Health Services 
District has approved this study.  Should you wish to discuss the study with someone not directly 
involved, in particular in relation to matters concerning policies, information about the conduct of 
the study or your rights as a participant, or if you wish to make a confidential complaint, please 
contact: 
RCH&HSD Ethics Committee Coordinator 
Royal Children’s Hospital and Health Services District 
Level 3, RCH Foundation Building,  
Royal Children’s Hospital 
Herston Road 
Herston  QLD  4029 
Tel: (07) 3636 9167 (Monday to Friday 9am-5pm)  
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Queensland Cerebral Palsy & Rehabilitation Research Centre 
Royal Children’s Hospital 
Herston Road 
HERSTON  QLD  4029 
Tel: (07) 3636 5542 
Fax: (07) 3636 5538 
 
STANDARD INFORMED CONSENT FOR PARENT/GUARDIAN TO GIVE CONSENT FOR 
THEIR CHILD TO PARTICIPATE IN A RESEARCH PROJECT 
 
Project Number 
RCH Brisbane: HREC/11/QRCH/35                                    UQ: 2011000608                                               
 
Title of Project 
MiTii - A Randomised Trial of Novel Internet-based Multimodal Therapy for Children 
with Congenital Hemiplegia. 
 
Investigator(s)  
Professor Roslyn Boyd, Professor Jenny Ziviani, A/Professor Stephen Rose, Dr David Abbott, 
Professor Richard Macdonell, Dr Robert Ware, Dr Leanne Sakzewski, A/Professor Anthony Smith, 
Professor Jens Bo Neilsen, Louise Mitchell, Sarah James, Peder Esben Bilde, Dr Koa Whittingham, Dr 
Radwa Badawy, Stephanie Ross, Carly Mayberry & Melinda Lewis. 
 
I (parent/guardian name) ______________________________ voluntarily consent for my child to 
take part in the above titled Research Project, explained to me by  
Mr/Ms/Dr/Prof ______________________________. 
I have received a Parent/Guardian Information Statement to keep and I believe I understand the 
purpose, extent and possible effects of my child's involvement 
I have been asked if I would like to have a family member or friend with me while the project was 
explained 
I have had an opportunity to ask questions and I am satisfied with the answers I have received 
I understand that the researcher has agreed not to reveal results of any information involving my 
child, subject to legal requirements 
If information about this project is published or presented in any public form, I understand that the 
researcher will not reveal my child's identity 
I understand that if I refuse to consent to my child's participation, or if I withdraw my child from the 
project at any time without explanation, this will not affect my child's access to the best available 
treatment options and care from the Royal Children's Hospital 
I understand I will receive a copy of this consent form 
 
- I consent for my child to participate in Part 1a: treatment component of this research 
project       YES □  NO □ 
- I consent for my child to participate in Part 1b: Neurological imaging component of 
this research (fMRI and TMS)   N/A □  YES □  NO □ 
- I consent for medical information (eg surgical notes) to be provided to staff at Centre 
for Advanced imaging to confirm safety for my child to have a fMRI scan. 
N/A □  YES □  NO □ 
- I consent for my child to have video recordings of their assessments being taken and 
digitally stored for research evaluation purposes YES □  NO □ 
- I consent to the use of my child’s data in other studies that are approved by a Human 
Research Ethics Committee.     YES □  NO □ 
 
PARENT/GUARDIAN SIGNATURE:   ____________________________  Date _____________ 
I have explained the study to the parent/guardian who has signed above, and believe that they 
understand the purpose, extent and possible effects of their child's involvement in this study. 
 
RESEARCHER’S SIGNATURE:  _________________________________  Date _____________ 
Note: All parties signing the Consent Form must date their own signature. 
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11.3  Participant information and consent forms 
 
 228 
 
Queensland Cerebral Palsy & Rehabilitation Research Centre 
Royal Children’s Hospital 
Herston Road 
HERSTON QLD 4029 
Tel: (07) 3636 5542 
Fax: (07) 3636 5538 
 
STANDARD PARTICIPANT INFORMATION STATEMENT AND ASSENT FORM 
  
Project Number:  Royal Children’s Hospital: HREC/11/QRCH/35 
University of Queensland: 2011000608                                                                                
  
Title of Project: Mitii – “Move it to improve it”: A Randomised Trial of Novel Internet-based 
Multimodal Therapy for Children with Congenital Hemiplegia. 
 
Chief Investigators: Professor Roslyn Boyd, Professor Jenny Ziviani, A/Professor Stephen 
Rose, Dr Robert Ware, Dr Leanne Sakzewski, A/Professor Anthony Smith, Professor 
Richard MacDonnell, Dr David Abbott, Dr Tracy Comans, Professor Paul Scuffam 
Associate Investigators: Louise Mitchell, Sarah James, Prof Jens Bo Neilsen, Peder Esben 
Bilde, Dr Koa Whittingham, Melinda Lewis, Rachel Thomas, Dr Lynne McKinlay, Stephanie 
Ross, Naomi Westwood, Julien Savina, Lee Reid, Kelly Hentschke and Adina Piovesana.  
 
You are invited to participate in a Research Project that is explained below. 
 
Thank you for taking the time to read this Information Statement. 
This information statement and consent is 10 pages long.  Please make sure you have all the 
pages. 
 
For people who speak languages other than English: 
If you would also like information about the research and the Consent Form in your language, 
please ask the person explaining this project to you. 
 
What is an Information Statement? 
These pages contain a lot of information about a research project we are inviting you to take part 
in. Please read this information carefully as it explains clearly and openly what is involved in 
participating in this project. This information is to help you to decide whether or not you would like 
to take part in the research.  
 
Before you decide to take part or not, you can ask us questions you have about the project.   You 
may want to talk to about the project with your family, friends or one of your therapists.  
 
If you would like to take part in the research project, please sign the consent form at the end of this 
information statement. By signing the consent form you are telling us that you: 
 understand what you have read 
 had a chance to ask questions and receive satisfactory answers 
 consent to taking part in the project. 
We will give you a copy of the information and consent to keep. 
 
What is the Research Project about? 
Hemiplegia is a type of cerebral palsy that involves just one side of the body – impacting on 
function of the arm and the leg. Many children who have a hemiplegia attend regular school but 
may have physical and cognitive (eg. thinking, memory, attention, planning) difficulties. This might 
mean that children with a hemiplegia find it difficult to participate in the things that they would like to 
do at school, home or in the community. In this study we want to see if a new form of therapy (Mitii 
– Move it to improve it) is effective at improving some physical, manipulation, coordination & 
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cognitive difficulties in children with Hemiplegia. Mitii is delivered over the internet and uses a web-
cam to pick up movements of your arm, leg or head which allows you to play computer games on 
the screen. The therapy can be completed at any time at home. 
 
 
This project has two parts.  Part A is the Assessment and treatment component.  Part B is 
the neuroscience component.  
 
In Part A we want to see if Mitii can help children with hemiplegia improve their physical and 
cognitive skills. We do this by comparing two groups – one who will receive the Mitii training 
straight away for 20 weeks and one who will continue with normal therapy and receive Mitii after 20 
weeks. 98 families will join the study and you will be allocated randomly to one of two groups. The 
group that you are in is decided by chance – like a flip of a coin. No one is able to influence which 
group you will be in, however you will receive Mitii despite which group you are in. 
 
When you are doing the Mitii training we would like you to do it at home every day for 20 weeks – 
this will mean you get to access up to 60 hours of therapy. The Mitii program is completed at home 
using the internet and a webcam – if you don’t have these things we can loan them to you. The 
webcam picks up the movements of green bands and you play the games by moving your arm, leg 
or your head. The Mitii therapists back in Brisbane (occupational therapist, physiotherapist and 
neuropsychologist) will be your ‘virtual trainers’. They will log on and see how you are going and 
make sure that the program is just right for you by making it harder or easier. If we can prove that 
Mitii does help children with hemiplegia it will mean that children who don’t receive a lot of therapy 
or who live a long way away, will be able to access it at home.  
 
If you participate in the first part of the study (Part A Assessment and Mitii Training) we will also 
ask you if you want to be in the second part (Part B the Neuroscience). In this part we want to find 
out how your brain actually controls your hand movements and whether this might change after the 
training. The tests we use are: 
(i) Functional Magnetic Resonance Imaging (fMRI) which shows the parts of the brain that are 
active when you move your hand.  
(ii) Transcranial Magnetic Stimulation (TMS) which measures which side of the brain controls each 
hand. 
 
Both fMRI and TMS are safe to receive as there is no radiation (unlike X rays).  In our study we will 
involve children with a hemiplegia aged 8 to 16 years. We will do the assessments and training at 
the University of Queensland. 
 
Who are the Researchers? 
12. Professor Roslyn Boyd is a Paediatric Physiotherapist. She is the lead investigator of the study 
and will coordinate the project and supervise the staff conducting the assessments and training 
in the program. 
13. Professor Jenny Ziviani is an Occupational Therapist at the University of Queensland who will 
be involved in the study design and analysis. 
14. Associate Professor Stephen Rose, Dr Jens Bo Neilsen are all experienced neurologists and 
neuroscience researchers who are involved in the neuroscience part of the study (the brain 
imaging and measures of brain activity). 
15. Dr Robert Ware is a biostatistician from the School of Population Health, University of 
Queensland who will provide expert opinion on biostatistical analyses. 
16. Sarah James (Occupational Therapist), Stephanie Ross (Psychologist), Louise Mitchell 
(Physiotherapist), Kelly Hentschke (Occupational Therapist) and Adina Piovesana 
(Psychologist) are therapists conducting research. They will do assessments and run the online 
treatment programs. 
17. Dr Leanne Sakzewski is an Occupational Therapist who will assist with the research process 
and conduct some of the analysis. 
18. Peder Esben Bilde is part of the team in Denmark who devised the Mitii program and will 
provide expert assistance with the program implementation and technical support. 
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19. Dr Koa Whittingham is a psychologist who will provide guidance and assistance with measures 
of Executive Functioning. 
20. A/Professor Anthony Smith is the Deputy Director of the Centre for Online Health. He will 
provide technical assistance for the web-based program delivery. 
21. Melinda Lewis is an Occupational Therapist experienced in working with children with CP and 
is the study clinical co-ordinator. 
22. Rachel Thomas (physiotherapist) and Dr Lynne McKinlay work within the Department of 
Paediatric Rehabilitation. They provide clinical support to the Mitii project. 
 
Why am I being asked to be in this research project? 
You are  
- between 8 and 16 years old and  
- have hemiplegia 
- do not have uncontrolled seizures  
 
What are my alternatives to participating in this project? 
You do not have to take part in this project if you do not want to.  If you decide not to participate 
you will still have access to your normal care and treatment in the Department of Paediatric 
Rehabilitation at the Royal Children’s Hospital, Brisbane. 
You might decide to take part in Part A (the individual assessment and training) but not do Part B 
(the fMRI and TMS). If you decide you don’t want to do Part B it won’t impact on you doing the Mitii 
assessment and training (part A).  
 
What do I need to do to be in this research project? 
Before you are accepted into the study we will call your parent/guardian to do a screening 
checklist. This will help us work out if this study is one that you can participate in. This is also a 
chance for us to answer any questions or concerns that you or your parent/guardian might have.  
 
Part A: Assessment Treatment Component 
Once you have consented to participate and have been accepted into the study, you and your 
parent/guardian will need to come to the University of Queensland at St Lucia for 3-4 assessment 
sessions. You will have the opportunity to complete the Mitii training either immediately or after a 
20 week wait. You will be randomly allocated to either the IMMEDIATE or the WAITLIST group 
using the toss of a coin.  
 
All children will be assessed at baseline and then at 20 weeks (straight after the first group finishes 
training) and 40 weeks after this baseline assessment. If you are in the WAITLIST group you will 
come back for one further assessment at 60 weeks. 
 
What is the Mitii training – “Move it to improve it”? 
 A web-based, intensive and individualized therapy program; 
 Completed at home using a webcam and computer; 
 Involves a series of interactive, game-like activities that will take approximately 30 minutes 
to complete each day.  
 Uses green band technology to track the movements of the hand/head bands you wear. 
 We ask you to use the Mitii program each day, over 20 weeks (total of 60 hours training).  
 Is Multimodal – uses your physical and thinking skills at the same time.  
 Can be made more challenging each week 
 
You and your family will discuss your progress with the research staff on a weekly basis by email, 
computer skype or phone contact. As this is a new type of treatment we are very interested to find 
out what you think about it.  
 
All assessments will be completed by an Occupational Therapist, Physiotherapist and/or 
Neuropsychologist. The following flow chart outlines the assessments you and your parents would 
do: 
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BASELINE ASSESSMENT: 
 All children come to UQ for an assessment looking at: 
- hand and arm skills 
- physical skills and activity levels 
- attention, memory and other thinking skills. 
- we will also give you a device called an accelerometer – which is similar to wearing a watch 
on a belt around your waist. This will measure your physical activity and you will wear it for 
4 days 
IMMEDIATE GROUP comes for two days so they can do the Mitii training 
WAITLIST GROUP comes for one day of assessment.  
We will support travel and overnight accommodation if you need it. 
IMMEDIATE GROUP (48 children) 
Starts 20 weeks of Mitii training. 
If you train every day you will get access to up 
to 60 hours of therapy. 
 
WAITLIST GROUP (48 children) 
Continue with usual therapy for 20 weeks 
ASSESSMENT 2 at 20 weeks 
All children come back to UQ for an assessment  
We will do a lot of the same assessments that were done with you at the first assessment to see if 
there have been any changes. 
 
WAITLIST GROUP comes for two days so they can do the Mitii training 
IMMEDIATE GROUP comes for one day of assessment.   
We will support travel and overnight accommodation if you need it. 
IMMEDIATE GROUP 
Continue with usual therapy for 20 weeks 
WAITLIST GROUP 
Starts 20 weeks of Mitii training. 
If you train every day you will get access to up 
to 60 hours of therapy. 
 
ASSESSMENT 3 at  40 weeks 
All children come back to UQ for an assessment  
We will do a lot of the same assessments that were done with you at the first assessment to see if 
there have been any changes. 
BOTH GROUPS come for one day of assessment. We will support travel if you need it. 
 
ASSESSMENT 4 at 60 weeks 
WAITLIST GROUP ONLY will come back to UQ for an assessment for one day 
 
Part B: Neuroimaging Component 
The Neuroimaging component of the assessment will take 1½ - 2 hours and will occur at the same 
visits as the functional assessments.  
 
Whole-brain functional MRI studies (fMRI)  
MRI stands for Magnetic Resonance Imaging. A MRI scanner is a machine that uses 
electromagnetic energy (from strong magnets) to take pictures of the inside of the body. MRI is 
safe and is not the same as ionising radiation, for example, in X-rays. 
Functional MRI (or fMRI) measures the change in blood flow that is related to a change in brain 
activity. This change in brain blood flow is directly related to the hand movements that you will 
perform while you are in the MRI scanner.  
 
We will ask you to lie on a firm bed which moves inside the MRI scanner tunnel. The scanner 
will take pictures of the brain. It is very important that you keep very still during the scanning so 
that the pictures are not blurry. We will make sure that you are in a comfortable position so that 
you can keep still. To help keep your head still we will place some padding around your head. 
We will also use some Velcro straps and padding to help you keep your body still. The MRI 
scanner can be very noisy and we can give you special earphones to reduce the noise and so 
that you can hear the radiographer explaining to you what will happen next. A member of the 
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research team can stay with you at all times and your parent/guardian will be just outside. You 
can talk to the team at any time through a special microphone in the headpiece. For some of the 
scan you will be able to watch a favourite movie or DVD of your choice.  The test should take 
approximately 1-1.5 hours to complete, but only 30-45 minutes of this time will be spent inside 
the MRI scanner. 
 
There are no proven long-term risks related to MRI scans as used in this research project. MRI is 
considered to be safe when performed at a centre with appropriate procedures. However, the 
magnetic attraction for some metal objects can pose a safety risk, so it is important that metal 
objects are not taken into the scanner room. 
 
We will thoroughly examine you to make sure there is no reason for you not to have the scan. You 
must tell us if you have metal, electronic, magnetic or mechanical implants, devices or objects in 
your body, such as a pacemaker, brain clip, ventricular shunt or metal pins. You must advise if you 
have had any previous procedures involving surgery or a general anesthetic, so that any devices or 
objects inside your body can be checked that they are safe for use with the 3T MRI scanner. The 
magnet used in the research MRI scanner is very strong (called 3 Tesla or 3T), and is twice as 
strong as the magnet normally used in hospitals. So even if you have had a clinical MRI previously, 
it is important that we check all past procedures again to ensure safety for you in this higher 
strength MRI scanner.   
 
Transcranial Magnetic Stimulation (TMS): is a non-invasive method of measuring how the 
brain works, which will involve you sitting very still in a chair. The researcher will place a special 
metal coil above your head. The coil will send a message to your brain – this is called a 
stimulus. This will cause a slight twitch in the muscle in your hand. The twitch in your muscle will 
be measured by a small metal disc on your skin (a small electrode). At the same time as the 
twitch in your hand, you might feel the muscles of your scalp tighten. You will also hear a click.  
This may cause surprise and sometimes people find this uncomfortable. At the start the coil will 
deliver a very small stimulus. We will try and find the smallest message or stimulus that is 
needed to make the twitch. This is called the threshold stimulus. Some children may get a slight 
headache by the end of the procedure. The test will take about an hour. You do not need to do 
anything during the test and again you can choose a video to watch during the test.  
 
All assessments for Part A and Part B are outlined in the following table: 
 Assessment Table 
Visit 1 :  
BASELINE 
ASSESSMENT  
 
 
Assessments with you 
will take approximately 3-
4 hours 
 
 
 
 
 
 
 
 
 
 
 
 
Part A: Clinical Tests: 
Assessments you will do: 
 Upper-limb and lower-limb passive range of motion  
 Sensory Assessments 
 Grip Strength 
 Assisting Hand Assessment (AHA) 
 Assessment of Motor and Process Skills (AMPS) 
 Melbourne Assessment of Unilateral Upper limb Function 
(MUUL) 
 Jebsen-Taylor Test of Hand Function (JTTHF) 
 Wechsler Intelligence Scale for Children – Version IV 
(WISC-IV) 
 Executive functioning tests 
 Test of Visual Perception Skills (TVPS)  
 Functional strength testing 
 Six-minute walk test 
 4 day Actigraph physical activity recording with written 
record 
 
Questionnaires for your parent/guardian to complete 
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The questionnaires for 
your parents to complete 
will take between 1-2 
hours. They are done 
while you are doing the 
other assessments.  
 
 
 Canadian Occupational Performance Measure (COPM) 
 Brief Rating Inventory of Executive Function (BRIEF) 
 Assessment of Life Habits – modified questionnaire (LIFE-
H) 
 Mobility Questionnaire (Mobques47) 
 Participation and Environment (PEM-CY) 
 Strengths and Difficulties Questionnaire (SDQ) 
 Baseline study questionnaire 
 
Part B: NeuroscienceTests:  
 Functional Magnetic Resonance Imaging (fMRI) 
 Transcranial Magnetic Stimulation (TMS) 
  
 
ALLOCATION to either 
WAITLIST OR 
IMMEDIATE MITII 
GROUP is revealed to 
each family.  
 
 
WAITLIST MITII GROUP is waitlisted for 20 weeks and 
continues usual care at home. They then return for re-
assessment and training in the Mitii system 
Families allocated to the Immediate Mitii group will receive: 
 Training in the Mitii system  
 Training in the activity log and accelerometer 
measurements 
 They will then receive all equipment required to return home 
and complete the 20 weeks intervention. 
 
Visit 2  
 
20 WEEK FOLLOW-UP 
ASSESSMENT 
 
20 weeks after the 
baseline assessment. 
  
Assessments with you 
will take approximately 3-
4 hours 
 
 
 
The questionnaires for 
your parents to complete 
will take between 1-2 
hours. They are done 
while you are doing the 
other assessments. 
 
 
 
 
 
Part A: Assessment and Training Clinical Tests: 
Assessments you will do: 
 Assisting Hand Assessment (AHA) 
 Assessment of Motor and Process Skills (AMPS) 
 Melbourne Assessment of Unilateral Upper limb Function 
(MUUL) 
 Jebsen-Taylor Test of Hand Function (JTTHF) 
 Executive functioning tests 
 Test of Visual Perception Skills (TVPS)  
 Functional strength testing 
 Six-minute walk test 
 4 day Actigraph physical activity recording with written 
record 
 
Questionnaires for your parent/guardian to complete 
 Canadian Occupational Performance Measure (COPM)  
 Brief Rating Inventory of Executive Function (BRIEF) 
 Assessment of Life Habits – modified questionnaire (LIFE-
H) 
 Mobility Questionnaire (Mobques47) 
 Participation and Environment (PEM-CY) 
 Strengths and Difficulties Questionnaire (SDQ) 
 Study Questionnaire 
Part B: Neurological Tests:  
 Functional Magnetic Resonance Imaging (fMRI) 
 Transcranial Magnetic Stimulation (TMS) 
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Visit 3:  
40 WEEK FOLLOW-UP 
ASSESSMENT 
 
 
40 weeks after the 
baseline assessment 
 
Assessments with you 
will take approximately 3-
4 hours 
 
 
The questionnaires for 
your parents to complete 
will take between 1-2 
hours. They are done 
while you are doing the 
other assessments. 
 
Part A: Clinical Tests: 
Assessments you will do: 
 Assisting Hand Assessment (AHA) 
 Assessment of Motor and Process Skills (AMPS) 
 Melbourne Assessment of Unilateral Upper limb Function  
 Jebsen-Taylor Test of Hand Function (JTTHF) 
 Executive functioning tests 
 Test of Visual Perception Skills (TVPS)  
 Functional strength testing 
 Six-minute walk test 
 4 day Actigraph physical activity recording with written 
record 
 
Questionnaires for your parent/guardian to complete 
 Canadian Occupational Performance Measure (COPM) 
 Brief Rating Inventory of Executive Function (BRIEF) 
 Assessment of Life Habits – modified questionnaire (LIFE-
H) 
 Mobility Questionnaire (Mobques47) 
 Participation and Environment (PEM-CY) 
 Strengths and Difficulties Questionnaire (SDQ) 
 Study questionnaire  
 
Part B: Neurological Tests:  
 Functional Magnetic Resonance Imaging (fMRI) 
 
 
Visit 4:  
60 WEEK FOLLOW-UP 
ASSESSMENT 
WAITLIST GROUP 
ONLY 
 
60 weeks after the 
baseline assessment 
 
Assessments with you 
will take approximately 3-
4 hours 
 
 
The questionnaires for 
your parents to complete 
will take between 1-2 
hours. They are done 
while you are doing the 
other assessments. 
 
Part A: Clinical Tests:  
Assessments your will do: 
 Assisting Hand Assessment (AHA) 
 Assessment of Motor and Process Skills (AMPS) 
 Melbourne Assessment of Unilateral Upper limb Function  
 Jebsen-Taylor Test of Hand Function (JTTHF) 
 Executive functioning tests 
 Test of Visual Perception Skills (TVPS)  
 Functional strength testing 
 Six-minute walk test 
 4 day Actigraph physical activity recording with written 
record 
 
Questionnaires for your parent/guardian to complete 
 Canadian Occupational Performance Measure (COPM) 
 Brief Rating Inventory of Executive Function (BRIEF) 
 Assessment of Life Habits – modified questionnaire (LIFE-
H) 
 Mobility Questionnaire (Mobques47) 
 Participation and Environment (PEM-CY) 
 Strengths and Difficulties Questionnaire (SDQ) 
 Study questionnaire  
 
Descriptions of the Assessment Measures  
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18) Range of motion, spasticity (stiffness), sensation and strength of your impaired arm and 
lower leg. 
19) Assisting Hand Assessment (AHA) – a measure of your skill in using both hands 
together.  This assessment will be videotaped then scored by an independent rater masked 
to the group allocation.   
20) The Assessment of Motor and Process Skills (AMPS) – you will be asked to complete 
an activity that you might complete during your daily life so that it can be used to measure 
the way you use your motor and thinking skills to do daily tasks.  The Occupational therapist 
will measure the quality (by rating the effort, efficiency, safety, and independence of motor 
and process skill items 
21) The Melbourne Assessment of Unilateral Upper limb function (MUUL) - is a videotaped 
measure of your arm and hand skills.  It looks at movement quality during tasks which will 
be videotaped and scored by an occupational therapist. 
22) Jebsen-Taylor Test of Hand Function (JTTHF) – is a measure of speed of hand dexterity. 
23) The Wechsler Intelligence Scale for Children (WISC-IV) will be used to measure intellectual 
functioning at baseline to see if it has an impact on your results with Mitii.  
24) Executive Functioning will be assessed with a selection of neuropsychological tests: (i) The 
Colour-Word Interference Test, Trail Making Test and the Tower Test from the Delis-Kaplan 
Executive Function System (DKEFS) to measure cognitive flexibility and response inhibition; 
and (ii) Digit Span, Coding and Symbol Search from the (WISC-IV) to measure working 
memory. Executive Functioning in Everyday Life will be assessed using the parent-report 
questionnaire the Brief Rating Inventory of Executive Function (BRIEF). 
25) Test of Visual Perceptual Skills (TVPS) will be performed on 7 subtests (visuo-spatial 
relationships, visual discrimination, visual memory, visual sequencing memory, visual 
closure, visual constancy and visual figure ground).  
26) Functional strength testing measures how many repetitions of sit to stand and step ups 
you can do in 30 seconds. 
27) Six-minute walk test (6MWT) will measure the maximum distance walked over a six minutes. 
28) An Activity diary will be used to report on your physical activities. The ActiGraph GT3M 
triaxial accelerometer will also be used and log accelerations of movement. This will be 
worn in the centre of your back and will be worn for 4 days pre-intervention and 4 days 
post-intervention 
29) Canadian Occupational Performance Measure (COPM): asks you to identify some things 
you find difficult in everyday life. You will score how you are going and how satisfied you are 
with how you do those things. This helps to identify goals and whether or not the MiiTi 
training has helped you meet these goals. 
30) Assessment of Life Habits (LIFE-H) is designed to habits in home, school and community 
as appropriate. Four categories will be tested: nutrition (mealtimes), personal care (dressing), 
education and recreation. Your parent/guardian will complete this.    
31) Mobility Questionnaire (Mobques47) is a questionnaire that measures mobility limitations 
based on caregiver-reported items.  
32) Participation and Environment (PEM-CY) provides important information about how the 
environment influences participation in the home, school and community.  
33) The Strengths and Difficulty Questionnaire (SDQ) will be used to measure parent’s 
perceptions of prosocial and difficult behaviours in their child. 
34) Neuroimaging tests: 
(i) Whole-brain functional MRI studies (fMRI) is a non-invasive procedure that measures the 
haemodynamic response (change in blood flow) related to neural activity in the brain.  
(ii) Transcranial Magnetic Stimulation (TMS) measures which side of the brain controls each 
hand. 
 
Assessment of Motor and Process Skills (AMPS) test-retest sub-study 
If you are coming for your assessments over two days, you will be asked if they are happy to 
participate in the AMPS test-retest sub-study.  You would do the same two daily tasks on DAY 
TWO that they completed on DAY ONE.  The tasks are activities like putting on your shoes or 
making a jam sandwich.  This activity would take about 10-20 minutes each day.  If you do not 
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want to do this part of this study, it will not affect your participation or treatment in the overall Mitii 
study in any way.   
 
Mitii Exit Interviews  
After finishing the Mitii program, you and your parent/guardian may be invited to participate in an 
interview to talk about the Mitii program.  These interviews can be done by yourself or together 
with your parent/guardian.  The interviews will be audio recorded and take about 10-20 minutes.  
You will be asked some simple questions for example, (i) What did you like about Mitii? (ii) What 
didn’t you like about Mitii? (iii) How does this therapy compare to going to see a therapist? If you 
don’t want to do an interview, this will not affect your child’s participation in the overall Mitii study 
at all.   
 
Is there likely to be a benefit to me? 
All participants will receive the Mitii Program in the study. If you log on to the program for 30 
minutes a day you will have the opportunity to access around 60 hours of an online, interactive, 
multimodal therapy program. Based on information from previous studies you might see 
improvements in your physical skills (strength and endurance), motor processing and task 
performance, and visual perception skills. With these improvements it might lead to more self-
confidence and self-esteem. You might also be able to participate and enjoy more things at school, 
home and in the community. 
  
Is there likely to be a benefit to other people in the future? 
We hope that the results of our project will help other children with hemiplegia and their families in 
the future.  If we find that this type of therapy has better and longer lasting effects on physical and 
cognitive skills, it may change the way we provide treatment in the future.  Better outcomes for 
physical and cognitive training may improve these children’s ability to participate in activities at 
home and school. 
 
11.3.1.1.1.1.1 What are the possible risks and/or side effects? 
We do not think that there will be any risks or side effects from completing the Mitii program. If you 
or your parent/guardian would like, we can give you information about making sure you have a 
good balance of sedentary ‘screen time’ with electric media and more ‘active’ leisure activities. 
(Australian Government’s National Guidelines for Physical Activity for all children)  
 
There is no known health risks associated with the magnetic radiation in MRI scans. MRI is 
considered a safe procedure when performed at a centre with appropriate guidelines. However, the 
electromagnetic attraction for some metal objects can pose a safety risk, so it is important that 
metal objects are not taken into the scanner room. We will thoroughly examine you to make sure 
there is no reason for you not to have the scan. You must tell us if you have metal in your body 
such as a pacemaker, or metal pins/plates after surgery.  The MRI could be mildly inconvenient as 
you have to remain very still while in the scanner. The noise during fMRI test can be loud but we 
use high-quality headphones to make sure this is comfortable. Keeping still during the fMRI is 
important, so we will use Velcro strapping to keep your head still - this can be a little uncomfortable 
after 30-45 minutes of scanning.  You will receive a practice session in a mock scanner before the 
real fMRI.  At this time you can try lying in a mock scanner and ask any questions. The research 
team has safely performed over 150 functional MRIs with children with cerebral palsy.  
 
The MRI scans taken are for research purposes. They are not intended to be used like brain scans 
taken for a full clinical examination. The scans cannot be used to help diagnose, treat or manage a 
particular condition. A specialist will look at the MRI scans for features relevant to the research 
project. On rare occasions, the specialist may find an unusual feature that could have a significant 
risk to a participant’s health. If this happens, we will contact families to talk about the findings. In 
the unlikely event that we find an unusual feature, it could have consequences for a participant. It 
may impact on their ability to work in certain professions, or get life or health insurance. However, if 
we do find an unusual feature, a participant may be able to get treatment that might be of benefit. 
We cannot guarantee that we will find any/all unusual features. Participants will be notified of these 
issues when they are considering being in the study.  
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Transcranial Magnetic Stimulation (TMS) is a safe procedure. We do not anticipate any adverse 
side effects.  Some children may get a slight headache by the end of the procedure.  There is an 
extremely low (0-3.6%) risk of TMS causing a seizure. It should be noted that in all the reports in 
which seizures have been associated with TMS, it was unclear whether this really was due to TMS 
or a coincidental finding in patients already having frequent seizures.  
 
What are the possible discomforts and/or inconveniences? 
You will have 3-4 visits to the university to do the assessments. We will do our best to make sure 
that you have a lot of time to plan for these visits. The only inconvenience to you and your family 
will be the time of the assessments.  The assessments will take approximately 5 hours in total (3-4 
hours for the clinical assessments, and 1-2 hours for the neurological assessments with a break in 
between). You will do this on three separate occasions over the 10 months of the study at UQ. You 
can do your Mitii training at home at any time that suits you and your family.  
  
What will be done to make sure the information is confidential?   
All results of assessments will be stored without your name on them. A number will be used to 
identify them. This number will be linked to your name but the linking file will be kept confidential, 
separate to your data and only made available to the researchers.  Data collection sheets 
recording the assessment scores and the videotapes of the assessments and group program will 
be stored in a secure filing cabinet and only the researchers will have access to this information. 
On the video files, you will be able to be identified and these files will be used for assessment 
purposes only for this study.  These video files would not be used for teaching or promotional 
material for the project without directly seeking your permission separate to your participating in 
this study. These data sheets and video CDs/files will be kept at the RCH in a locked filing cabinet 
or in a password-protected digital file on a secure server that is only able to be accessed by the 
researchers until the youngest child in the study turns 21 years of age, and then destroyed. If we 
give presentations or write about the results of this project, we will not use any names or identifying 
details. 
 
Will I be informed of the results when the research project is finished? 
If at any time you would like information about your results, an appointment will be organised with 
one of the researchers.   A newsletter will also be sent to you about the progress of the study every 
6 months. At the end of the study, all families will be sent a summary of the results. The newsletter 
and final summary will talk about the children as a group and you will not be identified in person.  
 
You can decide whether or not to give permission to take part in this research project.  You 
can decide whether or not you would like to withdraw at any time without explanation. 
You can talk to your family or other people about this study. You can ask for any information 
before you decide if you would like to participate.  If you would like more information about the 
study or if you need to contact a study representative in an emergency, the person to contact is:                                      
 
Name:    Professor Roslyn Boyd   Melinda Lewis 
                                     Chief Investigator                                           Study Co-coordinator 
Contact telephone:   + 61 (7) 3365 5315    +61 (7) 3646 6423 
QCPRRC Administration:   + 61 (7) 3646 5542   
 
What are my rights as a participant? 
 I am informed that except where stated above, no information regarding my medical history will 
be released.  This is subject to legal requirements. 
 I am informed that the results of any tests involving me will not be published so as to reveal my 
identity.  This is subject to legal requirements. 
 The detail of the procedure proposed has also been explained to me.  This includes how long it 
will take, how often the procedure will be performed and whether any discomfort will result. 
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 It has also been explained that my involvement in the research may not be of any benefit to 
me.  I understand that the purpose of this research project is to improve the quality of medical 
care in the future. 
 I have been asked if I would like to have a family member or a friend with me while the project 
is explained to me. 
 I understand that this project follows the guidelines of the National Statement on Ethical 
Conduct in Research Involving Humans (2007). 
 I understand that this research project has been approved by the Royal Children’s Hospital 
Ethics in Human Research Committee on behalf of the Royal Children’s Hospital Board. 
 I have received a copy of this document. 
 
Ethics Contact:  
The Human Research Ethics Committee of the Royal Children’s Hospital and Health Services 
District has approved this study.  Should you wish to discuss the study with someone not directly 
involved, in particular in relation to matters concerning policies, information about the conduct of 
the study or your rights as a participant, or if you wish to make a confidential complaint, please 
contact: 
RCH&HSD Ethics Committee Coordinator 
Royal Children’s Hospital and Health Services District 
Level 3, RCH Foundation Building,  
Royal Children’s Hospital 
Herston Road 
Herston  QLD  4029 
Tel: (07) 3636 9167 (Monday to Friday 9am-5pm) 
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Queensland Cerebral Palsy & Rehabilitation Research Centre 
Royal Children’s Hospital 
Herston Road 
HERSTON  QLD  4029 
Tel: (07) 3636 5542 
Fax: (07) 3636 5538 
 
STANDARD PARTICIPANT INFORMED CONSENT FORM TO PARTICIPATE IN A 
RESEARCH PROJECT 
 
Project Number 
RCH Brisbane HREC/11/QRCH/35                                     UQ 2011000608                                               
 
Title of Project 
MiTii - A Randomised Trial of Novel Internet-based Multimodal Therapy for Children with 
Congenital Hemiplegia. 
 
Investigator(s)  
Professor Roslyn Boyd, Professor Jenny Ziviani, A/Professor Stephen Rose, Dr David Abbott, Professor Richard 
Macdonell, Dr Robert Ware, Dr Leanne Sakzewski, A/Professor Anthony Smith, Professor Jens Bo Neilsen, Louise 
Mitchell, Stephanie Ross, Sarah James, Carly Mayberry, Peder Esben Bilde, Dr Koa Whittingham, Dr Radwa 
Badawy & Melinda Lewis. 
 
I (name) ______________________________ voluntarily consent to take part in the above 
titled Research Project, explained to me by Mr/Ms/Dr/Prof ____________________________. 
 I have received a Participant Information Statement to keep and I believe I understand the 
purpose, extent and possible effects of my involvement 
 I have been asked if I would like to have a family member or friend with me while the project 
was explained 
 I have had an opportunity to ask questions and I am satisfied with the answers I have received 
 I understand that the researcher has agreed not to reveal results of any information involving 
me, subject to legal requirements 
 If information about this project is published or presented in any public form, I understand that 
the researcher will not reveal my identity 
 I understand that if I refuse to consent to my participation, or if I withdraw myself from the 
project at any time without explanation, this will not affect my access to the best available 
treatment options and care from the Royal Children's Hospital 
 I understand I will receive a copy of this consent form 
 
- I consent to participate in Part 1a: treatment component of this research project 
        YES □  NO □ 
- I consent to participate in Part 1b: Neurological imaging component of this research 
(fMRI and TMS)     YES □  NO □ N/A □ 
- I consent to have video recordings of their assessments being taken and digitally 
stored for research evaluation purposes   YES □  NO □ 
- I consent to the use of my data in other studies that are approved by a Human 
Research Ethics Committee.     YES □  NO □ 
 
PARTICIPANT SIGNATURE:   __________________________________  Date _____________ 
I have explained the study to the participant who has signed above, and believe that they understand 
the purpose, extent and possible effects of their involvement in this study. 
 
 
RESEARCHER’S SIGNATURE:  _________________________________  Date _____________ 
Note: All parties signing the Consent Form must date their own signature. 
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11.4  Recruitment information 
Recruitment flyer 
Parent/Guardian recruitment letter 
Clinician referral letter 
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11.4.1 Recruitment flyer 
  
  
Queensland Cerebral Palsy & Rehabilitation Research Centre 
Level 7, Block 6, Royal Brisbane and Women’s Hospital 
Herston  QLD  4029  Australia 
Telephone  07 3646 5542  •  Facsimile  07 3636 5538 
Email  qcprrc@uq.edu.au 
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Mitii (Move it to Improve It) Australia: 
A Novel Internet-based Therapy Program for  
Children with Congenital Hemiplegia 
 
11.4.2 Parent/Guardian recruitment letter 
The team at QCPRRC have successfully launched Mitii!  
We now have children across the state, from Townsville to Toowoomba, using this  
internet delivered therapy program in their own home! Feedback has been very good, with 
children really enjoying the fun games and parents seeing the potential of this multi-modal 
training. We are hoping that you would be interested in participating in this exciting research 
project in our next cohort.  
 
Mitii is a multi-modal training program comprising upper-limb, cognitive and physical 
activity training. However, Mitii makes this fun by delivering therapy using an interactive 
computer game, which is controlled by movement of the hands and body. All that is required 
is a home computer connected to the internet, a web-camera (these can be provided if needed) 
and some green bands which are worn on the hand or head. A Physiotherapist, Occupational 
Therapist and a Psychologist act as virtual trainers, remotely accessing the Mitii program 
regularly to set up and progress an individualised series of games. 
 
Mitii was designed in Denmark by researchers at the Helene Elsass Centre and the University 
of Copenhagen, in collaboration with worldwide expert in neuroplasticity, Professor Michael 
Merzenich. Since the development of this program, many children in Denmark have 
completed their home therapy programs using Mitii with great success.  
 
We are currently recruiting children and adolescents aged between 8 and 18 years with mild 
to moderate congenital hemiplegia Cerebral Palsy (one side of their body impaired) to 
participate in this exciting study. As part of this, all participants will receive specialist 
assessments from the Mitii therapists (including neuropsychological tests of executive 
function), and an intensive daily therapy program of 30 minutes each day for 20 weeks that 
will be individualised and tailored to each child’s needs. Children will be in regular contact 
with their virtual trainers (using Skype and email) to keep them on track and ensure the Mitii 
program is at the right level. 
 
Children will be randomly assigned to one of two Mitii groups (like the toss of a coin): 
1. Immediate intervention group – children attend two days in Brisbane for assessment and 
learning the Mitii program and then complete daily Mitii training for 20 weeks in their 
own home;      OR 
2. Waitlist intervention group – children attend one day in Brisbane for assessments and 
return home  for 20 weeks, before returning to Brisbane for 2 days of assessments and 
™ 
  
  
Queensland Cerebral Palsy & Rehabilitation Research Centre 
Level 7, Block 6, Royal Brisbane and Women’s Hospital 
Herston  QLD  4029  Australia 
Telephone  07 3646 5542  •  Facsimile  07 3636 5538 
Email  qcprrc@uq.edu.au 
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learning the Mitii program and then complete daily Mitii training for 20 weeks in their 
own home. 
 
Children and adolescents who receive Botulinum Toxin A (BTXA) injections through the 
Cerebral Palsy Health Service will be still be able to participate in the study, receiving 
either Mitii group allocation after their Botulinum Toxin A injections and follow up care. 
Children and adolescents who would benefit from intensive training and not requiring 
Botulinum Toxin A injections are also welcome to participate in the study. 
 
All participants would be required to attend 3 assessment visits in Brisbane at the start of the 
study, and then at 20 weeks (5 months) and 40 weeks (10 months). Depending on group 
allocation, the 2
nd
 day of Mitii training would be at the start of the study (Immediate 
intervention group), or at 20 weeks (Waitlist intervention group). Children and adolescents 
would be expected to participate in 20 weeks of 30 minutes of daily Mitii training; however 
this would be conducted within your own home and at your own convenience as your would 
have access to the Mitii program 24hrs a day. 
 
Please find attached a flyer providing you with more information regarding this study. We 
will be giving you a call in the next few weeks to discuss any questions you may have about 
the Mitii study. 
 
If you would like further information before this time or wish to discuss your child’s potential 
participation in this study, please contact the Mitii team below. 
 
(Study Coordinator) Melinda Lewis: m.lewis3@uq.edu.au or 3646 6423 
 
Louise Mitchell: louise.mitchell@uq.edu.au or 3646 6423 
Sarah James: s.james2@uq.edu.au or 3646 5361 
Laura Pareezer: Laura_Pareezer@health.qld.gov.au or 3646 5061 
Professor Roslyn Boyd: r.boyd@uq.edu.au or (07) 3345 5315 
 
 
Thank you, 
The Mitii team 
(Melinda Lewis, Louise Mitchell, Sarah James, Laura Pareezer, Jenny Ziviani, Ros Boyd
  
  
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11.4.3 Clinician referral letter 
Referral to: 
Mitii (Move it to Improve It) Australia: 
A Novel Internet-based Therapy Program for  
Children with Congenital Hemiplegia 
 
Name of Referrer: ____________________________________________________________ 
Profession: _________________________________________________________________ 
Address: ___________________________________________________________________ 
Phone No: ____________________________    Fax No: _____________________________ 
Email: ______________________________________________________________________ 
 
Child’s Name: _______________________________________________________________ 
DOB: ________________________   Gender: Male / Female 
Parent Name & Relationship: __________________________________________________ 
Address: ___________________________________________________________________ 
Phone No: H) ________________________M)_____________________________________ 
Hospital Record Number (if applicable): _________________________________________ 
1. Parent of the child is aware of this referral? Yes  
2. Are the family aware of Cerebral Palsy diagnosis? Yes / No 
3. Has the child recently had Botulinum Toxin Type-A Injections, serial casting, or surgery of 
any kinds? If yes, when and what?  Yes / No 
 If yes, where and when? _______________________________________________ 
4. Child has already had an MRI? Yes / No 
 If yes, where and when? _______________________________________________ 
Please note that the parent must be aware of this referral under privacy guidelines. 
The study flyer can also be provided to parents to enable them to self refer to the study. 
 
Signed: ________________________________  Date: ___________________ 
 
SEND TO: Mitii Study, Attention: Louise Mitchell  
Queensland Cerebral Palsy & Rehabilitation Research Centre 
Level 7, Block 6, Royal Brisbane and Women’s Hospital, 
Herston QLD 4029 Australia 
 
Or email louise.mitchell@uq.edu.au 
Or call on 07 3646 6423  
▪ QCPRRC Phone:  07 3636 5542 • Facsimile 07 3636 5538 • Email:  qcprrc@uq.edu.au
™ 
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  
11.5  Appointment information packs 
Baseline Information pack 
Follow up information pack
   
 
Queensland Cerebral Palsy & Rehabilitation Research Centre 
Royal Children’s Hospital 
Herston Road, Herston  QLD  4029  Australia 
Telephone  07 3646 5542  •  Facsimile  07 3636 5538 
Email  CP&Rehab_Research_Centre@health.qld.gov.au 
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Mitii Study Information Pack for Parents 
11.5.1 Baseline Information pack 
Thank you for participating in the Mitii study! 
 
The details for your child’s assessments are below. We need your child to participate in 
several assessments with different therapists. These have been arranged over either one 
or two days. All children will return again at 20 weeks for further assessment. We have 
provided an approximate time for these assessments below however these will be 
confirmed closer to the time. 
 
Assessment Dates  
 
Important dates for you to remember: 
 
Initial assessment 
 
Date: Time:  
 
MRI Scan Time: 
 
 
Re-assessment (20 weeks) 
  
Dates: Time:  
 
MRI Scan Time: 
 
 
Re-assessment and feedback (40 weeks) 
 
Dates: Time:  
 
Assessment Locations and Parking 
 
Motor and cognitive assessments will be conducted at the University of Queensland St 
Lucia Campus, in the Seddon Building (Building Number 82) (see Map 1 attached). A 
parking voucher has been included for the Multi-story car park on Sir Fred Schonell Drive 
(see Map 1).  The Seddon Building is a short walk from this car park.  This building has the 
   
 
Queensland Cerebral Palsy & Rehabilitation Research Centre 
Royal Children’s Hospital 
Herston Road, Herston  QLD  4029  Australia 
Telephone  07 3646 5542  •  Facsimile  07 3636 5538 
Email  CP&Rehab_Research_Centre@health.qld.gov.au 
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Mitii assessment room, an area for parents with magazines, kitchen with a fridge and 
tea/coffee equipment and amenities.   
 
MRI scans (if your child is having one) will be done in the Gehrmann Laboratories 
(Building Number 60).  If your child is having a MRI scan, please note the MRI Scan Time 
in the box above - you will need to be at the Gerhmann Laboratory at this time. The Mitii 
team members can help you to find this building within the university so come to the 
Seddon Building first.        
 
Assessment Day Program 
 
Three children will typically be completing assessments or Mitii training on each day.  On the 
day of assessment, your child will rotate through various assessments with scheduled breaks 
throughout the day.   
 
What to Bring 
 
Please ensure your child wears clothes suitable on the day for exercise and socks and 
sneakers.  Please bring with you food (or money to purchase lunch/snacks at various food 
outlets on the campus) and water.  For one of the assessments, your child will be observed 
performing two typical daily tasks that will be chosen on the day.  For this purpose, please 
also bring the following items with you: 
 
o Hairbrush  
o Toothbrush  
o Toothpaste 
o Face towel 
o Face wash (if a particular one is used, face soap can be provided) 
o Snack to be eaten with spoon/fork 
o Optional - Typical meal that you child could eat for lunch with a knife and fork 
 
Online Questionnaires  
 
You will have been sent an email with links to online questionnaires.  Please complete 
these questionnaires before the day of the initial assessment.  Please call any of the Mitii 
Team if you have any questions about these questionnaires between 8.30am-4.30pm on 
07 3636 5361 or 07 3636 6423. 
 
 
 
 
   
 
Queensland Cerebral Palsy & Rehabilitation Research Centre 
Royal Children’s Hospital 
Herston Road, Herston  QLD  4029  Australia 
Telephone  07 3646 5542  •  Facsimile  07 3636 5538 
Email  CP&Rehab_Research_Centre@health.qld.gov.au 
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Activity monitors 
 
Your child will be wearing an activity monitor for four days following the initial day of 
assessment re-assessment.  You will be provided with further instructions about these 
monitors on the day. 
 
Reimbursement of travel costs 
Reminder that if you are requesting reimbursement of travel costs that you will need to 
provide us with ORIGINAL receipts. 
 
Parking vouchers 
These have been provided for the number of days you are attending. Please read the 
instructions on the card and remember to scratch off the dates that you are attending. 
 
 
Concerns or questions 
 
If you have any concerns or questions on the day of assessment, please contact us on 
Mitii Mobile: 0417 604 935 
 
Or call us on any other day from 8.30am – 4.30pm at QCPRRC on 07 3636 6423. 
 
Feel free to email us on: 
 
Melinda Lewis (Study Coordinator) m.lewis3@uq.edu.au  
Louise Mitchell (Physiotherapist) (louise.mitchell@uq.edu.au); or 
Stephanie Ross (Psychologist) (stephanie.ross@uq.edu.au); or  
Sarah James (Occupational Therapist) (s.james2@uq.edu.au); or  
 
 
Thank you once again for participating in this study and we look forward to meeting you on 
the day of assessment! 
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Mitii Study Information Pack for Parents 
11.5.2 Follow up information 
Thank you for participating in the Mitii study! 
 
The details for your child’s assessments are below. We need your child to participate in 
several assessments with different therapists. These have been arranged over either one 
or two days.  
 
Assessment Dates  
 
Re-assessment (20/40/60 weeks)  
Dates: Time:  
 
MRI Scan Time: 
 
Assessment Locations and Parking 
Motor and cognitive assessments will be conducted at the University of Queensland St 
Lucia Campus, in the Seddon Building (Building Number 82) (see Map 1 attached). A 
parking voucher has been included for the Multi-story car park on Sir Fred Schonell Drive 
(see Map 1).  The Seddon Building is a short walk from this car park.  This building has the 
Mitii assessment room, an area for parents with magazines, kitchen with a fridge and 
tea/coffee equipment and amenities.   
 
MRI scans (if your child is having one) will be done in the Gehrmann Laboratories (Building 
Number 60).  If your child is having a MRI scan, please note the MRI Scan Time in the box 
above - you will need to be at the Gerhmann Laboratory at this time. The Mitii team 
members can help you to find this building within the university so come to the Seddon 
Building first.        
 
What to Bring 
Please ensure your child wears clothes suitable on the day for exercise and socks 
and sneakers.  Please bring with you food (or money to purchase lunch/snacks at 
various food outlets on the campus) and water.  For one of the assessments, your 
child will be observed performing two typical daily tasks that will be chosen on the 
day.  For this purpose, please also bring the following items with you: 
o Hairbrush  
o Toothbrush, toothpaste 
o Face towel 
o Face wash (if a particular one is used, face soap can be provided) 
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Online Questionnaires  
You will have been sent an email with links to online questionnaires.  Please complete 
these questionnaires before the day of the initial assessment.  Please call any of the Mitii 
Team if you have any questions about these questionnaires between 8.30am-4.30pm on  
07 3636 6423. 
 
Activity monitors 
Your child will be wearing an activity monitor for four days following the initial day of 
assessment re-assessment.  You will be provided with further instructions about these 
monitors on the day. 
 
Reimbursement of travel costs 
Reminder that if you are requesting reimbursement of travel costs that you will need to 
provide us with ORIGINAL receipts. 
 
Parking vouchers 
These have been provided for the number of days you are attending. Please read the 
instructions on the card and remember to scratch off the dates that you are attending. 
 
Concerns or questions 
If you have any concerns or questions on the day of assessment, please contact us on 
Mitii Mobile: 0417 604 935 
 
Or call us on any other day from 8.30am – 4.30pm at QCPRRC on 07 3646 6423. 
 
Feel free to email us on: 
Melinda Lewis (Study Coordinator) m.lewis3@uq.edu.au  
Louise Mitchell (Physiotherapist) (louise.mitchell@uq.edu.au); or 
Stephanie Ross (Psychologist) (stephanie.ross@uq.edu.au); or  
Sarah James (Occupational Therapist) (s.james2@uq.edu.au) 
 
Thank you!  
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Queensland Cerebral Palsy & Rehabilitation Research Centre 
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11.6.1 Instruction booklet 
 
 
 
 
 
 
 
Move it to improve it 
 
Participant Training Manual  
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Thank for participating in this important study testing Mitii. 
Chief Investigators: Researchers: 
Professor Roslyn Boyd Louise Mitchell 
Professor Jenny Ziviani Stephanie Ross 
Dr. Leanne Sakzewski Sarah James 
Dr. Koa Whittington Dr. Carly Mayberry 
Dr. Anthony Smith Melinda Lewis 
Dr. Ross Cunnington  
 
Should you have any concerns, questions or need to speak to us for 
any reason, please contact: 
Call us on: (07) 3636 5361; Or email: 
Louise Mitchell Email: louise.mitchell@uq.edu.au (Mitii Physiotherapist) 
Sarah James Email: s.james2@uq.edu.au (Mitii Occupational Therapist)  
Stephanie Ross Email: stephanie.ross@uq.edu.au (Mitii Neuropsychologist) 
Melinda Lewis Email: m.lewis3@uq.edu.au (Mitii study coordinator) 
 
To contact the chief investigators:  
Prof Roslyn Boyd Email: r.boyd@uq.edu.au   Phone: (07) 3365 5315 
Prof Jenny Ziviani Email: j.ziviani@uq.edu.au Phone: (07) 3365 3008 
For general enquiries please contact QCPRRC Admin Officer: Sabina Scott - Phone: (07) 3636 5542 
 
 
Miti was designed in Denmark, Copenhagen by the Helene Elsass Center, The University of 
Copenhagen and Mitii Development A/S. 
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Getting Started 
Before logging into Mitii you will need the following: 
1. Computer or Laptop that is connected to the internet 
Ideally plug the computer directly into the internet by connecting the network cable to the 
computer, otherwise wireless will work – but it might be a little slower to load the 
programs 
2. Web-camera connected to computer or laptop.  
Most laptops will have a camera built into them. 
If your computer does not have one and you need to use a web-camera, this usually plugs 
into a USB port and the required programs and/or drivers will automatically install. 
However you may need to insert a CD and install a program. This will depend on your 
individual web-camera.  
3. Green sweatbands – one for the head and two for your hands 
Two sets will be provided by us. If you lose them (or the dog eats them) any bright green 
object or material will work until we send you out replacements. 
4. A “green-free” zone to train in 
The Mitii program is very sensitive to green and if the camera can detect green in the 
background or the paint it will make the training much harder. If you can find a white wall 
this works best, or you could always pin up a white sheet onto a wall. Be sure to clear away 
any green objects, paintings or plants from the camera field. 
 
Once you have your Mitii training area set up you will need to log into the program. 
Connect to the internet and enter the following URL: http://queensland.mitii.dk 
 
Use your username (email address) and password to log into the program. 
My Username is: _____________________________ 
My Password is: _____________________________ 
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When you log in you will come to this screen:  
 
 
All your new programs will be listed here and old ones will be deleted. 
Click on Start to begin loading the program (make sure pop-ups are enabled for this site!) 
This may take a little while to load as it’s coming all the way from Denmark! 
(A good idea might be to start loading your training program and then go do something, and it will 
be ready to go by the time you are finished). This could be up to 5 minutes. 
 
 
 
 This box may appear 
 Click Allow 
 
 
 
 
 
 
As the program is loading this 
screen will appear and will 
gradually count to 100% 
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Mitii Games 
There are 14 different Mitii games which the team will select for you based on your needs. 
We will go through these in detail on the training day but the table below is provided to remind 
you of what to do for each game. There are also videos may come up before each game which give 
instructions.  
The background and the pictures may change and the order they come in will be different from 
the ones shown below however the game remains the same.  
 
Name  Green band 
on your... 
Description Instructions Sample Screen 
Memory Hand Memorise the 
order of images 
Look at a series of 
pictures.  
These pictures then 
disappear and you must 
memorise them in the 
order in which they were 
shown.  
Hold your hand over 
picture to select the order. 
 
 
 
 
Brick Hand Match shape to 
the blank image 
There are a series of 
pictures displayed, one of 
which matches the blank 
shape.  
Uses your hand to drag 
the matching picture to 
the blank shape. 
 
 
 
 
Figure 
builder 
Hand Construct the 
picture from 
smaller pieces 
falling down the 
side 
The full picture is in the 
middle of screen.  
Small pieces of this and 
other pictures are falling 
down the side.  
Reach and drag the piece 
that matches using your 
hand to build the picture 
image from bottom to top. 
 
 
  
This shadow is where the 
green tracking band is 
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Name  Green band 
on your... 
Description Instructions Sample Screen 
Figure 
ground 
Hand Match the small 
piece of the 
larger picture 
Down the bottom of the 
screen is a small part of a 
larger picture. 
Pick up the part at the 
bottom with your hand 
and then drag and hold it 
where it matches on the 
big background picture.  
 
 
 
 
Spatial 
relation 
Hand Pick out which 
picture does not 
match 
Hold your hand over the 
picture which does not 
match (eg. Middle dog has 
smaller ears) 
 
 
 
 
 
 
Visual 
closure 
Hand Pick out which 
part-drawn 
picture matches 
A series of part-drawn 
pictures is shown.  
Drag the part-drawn 
picture that matches to 
the fully drawn picture 
underneath. 
 
 
  
 
 
Balloon 
maths 
Hand Solve the maths 
problem 
A maths question will 
be shown. Pick up the 
pin with your hand and 
drag it to the balloon 
with the correct answer 
to solve the maths 
problem.  
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Name  Green band 
on your... 
Description Instructions Sample Screen 
Combo 
(2-hand 
exercise) 
Both hands Use both hands 
to drag the 
matching pictures 
into the circle 
Find the matching 
pictures on the side of 
the screen. Pick up one 
picture from each side 
(both hands) and drag 
into the circle 
 
 
 
 
 
Flight 
simulator 
Head Keep the plane 
upright! 
Put the band on your 
head and your arms out 
wide. You need to keep 
the middle of the plane 
as upright as possible 
but the wind will try to 
blow you off course. 
 
 
 
 
Follow Head Keep the man dry 
under the 
umbrella 
Put the band on your 
head and move the 
umbrella around on the 
screen so that the man 
stays dry. 
 
 
 
 
 
Follow the 
leader 
Head Follow the video 
sequence so that 
they match 
The screen will split 
into two and a video 
will play on one side. 
Follow the leader so 
that you match the 
screen! 
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Name  Green band on 
your... 
Description Instructions Sample Screen 
UFO Head Steer the UFO 
through the 
tunnel 
Use band on head to 
steer UFO through a 
series of tunnels. Squat 
up and down and make 
sure it doesn’t hit the 
walls! 
 
 
 
 
Move Both Hands Blow up the 
balloon until it 
pops 
Move both hands back 
and forth  to inflate the 
balloon until it bursts 
 
 
 
 
 
 
 
Get 
up/Get 
down 
Head Let’s get moving! 
Squat/Jump/Lung
e to get the 
object into the 
target 
Put the band on your 
head, pick up the 
object and put it into 
the target (eg. Cannon 
blows up the ship!) (We 
will email you 
instructions about 
whether you are to 
jump, squat, lunge, or 
use step up etc) 
 
 
 
There will be an instruction video before each game to help you learn the games. You can skip 
over these videos by moving the green band over the Start button. As you become more familiar 
with Mitii we will remove these videos unless we have specific instructions to give you. 
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Challenging you over the whole program 
We will be in contact with you by email (approximately once a week) to let you know when we 
have changed your program and tell you which games we want you to add a step block or foam to 
make it harder. 
For any game you may be asked to: 
Lunge (one leg in front of the other) Sit to stand on and off a chair 
 
 
 
 
 
 
Step up onto the step Squat down and either stand or jump up 
 
 
 
 
 
 
Step up sideways onto the step Or stand on the foam and balance 
 
 
 
 
 
Have fun! 
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Study Information and Important dates 
I have been allocated to the Immediate / Waitlist group. 
My first baseline assessment was: ___________________________________________________ 
I will be training for 20 weeks from _______________________ to ________________________ 
 
My 20 week assessment will be: _____________________________________ 
My final assessment will be: ________________________________________________________ 
These are approximate dates. Exact dates and times will be confirmed with you closer to the time. 
 
If you need help with Mitii or have any questions, contact the Mitii team on 07 3636 4361 
Or email us on: 
Louise Mitchell Email: louise.mitchell@uq.edu.au (Mitii Physiotherapist) 
Sarah James Email: sarah.james@uqconnect.edu.au (Mitii Occupational Therapist)  
 
Thank you once again for you help in this important study. 
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11.6.2 Reward charts 
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11.7  Parent/Guardian and Participant Questionnaires 
Parent/Guardian baseline questionnaire 
Parent/Guardian follow up questionnaire 
Mitii™ exit questionnaire 
Accelerometer log diary 
Participation and Environment Measure for Children and Youth (PEM-CY) 
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Introduction 
Welcome to the questionnaires for the  Mitii study. 
You will have been sent a copy of the Information statement. These questionnaires are outlined in detail in this statement. 
Should you have any questions or concerns, about the overall study or any particular questions, please feel free to contact 
the Mitii team on 3636 6423. 
It will take approximately 40 minutes to complete these questionnaires. 
The questionnaires are broken into  5 sections: 
* Some questions about your child and your family 
* Your child's function and mobility 
* Your child's participation and the environment 
* Your child's behavior 
* Your child's quality of life. 
Each questionnaire will tell us something important about how Mitii could be used to better support parents of 
children with Cerebral Palsy and help children with Cerebral Palsy. 
It is possible to complete these questionnaires in several sittings.  Every time you finish a section and click the >> button at 
the bottom of the screen the information that you have entered so far will be saved.  The next time you return to the website 
you will be prompted for your Study ID again and the program will remember which section you were up to. It is 
possible to go back to questionnaires that you have already completed using the << button at the bottom of the screen. 
By clicking the >> button below, you consent to taking part in this study. By clicking the >> button below, you consent to the 
off-site storage of all de-identified data. All the information provided in this survey is de-identified, meaning that your 
responses will be anonymous. The information and results of these surveys is stored off-site on a secure server in the United 
States of America, in accordance with the Privacy Act and within the University and Queensland Health Ethics Guidelines. 
Should you have any questions about this please feel free to call the Mitii team on 3636 6423. 
Should you NOT consent to participate in the Mitii study, close the browser. However, please note each time you press the >> 
button to advance the survey, your responses will be saved. If you do NOT consent to participate in the Mitii study, please 
contact the team on 3636 6423. Thank you. 
If you are confused by some of the questions or have any queries, you can contact the study coordinator, Louise Mitchell on 
phone 3636 6423 or email louise.mitchell@uq.edu.au with any questions. 
Information about your child and your family 
We will start our questionnaires by asking about your child and your family 
Please enter your ID number (sent in the email) eg. 01 
Your child's date of birth as day/month/year (eg. 01/01/2001) 
Your child's current age in years 
8 9 10 11 12 13 14 15 16 17 18 
 
 
 
 
 
 
 
1.1.1 Study demographic questionnaire: baseline assessment 
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Please read the following and mark only one box beside the description that best represents your child's 
movement abilities.  My child... 
I: Can walk on their own without using a walking aid, and can go up and down stairs without needing to hold the handrail 
AND walks whenever they want to go (including uneven surfaces, slopes or in crowds) AND can run and jump although 
their speed, balance and coordination may be slightly limited 
II: Can walk on their own without using walking aids, but needs to hold the handrail when going up or down stairs often 
finds it difficult to walk on uneven surfaces, slopes or in crowds 
III: Can stand on their own and only walks using a walking aid (such as a walker rollator, crutches, canes etc) AND finds it 
difficult to climb stairs or walk on uneven surfaces AND may use a wheelchair when traveling for long distances or in 
crowds 
IV: Can sit on their own but does not stand or walk without significant support AND therefore relies mostly on wheelchair at 
home, school and in the community AND may achieve self-mobility using a powered wheelchair 
V: Has difficulty sitting on their own and controlling their head and body posture in most positions AND has difficulty 
achieving any voluntary control of movement AND needs a specially-adapted supportive chair to sit comfortably AND has 
to be lifted or hoisted by another person to move 
Please read the following and mark only one box beside the description that best represents your child's 
movement abilities.  My teenager... 
I: Can walk on their own without using a walking aid, and can go up and down stairs without needing to hold the handrail 
AND walks whenever they want to go (including uneven surfaces, slopes or in crowds) AND can run and jump although 
their speed, balance and coordination may be slightly limited 
II: Can walk on their own without using walking aids, but needs to hold the handrail when going up or down stairs AND 
therefore walks in most settings AND often finds it difficult to walk on uneven surfaces, slopes or in crowds AND may 
occasionally prefer to use a walking aid (such as a stick or a crutch) or a wheelchair to travel quickly or over long distances 
III: Can stand on their own and only walks using a walking aid (such as a walker rollator, crutches, canes etc) AND finds it 
difficult to climb stairs or walk on uneven surfaces AND may use a wheelchair when traveling for long distances or in 
crowds AND prefers to use a wheelchair to travel quickly or over longer distances 
IV: Can sit on their own but does not stand or walk without significant support AND therefore relies mostly on wheelchair at 
home, school and in the community AND may achieve self-mobility using a powered wheelchair AND can crawl or roll to a 
limited extent to move around indoors 
V: Has difficulty sitting on their own and controlling their head and body posture in most positions AND has difficulty 
achieving any voluntary control of movement AND needs a specially-adapted supportive chair to sit comfortably AND has 
to be lifted or hoisted by another person to move 
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Now please think about your child's ability to handle objects in important daily activities, for example how they 
pick up toys or objects during play and leisure, how they handle their cutlery during eating and or put their clothes 
on during dressing tasks. 
In which situation is the child independent and to what extent do they need support and adaptation? 
Please click which best describes your child's ability to handle objects in important daily activities. 
I. Handles objects easily and successfully. At most might have some problems with tasks requiring speed and accuracy. 
However, these do not restrict the child being able to do these independently. 
II. Handles most objects but with reduced quality and/or speed of achievement. Certain activities may be avoided or be 
achieved with some difficulty. The child may find alternative ways to complete these tasks but this does not normally restrict 
them being able to carry these out independently. 
III. Handles objects with difficulty; needs help from another person to prepare and/or modify the activity. The performance is 
slow and achieved with limited quality and quantity. Activities are performed independently if they have been set up or 
adapted. 
IV. Handles a limited selection of easily managed objects in adapted situations. Performs part of activities with effort and 
with limited success. Requires continuous support and assistance and/or adapted equipment, for even partial achievement 
of the activity. 
V. Does not handle objects and has severely limited ability to perform even simple actions. Requires total assistance. 
Your child's sex 
Male 
Female 
What hand does your child normally write with? 
Right 
Left 
Has your child been diagnosed with any of the following? (please tick all relevant boxes) 
Intellectual Disability 
Learning Difficulties 
Autism Spectrum Disorder (includes Apsergers) 
ADHD 
Vision impairment 
Hearing impairment 
Epilepsy 
Other 
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What type of school does your child attend? 
Public primary 
Public secondary 
Special school 
Special education classroom at a mainstream school 
Private primary 
Private secondary 
Home schooled 
Other 
What grade is you child currently in? 
1 2 3 4 5 6 7 8 9 10 11 12 
Does your child receive any other assistance for schooling (eg. tutoring)? 
Yes, please describe.... No 
The next questions about your family. 
Their are many factors that can impact on a child's participation in home, school and community activities. Some of these 
relate to families. These answers will help us understand some of these factors. You responses will in no way be identified. 
What is your relationship to this child? 
Mother (biological or adoptive) 
Father (biological or adoptive) 
Step mother 
Step father 
Legal Guardian 
What is your current age in years? 
Does your child have any siblings, 
Yes, please indicate the number of OTHER siblings living in thehousehold 
No 
Is English the main language spoken at home? 
Yes No 
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What is your postcode? 
What is your current marital status? 
Married 
Separated 
Defacto 
Never married/defacto 
Divorced 
Widow/er 
These questions relate to household education and income level, factors thought to influence many health outcomes. 
Which best describes the household in which your child is presently living? 
Original family (both biological or adoptive parents present) 
Step-family (two parents, one being a step-parent) 
Sole parent family 
Other 
What is your highest level of education? 
Less than year 10 
Year 10/11 
Year 12 
Trade/apprenticeship 
TAFE/college certificate 
University degree 
Which best describes your current employment? 
Full time 
Part time 
Full time parent/home duties 
Unemployed (seeking work) 
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These questions relate to household education and income level, factors thought to influence many health 
outcomes. 
If you do not have a partner please leave blank. 
What is your partner's highest level of education? 
Less than year 10 
Year 10/11 
Year 12 
Trade/apprenticeship 
TAFE/college certificate 
University degree 
Which best describes your partner's current employment? 
If you do not have a partner please leave blank. 
Full time 
Part time 
Full time parent/home duties 
Unemployed (seeking work) 
Which best describes your family's combined annual income? 
<25,000 
25,000-50,000 
50,000-75,000 
75,000+ 
The next questions relate to the usual therapy services that your child receives. 
Have you sought professional assistance from any of the following (please tick all that apply), and then 
please indicate then how often where indicated. 
More 
than Once Once Once Once 
fortnight   once a 
a week month term year 
 Does 
your 
child 
receive 
services 
from.... 
 
 
 
Yes   No 
 
 
 
 
How often does your child receive these? 
 
 
 
More 
once a 
Once a    than 
a a a 
week   
fortnight 
 
Physiotherapist 
Occupational therapist 
Psychologist 
Orthotist/Prothetist 
Pediatrician 
Other, please specify 
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Your child's date of birth as month/day/year 
Please write down your unique ID number eg. 001 
We will start our questionnaires by asking about your child and your family. Some of these are 
the same as the last questionnaire you competed at the start of Mitii, but it is important for us 
to know any changes in these. 
About your child and family 
If you are confused by some of the questions you can contact, Louise Mitchell on 
phone 3636 6423or email louise.mitchell@uq.edu.au with any questions. 
BUT in order to do the questionnaire in multiple sessions, you must use the same 
computer! This questionnaire program remembers your IP address, so if you try again 
on another computer you will need to start at the beginning. 
It is possible to complete these questionnaires in several sittings.  Every time you 
finish a section and click the >> button at the bottom of the screen the information that 
you have entered so far will be saved.  The next time you return to the website you 
will be prompted for your Study ID again and the program will remember which 
section you were up to. It is possible to go back to questionnaires that you have 
already completed using the << button at the bottom of the screen. 
Each questionnaire will tell us something important about how Mitii could be 
used to better support parents of children with Cerebral Palsy and help children 
with Cerebral Palsy. 
* Some questions about you and your family 
* Some feedback about Mitii if you have been doing the training 
* Some questions about Life Habits 
* Some questions about mobility tasks 
* Some questions about behaviours 
* And finally some questions about quality of life 
The questionnaires are broken into  6 sections: 
It will take approximately 40 minutes to complete these questionnaires. 
Welcome to the questionnaires for the  Mitii study 20 week follow up. This includes all 
the surveys you completed at the last assessment point. 
Introduction 
 
1.1.2 Study demographic questionnaire: follow up assessments 
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Mother (biological or adoptive) 
 
Father (biological or adoptive) 
Step mother 
Step father 
 
Legal Guardian 
What is your relationship to this child? 
The next questions about your family. 
Their are many factors that can impact on a child's participation in home, school and 
community activities. Some of these relate to families. These answers will help us understand 
some of these factors. We are looking to see if any of these have changed in the past 20 
weeks. Your responses will in no way be identified. 
No Yes, please describe.... 
Has your child received any new assistance for schooling (eg. tutoring) since starting the Mitii 
program? 
12 11 10 9 8 7 6 5 4 3 2 1 
What grade is you child currently in? 
No 
Yes, please describe change... 
Has your child changed school since the start of the Mitii study? 
Left 
Right 
What hand does your child normally write with? 
Male 
 
Female 
Your child's sex 
18 17 16 15 14 13 12 11 10 9 8 
Your child's current age in years 
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Full time 
 
Part time 
 
Full time parent/home duties 
 
Unemployed (seeking work) 
Which best describes your partner's current employment? 
Unemployed (seeking work) 
Full time parent/home duties 
Part time 
Full time 
Which best describes your current employment? 
Step-family (two parents, one being a step-parent) 
 
Sole parent family 
 
Other 
Original family (both biological or adoptive parents present) 
Which best describes the household in which your child is presently living? 
Divorced 
 
Widow/er 
Never married/defacto 
Separated 
 
Defacto 
Married 
What is your current marital status? 
No 
Yes 
Have you moved house or relocated since the start of the Mitii study? 
What is your postcode? 
No 
Yes, please indicate the number of OTHER siblings living 
in the household 
Does your child have any siblings, 
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  Physiotherapist 
 
Occupational 
therapist 
 
Psychologist 
Orthotist/Prothetist 
Paediatrician 
Botox and follow up 
therapy 
 
Splinting/Casting 
 
Any surgery, if yes 
please describe 
 
 
Other, please specify 
 
  
 
 
 
How often did your child receive these 
services? 
 
 
 
More   
More  
Once 
once a 
fortnight   once a 
a   last
 
week 
fortnight 
weeks
 
In the 
last 20 
weeks, 
did your 
child 
receive 
services 
from.... 
 
 
 
Yes  No 
 
 
Please comment on any therapy, surgical or botox procedures your child has received in the 
past 20 weeks 
20 month week a 
than Once a 
in the Once Once than 
Since your last assessments for Mitii, 20 weeks ago, please comment on how often your 
child received the following.... 
The next questions relate to the usual therapy services that your child receives. 
50,000-75,000 
 
75,000+ 
<25,000 
 
25,000-50,000 
Which best describes your family's combined annual income? 
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11.7.1 Mitii™ exit questionnaire 
Mitii service offered: 
In an overall sense, how satisfied were you with the Mitii program that you and your child 
received? 
 
1 2 3 4 5 6 7 8 9 10 
Not satisfied   Quite satisfied    Very satisfied 
How would you rate the quality of the Mitii your child received? 
 
1 2 3 4 5 6 7 8 9 10 
Not satisfied   Quite satisfied    Very satisfied 
How would you rate support your child received during the Mitii training? 
 
1 2 3 4 5 6 7 8 9 10 
Not satisfied   Quite satisfied    Very satisfied 
How satisfied were you with the type of help gained from the Mitii program? 
 
1 2 3 4 5 6 7 8 9 10 
Not satisfied   Quite satisfied    Very satisfied 
To what extent has the program met your child’s needs?  
 
1 2 3 4 5 6 7 8 9 10 
Not at all    Somewhat     All have been met 
To what extent has the program met your needs? 
 
1 2 3 4 5 6 7 8 9 10 
Not at all    Somewhat     All have been met 
 
Mitii Therapy questions: 
Do you consider the Mitii program met your child’s therapy needs and goals? 
Please comment 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
Compared to the usual amount of therapy you receive, can you rate the amount of therapy 
you think the Mitii program offered:  
 
1 2 3 4 5 6 7 8 9 10 
Less than usual   A but more than usual   Much more than usual 
How satisfied were you with the amount of therapy you and your child received with the 
Mitii program? 
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1 2 3 4 5 6 7 8 9 10 
Not satisfied   Quite satisfied    Very satisfied 
How satisfied were you with the amount of help and support with the Mitii program you 
and your child received? 
1 2 3 4 5 6 7 8 9 10 
Not satisfied   Quite satisfied    Very satisfied 
Has the Mitii program helped your child to use his/her  upper limb more effectively? 
1 2 3 4 5 6 7 8 9 10 
Not at all    Somewhat     A lot more 
Has the Mitii program helped your child to use his/her lower limbs more effectively? 
1 2 3 4 5 6 7 8 9 10 
Not at all    Somewhat     A lot more 
Has the Mitii program helped your child perform daily tasks that are important to him/her, 
such as preparing food, brushing teeth or getting dressed? 
1 2 3 4 5 6 7 8 9 10 
Not at all    Somewhat     A lot 
Has the Mitii program helped your child to do more physical activity e.g. go for walks or 
bike rides? 
1 2 3 4 5 6 7 8 9 10 
Not at all    Somewhat     A lot 
Has the Mitii program helped your child to participate in more organised sports e.g. soccer, 
netball, swimming, etc? 
1 2 3 4 5 6 7 8 9 10 
Not at all    Somewhat     A lot 
Has the Mitii program helped your child to perform better at school? 
1 2 3 4 5 6 7 8 9 10 
Not at all    Somewhat     A lot 
Has the Mitii program helped your child’s problem solving, decision-making or 
organisational skills? 
1 2 3 4 5 6 7 8 9 10 
Not at all    Somewhat     A lot 
Has the Mitii program helped your child to improve his/her r self-esteem? 
1 2 3 4 5 6 7 8 9 10 
Not at all    Somewhat     A lot 
Has the Mitii program helped your child to make friendships with other children with CP? 
1 2 3 4 5 6 7 8 9 10 
Not at all    Somewhat     A lot  
Has the Mitii program helped your child to use a computer? 
1 2 3 4 5 6 7 8 9 10 
Not at all    Somewhat     A lot 
How would you describe your feelings at this point about your child’s overall progress? 
1 2 3 4 5 6 7 8 9 10 
Not satisfied   Quite satisfied    Very satisfied 
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Comments of future Mitii programs: 
If you were to seek help again, would you come back to Mitii? 
1 2 3 4 5 6 7 8 9 10 
Not at all    Maybe     Definitely 
 
How satisfied were you accessing therapy using an online therapy program? 
1 2 3 4 5 6 7 8 9 10 
Not satisfied   Quite satisfied    Very satisfied 
Can you please comment on the length of the Mitii program i.e. 20 weeks: 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
Can you please comment on the frequency of the Mitii program ie. daily: 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
Can you please comment on the time required to do the daily Mitii program ie. 30 minutes: 
Much too long, A little too long, just right, a little too short, much too short 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
If you were unable to complete Mitii training daily please list the top 3 reasons why you did 
not: 
1. Issues with the Mitii program which limited access .eg. Game froze or couldn’t log 
in because of program errors 
2. Internet access limited e.g. Could not get onto internet to log in 
3. Unable to find time to do Mitii 
4. Lacked motivation to do Mitii 
5. Other 
Can you please rank the top 5 things you most liked about the Mitii training? 
1. Intensive therapy program (Daily for 20 weeks) 
2. Online delivery 
3. Flexibility of location of delivery (can do at home or wherever internet access) 
4. Flexibility of time of access (can do program at time that suits you/your child) 
5. “Game like” design of Mitii 
6. Virtual trainers and interaction with them using Skype/email 
7. Progressive nature of training (made more difficult each week) 
8. None of the above (please list) …. 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
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11.7.2 Accelerometer log diary 
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FOR OFFICE USE ONLY: _____________ (ID) 
Participation and Environment Measure – Children and Youth 
 
Wendy Coster, Mary Law, Gary Bedell 
Child name: ____________________________________ 
Date survey was completed (MM/DD/YYYY): -----/-----/-------- 
Relationship of respondent to child: Mother _____ Father _______ Other (please describe) ____________________________________ 
Not to be reproduced without permission of authors Coster, Law, & Bedell 
11.7.3 Mobility Questionnaire 28-item (MobQues28) 
11.7.4 Participation and Environment Measure for Children and Youth (PEM-CY) 
 
 280 
  
SURVEY INSTRUCTIONS 
Participation refers to a child’s involvement in important everyday activities at home, in school, and in the community. The meaning of 
participation includes both how often a child does activities AND how involved he or she is when doing these activities. 
The survey asks a set of questions about your child’s participation in 25 types of activities that take place in three environments: home, 
school, and community.  We give a few examples to illustrate each type of activity. However, you should think about all of the activities 
that belong to the category when answering these questions. 
For each type of activity we ask: 
1. 
2. 
3. 
how often your child has participated over the last 4 months 
how involved your child is when participating in 1 or 2 activities of this type that he or she does most often 
whether or not you would like your child’s participation to change, and if so, how you would like it to change 
IMPORTANT 
 
This survey is not asking about your child’s level of independence when participating in activities. “Involvement” refers to how engaged 
your child is in an activity, using whatever supports, assistance, adaptations, or methods he or she routinely uses or has available. 
When selecting your response, please think about your child’s level of attention, concentration, emotional engagement, or satisfaction 
(using whatever supports or assistance are usually available). 
Very involved = In general, child is engaged throughout the activity. He or she shows a lot of initiative and/or interest in and 
attention to what he or she and others are doing during the activity. 
 
Somewhat involved = Child is engaged in the activity some of the time. He or she shows some initiative and/or interest in and 
attention to what he or she and others are doing during the activity. 
 
Minimally involved = Child is engaged in a small part of the activity. He or she only shows a little initiative and/or interest in and 
attention to what he or she and others are doing during the activity. 
If there are things that help or make your child's participation more difficult, such as equipment or support from others, you can tell us 
about their impact in the home environment, school environment, and community environment sections of this survey. 
Not to be reproduced without permission of authors Coster, Law, & Bedell 
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10) Homework 
(e.g., daily reading, homework assignments, 
school projects) 
Not to be reproduced without permission of authors Coster, Law, & Bedell PEM-CY Home Section - 1 of 03    281 
1) Computer and video games 
 
2) Indoor play and games 
(e.g., playing with toys, puzzles, or board 
games, playing kitchen or dress-up) 
3) Arts, crafts, music, and hobbies 
(e.g., doing arts and crafts, listening to 
music, playing an instrument, collecting, 
reading for leisure, cooking for fun) 
4) Watching TV, videos, and DVDs 
 
5) Getting together with other people 
(e.g., interacting with peers, family, other 
houseguests) 
6) Socializing using technology 
(e.g., telephone, computer) 
7) Household chores 
(e.g., unloading/loading the dishwasher, 
cleaning room or other areas of the house, 
cooking, taking out the garbage, setting the 
table, caring for household pet) 
8) Personal care management 
(e.g., getting dressed, choosing clothing, 
brushing hair or teeth, applying makeup) 
9) School preparation (not homework) 
(e.g., gathering materials, packing school 
bag, packing lunch, reviewing schedule) 
 
 
 
 
HOME Participation 
 
A) Typically, how often does your child 
participate in 1 or more activities of this type? 
 
 
 
 
 
CHECK ONE RESPONSE 
 B) Think about 1 or 2 
activities of this type that 
your child participates in 
most often. Typically, how 
involved is your child when 
doing these activities? 
 
CHECK ONE RESPONSE 
 C) Would you like your child’s 
participation to change in this type of 
activity? 
 
 
 
 
IF YES, CHECK ALL THAT APPLY 
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harder 
Not to be reproduced without permission of authors Coster, Law, & Bedell PEM-CY Home Section - 2 of 3 
Do the following things help or make it harder for your child to participate in activities at home? 
 
 
CHECK ONE RESPONSE 
 
Not an 
issue 
 
Usually 
helps 
 
Sometimes 
helps; 
sometimes 
makes 
 
Usually 
makes 
harder 
 
 
1. The physical layout or amount of space and furniture in your home 
    
 
2. The sensory qualities of the home environment (e.g., amount and/or type of sound, light, temperature, 
textures of objects) 
    
 
3. The physical demands of typical activities in the home (e.g., strength, endurance, coordination) 
    
 
4. The cognitive demands of typical activities in the home (e.g., concentration, attention, problem-solving) 
    
 
5. The social demands of typical activities in the home (e.g., communication, interacting with others) 
    
 
6. Your child’s relationships with family members in the home (e.g., siblings, parent, grandparent) 
    
 
7. The attitudes and actions of babysitters, therapists, and other professionals who care for your child at home 
    
 
 
 
 
HOME Environment 
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Are the following available and/or adequate to support your child’s participation at home? 
 
 
CHECK ONE RESPONSE 
 
Not 
needed 
 
Usually, 
yes 
 
Sometimes 
yes; 
sometimes 
no 
 
Usually, 
no 
 
 
8. Services in the home (e.g., therapists, tutors, etc.) 
    
9. Supplies in the home (e.g., sports equipment, crafts supplies, reading materials, assistive devices or 
technology, picture or word schedules) 
    
 
10. Information (e.g., about activities, services, programs) 
    
 
11. Do you (and your family) have enough time to support your child’s participation at home? 
    
 
12. Do you (and your family) have enough money to support your child’s participation at home? 
    
 
 
 
 
HOME Environment 
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1) Classroom activities 
(e.g., group work, classroom discussions, 
tests, in-class assignments) 
2) Field trips and school events 
(e.g., going to a museum, the school fair, 
spring concert or play, dances, fundraisers) 
3) School-sponsored teams, clubs and 
organizations 
(e.g., groups, clubs, teams, student council) 
4) Getting together with peers outside 
of class 
(e.g., hanging out during lunch, at recess, or 
other breaks during the school day) 
5) Special roles at school 
(e.g., lunch room supervisor, student mentor) 
 
 
 
 
 
SCHOOL Participation 
 
A) Typically, how often does your child 
participate in 1 or more activities of this type? 
 
 
 
 
 
CHECK ONE RESPONSE 
 B) Think about 1 or 2 
activities of this type that 
your child participates in 
most often. Typically, how 
involved is your child when 
doing these activities? 
 
CHECK ONE RESPONSE 
 C) Would you like your child’s 
participation to change in this type of 
activity? 
 
 
 
 
IF YES, CHECK ALL THAT APPLY 
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Do the following things help or make it harder for your child to participate in activities at school? 
 
 
CHECK ONE RESPONSE 
 
Not an 
issue 
 
Usually 
helps 
 
Sometimes 
helps; 
sometimes 
makes 
 
Usually 
makes 
harder 
 
 
1. The physical layout or amount of space in the classroom, on the playground, or on other parts of school 
premises (e.g., presence of sidewalks, availability of ramps or elevators in school building) 
    
 
2. The sensory qualities of the school environment (e.g., noise, crowds, lighting, etc.) 
    
 
3. Outside weather conditions (e.g., temperature, climate) 
    
 
4. The physical demands of typical school activities (e.g., strength, endurance, coordination) 
    
 
5. The cognitive demands of typical school activities (e.g., concentration, attention, problem-solving) 
    
 
6. The social demands of typical school activities (e.g., communication, interacting with others) 
    
 
7. Attitudes and actions of teachers, coaches, or staff towards your child 
    
 
8. Your child’s relationships with peers 
    
 
9. The safety of the school (e.g., supervision, crime, violence) 
    
 
 
 
 
SCHOOL Environment 
 
 
 286 
  
 
10. Access to personal transportation to get to school (e.g., family car, bicycle) 
 
11. Access to public transportation (e.g., school bus, train, or subway) to get to school 
 
10. Information (e.g., about activities, services, programs) 
 
11. Do you (and your family) have enough time to support your child’s participation at home? 
 
12. Do you (and your family) have enough money to support your child’s participation at home? 
Not to be reproduced without permission of authors Coster, Law, & Bedell PEM-CY School Section - 3 of 3 
Are the following available and/or adequate to support your child’s participation at school? 
 
 
CHECK ONE RESPONSE 
 
Not 
needed 
 
Usually, 
yes 
 
Sometimes 
yes; 
sometimes 
no 
 
Usually, 
no 
 
     
 
to et to school (e.g., school bus, train, subway) 
    
 
2 Pr grams and services (e.g., after chool, rec eational, special resources, educational assistant/aide) 
    
 
3 School–related policies and procedures (e.g., eligibility criteria for serv es, rules for behavior) 
    
4 Supplies (e.g., assistive devices or technolog , reading materials, sports equipment, crafts supplies) 
    
 
15. Information (e.g., about activities, services, programs) 
    
 
16. Do you (and your family) have enough time to support your child’s participation at school? 
    
 
17. Do you (and your family) have enough money to support your child’s participation at school? 
    
 
 
 
 
SCHOOL Environment 
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1) Neighborhood outings 
(e.g., shopping at the store/mall, going to a 
movie, eating out at a restaurant, visiting the 
local library/bookstore) 
2) Community events 
(e.g., attending a play, concert, sports game, 
parade) 
3) Organized physical activities (e.g., 
sports teams or classes such as baseball, 
hockey, martial arts, dance, horseback 
riding, swimming, gymnastics) 
4) Unstructured physical activities 
(e.g., nature trail walks, bicycle riding, 
rollerblading, skateboarding, playing 
hide-and-seek or chase, playing pick-up 
games like basketball) 
5) Classes and lessons (not school- 
sponsored) 
(e.g., music, art, languages, computers) 
 
 
 
 
COMMUNITY Participation 
 
A) Typically, how often does your child 
participate in 1 or more activities of this type? 
 
 
 
 
 
CHECK ONE RESPONSE 
 B) Think about 1 or 2 
activities of this type that 
your child participates in 
most often. Typically, how 
involved is your child when 
doing these activities? 
 
CHECK ONE RESPONSE 
 C) Would you like your child’s 
participation to change in this type of 
activity? 
 
 
 
 
IF YES, CHECK ALL THAT APPLY 
 
 
 288 
  
Not to be reproduced without permission of authors Coster, Law, & Bedell PEM-CY Community Section - 2 of 4 
6) Organizations, groups, clubs, and 
volunteer or leadership activities 
(e.g., Boy Scouts, Brownies/Girl Guides, 
youth groups, public speaking) 
7) Religious or spiritual gatherings and 
activities 
(e.g., attending places of worship, religion 
classes, groups) 
8) Getting together with other children 
in the community 
(e.g., hanging out, informal gatherings 
outside of the home or school) 
9) Working for pay 
(e.g., babysitting, paper route, working in a 
store, doing chores or running errands for 
pay) 
10) Overnight visits or trips 
(e.g., sleepovers, vacations, camp) 
 
 
 
 
 
COMMUNITY Participation 
 
A) Typically, how often does your child 
participate in 1 or more activities of this type? 
 
 
 
 
 
CHECK ONE RESPONSE 
 B) Think about 1 or 2 
activities of this type that 
your child participates in 
most often. Typically, how 
involved is your child when 
doing these activities? 
 
CHECK ONE RESPONSE 
 C) Would you like your child’s 
participation to change in this type of 
activity? 
 
 
 
 
IF YES, CHECK ALL THAT APPLY 
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Do the following things help or make it harder for your child to participate in activities in the community? 
 
 
CHECK ONE RESPONSE 
 
Not an 
issue 
 
Usually 
helps 
 
Sometimes 
helps; 
sometimes 
makes 
 
Usually 
makes 
harder 
 
 
1. The physical layout or amount of space outside and inside buildings (e.g., distances to stores, presence of 
sidewalks, availability of ramps or elevators) 
    
 
2. The sensory qualities of community settings (e.g., noise, crowds, lighting) 
    
 
3. The physical demands of typical activities (e.g., strength, endurance, coordination) 
    
 
4. The cognitive demands of typical activities (e.g., concentration, attention, problem-solving) 
    
 
5. The social demands of typical activities (e.g., communication, interacting with others) 
    
 
6. Your child’s relationships with peers 
    
 
7. The attitudes and actions of other members of the community  towards your child (e.g., shopkeepers, 
instructors, coaches, other families) 
    
 
8. Outside weather conditions (e.g., temperature, climate) 
    
 
9. The safety of the community (e.g., traffic, crime, violence) 
    
 
 
 
 
COMMUNITY Environment 
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Are the following available and/or adequate to support your child’s participation at school? 
 
 
CHECK ONE RESPONSE 
 
10. Access to personal transportation to get to school (e.g., family car, bicycle) 
 
11. Access to public transportation (e.g., school bus, train, or subway) to get to school 
 
10. Information (e.g., about activities, services, programs) 
 
11. Do you (and your family) have enough time to support your child’s participation at home? 
 
12. Do you (and your family) have enough money to support your child’s participation at home? 
Not to be reproduced without permission of authors Coster, Law, & Bedell 
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in the c mmunity? 
 
Not 
needed 
 
Usually, 
yes 
 
Sometimes 
yes; 
sometimes 
no 
 
Usually, 
no 
 
access ommunity ctivities  (e.g., family car, bicycle) 
    
to access community activities (e.g., bus, train, subway) 
    
 
2 Programs and services (e.g., nclusive sports programs, personal support worker) 
    
3 Information (e.g., about activities, services, programs)
    
14. Equipment or supplies (e.g., sports equipment, craft supplies, reading materials, assistive devices or 
technology) 
   
 
 
15. Do you (and your family) have enough time to support your child’s participation in the community? 
    
 
16. Do you (and your family) have enough money to support your child’s participation in the community? 
    
 
 
 
 
 
COMMUNITY Environment 
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Assessment of Life-Habits (LIFE-H) recreation domain 
11.8  Co-authored paper one 
Oftedal S, Bell K, Mitchell L, Davies P, Ware R, Boyd R (2012) “A systematic review of the 
clinimetric properties of habitual physical activity measures in preschool aged children with 
a motor disability”.  International Journal of Pediatrics. 2012:976425. doi:  
10.1155/2012/976425.  
 292 
  
Hindawi Publishing Corporation 
International Journal of Pediatrics 
Volume 2012, Article ID 976425, 12 pages 
doi:10.1155/2012/976425 
  
 
 
 
 
Review Article 
A Systematic Review of the Clinimetric Properties of 
Habitual Physical Activity Measures in Young Children with 
a Motor Disability 
 
 
 
Stina Oftedal,1, 2, 3, 4 Kristie L. Bell,1, 2, 3, 4 Louise E. Mitchell,1, 4 Peter S. W. Davies,2 
Robert S. Ware,3, 5 and Roslyn N. Boyd1, 3, 4 
 
1 Queensland Cerebral Palsy & Rehabilitation Research Centre, School of Medicine, The University of Queensland, Brisbane,  
QLD 4029, Australia 
2 Children’s Nutrition Research Centre, School of Medicine, The University of Queensland, Brisbane, QLD 4029, Australia 
3 Queensland Children’s Medical Research Institute, The Royal Children’s Hospital, Brisbane, QLD 4029, Australia 
4 The Royal Children’s Hospital, Herston, Brisbane, QLD 4029, Australia 
5 School of Population Health, The University of Queensland, Brisbane, QLD 4006, Australia 
 
Correspondence should be addressed to Stina Oftedal, s.oftedal@uq.edu.au 
 
Received 24 January 2012; Revised 4 April 2012; Accepted 23 April 2012 
 
Academic Editor: Kristie F. Bjornson 
 
Copyright © 2012 Stina Oftedal et al. This is an open access article distributed under the Creative Commons Attribution License, 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
 
Aim. To identify and systematically review the clinimetric properties of habitual physical activity (HPA) measures in young children 
with a motor disability. Method. Five databases were searched for measures of HPA including: children aged <6.0 years with a 
neuromuscular disorder, physical activity defined as “bodily movement produced by skeletal muscles causing caloric expenditure”, 
reported HPA as duration, frequency, intensity, mode or energy expenditure, and evaluated clinimetric properties. The quality of 
papers was assessed using the COSMIN-checklist. A targeted search of identified measures found additional studies of typically 
developing young children (TDC). Results. Seven papers assessing four activity monitors met inclusion criteria. Four studies 
were of good methodological quality. The Minimod had good ability to measure continuous walking but the demonstrated 
poor ability to measure steps during free-living activities. The Intelligent Device for Energy Expenditure and Activity and 
Ambulatory Monitoring Pod showed poor ability to measure activity during both continuous walking and free-living activities. The 
StepWatch showed good ability to measure steps during continuous walking in TDC. Interpretation. Studies assessing the 
clinimetric properties of measures of HPA in this population are urgently needed to allow assessment of the relationship between 
HPA and health outcomes in this group. 
 
 
 
 
1. Introduction 
 
Habitual physical activity (HPA) is an established deter- 
minant of health in children and is required for healthy 
development, including the growth of bone and muscle mass, 
improved balance and motor skills, maintaining a healthy 
weight and improved psychological wellbeing [1, 2]. Limited 
evidence suggests young children with motor disorders are 
less physically active than their typically developing peers [3]. 
Consequently they may be at risk of suboptimal growth and 
development in addition to the development of secondary 
conditions  such  as  chronic  pain,  fatigue,  and  low  bone 
density which can lead to diminished bone health [4, 5]. 
Australian physical activity guidelines state children aged 
from one to five years should be physically active for three 
hours throughout the day and should not be sedentary, 
restrained, or kept inactive, for more than one hour at a time, 
with the exception of sleeping [2]. Studies investigating the 
link between HPA and health outcomes for children with 
motor impairments have not been conducted. These studies 
are urgently needed to (i) determine the HPA patterns and 
intensities of children with motor disabilities, (ii) support 
the importance of physical activity promotion and inactivity 
prevention, (iii)  determine the dose-response relationship 
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between physical activity and health outcomes, and (iv) allow 
assessment of  the effectiveness of  interventions aimed  at 
increasing HPA. 
Physical activity is defined as “any bodily movements 
using skeletal muscles that results in energy expenditure” [6]. 
The International Classification of Functioning, Disability 
and Health (ICF) further divides physical activity into the 
concepts of “performance” and “capacity” [7]. Performance 
is  defined as  the  execution of  an  activity in  the  natural 
environment. This is distinct from capacity which refers to 
a child’s maximal ability to perform an activity in an ideal 
or  standardised  environment.  Performance  and  capacity 
to complete a task (e.g.,  jumping) can be determined by 
observing the child undertake that specific task within a 
limited time frame in their natural and ideal environment, 
respectively. HPA, on  the  other hand,  describes a  child’s 
typical  daily  activity  pattern  and  hence  includes  their 
performance of a multitude of activities which necessitates 
measurement  across  multiple  days  [8].  The  variables  of 
frequency (how often a child does an activity), intensity (how 
hard a child works to do the activity), duration (how long a 
child does an activity), and mode (what the child is doing) 
are used to characterise HPA patterns, while activity-related 
energy expenditure (AEE) is used as a summary variable of 
all the other indicators [9, 10]. 
Direct observation is considered the gold standard for 
physical activity classification, while doubly labelled water in 
combination with resting energy expenditure is considered 
the gold standards for calculating AEE [10].  Measures of 
HPA include both objective and subjective methods [11]. 
Objective measures include heart rate monitors, accelerom- 
eters, and pedometers. Subjective methods include self- or 
proxy reports, interviews, and diaries. The measurement of 
HPA in typically developing children (TDC) has received a 
great deal of attention in the last decade, primarily due to a 
concern over the increasing rate of overweight and obesity 
in childhood [12]. A systematic review of pedometers and 
accelerometers has identified moderate-to-good evidence of 
validity and strong evidence of reliability for the ActiGraph 
accelerometer in preschool-aged TDC [13]. Children with 
motor impairments may not be walking but instead cruising, 
crawling, bottom shuffing, rolling, use walking aids or a 
wheelchair as means of locomotion, and those who are 
walking  may  have  diﬀ erent  gait  patterns  and  speed  of 
movement than TDC [14]. This variation in movement 
patterns necessitates validation of motion sensors specifically 
for this population. 
Systematic reviews of measures of physical activity in 
children and adolescents with cerebral palsy (CP) have been 
conducted [15, 16]. Capio et al. [15] included children with 
CP from birth to 18 years and concluded that the subjec- 
tive measures of the Activities Scale for Kids-Performance 
Version (ASKp) and the Children’s Assessment of Partici- 
pation and Enjoyment (CAPE) are the only measures with 
established validity and reliability in children with physical 
disabilities from the age of six years. The review by Clanchy et  al.  
[16]  included  children  with  CP  aged  10–18  years and 
identified the CAPE as the measure with the strongest 
evidence of reliability and validity. It was also noted that no 
measures have been assessed in children with more severe 
disability who  are wheelchair dependent. This paper did 
not include the ASKp as it did not meet inclusion criteria 
of 60% of items relating to a domain of physical activity 
performance. This was done to ensure the included measures 
assess physical activity as traditionally defined by Caspersen 
et al. [6] and not “participation” which does not take into 
consideration the sedentary or active nature of the activity. 
Both reviews note the lack of HPA measures which can 
assess activity intensity, which limits their ability to provide 
meaningful comparison with physical activity guidelines, as 
children from the age of six years are advised to accumulate 
60 minutes of moderate-to-vigorous physical activity every 
day [17]. This current paper aims to systematically review the 
clinimetric properties (validity, reproducibility, and clinical 
utility) of measures of HPA in children less than 6 years of 
age with a motor disability [6]. 
 
2. Method 
 
2.1. Search Strategy. A systematic literature search was per- 
formed by one reviewer (SO) of the electronic bibliographic 
databases PubMed, CINAHL, EMBASE, SPORTDiscus, and 
Web of Science from their inception to September, 2011. 
Databases were searched using medical subject headings 
(MeSH) terms and text words for physical activity and 
disability, limiting the search to the age group <6.0 years. 
 
2.2. Inclusion and Exclusion Criteria. Measures of HPA were 
included which met the following criteria: (i) included 
children less than six years of age with a motor disability 
caused by neuromuscular disorders; (ii) defined physical 
activity as any bodily movement produced by skeletal 
muscles that results in caloric expenditure [6]; (iii) reported 
physical activity in terms of duration, frequency, intensity, 
or  energy expenditure; (iv)  questionnaires where at  least 
60% of items related to a domain of HPA; (v) evaluated 
clinimetric properties for the measurement of HPA. Studies 
were excluded if they were (i) not published in English, due to 
lack of translation services; (ii) primarily measured capacity 
or participation. 
The title and abstract of all retrieved references were 
screened by the first author to exclude any papers which did 
not include children in the target age group or were not on 
the topic of physical activity measures. A second screening 
of abstracts was performed by two authors (SO, LM) 
independently to exclude those that did not include habitual 
physical activity measures but rather assessed capacity or 
participation measures. For the remaining abstracts, full 
papers were retrieved and screened by two authors (SO, 
LM). Publications which did not assess the clinimetric 
properties of measures of HPA in children with motor 
disabilities were excluded. Upon disagreement between the 
two reviewers, a third reviewer (KB) reviewed the publication 
in question. The reference lists of included papers and 
relevant reviews were screened, and electronic author and 
citation tracking were performed when available, to identify 
relevant publications not identified by the initial search 
strategy. For  measures where  clinimetric properties were 
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found in children less than six years of age with a motor 
disability, a further search identified any evidence in typically 
developing children in the same age group. 
 
2.3. Data Extraction and Quality Review. The COSMIN 
(COnsensus-based Standards for the selection of health Mea- 
surement INstruments) checklist [18] was used to rate the 
methodological quality of the study designs used to evaluate 
the clinimetric properties validity and reproducibility for 
measures of  HPA. The COSMIN was developed through 
an international Delphi study to assess the methodological 
quality of studies on measurement properties of health- 
related patient-reported outcomes (HR-PROs) [18]; however 
the measurement properties are also relevant to other health- 
related measurement instruments. The scoring system was 
developed based on expert discussion and testing on 46 
articles identified by a systematic review and uses a “worst 
score counts” algorithm [19]. Each item within a specific 
measurement property is rated individually as “excellent” 
(+++),   “good”  (++),  “fair”  (+),  or  “poor”  (−)  and an 
overall score is  iven  by  taking  the  lowest  score  of  any 
of  the  items  within  the  assessment of  the  measurement 
property. Measurement properties included in  this paper 
were  measurement  error  (COSMIN  box  C),  hypothesis 
testing (COSMIN box F), and criterion validity (COSMIN 
box H). The methodological quality rating of the papers was 
separated into study design and statistical analysis. 
 
2.4. Rating of Study Design. The study design for the 
assessment of measurement properties was rated as having 
“excellent” quality if all relevant items within a given 
checklist scored “excellent.” Study design was rated as “good” if 
information for some items was not complete and therefore could 
not be scored “excellent,” though it could be assumed these were 
of “good” quality. A “fair” quality rating was given if there were 
minor flaws in the design. If the results were not to be trusted 
because of major flaws in the design, a study is rated as 
“poor” [19]. To assess if there were any important flaws in 
the design or methods of the study (COSMIN Box H, item 
five), items from the systematic review of activity monitors in 
TDC were used [13] as a guide in addition to whether or not the 
testing protocol included free-living activities. 
One modification was made to the original COSMIN 
checklist. Proposed sample size requirements [20] were 
applied in the clinimetric properties section instead of the 
study design section. The decision to separate study design 
and sample size requirements was made as sample size does 
not determine study design quality as such but does affect the 
statistical power available to detect a significant result. 
 
2.5. Statistical Methods and Clinimetric Properties of HPA 
Measures. For the assessment of  criterion  validity,  the 
COSMIN checklist accepts correlations or the area under 
the receiver operator characteristic (AUC-ROC) curve as 
“excellent” statistical methods for continuous measures [19]. 
For dichotomous scales sensitivity and specificity calcu- 
lations are considered “excellent” measures [19]. For the 
assessment of concurrent validity (hypothesis testing) it is 
up to the reviewer to assess if the method is “appropriate” and 
therefore scores “excellent.” For the assessment of 
measurement error (agreement), Standard Error of Mea- 
surement (SEM), Smallest Detectable Change (SDC), and 
Limits of Agreement (LoA) calculated using the Bland- Altman 
method are accepted as “excellent.” According to the COSMIN 
a sample size of less than 30 participants is considered “poor,”  
30–49 participants is considered “fair,” 50–99 participants is 
considered “good,” and 100 or more participants is considered 
“excellent” [19]. Authors were contacted to see if they had used 
any power calculations when determining their sample size. 
Quality criteria for the clinimetric properties of measures 
were proposed to give a framework to help distinguish 
between the quality of the studies and the performance of 
the measurement tools [20]. Agreement, criterion validity, 
and construct validity were therefore scored as good (+), 
indeterminate (unable  to  assess: u/a), or poor (−) [20]. 
Criterion validity was considered “good” if correlation with 
gold standard was ≥0.70, sensitivity and specificity ≥0.70, and 
area under receiver operating characteristic curve ≥0.70 [20]. 
Construct validity was considered “good”  if 75%  of the 
results were in accordance with the hypothesis [20]. 
Measurement error is considered “good” if the SDC or the 
LoA are smaller than the minimal important change or if 
“authors provide convincing arguments that the agreement is 
acceptable” in a sample size of at least 50 participants [20]. 
Studies that used a “poor” statistical method scored 
“indeterminate” for performance of clinimetric properties. 
The assessment of clinimetric properties of HR-PRO 
questionnaires might be of a different nature to those 
assessing activity measures due to the availability of gold 
standards, something which is not readily available for HR- 
PROs as these are usually questionnaires regarding patient 
outcomes such as pain and quality of life [21]. The statistical 
methods and performance of clinimetric properties were 
therefore scored according to the COSMIN but were also 
discussed further, and a different score was given if authors 
presented a convincing argument that the measure was 
acceptable. 
 
2.6. Clinical Utility. The clinical utility of measures of HPA 
was assessed in terms of the need for individual calibration of 
the equipment, the interpretability of the data output, and the 
need for software analysis, cost of equipment, and any required 
software. The feasibility of the equipment for using children 
aged less than six years with a motor disability in free living 
situations was also considered (size, weight, number of sensors, 
place worn, ease of correct placement, and battery life). The 
richness of data was also assessed in terms of what aspects of 
HPA (frequency, duration, intensity, mode, and energy 
expenditure) it was able to assess in children with a motor 
disability. 
 
2.7. Overall Level of Evidence. The overall level of 
evidence for the clinimetric properties of measures of HPA 
in young children with motor disabilities was determined 
as a whole by assessing the methodological quality of study 
design and statistical methods used in the assessment of 
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1771 abstracts yielded 
 
 
1st screening of titles and 
abstracts 
1567 abstracts excluded
 
et al. [24] and McDonald et al. [25] were identified for the 
StepWatch pedometer (Orthocare Innovations, WA, USA). 
A paper by Aviram et al. [26] assessed the Intelligent Device 
for  Energy  Expenditure  and  Activity  (IDEEA;  Minisun, 
CA, USA).  Only McDonald et  al. [25]  assessed children 
with Duchenne muscular dystrophy (DMD); others assessed 
children with CP who were able to walk with or without
2nd screening of 204 titles and 
abstracts 
 
 
3rd screening of 31 full papers 
and 2 abstracts from conference 
proceedings 
 
 
4 papers and 1abstract from 
conference proceeding included 
 
 
Identified measures in children 
with motor disabilities: 
• Activity monitoring pod 
• Minimod 
• StepWatch 
• Intelligent device for 
energy expenditure and 
activity (IDEEA) 
171 abstracts excluded 
 
 
27 papers and 1 abstract 
from conference 
proceeding 
 
 
 
 
 
 
Targeted search for 
measures in typically 
developing children (3 
papers) : 
• Minimod 
• StepWatch 
aids (Gross Motor Function Classification System levels I– 
III) [22–24, 26]. None of the study samples included children 
who did not walk as their main means of locomotion. 
All of the studies of children with motor disabilities 
included TDC as a reference group [22–26]. Sample sizes 
ranged from 17 to 27 children with motor disabilities and 
7–27 in the TDC reference group. All authors were contacted 
to clarify the proportion of children in their study who were 
under the age of six. The study by Brandes et al. [22] on 
the use of the Minimod included one child (5%)  with CP 
aged five years old and four children (20%) in the TDC 
sample aged three to five years. The study by Aviram et al. 
[26] included nine children (43%) aged four to five years 
with three children in each GMFCS category (I–III). The 
authors did not supply the number of TDC aged five years, 
but the youngest of the seven children in the TDC group 
was 5 years and 8 months old [26]. In the study by Kuo et 
al. [23] it was estimated that a maximum of two children 
in  the  CP (11%)  and  TDC (10%)  group were less than 
Figure 1: Flow diagram for search strategy. 
 
 
HPA measures using the “worst score counts” algorithm, 
agreement between studies on the quality of clinimetric 
properties of these HPA measures, and the number of studies 
available for each HPA measure. 
 
3. Results 
 
Description of the results of the search strategy can be seen in 
Figure 1. The initial search yielded 1771 titles, and abstracts 
after duplicates were deleted. The initial screening by titles 
and abstracts excluded 1567 titles, and the second screening 
excluded a further 171 papers. Thirty-one full papers and 
two abstracts from conference proceedings were further 
reviewed. Four papers and one abstract from conference 
proceedings on the clinimetric properties of four measures 
of HPA in children with motor disabilities were identified 
which included children aged less than six years in their 
sample. None of the studies focused exclusively on children 
aged less than six years, which led to the inclusion of 
studies with a wide age range (4–18 years). 
The characteristics of the studies are detailed in Table 1. 
Evidence of clinimetric properties was found for three 
accelerometer-based activity monitors [22–26] and one 
pedometer using inertial sensors [23]. A paper by Kuo et al. 
[23] and an abstract from conference proceedings by Brandes 
et al. [22] were identified for the Minimod pedometer 
(DynaPort McRoberts, Hague, Netherlands). The Activity 
Monitoring Pod-331 pedometer which uses inertial sensors 
(AMP; Dynastream Innovations, Alberta, Canada) was also 
assessed in the paper by Kuo et al. [23]. Papers by Stevens 
six  years old,  although  authors  were  not  able  to  readily 
access information to confirm this. It is not known how 
many children were under the age of six in the study by 
Stevens et al. [24] and McDonald et al. [25]. The targeted 
search for studies reporting on the clinimetric properties of 
the identified measures in young TDC identified a further 
three studies assessing the Minimod [27] and the StepWatch 
[28, 29]. The sample size in the three studies ranged from 20 to 
162 children, and ages ranged from 2 to 16 years. The 
StepWatch study by Bjornson et al. [28] reported results for 
two-to-three-year olds (n = 60) and four-to-five-year olds (n  
= 62) TDC separately. The StepWatch study by Song et al. 
[29] used two age bands (5–7 years and 9–11 years) with ten 
children in each group, but the number of five year old 
children in the youngest group was not specified by the 
authors upon request. In the paper by Brandes et al. [27], 
authors report on the same sample of TDC (n = 20, four 
children ≤6.0 years) as in the previously mentioned abstract 
from conference proceedings. The full paper and abstract 
from conference proceedings will be rated as one paper. 
 
3.1. Rating of Study Designs. Description of the study design of 
included papers is outlined in Table 1. None of the authors 
using manual step count as a criterion method reported on the 
accuracy of the manual step count (intra- or interrater 
agreement). Although it can be assumed that it is a gold 
standard, no evidence has been provided, and therefore the 
maximum attainable score for all studies according to the 
COSMIN checklist was “good” [19]. The study by Brandes et 
al. [22, 27] assessed the criterion validity of the Minimod in 
children with CP and TDC compared to manually counted steps 
and meters walked was rated “good” for study design. Authors  
report  complete  information  in  regarding  test 
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Table 1: Characteristics of studies describing measures of habitual physical activity. 
Population 
Mean age (range) 
Children aged Motor 
Reference 
≤5 years (n)  disorder 
Minimoda 
17 — 10 yr 6 mo 
(4–16 yr) 
∼2 CP1 DO
 
Continuous walking, structured activity lap, and 
stair climbing (steps and meters walked) 
n = 19, 4–16 yr Kuo et al. [23]
 
 
20 —  5–16 years (  )  1 CP2 Self-paced walking (steps and meters walked) n 20, 3–16 yr 
Brandes et al. 
[22, 27] 
AMPb 20 13 
10 yr 6 mo 
(4–16 yr) 
Continuous walking, structured activity lap, and 
stair climbing (steps and meters walked) 
n = 20, 4–16 yr Kuo et al. [23]
 
16 16 9 yr 2 mo (5–13 yr) —  DMD DO 
Slow/fast self-paced walking (steps) + 3-day HR 
and pedometer (steps and HR) 
McDonald et al. 
[25] 
StepWatchc 27 22 −(4–18 yr) —  CP3 DO Treadmill walking at diﬀ erent speeds (steps)  n = 27, age matched Stevens et al. [24] 
60 30 −(2-3 yr) 60 TDC DO Self-paced walking (steps)  n/a Bjornson et al. 
62 31 −(4-5 yr) 62 TDC DO Self-paced walking (steps)  n/a [28] 
IDEEAd 
20 10 −(5–11 yr) —  TDC DO Self-paced walking and running (steps)  n/a Song et al. [29] 
21 —  (4 yr–10 yr 1 mo)  9 CP1 IC + HR 
Series of everyday activities, walking on 
treadmill, climb staircase (energy expenditure 
kcal/min) 
a
 
n 7, 5 yr 8 mo–8 yr 
6 mo 
Aviram et al. [26]
 
Minimod, Dynaport, McRoberts BV, Hague, Netherlands; b AMP: Activity Monitoring Pod 331, Dynastream Innovations, Alberta, Canada; c StepWatch, Orthocare Innovations, WA, USA, d IDEEA: Intelligent 
Device for Energy Expenditure and Activity, Minisun, CA, USA; CP: cerebral palsy; GMFCS: Gross Motor Function Classification System; DMD: Duchenne muscular dystrophy; TDC: typically developing 
children; DO: direct observation; IC: indirect calorimetry; HR: heart rate monitor; 1 GMFCS I–III; 2 GMFCS not specified, able to walk; 3 GMFCS I–II; (—): not reported. 
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protocol (monitor settings, placement, data output, average 
steps needed for length walked, and range of steps across 
group) but only tests of continuous walking that may not 
adequately reflect free-living walking activity. The study by 
Kuo et al. [23] on the criterion validity of the Minimod and 
AMP compared to manually counted steps and measured 
meters walked was rated “good” on this construct. Authors 
report complete information on test protocol and use of a 
variety of structured activities: continuous walking; activity 
lap walking which includes walking, stopping, completing a 
simple task, and walking again; stair ascent and descent. 
The studies by Stevens et al. in children with CP [24], 
McDonald et al. in children with DMD [30], and Song et 
al. in TDC [29] all assessed the criterion validity of the 
StepWatch against manual step count and scored “poor” 
for study design due to providing no information on parts 
of their study protocol (number of steps, range of steps 
needed, and length walked). This does not necessarily mean 
the design was genuinely poor, but the lack of reporting does 
not enable assessment on applicability in measuring habitual 
walking activity and has implications for the interpretation 
of any reported statistics. The study by Bjornson et al. [28] 
assessed the StepWatch for criterion validity in TDC against 
manual step counts and was rated “good” for study design 
as they report a complete test protocol, though only assessed 
performance during continuous walking. 
The study by Aviram et al. [26] assessed the criterion 
validity of energy expenditure (EE) measured by the IDEEA 
compared to the gold standard of indirect calorimetry using 
the Cosmed (K4b2, Rome, Italy) which measured oxygen 
consumption (VO2 ) in five-second epochs. Authors reported 
complete study protocol information and assessed a range 
of everyday activities in addition to comfortable and fast 
treadmill walking and stair climbing. The study scored 
“good” for study design due to not providing any evidence 
of the Cosmed being a gold standard measurement although 
it can be assumed adequate [19]. Authors discuss possible 
limitations of the use of the Cosmed, which include a poor 
fitting mask, which may lead to inaccurate measurement. 
This study also assessed the test-retest reliability of the 
IDEEA and received an “excellent” rating for study design in 
the assessment of this construct. 
The StepWatch study in children with DMD [25] used a 
heart rate monitor to assess its concurrent validity over four 
days of wear. This study was rated “fair” for study design in 
the assessment of this construct as an a priori hypothesis of 
the relationship between the StepWatch and heart rate was 
not stated, but it was possible to deduce what was expected 
[19]. 
 
3.2. Rating of Statistical Methods and Clinimetric Performance 
of Measures. The clinimetric properties measured for all the 
studies reviewed are outlined in Table 2. All studies apart 
from the study by Bjornson et al. [28] had a sample size of 
less than 30 children which constitutes a “poor” score on the 
COSMIN checklist, while the sample size of 60–62 children 
in each age group found in the Bjornson et al. study [28] 
receives “good” rating on this item. Three of the four authors 
who replied had not used a power calculation to determine 
sample size [22, 23, 26, 27], and one author stated in their 
reply that  the  recruitment of  60  children in  each group 
(30 boys and 30 girls) was chosen as it was expected this 
would “increase the likelihood of approximating a normal 
distribution”  [28].  It  is not  known if  Stevens et  al.  [24] 
and McDonald et al. [25] used any power calculations to 
determine their sample size. As the COSMIN works on a 
“worst score counts” algorithm, the highest score possible 
for  all  but  one  study  is  therefore  “poor,” but  as  several 
studies report significant results, further discussion about the 
clinimetric performance of measures is warranted. 
Percent agreement was used to assess the criterion 
validity  of  the  Minimod  in  children  with  CP  and  TDC 
by  Brandes et  al.  [22,  27],  and  the  use  of  this  method 
leads to a “poor”  rating for statistical methods according 
to the COSMIN as it comes under “any other statistical 
method” [19]. Percent agreement is a relative measure and 
therefore depends on reporting of the absolute values for 
meaningful interpretation. Authors present rich information 
such as the average steps needed to walk the 20-meter track 
(CP  children)  and  160-meter  track (TDC)  and  range of 
steps taken [22, 27]. It is therefore possible to see that the 
measurement error is small. Children with CP (n  = 19) 
walked an average of 79.8 steps (min:57; max: 126), and on 
average the Minimod over- or underestimated by one step 
(agreement= 98.7%; range: 94.1 to 101.8%) [22, 27]. TDC 
(n = 20) walked an average of 273.7 steps (min:207; max: 
377), and on average the Minimod over or underestimated 
by one step (agreement = 99.6%;  range: 98.5 to 101.5%) 
[22,  27].  Children with CP walked only one-third of the 
steps TDC walked, and a higher likelihood that agreement 
occurred by chance exists. Due to good reporting of study 
protocol and results, percent agreement was considered an 
“excellent” statistical method. The Minimod showed “good” 
accuracy and precision for the measurement of continuous 
walking. A limitation of this study was the assessment of 
continuous walking only, and therefore the criterion validity 
for measuring HPA is “indeterminate.” 
The issue of use of percent agreement arises in two other 
studies assessing the StepWatch in TDC. Percent agreement 
is used by Song et al. [29] who compare steps measured and 
manual step count. They found a measurement error of 3 ± 
1% [29] but did not report how long children walked or how 
many steps they took which does not allow the assessment of 
absolute measurement error or the likelihood that the error 
was low by chance. For this same study, a Pearson correlation 
coefficient has been reported in a separate paper [31] which 
by COSMIN standards was an “excellent” statistical method, 
but the lack of information about the study protocol still 
applies as correlation could have been estimated based on 
a  small  number  of  steps.  The  use  of  percent  agreement 
and Pearson correlation coeffcient in this study receives a 
“poor” rating, and evidence of criterion validity based on 
this study was “indeterminate.” Percent agreement was also 
used in the study by Bjornson et al. [28] but total steps taken 
are reported as ≥100 steps, and therefore it is possible to 
assess the absolute value of agreement in step count for two- 
three-year olds (99.2 ± 4.6%)  and 4-5-year olds (100.0 ± 
4.4%). In this study, the use of percent agreement therefore 
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rates as “excellent,” and the evidence of criterion validity for 
continuous walking is “good” which is further strengthened 
by the large sample size. Criterion validity for measurement 
of HPA cannot be determined based on this study. A further 
two studies assess the use of the StepWatch in children with 
CP [24] and DMD [25] but do not report any statistical 
methods or results which was rated “poor,”  and criterion 
validity for these populations was therefore “indeterminate.” 
Bland-Altman plots  [32]  and  percent of  activity laps 
which were detected were used to assess criterion validity 
in the combined study of the Minimod and AMP by Kuo 
et al. [23]  and due to this would have scored “poor”  on 
the COSMIN checklist [19]. The lack of a specific index 
to summarise the degree of agreement is a limitation of 
the Bland-Altman technique, and inferences about the 
estimate cannot be performed [33].A strength of the Bland-Altman 
technique is that it produces a meaningful graph and 
computes the confidence limits from the paired differences 
between the criterion method (manual step count or meters 
walked) and the same variables measured by the Minimod 
[33]. This provides us with the ability to assess both 
accuracy and precision of measures and allows a comparison 
between groups and therefore still allows a thorough 
assessment of the agreement between methods and can be 
rated as an “excellent” statistical method. The Minimod 
performed well in continuous walking trials compared to 
measured length and direct observation of steps (mean 
difference = −0.4 m/−0.4  steps, 95%  limits  of  agreement  
=  −4.7 to 4 m/−4.1 to 3.3 steps) but showed a larger random 
error for activity lap walking (mean diff.. =−2.3 m/−0.4 
steps, 95%  LoA =  −27.9 to 23.3 m/−87.8  to  10.4  steps)  
[23]. The Minimod  only  detected  walking activity in  19–
37% of stair walking trials (ascent/descent) [23].  In 
TDC, the Minimod performed well for continuous walking 
trials and poor in structured activity laps (see Table 2); 
however it performed better for detecting stair walking 
(84%)  [23]. The AMP showed greater underestimation and 
random error in continuous walking  trials  (mean  diff.  =  
−4.8 m/−3.5 steps,  95%  LoA = −20.1  to  10.5 m/−16.9  
to  10  steps) which increased with increasing distance 
walked [23]. The AMP performed better than the Minimod 
in the structured activity lap walking trials, but still showed 
considerable bias difference and large random error in this 
trial (mean diﬀ . = −3.6 m/−11.2 steps, 95% LoA = −19.2 
to 12.0 m/−40 to 17.7  steps),  however detected more of  
the stair climbing trials (85%) [23]. Results were similar 
for TDC (see Table 2) [23]. Due to the lack of an index, a 
specific cut-off for what classifies as a “good” result cannot 
be set; however the results indicate that the Minimod has 
“good” accuracy and precision for continuous walking. 
When it comes to more free-living type activities such as 
the structured walking trial and stair walking, the 
performance of the Minimod is “poor.” The AMP showed 
“poor” precision and accuracy in both walking trials, 
however detected more stair trials. As the focus of this 
paper is the ability to measure free-living activities, both 
monitors score “poor” for evidence of criterion validity for 
measuring HPA. 
A Pearson correlation coeffcient was used  to assess 
agreement between the EE measured by the IDEEA and the 
criterion method of indirect calorimetry using the Cosmed 
[26]. A Pearson correlation is considered an “excellent” sta- 
tistical method by the COSMIN [19]. For the daily activities 
trial, total energy expenditure was used as the outcome mea- 
sure. For comfortable and fast treadmill walking and stair 
climbing trials, energy expenditure rate (kcal/minute) was 
used. For children with CP and TDC the correlation between 
measurement outputs was “good”  by COSMIN standards 
during all activities (CP: r  = 0.70–0.88; TDC: r  = 0.74– 
0.97, P ≤ 0.05) [26]. A limitation of the Pearson correlation 
coeﬃcient is that it only measures precision not accuracy 
and is therefore not a true measure of agreement [33]. This 
is demonstrated by the authors of this paper as the IDEEA 
significantly overestimated energy expenditure during the 
series of everyday activities and during comfortable treadmill 
walking both in children with CP and TDC, and during fast 
treadmill walking in TDC (paired t-test, P  <  0.01) [26]. 
During fast treadmill walking in children with CP and during 
stair walking in both groups, measured energy expenditure 
did not differ significantly between methods (paired t-test, 
P  > 0.01) [26]. A limitation of the t-test is that it will only 
show a significant difference if there is a systematic constant 
difference between two values, not if there is a systematic 
proportional difference as the paired difference will end up 
close to zero [34]. A Bland-Altman plot or a regression 
analysis would provide a better identification of the nature of 
any systematic differences in the EE estimation of the 
IDEEA. The  present energy expenditure calculations used  
in  the IDEEA software do not accurately assess energy 
expenditure, and the clinimetric properties of the IDEEA 
are therefore considered  “poor.”  Authors suggest  the  
good  correlation between the IDEEA and the Cosmed 
indicates it can be used as a clinical follow-up tool for 
quantitative evaluation of eﬃcacy of treatment 
interventions. As the IDEEA appears to perform better at 
higher intensities, systematic differences may exist which 
may lead to inaccurate conclusions. The reliability of EE 
measurement by the IDEEA was assessed in children with 
CP (n = 12) [26] using a Pearson’s correlation coeffcient  
and  a  paired  t-test.  Authors  aimed  to  assess 
“agreement” between repeated measures as discussed in de 
Vet et al. [35]. This study therefore scored “poor” for choice 
of statistical method as measures can significantly correlate 
despite being significantly diﬀ erent, and the inability of a t- 
test to detect systematic proportional diﬀ erences as discussed 
previously still applies [33, 34]. Agreement between 
repeated measures of EE using the IDEEA is therefore 
“indeterminate” based on this study. 
Authors of the StepWatch study in children with DMD 
[25] used a heart rate monitor to assess its concurrent validity 
and received a “good” rating for statistical method as they 
used a Pearson correlation coeffcient but did not report 
standard deviation. Evidence of concurrent validity was rated 
poor as r < 0.70 (CP: r = 0.295; TDC: r = 0.477; P < 0.05).  
 
3.3. Clinical Utility. Clinical  utility  was  assessed for  the 
four  identified measures and  is  summarised in  Table  2. 
The Minimod and StepWatch require individual calibration 
and software for analysis. The StepWatch is expensive (cost 
not available for Minimod). The rich data collected by the 
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Table 2: Evidence of criterion or construct validity, reliability and utility. 
 
Measure Utility Study 
n, age (years), 
disability 
 
Criterion validity 
Construct 
validity 
Mean diﬀ erence ± 2SD: (−3.3 ± 2.2)–(8.9 ± 2.5) m; 
 
Reliability 
Cost not available  
Kuo et al. [23] 
n = 17, 4–16, CP (−38.7 ± 49.1)–(−1.0 ± 1.7) steps; rate of activity 
detection: 19–97% 
n/a n/a 
Mean diﬀ erence ± 2SD (−0.6 ± 5.2)–(7.5 ± 2.8) m; 
Calibration and analysis software n = 19, 4–16, TDC (−57.4 ± 67)–(−1.0 ± 2.0) steps; rate of activity 
detection for stair ascent and descent 84–100% 
Minimod Rich data collection Agreementsteps = 98.9% (range: 94.1–101.8%) 
n = 19, 5–16, CP Agreementdistance = 101% (range not reported) 
Feasible HPA measure 
 
 
Cost not available 
Brandes et al. 
[22, 27] 
Agreementsteps = 99.6 ± 0.6% (range: 98.5–101.5%) n/a n/a 
n = 20, 3–16, TDC Agreementdistance = 100.6 ± 3.3% (range: 93–106.7%) 
Agreementtime = 101.3 ± 2.8% (range: 94.5–106.6%) 
Mean diﬀ erence ± 2SD (−4.8 ± 15.3)–(1.3 ± 2.5) m; 
 
AMP 
No calibration 
Analysis software 
Kuo et al. [23] 
Only total steps and meters walked 
n = 20, 4–16, CP (−11.2 ± 28.8)–(−3.5–13.4) steps; rate of activity 
detection 85–95% 
Mean diﬀ erence ± 2SD (−2.5 ± 7.1)–(0.7 ± 1.0) m; 
n/a n/a 
Feasible HPA measure 
n = 20, 4–16, TDC
 
(−4.4 ± 14.5)–(−1.3 ± 1.6) steps; rate of activity 
detection: 92–100% 
 
 
r = 0.295, 
Expensive (unit: $500, software: $1500) McDonald et al. 
n = 16, 5–13, DMD  Authors state “no diﬀ erence between observed and P < 0.05 
[25] n = 20, 5–13, TDC measured”; no statistical measure reported r = 0.477, n/a 
Calibration and analysis software P < 0.05 
StepWatch Stevens et al. [24] n = 27, 4–18, CP Authors state “readjusted until all valid step activity n/a n/a 
Rich data collection n = 27, 4–18,TDC recorded”; no statistical measure reported 
Bjornson et al. [28]    n 162, 2–5, TDC  
Agreement = 99.2 ± 4.6% (2-3yr); 
Agreement = 100.0 ± 4.4% (4-5yr) 
Feasible HPA measure Song et al. [29] n 20, 5–11, TDC 
Walking: r = 0.97; Running: r = 0.96; (P < 0.05); 
measurement error 3 ± 1% 
n = 21, 4–10, CP 
r = 0.72 (P < 0.001); diﬀ erence means (t-test): 
n/a n/a 
 
n/a n/a 
Test-retest 
IDEEA 
Cost not available 
Poor battery life (60 hrs) 
Poor utility in HPA research 
Aviram et al. [26]  
n = 7, 5–8, TDC 
P = 0.000 
r = 0.88 (P < 0.05); diﬀ erence means (t-test): 
P = 0.002 
n/a  
r ≥ 0.995; 
Diﬀ erence mean: 
t-test: P = 0.33 
CP: cerebral palsy; DMD: Duchenne muscular dystrophy; TDC: typically developing children; AMP: ambulatory monitoring Pod; IDEEA: Intelligent Device for Energy Expenditure and Activity; n/a: not assessed. 
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Table 3: Evidence of criterion validity. 
 
Measure Study Study design Statistical method Criterion validity for HPA 
Minimod Kuo 
Brandes 
++ 
++ 
+++ 
+++ 
− 
u/a 
AMP 
IDEEA 
StepWatch 
Kuo 
Aviram 
Stevens 
McDonald 
Song (TDC only) 
Bjornson (TDC only) 
++ 
++ 
− 
− 
− 
++ 
+++ 
+++ 
u/a 
u/a 
− 
+++ 
− 
− 
u/a 
u/a 
u/a 
u/a 
IDEEA: Intelligent Device for Energy Expenditure and Activity; TDC: typically developing children; (+++): excellent; (++): good; (+): fair, (−): poor, (u/a): 
unable to assess/indeterminate. 
 
 
StepWatch and Minimod allows measurement of intensity, 
frequency, and duration of walking activity. The units are 
both small and unobtrusive and have battery lives of seven 
days for the Minimod and up to six weeks for the StepWatch, 
depending on settings. This makes them both feasible tools 
for the measurement of habitual walking activity. In the event 
that data collection is delayed once the device is provided to 
the child’s parents, having a battery life of more than seven 
days, and therefore not requiring recharging is a strength 
of the StepWatch as there is less likelihood of loss of data. 
The Minimod is worn around the waist centred at the lower 
lumbar spine, while the StepWatch is worn on the ankle in 
a small cuff. Consistency of placement for repeated and all- 
day wear may be easier to achieve with an ankle placement 
which would reduce measurement error due to inconsistent 
placement. Both pedometers were considered to have good 
clinical utility. The AMP is small, worn around the ankle, 
does not require calibration or software analysis, and has a 
good battery life; however it only measures total step count or 
meters walked per wear period. The AMP was considered to 
have good clinical utility. The IDEEA consists of a data 
recorder worn on the waist with 5 individual sensors attached 
to the chest, thighs, and under each foot connected by wires 
to allow measurement of postures and energy expenditure, 
and it only has a battery life of 60 hours. Both of these factors 
limit the IDEEAs utility in the measurement of HPA in young 
children. 
 
3.4. Level of Evidence. A summary of the quality of evidence for 
criterion validity is provided in Table 3. Two studies assess the 
Minimod in children with CP and TDC in samples which include 
children under the age of  six. Both studies were rated “good” for 
study design and “excellent” for statistical method. They 
provided “good” evidence of the ability of the Minimod to 
accurately measure continuous walking. One of these studies 
[23] also used free-living type activities, and the Minimod 
displayed “poor” accuracy and precision in this setting. The 
AMP was assessed in one study of “good” study design quality 
which used an “excellent” statistical method, though displayed 
“poor” accuracy and precision in both continuous walking and 
free-living type activities. 
Four studies assess the StepWatch in samples which 
included children under the age of six. Reporting of study 
protocol  and  statistical  method  was  “poor”  in  three  of
these studies. The fourth study was of “good” quality and 
used an “excellent” statistical method. It provided “good” 
evidence of the ability of the StepWatch to accurately 
measure continuous walking in TDC. The ability of the 
StepWatch to accurately measure free-living activities cannot 
be determined based on this study. The ability of the IDEEA 
to measure EE was assessed in one study of “good” study 
design quality which used an “excellent” statistical method; 
however the IDEEA displayed “poor” accuracy and precision 
in both free-living type activities and continuous walking 
trials. 
 
4. Discussion 
 
This paper has systematically reviewed the clinimetric 
properties (validity, reliability, and clinical utility) of four 
measures of HPA in children with a motor disability which 
included children aged less than six years. A precise and 
accurate measurement of the daily physical activity levels in 
this population will allow researchers to investigate the dose- 
response relationship between HPA and health outcomes. It 
will also allow the assessment of the eﬃcacy of interventions 
aimed at increasing HPA in terms of establishing the dose and 
distribution of treatment necessary to achieve worthwhile 
results in the long term. For clinicians, an accessible, precise, 
and accurate measurement tool would allow the identifica- 
tion of children with low levels of HPA and in turn the 
assessment of the effectiveness of prescribed interventions. 
Promising measures of HPA have been assessed in young 
children with motor disabilities, and the methodological 
quality of the papers was good to poor for study design 
and excellent to poor for statistical methods. A limitation 
of  the  findings  of  this  paper  is  that  only  two  studies 
of overall “good” methodological quality assessed children 
while undertaking free-living type activities. Under these 
conditions, both activity monitors displayed poor accuracy 
and precision [23, 26]. Two activity monitors displayed 
“good” accuracy during continuous walking [23, 28]. This 
relates more to the ICF definition of walking “capacity” 
rather than habitual walking activity (i.e., how many steps 
does a child need to walk a set distance in an ideal envi- 
ronment compared to how many steps do they take during 
the day in a variety of settings and intensities). Another 
limitation is  that  studies included in  this  paper  assessed 
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children across a wide age range (4–18 years), with no studies 
of children with motor disabilities exclusively focusing on the 
under six-year age group which limits this review’s ability 
to make specific recommendations for this age group. The 
proportion of children aged less than six in the study samples 
ranged from 5 to 43% for the studies which provided a 
breakdown of  their  sample  [22,  23,  26,  27].  The  use  
of the COSMIN checklist for the assessment of methodological 
quality together with quality rating criteria of measurement 
properties is also a possible limitation. The COSMIN check- 
list was developed for assessing HR-PROs and does not have 
established psychometric properties in assessing objective 
physical activity measurement tools, and the quality rating 
criteria were not developed based on consensus. This issue was 
minimised by being guided by a systematic review of activity 
monitors in TDC for the assessment of the somewhat 
ambiguous “flaws in design or methods” item used in the 
COSMIN (Box H, item 5) [19] and by providing an in-depth 
appraisal of the statistical methods. 
The current Australian physical activity guidelines rec- 
ommend children aged from 1 to 5 years engage in active play 
for at least three hours per day without specific intensity 
recommendations [2]. This recognises the sporadic and 
intermittent nature of young children’s activity patterns and 
places demands on the measurement tools used to assess HPA 
in  this  population.  Firstly they  have  to  be  able  to record  
activity as  a  measure of  time,  and  secondly they need to 
accurately recognise “active play” behaviours. The 
accelerometer-based pedometers StepWatch and Minimod 
have the ability to collect the most complete information on 
habitual walking activity as they record steps within an epoch 
of time which can be downloaded onto a computer to visualise 
an activity pattern. They allow the assessment of intensity (e.g., 
steps/min), frequency (e.g., number of walking bouts), and 
duration (e.g., length of walking bouts). The validation 
protocols of the included studies primarily used structured 
walking activities which may not accurately represent the way 
young children move in active play, and therefore it cannot be 
assumed activity monitors that do well in continuous walking 
trials would have done equally well had the children’s steps 
been counted during free-living play. This was demonstrated in 
the assessment of the Minimod by Kuo et al. [23]. In typically 
developing children, activity monitors are usually validated by 
direct observation of free play to circumvent this issue, and 
validation studies typically use a narrower age range to control 
for differences in motor skills [36, 37]. 
Children with a motor disability may not be able to walk 
but  instead use a range of other methods of ambulation such as 
crawling, cruising, rolling, bottom shuffing, walking 
aids, or wheelchairs. Those who are able to walk may have 
diﬀ erent  gait  patterns  than  typically  developing  children 
[14]. This could explain why the accelerometer Minimod, 
which relies on  recognising gait  patterns to  count  steps, 
had a lower rate of activity detection in children with CP 
(19–97%) than in typically developing children (84–100%) 
[23]. Other measurement tools such as accelerometers, which 
report raw activity counts per epoch of time, bypass this 
limitation but are yet to be validated in young children with 
a motor disability. A systematic review of measures of HPA 
in TDC preschoolers identified the ActiGraph (Shalimar, FL, 
USA) accelerometer as having the best clinimetric properties 
in this population. Similarly, the systematic review of HPA 
measurements in adolescents with CP by Clanchy et al. [16] 
identified accelerometers as the most comprehensive mea- 
sure of HPA patterns despite the limited evidence available, 
and the ActiGraph has since been validated in adolescents 
with CP [38, 39]. Studies of doubly labelled water [40, 41], 
the Compendium for Physical Activity Questionnaires [3] 
and ActiGraph in infants at risk of neurodevelopmental delay 
[42], did not meet inclusion criteria as their clinimetric 
properties for the measurement of HPA in children with 
motor disabilities aged less than six years had not been 
assessed. 
 
5. Conclusion 
 
This  systematic review  identified four  measures of  HPA 
with evidence of clinimetric properties in study samples 
which included children aged less than six with motor 
disabilities. Only a very small number of studies assessing 
activity monitors in this population are available, and none 
of the studies focus exclusively on children aged less than 
six years. The pedometers StepWatch and Minimod are the 
most comprehensive measures of habitual walking activity 
utilised in the current literature. While both demonstrate 
good accuracy for step count during continuous walking, 
only the Minimod has been tested during conditions which 
included  walking  trials  other  than  continuous  walking, 
and it performed poorly during these conditions. It is 
possible the ankle placement of the StepWatch would allow 
a more accurate assessment of free-living walking activities 
in children with motor disabilities but this is yet to be 
demonstrated. Pedometers are only suitable as an estimate of 
HPA for children with high functional capacity as children’s 
HPA patterns are likely to consist of a progressively smaller 
proportion of walking as the severity of their impairment 
increases. In the most severely impaired children walking 
activity is completely nonexistent. Further research is needed 
to ascertain the clinimetric properties of activity monitors 
available for measuring HPA in young children with motor 
disabilities, and testing protocols should include a range of 
activities and ideally direct observation of free play. This will 
enable an understanding of the HPA patterns of children 
with motor disabilities across the spectrum of functional 
capacity for clinicians and researchers alike. 
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Participation in regular physical activity is recognized  as a 
necessary contributor to health and well-being for children 
and adolescents with cerebral palsy (CP). Over recent years 
the number of papers on this topic has increased,  attesting 
to the importance being afforded this issue.  Despite this 
interest, research investigating the psychometric properties 
of measures of physical activity in individuals with CP has 
been relatively limited. This is of concern,  as the underpin- 
ning of a  good study design lies in the selection of mea- 
sures which are known to be valid, reliable, and responsive 
to change in the population studied. Research in typically 
developing children supports the use of pedometers  and 
accelerometers to   accurately record  physical  activity.1 
However,  differences in  gait  biomechanics and  energy 
expenditure means  that specific validation is required for 
children and adolescents with CP. 
Systematic reviews on measurement of physical activity in 
individuals with CP have drawn limited conclusions other 
than to plead for additional high quality research. When the 
Consensus-based Standards for the selection of health Mea- 
surement Instruments (COSMIN)2  criteria have been 
applied, studies investigating the validity  of  measures  of 
physical activity ranged from Fair to Poor in quality, with 
little evidence to support the reliability of these measures in 
children with CP.
3 
Maher et al.
4 
answer this call, providing 
a robust evaluation of the NL-1000 pedometer (New Life- 
styles Inc., Lee’s Summit, MO,  USA). The authors have 
carefully considered their  study design and reporting, 
enabling readers to interpret these results with confidence. 
Application of the COSMIN  criteria to this paper rates the 
overall study quality as Excellent, with the exception of the 
description of missing data handling (which was Good). Rig- 
orous statistical testing has been applied, sample size justi- 
fied, and their findings carefully interpreted to highlight that 
the results apply to independently ambulant children, classi- 
fied at Gross Motor  Functional Classification System 
(GMFCS) levels I or II, and under controlled settings only. 
The accuracy of the NL-1000 in an individual classified at 
GMFCS level III,  who walks with an external support and 
typically in a more crouched position, may be quite different 
and should be investigated separately. 
Future research that considers the measurement of phys- 
ical  activity  in  individuals across all  GMFCS  levels is 
required, but when doing so it is important to consider if 
step counts provide a relevant measure of physical activity 
for all. For an individual using primarily wheeled mobility, 
a  step counting device is of  limited  use, given that the 
majority of physical activity performed would be missed by 
a  pedometer. Accelerometers  have an advantage  in  that 
they can be either wrist or waist mounted, meaning they 
are appropriate for children across all GMFCS levels, and 
most importantly provide data on activity intensity, which 
has been validated  against energy expenditure  in ambulant 
children and adolescents with CP.5  In addition, prelimin- 
ary work in typically developing children suggests that pat- 
tern recognition can be applied to raw accelerometer data, 
which  can be used to  determine time  spent in  various 
activities, such as sitting, lying, walking, or running.
6  
This 
could be the way forward for measurement of physical 
activity, as different intensity levels can be applied to each 
activity type meaning accuracy could be improved. 
Maher et al. also highlight that their findings apply only 
to controlled settings. This is an important distinction, as 
during free play in a naturalistic  environment  an individual is 
likely to transition quickly between different movements or 
postures and at varying speeds.  While  methodologically 
more challenging, the accuracy of pedometers or accelero- 
meters in  a  naturalistic setting is important  to ascertain. 
Knowledge that performance of physical activity can be mea- 
sured accurately in the ‘real world’ is vital, as ultimately it is 
the performance in this environment that will  provide the 
benefits to health and well-being that we hope to achieve. 
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